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 Abbreviations 
  
13C NMR           carbon–13  nuclear magnetic resonance 
1H NMR            proton–1  nuclear magnetic resonance 
31P NMR           phosphorus–31  nuclear magnetic resonance 
ATP                  adenosine triphosphorane 
BINAP               2,2’–bis(diphenylphosphin)–1,1’– bisnaphtyl 
Boc group         tert–butoxcarbonyl group 
Boc2O                di–tert- butyldicarbonate  
CCD                   charge coupled device – analogue  shift register 
Celite®               the perlite product for filtration 
Cs2CO3              cessium carbonate 
CuAAC             Copper(I)-catalyzed Azide-Alkyne Cycloaddition 
DEAD               diethylacetylene dicarboxylate 
DIOP                 2,3–O–isopropylidene–2,3–dihydroxyl–4–bis(diphenylophosphino)butane 
DiPAMP           1,2’–bis[(methoxyphenyl)(phenylophosphino)]ethane 
DMAD             dimethylacetylene dicarboxylate 
DMAP              dimethylaminopyridine 
DMF                  dimethylformamide 
DMF                 N,N-dimethylformamide 
DMSO               dimethylsulfoxide 
DNA                 deoxyribonucleic acid 
DO3A               1,4,7,10-tetraazacyclododecan-1,4,7-triacetic acid 
dppfPdCl2        1,1’–bis(diphenylophosphino)ferrocene dichloropalladium 
EtOAc                ethyl acetate 
F(hkl)                structure factor 
GooF                 goodness of fit parameter 
HEPES buffer  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer 
HMPA              hexamethylphosphoramide 
HPLC                high pressure liquid chromatography  
HRMS               high resolution mass spectrometry 
iPr2NEt             diisopropylethylamine 
K2CO3               potassium carbonate 
LDA                  lithium diisopropylamide 
L–DOPA          (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid 
LiHMDS           lithium hexamethyldisilylamide 
MoKα               molybdenium radiation  
MS                     mass spectrometry 
Ms                     mesyl 
MW                   molecular weight 
MWv                 microwave conditions of reaction 
n – BuLi            n– butyl lithium 
NIR                    Near Infrared 
ORTEP              program for a plotting a single molecule (Oak Ridge Thermal Ellipsoid Plot) 
PAMP               methylphenyl-o-anisylphosphine 
PBS buffer       phosphate buffered saline 
PE                      petroleum ether  
QUINAP           1-(2-Diphenylphosphino-1-naphthyl)isoquinoline 
R value             residual factor and also reliability factor 
R1                      residual normal factor  
RNA                  ribonucleic acid 
SFC                   Supercritical Fluid Chromatography 
t – BuOK          potassium tert-butoxide 
TBAF                Tetra-n-butylammonium fluoride 
TEA                   triethylamine 
TFA                   Trifluoroacetic acid 
THF                   tetrahydrofuran 
THPTA              tris(hydroxypropyl)triazolylmethyl-amine 
TIS                    triisopropyl silane 
TLC                   thin layer chromatography 
TMS                  tetramethylsilan 
Ts                      tosyl 
wR2                   residual weight factor  
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Taking into account their presence in the majority of biologically important molecules, 
heterocycles containing nitrogen atom have focused a great attention of scientists. The tremendous 
number of patents deposited in the field of therapeutic chemistry is therefore based on the synthesis 
of heterocyclic compounds.1 Moreover, heterocycles are also ubiquitous in other domains of the 
everyday life.2 In the living organism, they are responsible for biological process like the energy 
accumulation and disposition (ATP), the signal transmission (receptors i.e. serotonin), the transfer of 
information in living system (nucleic acids based on purines and pyrimidines bases), vitamins necessary 
for humans from the group B (as thiamine, riboflavin, niacin, biotin, cobalamine and folic acid) and 
many of other examples. At the same time, in the numerous plants’ family natural products are 
heterocycles, such as chlorophyll molecules based on a porphyrin system complexing magnesium 
cation, responsible for the photosynthesis process. Also, flavonoids and anthocyanins are plant 
metabolites constituted with heterocyclic structure. 
From the other hand, heterocyclic compounds are fundamental for the agriculture domain by 
their utilization as herbicides, insecticides and fungicides, as well as regulators of the growth and 
development of plants (phytohormones – cytokinins and auxins) (Scheme 1). In the various sectors of 
industry, heterocycles are used as colorants, perfumes, preservatives, flame retarders and others.  
 
Scheme 1 Examples of nitrogen containing heterocycles in the agriculture 
 
The first application among the large range of utilization of heterocycles was notably in the 
domain of active compounds in pharmacology (Scheme 2). The natural medicine was an inspiration for 
new discoveries of heterocycles with medical applications and practically, the history of the medicine 
can be described by inventions in this area. The first important pure drugs were alkaloids, several of 
which were extracted from long-known botanical sources at the beginning of 19th century. Quinine, an 
alkaloid isolated from Chincona tree in Peru and Bolivia first used in the treatment of malaria in 17th 
century in Europe, has been synthesized in the laboratory long after its application (in 1940's). The 
discovery of its structure and possible synthesis pathways enabled the construction of a library of 
                                                           
1 (a) K. Turner, Org. Process Res. Dev., 2007, 11, 663; (b) K. Turner, Org. Process Res. Dev., 2007, 11, 802. 
2 A. F. Pozharski, A. T. Soldatenkov, A. R. Katritzky, Heterocycles in life and society, John Wiley & Sons Ltd., 1997. 
 14
quinine analogues. Morphine was isolated by the pharmacist Friedrich Wilhelm Sertürner (1783-1841) 
in 1806. The first synthetic heterocyclic medicament seemed to be antipyrine (called also phenazon) 
discovered in 1887 by Ludwig Knorr (1859-1921). This compound was used as analgesic and antipyretic 
drug for fever treatment, until the apparition of non-steroidal anti-inflammatory compounds. The 
discovery of penicillin in 1928 by Alexander Fleming has revolutionized the medicinal chemistry by 
entering on the market antibiotics which can deal with a large spectrum of bacterial diseases (such as 
syphilis). This drug was largely produced and used during the II World War against bacterial infections 
of wounds, saving estimated 12% - 15% of lives. As a continuation in this research, sulfapyridine – the 
first synthetic antibiotic has been obtained in 1938.3 Otherwise, at the end of 1970's the first 
medicament synthesized on the large scale the hundreds of tones was cimetidine (Tagamet®) – the 
antagonist of H2 receptor, largely used for heartburns and peptic ulcers. It was the first “blockbuster of 
the history” - the medicament which gained pharmaceutical companies more than billions of dollars. 
Finally, the sidenafil citrate (Viagra®) launched in 1998 as a drug for erectile dysfunction and pulmonary 
arterial hypertension belongs to the most common recent medicaments. 
 
Scheme 2 Examples of heterocyclic N-containing drugs 
 
Due to the rich chemistry of nitrogen containing compounds and their evident biological 
interest, synthesizing N-heterocycles has been a central and important theme within organic 
chemistry. Enecarbamates or enamides, a class of deactivated enamines, are versatile intermediates 
for the synthesis of alkaloids and nitrogen-containing heterocycles.  
Among the available methodologies for the preparation of enamides or enecarbamates, the 
palladium catalyzed cross-coupling reaction of the corresponding enol ether appears a very fruitful 
                                                           
3 A. Burger, Medicinal Chemistry, Wiley-Interscience, 1970. 
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approach. Several research groups (e.g. Nicolaou,4 Skrydstrup,5Fuwa6) have indeed demonstrated that 
lactam- and imide-derived vinyl phosphates represent versatile intermediates for the construction of 
various enamides. The ability to easily convert enol phosphates into a myriad of functional motifs of 
synthetic relevance is well-known. The capacity of these synthetic intermediates to undergo cross-
coupling reactions in the presence of various heteroatoms makes them attractive functional groups for 
the construction of diverse substituted heterocyclic systems. This methodology has been elaborated 
since several years in our team to prepare a number of original privileged heterocyclic structures (e.g. 
1,4-dihydropyridines, 1,4-oxazines, 1,4-dihydropyrazines) bearing an enecarbamate moiety (Scheme 
3). 
 
 
Scheme 3  
 
Considering the great expertise and investigations undertaken in the field of synthesis and 
reactivity of enecarbamates in our laboratory, we will focus on the extension of this methodology onto 
the original heterocycles with diverse applications. The first part of this dissertation will be devoted to 
the reactivity of enecarbamates and enamides in the reaction of direct C-P cross-coupling and 
nucleophilic addition of phosphide anions in order to create novel building blocks containing 
phosphorus atom. The second part of this work will concern the synthesis and characterization of 
original chromophores based on the pyrazinic core derived from the dihydropyrazine moiety. These 
chromophores are envisaged to be efficient sensitizers of lanthanide cations and, therefore, may be 
applied as organic antennae for molecular imagining in near infrared. 
 
 
Chapter 1 Organophosphorus heterocyclic compounds: carbon - phosphorus bond formation 
 
The synthesis of new P-containing compounds is an ever-growing subject in recent organic 
chemistry. In the first chapter, we will describe the possible methods of introduction the P-atom to the 
                                                           
4 K. C. Nicolaou,  K. Namoto, Chem. Commun., 1998, 1757. 
5 (a) A. L. Hansen, J.-P. Ebran, T. Gøgsig, T. Skrydstrup, Chem. Commun., 2006, 4137; (b) A. L. Hansen, J.-P. Ebran, T. M. Gøgsig, 
T. Skrydstrup, J. Org. Chem., 2007, 72, 6464. 
6 H. Fuwa, M. Sasaki, J.Org. Chem., 2009, 74, 212. 
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heterocyclic scaffold and we will focus on the importance of P-containing products in the asymmetric 
catalysis and the domain of bioactive compounds. 
Our scope is to introduce the phosphorus atom to the enecarbamate and enamide moiety in an 
efficient and stereospecific way by the means of two particular reactions: the C-P cross-coupling 
reaction catalyzed by palladium complexes and the nucleophilic addition of lithiated phosphines onto 
the double bond of acyclic enecarbamates. In the first approach, starting from commercial available 
lactames, we have envisaged the three-step synthesis of α-enamido phosphane derivatives (Scheme 
4). 
 
Scheme 4 
 This methodology is based on the reactivity of enol phosphates, derived from protected lactames and 
already studied in our laboratory.7 The proposed strategy may thus provide an access to 
phosphinoheterocyclic compounds based on privileged structures with potential biological interest. 
The second part of this chapter will discuss about the phospholithiation reaction onto the acyclic 
enecarbamates, derived from enol phosphates of various amides. Inspired by the anterior work 
previously described in the laboratory,8 we have envisaged the addition of nucleophilic phosphorus 
agent onto the enecarbamate moiety providing a spontaneous migration of the alkyloxycarbonyl group 
to lead to derivatives of non-natural amino acids. Thus, we would like to confirm the strategy and 
enlarge the scope for the non-natural β-phospho α-amino acids (Scheme 5). 
 
Scheme 5 Strategy to synthesize analogues of non-natural amino acids 
                                                           
7 F. Lepifre, S. Clavier, P. Bouyssou, G. Coudert, Tetrahedron, 2001, 57, 6969. 
8 B. Cottineau, I. Gillaizeau, J. Farard, M.-L. Auclair, G. Coudert, Synlett, 2007, 12, 1925. 
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This synthesis is also based on the reactivity of enol phosphates, derived from the N-Boc protected 
amide. The involved strategy gives an easy access to precursors of non-natural amino acids and offers 
the potential advantage by directly introducing further diversity onto the molecules as a result of the 
original choice of starting primary amine, the partner for the cross-coupling and the phospholithium 
reagent. 
 
Chapter 2 Sensitizers for lanthanide complexes: an original access to novel pyrazine chromophores 
 
The lanthanide complexes begin to mark a territory in the domain of molecular imaging, 
especially nowadays with the great development of techniques and devices compatible with the near 
infrared domain. The emission of lanthanide complexes in the near infrared fits the spectral region 
called biological window for tissues, and it is undisturbed by the emission of biological fluids, tissues 
and hemoglobin. Moreover, the use of NIR photons allow the discrimination from autofluorescence in 
biological tissue as these do not have native NIR emission, give good signal to noise ratio and can pass 
through the tissue until few centimeters without damages to the biological systems. An important 
limitation to take advantage of the luminescence of lanthanide complexes is that their direct excitation 
is inefficient and they require a sensitizer molecule attached to them to provoke the energy transfer in 
the system.  
In the second chapter of this dissertation, we will focus on the original way of synthesis of 
pyrazinic chromophores as sensitizers for lanthanide complexes. Taking advantage from the proven 
high reactivity of the 1,4-dihydropyrazine moiety,9 derived from 2,5-piperazinedione, we intend to 
functionalize this scaffold in a versatile way and introduce numerous functional groups in order to 
construct the sensitizing system. As a chelating ligand for lanthanides we have chosen macrocyclic 
compound DO3A (1,4,7,10-tetraazacyclododecan-1,4,7-triacetic acid) because of its great affinity for 
lanthanide cations and hence the possibility of formation of thermodynamically and kinetically stable 
complexes.  
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Scheme 6 Sensitizers based on pyrazinic core 
                                                           
9 M. Chaignaud, I. Gillaizeau, N. Ouhamou, G. Coudert, Tetrahedron, 2008, 64, 8059. 
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We envisage the formation of sensitizers in two distinct ways:  
 by the functionalization of the dihydropyrazine moiety under anionic conditions by using 
standard transformations, deprotection and aromatization providing the pyrazinic core 
 via cycloaddition Diels-Alder reaction with different dienophiles leading to more 
complex conjugated heterocyclic systems.  
The formation of specific linker called "spacing arm" between the chromophore center and the 
chelate will be widely studied (Scheme 6). The spectroscopic properties of new complexes, such as 
absorption, emission in near-infrared and quantum yields will be studied in the Center of Molecular 
Biophysics in collaboration with S. Petoud.10 
The last part will be devoted to the synthesis and characterization of azo-dyes derivatives as 
potential sensitizers for lanthanides (Fig.1). This conjugated system may be applied as chromophore 
alone or in conjunction with the pyrazinic core.  
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Fig. 1 Sensitizer based on azo derivatives 
In order to denote the biological application, we will attach our sensitizers to the biomolecule to test 
the activity of vector molecule in the biological system. The cyclopeptide RGD is a model compound 
showing the high affinity to cancer cells and therefore it became a valuable target for our 
investigations. 
 
  
                                                           
10 H. Uh, S. Petoud, CR Chimie, 2010, 13, 668. 
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I. Bibliographic introduction 
Over 240 years have passed since the discovery of elemental phosphorus. For centuries before 
the modern chemistry was defined, alchemists were searching the prescription for the philosophers’ 
stones – substances that will allow turn every inexpensive metal into gold. With this aim, in 1669 
German alchemist Henning Brand and his co-workers were undertaking the long and arduous process 
of isolation of some matter from urine sample and accidently they discovered a new element. After its 
particular property – glowing at dark and burning brilliantly – it was called “phosphorus” which in 
Greek means “light-bearing” or “light bearer”. Starting from this discovery, the elemental phosphorus 
and its inorganic and organic compounds have found an important role in the chemistry. The great 
structural and electronic diversity of organophosphorus compounds and their specific chemical 
behavior make them particular reagents in modern synthetic organic chemistry.11 Moreover, optically 
active organophosphorus products are also building blocks for the synthesis of natural products12 and 
play an important role as ligands or catalyst in different enantioselective transformations.13 From the 
biological point of view, compounds containing phosphorus play a crucial role for process of energy 
transmission in living organism under the form of adenosine triphosphate (ATP) as well as 
phospholipids which create the cell membrane and are responsible for signal transduction. They are a 
part of living organisms’ genetic instructions as a phosphate in the nucleic acids DNA and RNA. Taking 
into account their particular properties in the field of signal transduction and organism growth, they 
found an application as fertilizers for plants and also as pesticides irreversibly inactivating an enzyme 
acetylcholinesterase, which is essential to nerve function of insects, humans and other animals. 
Likewise, organophosphorus is present in phosphoproteins and peptidomimectics. Considering the 
interesting chemical behavior and versatile biological features of organophosphorus compounds, a 
great need exists to develop new methods for preparation of this class of products. 
A limited number of reactions for organophosphorus compound synthesis are reported in the 
modern chemistry. Apart from well-known Michaelis-Arbuzov and Michaelis-Becker reaction, the 
phospha-Michael addition is probably one of the most important tools for C-P bond formation. Also, 
transition metal catalyzed cross-coupling reactions are worth mentioning. 
The importance of these compounds can be regarded in their great utility in organic synthesis,14 
nucleophilic15 and Brønsted acidic16 organocatalysts, chiral ligands for transition metals17 and 
peptidomimetics.18 
                                                           
11 P. Savignac, B. Iorga, Modern Phosphonate Chemistry, CRC, New York, 2003. 
12 M. Mikołajczyk, P. Bałczewski, Top. Curr. Chem., 2003, 223¸161. 
13 A. Börner, Phosphorus Ligands in Asymmetric Catalysis: Synthesis and Applications, Wiley-VCH, Weinheim, 2008. 
14 (a) W.S. Wadsworth Jr., W.D. Emmons, J. Am. Chem. Soc. 1961, 83, 1733; (b) B.H. Lipshutz, D.W. Chung, B. Rich, R. Corral, 
Org. Lett., 2006, 8, 5069; (c) M. Shi, Y.-H. Liu, Org. Biomol. Chem., 2006, 4, 1468. 
15(a) N.T. McDougal, S.E. Schauls, J. Am. Chem. Soc., 2003, 125, 12094; (b) Y.K. Chung, G.C. Fu, Angew. Chem. Int. Ed., 2009, 
48, 2225.  
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I.1. Applications of organophosphorus compounds 
I.1.1. Organophosphorus compounds as nucleophilic and Brønsted acid organocatalysts 
The term organocatalyst refers to low-weight organic molecules composed of carbon, hydrogen, 
oxygen, nitrogen, sulphur or phosphorus, which are able to accelerate chemical reactions. Among 
these organocatalysts, phosphines found their important role due to the great tunability from the 
electronic and steric point of view and owing to chirality that can be induced on the phosphorus 
atom.13 Acyclic phosphines retain chirality on the P-atom at room temperature, contrary to amines. 
Among the most widely used phosphine organocatalyst are both cyclic and acyclic ones, particularly 
compounds presented on the Scheme 7. 
 
Scheme 7 Phosphine organocatalysts 
The range of stereoselective syntheses catalyzed by trivalent phosphorus compounds covers the 
acylation, desymmetrization reaction and asymmetric transformations starting from prochiral 
substrates. Examples of typical C-C bond formation reactions catalyzed by phosphine organocatalyst 
are: Michael-type addition called Morita-Baylis-Hillman reaction19 and its aza-equivalent,20 alkyne to 
1,3-diene isomerisation,21 Umpolung γ-addition, [3+2] cycloaddition22 and [4+2] annulation.23 In 
addition, phosphoramidites have proven to be efficient organocatalyst for the Michael reaction.24 
In 2004, the research groups of Akiyama25 and Terada26 independently reported the first 
application of a new class of chiral phosphoric Brønsted acids as catalyst in Mannich reaction (Fig. 2).  
                                                                                                                                                                                        
16 (a) T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem. Int. Ed., 2004, 43, 1566; (b) M. Rueping, A. P. Antonchick, T. 
Theissmann, Angew. Chem. Int. Ed., 2006, 45, 3683; (c) S. Hoffmann, A. M. Seayad, B. List, Angew. Chem. Int. Ed., 2005, 44, 
7424; (d) S. Hoffmann, S. Nicoletti, B. List, J. Am. Chem. Soc., 2006, 128, 13074; (e) S. J. Connon, Angew. Chem. Int. Ed., 2006, 
45, 3909. 
17 W. Tang, X. Zhang, Chem. Rev., 2003, 103, 3029. 
18 (a) F. Palacios, C. Alonso, J. M. Santos, Chem. Rev., 2005, 105, 899; (b) J. G. Allen, F. R. Atherton, M. J. Hall, C. H. Hassall, S. 
W. Holmes, L. W. Lambert, L. J. Nisbet, P. S. Ringrose, Nature, 1978, 272, 56; (c) S. Fushimi, K. Furihata, H. Seto, J. Antibiot 
(Tokyo), 1989, 42, 1019. 
19 (a) K. Morita, Z. Suzuki, H. Hirose, Bull. Chem. Soc. Jpn, 1968, 41, 2815; (b) T. Hayase, T. Shibata, K. Soai, Y. Wakatsuki, 
Chem. Commun., 1998, 1271. 
20 M. Shi, L.-H. Chen, C.-Q. Li, J. Am. Chem. Soc., 2005, 127, 3790. 
21 (a) B. M. Trost, U. Kazmaier, J. Am. Chem. Soc., 1992, 114, 7933; (b) C. Guo, X. Lu, J. Chem. Soc., Perkin Trans. 1, 1993, 1921. 
22 (a) C. Zhang, X. Lu, J. Org. Chem., 1995, 60, 2906; (b) J. E. Wilson, G. C. Fu, Angew. Chem. Int. Ed., 2006, 45, 1426. 
23 (a) X.-F. Zhu, J. Lan, O. Kron, J. Am. Chem. Soc., 2003, 125, 4716; (b) R. P. Wurz, G. C. Fu, J. Am. Chem. Soc.,2005, 127, 
12234. 
24 R. B. Grossman, S. Comesse, R. M. Rasne, K. Hattori, M. N. Delong, J. Org. Chem., 2002, 68, 871. 
25 T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem. Int. Ed., 2004, 43, 1566. 
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Fig. 2 Chiral phosphoric acid 
This axially chiral phosphoric acid has a particular characteristic; the phosphorus atom is built into 
seven-membered ring, which prevents free rotation around the P-O bond and fixes conformation of 
Brønsted acid. The phosphate derivative with appropriate acidity can activate potential substrates via 
protonation and increases their electrophilicity. Subsequent attack of a nucleophile can result in the 
formation of enantioenriched products via stereochemical communication between the cationic 
protonated substrate and the chiral phosphate anion. Moreover, the phosphoryl oxygen atom has 
basic proprieties and thus chiral BINOL phosphate can act as bifunctional catalyst.  
The development of new asymmetric transformations requires new chiral catalysts with 
different electronic and steric properties. Therefore, the number of phosphoric acids derived from 
TADDOL, VAPOL, BINAM and bis-BINOL has been prepared (Scheme 8).  
 
Scheme 8 Examples of phosphoric acid catalysts 
The first asymmetric organocatalytic reductive amination using phosphoric acid derivatives was 
decribed by MacMillan et al.27 Simultaneously, these organocatalysts were applied in many other 
transformations, such as cascade transfer hydrogenation of quinolinones,28 asymmetric 
hydrophosphonylation,29 cycloaddition reaction, for example aza-Diels–Alder reaction for preparation 
nitrogen containing heterocycles,30 dihydropyridine synthesis31 and much more, which will not be 
depicted in this thesis. 
                                                                                                                                                                                        
26 D. Uraguchi, M. Terada, J. Am. Chem. Soc., 2004, 126, 5356. 
27 R. I. Storer, D. E. Carrera, Y. Ni, D. W. C. MacMillan, J. Am. Chem. Soc., 2006, 128, 84. 
28 M. Rueping, A. P. Antonchick, T. Tiessmann, Angew. Chem. Int. Ed., 2006, 45, 3683. 
29 T. Akiyama, H. Morita, J. Itoh, K. Fushibe, Org. Lett., 2005, 7, 2583. 
30 T. Akiyama, Y. Tamura, J. Itoh, H. Morita, K. Fuchibe, Synlett., 2006, 141. 
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All presented examples of application of BINOL phosphoric acid shows its potential to activate 
various imine compounds, however with less reactive substrates like carbonyl compounds its acidity is 
insufficient. Guided by this idea, the group of Yamamoto has introduced a strong electron acceptor, 
such as N-triflate in the place of hydroxyl group and has created a new stronger Brønsted acid – a 
chiral N-triflyl phosphoramide.32 This organocatalyst was first tested with success in the asymmetric 
Diels-Alder reaction of α,β-unsaturated ketones with silyloxydienes,28 asymmetric Nazarov 
cyclization.33 
 
I.1.2. Chiral ligands for reactions catalyzed by transition metals 
The increasing demand to produce enantiomerically pure pharmaceuticals, agrochemicals and 
other fine chemicals has inspired the field of asymmetric catalysis. The domain of asymmetric 
synthesis can be divided into chiral organocatalysis, enzymatic asymmetric synthesis and transition 
metal-catalyzed synthesis, which plays a major role nowadays. Phosphorus-containing compounds are 
one of the most common group among ligands for transition metals, due to their great variability, the 
possibility to bear chirogenic center on the P or C-atom and their ability to make complexes with many 
different metals, such as Pd, Rh, Ru, Ir, Pt, Ti, Zr and Au. 
Since the first application of phosphine heterogenous ligand for asymmetric hydrogenation by 
Knowles34a and Horner34b, the great progress in this domain has been made. Although the first results 
showed poor enantioselectivity, the next investigations were encouraging and led to the application of 
C2-symmetric chelating bisphosphine ligands DIPAMP in Rh-catalyzed asymmetric hydrogenation of 
dehydroamino acids and in the industrial production of drug for the Parkinson’s disease – L-DOPA (3,4-
dihydroxy (S)-phenylalanine) (Scheme 9).35  
  
Scheme 9 The first chiral synthesis of (L)-DOPA 
                                                                                                                                                                                        
31 J. Jiang, J. Yu, X.-X. Sun, Q.-Q. Rao,  L.-Z. Gong, Angew. Chem. Int. Ed., 2008, 47, 2458. 
32 D. Nakashima, H. Yamamoto, J. Am. Chem. Soc., 2006, 128, 9626. 
33 M. Rueping, W. Ieawsuwan, A. P. Antonchick, B. J. Nachtsheim, Angew. Chem. Int. Ed., 2007, 46, 2097. 
34  (a) S. W. Knowles, M. J. Sabacky, Chem. Commun., 1968, 1445; (b) L. Horner, H. Siegel, H. Büthe, Angew.Chem. Int. Ed. 
Engl., 1968, 7, 941. 
35 (a) W. S. Knowles, Acc. Chem. Res., 1983, 16, 106; (b) W. S. Knowles, Angew. Chem. Int. Ed., 2002, 41, 1999.  
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Kagan et al.36 first introduced the concept of C2-symmetry in ligands with the development of the 
phosphine ligand DIOP for Rh-catalyzed asymmetric hydrogenation of enamides to give rise to the 
corresponding amino acids. A significant advance in the field of asymmetric catalysis was also achieved 
with the preparation of 1,2-bis(phospholano)ethane BPE and 1,2-bis(phospholano)benzene DuPHOS 
by the group of Burk.37  
In 1980, the group of Noyori and Takaya presented a synthesis of atropoisomeric C2-symmetric 
bisphosphine ligand BINAP and its use in the Rh-catalyzed asymmetric hydrogenation of α-
(acylamino)acrylic acids.38 Their discovery did not gain much attention until BINAP was applied as the 
Ru-complex in the asymmetric hydrogenation of functionalized olefins and ketones. It appeared that 
this catalytic system is able to reduce ketones in the presence of carbon-carbon double bond with high 
selectivity,39 which was a great challenge until these days.  
 
Fig. 3 Examples of chiral ligands  
 
Chiral ligands containing phosphorus atom might be classified into three main categories 
depending on the position of chiral centre:  
 Ligands with axial chirality, such as BINAP or MOP 
 Ligands presenting a chiral carbon-backbone, i.e. DIOP or DuPHOS 
 Ligands with P-chirogenic centre like DIPAMP or CAMP.  
                                                           
36 (a) T. P. Dang, H. B. Kagan, J. Chem. Soc. Chem. Commun., 1971, 481; (b) T. Satyanarayana, S. Abraham, H. B. Kagan, Angew. 
Chem. Int. Ed., 2009, 48, 456. 
37  M. J. Burk, J. E. Feaster, W. A. Nugent, R. L. Harlow, J. Am. Chem. Soc., 1993, 115, 10125. 
38  A. Miyashita, A. Yasuda, H. Takaya, K. Toriumi, T. Ito, T. Souchi, R. Noyori, J. Am. Chem. Soc., 1980, 102, 7932. 
39  T. Ohkuma, H. Ooka, T. Ikariya, R. Noyori, J. Am. Chem. Soc., 1995, 117, 10417. 
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Each of these categories has their own particularities, which makes it specific for the chosen 
asymmetric reaction. Ligands bearing chirality on the P-atom ensure the direct contact between the 
asymmetric center and the transition metal (i.e. the reaction site), achieving high enantioselectivity 
with great affinity to the hydrogen for electron-rich catalyst such as trialkylated P-chirogenic ones. 
They enable also elevated turnover numbers, which reduce the usage of catalyst to few molar 
percents. In the ligands with the chirality on the carbon atom the phenomenon of the pseudo-chirality 
on the phosphorus atom is present. Thanks to that, these ligands show high activity to the 
corresponding metal complex and independent enantioselection for the conformation properties of 
the chelate cycle. Exceeding high enantioselectivities were achieved in the hydrogenation of a variety 
of unsaturated systems with these ligands. Modifications of electronic/steric properties of ligands 
presenting axial chirality are more difficult to manage due to the cumbersome procedures for 
structural modification of the ligand scaffold, however, once the proper structure is acquired, they are 
excellent catalyst for the asymmetric hydrogenation of C=C, C=O and N-C bond, and also for 
asymmetric C-C bond formation. Moreover, ever-growing interest in this domain increases the family 
of axial ligands with new heterocyclic representatives such as QUINAP (Fig. 3). 
Thousands of new catalytic complexes has been synthesized and tested for asymmetric 
hydrogenation,40 but also for palladium catalyzed allylic alkylation,41 asymmetric oxygenation, as well 
as nucleophilc additions of organometallic reagents to aldehydes,42 ketones and imines, conjugate 
addition, aldol reaction, Diels-Alder reactions, 1,3-dipolar additions, enyne cyclization and olefin 
metathesis.43 
 
I.1.3. Biological importance of organophosphorus compounds 
I.1.3.a. Peptidomimetics 
A molecule bearing identifiable similarity to a peptide, preferably with a low molecular weight, 
which can act as a ligand or a biological receptor to imitate or inhibit the effect of a natural peptide, is 
called peptidomimetic. Among many chemical transformations of amino acids to obtain modified ones 
for construction of peptidomimetics, an introduction of phosphorus atom plays an important role. For 
a long time "phosphorus analogues" of the amino acids, in which carboxylic group was replaced by 
phosphonic, phosphinic or phosphonate group, have attached special interest in the preparation of 
isosteric or bioisosteric analogues of number of natural products. Particularly, β-aminophosphonic44 
                                                           
40 S. Prevost, S. Gauthier, M. C. C. de Andrade, C. Mordant, A. R. Touati, P. Lesot, P. Savignac, T. Ayard, P. Phansavath, V. 
Ratovelomana-Vidal, J.-P. Genêt, Tet.:Asym., 2010, 21, 1436. 
41 I. G. Rios, A. Rosas-Hernandez, E. Martin, Molecules, 2011, 16, 970. 
42 Y. Wei, M. Shi, Acc.Chem. Res., 2010, 43, 1005. 
43 C. Lexer, D. Burtscher, B. Perner, E. Tzur, N. G. Lemcoff, C. Slugov, J. Org. Chem. 2011, 696, 2466. 
44 (a) F. Orsini, G. Sello, M. Sisti, Curr Med Chem, 2010, 17, 264; (b) E. D. Naydenova, P. T. Todorov, K. D. Troev, Amino Acids., 
2010, 38, 23. 
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acids as isosteres of β-amino acids (Fig.4) became valuable and interesting products with biological and 
biochemical properties: as enzymes' inhibitors,45 antibacterial agents46 and anti HIV agents.47 
 
Fig. 4 Isosteric analogues of amino acids 
Aminophosphonic acids can be obtained on the way of carbon-phosphorus bond formation such as 
reactions between aminoalkyl halides and phosphinites48 (the Arbuzov reaction), the nucleophilic 
addition of phosphorus derivatives to small heterocycles,49 the hydrophosphinylation to α-amino 
aldehydes50 and the addition of phosphorus derivatives to unsaturated C-C and C-N bond.51 A great 
deal of different transformations to obtain aminophosphonates exists also, but this topic will not be 
discussed here. 
Below, few examples of organophosphorus compounds playing role of peptidomimetics will be 
presented. First of them is HIV-1 protease inhibitor (Fig. 5a) designed and synthesized by the group of 
Janda,52 showing a great antagonist potential (Ki = 8.2 nM in vitro against protease). Second 
peptidomimetic (Fig. 5b) belongs also to the class of HIV protease inhibitors.51b  
 
Fig. 5 Examples of HIV proteases inhibitors 
Another citation of active peptidomimetics is human renin inhibitor and norstatine renin inhibitor (Fig. 
6). 
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Fig. 6 Examples of active peptidomimetics 
                                                           
45
 W. W. Smith, P. A. Bartlett, J. Am. Chem. Soc., 1998, 120, 4622. 
46
 J. G. Allen, F. R. Arthenton, M. J. Hall, C. H. Hassall, S. W. Holmes, R. W. Lambert, L. J. Nisbet, P. S. Ringrose, Nature, 1978, 
272, 56. 
47 E. Alonso, E. Alonso, A. Solis, C. del Pozo, Synlett, 2000, 698. 
48 H. Gali, K. R. Prabhu, S. R. Karra, K. V. Katti, J. Org. Chem., 2000, 65, 676. 
49 F. Palacios, A. M. Ocha de Retana, E. Martinez de Marigorta, J. M. de los Santo, Org. Prep. Proc. Int., 2002, 34, 219. 
50 (a) D. V. Patel, K. Reilly-Gauvin, D. E. Ryono, C. A. Free, W. L. Rogers, S. A. Smith, J. M. DeForrest, R. S. Oehl, E. W. Pertillo Jr., 
J. Med. Chem., 1995, 38, 4557; (b) B. Stowasser, K.-H. Budt, L. Jian-Qi, A. Peyman, D. Ruppert, Tetrahedron Lett., 1992, 33, 
6625. 
51 C. de Risi, D. Perrone, A. Dondoni, G. P. Pollini, V. Vertolasi, Eur. J. Org. Chem., 2003, 1904. 
52 S. Ikeda, J. A. Ashley, P. Wirsching, K. D. Janda, J. Am. Chem. Soc., 1992, 114, 7604. 
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Recently, antiviral agent HPMPC - 9-[(2S)-3-hydroxy-2-phosphonomethyloxypropyl] adenine has been 
introduced to the short chain peptide to create peptidomimetic playing role of the prodrug53 for 
treatment for human cytomegalovirus (HCMV) (Fig.7).  
 
Fig. 7 Examples of peptidomimetic playing role of prodrugs 
I.1.3.b. Phosphorus compounds as bioactive agents  
Other classes of compounds containing phosphorus are organophosphates or in other words 
organic esters of phosphoric acid.  Many of the most important biomolecules are organophosphates, 
including DNA, RNA and cofactors essential for proper functioning of organisms (i.e. thiamine 
diphosphate - vitamin B1). Organophosphates are also the basis of insecticides, herbicides and nerve 
gases, because they act as inhibitors of acetylcholinesterase AChE, an enzyme degrading the 
neurotransmitter - acetylcholine. They poison an enzyme by phosphorylation reaction. The effector 
organ becomes overstimulated by the excess of acetylcholine, what provokes the perturbation in the 
nervous system. Some examples of organophosphates are Sarin (propan-2-yl 
methylphosphonofluoridate) - the paralyzing gas used as a chemical weapon during II World War, the 
insecticide Malathion, the herbicide Glyphosate or Glufosinate (Fig.8). 
 
Fig. 8 Organophosphates as inhibitors of acetylcholinesterase 
Notwithstanding, organophosphates have got also significant role in the pharmaceutical field: 
Fosinopril (Fig. 9a) shows a valuable hypertensive activity, naphtylmethylphosphonate (Fig.9b) is an 
inhibitor of insuline receptor tyrosine kinase, the phosphinopeptide analogue of the 
glutathionylspermidine GSP (Fig. 9c) reveals potent tripanocidal activity through inhibition of GSP 
synthetase and fosfomycin - the broad spectrum antibiotic produced by certain Stroptomyces species 
(Fig.9d).  
                                                           
53 L. W. Peterson, M. Sala-Rabanal, I. S. Krylov, M. Serpi, B. A. Kashemirov, C. E. McKenna, Molecular Pharmaceutics, 2010, 7, 
2349. 
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Fig. 9 Pharmaceutics organophosphates 
I.1.3.c. Phosphine containing amino acids 
In 1994, the group of Gilbertson pioneered the chemistry of phosphine-containing peptides and 
their application in asymmetric catalysis.54 The original approach to phosphine-containing serine 
derivatives was developed based on Evan's chiral oxazolidinone chemistry (Scheme 10).  
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Scheme 10 Synthesis of phosphine sulfide containing serine based on Evans' oxazolidinone methodology 
Several phosphines was prepared according to this methodology, however several steps required 
chromatography purification were limiting agents for wide applicability of this method. A more direct 
pathway was developed to transform (S)-serine into a highly functionalized Knochel cuprate, 55 which 
easily reacts with chlorophosphine derivatives (Scheme 11). A number of compounds bearing different 
phosphines (i. e. aromatic or alkyl groups) were prepared.56 To avoid oxidation of the phosphine, the 
protection of P-atom must be undertaken. Methods of reduction of phosphine oxide or deprotection 
of borane group proved to be inefficient, notwithstanding it was found that phosphine sulfides are 
excellent protectors and they can be cleaved at the final step with Raney nickel or by sulfur 
methylation by HMPT. 
                                                           
54 R. S. Gilbertson, G. Chen, M. MacLoughlin, J. Am. Chem. Soc., 1994, 116, 4481. 
55 P. Knochel, M. Ch. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem., 1988, 53, 2390. 
56 (a) S. J. Greenfield, S. R. Gilbertson, Synthesis, 2001, 15, 2337; (b) A. Agarkov, S. J. Greenfield, D. Xie, R. Pawlick, G. Starkley, 
S. R. Gilbertson, Peptide Science, 2006, 84, 48. 
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Scheme 11 Synthesis of diphenylphosphinoserine 
Gilbertson's group has described also synthesis of phosphine analogues of proline, tyrosine and 
phenylglycine. For the aromatic amino acids, the methodology with cross-coupling of corresponding 
triflates has been applied. This approach enables to achieve desired phosphine derivatives after two 
steps with excellent yields (Scheme 12).57 
 
Scheme 12 Synthesis of aromatic acids containing diphenylphosphino sulfide 
While the reaction is very efficient for single amino acid it also presents the possibility for the 
conversion of tyrosine to its phosphine derivative in already constructed larger peptides.57a Presented 
methodology have been applied to the synthesis of libraries of building blocks for construction of 
peptides, especially β-turn ones to control the selectivity of palladium-catalyzed allylation.58 Peptides 
possessing both helical and β-turn secondary structure (Fig. 10) were examined in rhodium-catalyzed 
asymmetric hydrogenation, however selectivities obtained with these systems were low and varied 
widely depending on the solvent used as well as the mobility of the catalyst.56b  
 
Fig. 10 Phosphine-containing peptides as catalysts 
                                                           
57 S. R. Gilbertson, G. W. Starkey, J. Org. Chem., 1996, 61, 2922. 
58 A. Agarkov, S. J. Greenfield, T. Ohishi, S. E. Collibee, S. R. Gilbertson, J. Org. Chem., 2004, 69, 8077. 
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Also, the team of Jugé described the application of oxazolines, derived from L-serine, for the 
hemisynthesis of the racemic β-phosphorus amino acids (Fig. 11).59  
 
Fig. 11 Strategy for hemisynthesis of β-phosphorus amino acids 
They elaborated the methodology to introduce the ferrocenylphosphide borane to the L-aspartic acid, 
which is used as an electrochemical probe to detect autoantibodies in multiple sclerosis.60 
I.2. Formation of organophosphorus compounds 
 
I.2.1. General introduction 
The great interest of developing novel organophosphorus compounds exists since the first 
synthesis of phoshonates from alkyl halides and phosphinite by German chemist August Michaelis in 
1898 (Fig.12).  
 
Fig. 12 Scheme of Arbuzov reaction 
Aleksandr Arbuzov extended this reaction on the whole group of various phosphinates and phosphine 
oxides. The first step involves nucleophilic attack by the phosphorus on the alkyl halide, followed by 
the halide ion dealkylation of the resulting trialkoxyphosphonium salt. However, this reaction is useful 
from the synthetic point of view, it requires very drastic reaction conditions, like heating in the reflux 
of alkyl halides; therefore many of variation exists nowadays. One of them is the Lewis acid-mediated 
Michaelis-Arbuzov reaction at room temperature,61 which leads to arylmethyl and heteroarylmethyl 
phosphonates with excellents yields (Scheme 13). 
 
Scheme 13 Michaelis-Arbuzov reaction assisted by Lewis acid 
                                                           
59 (a) F. Meyer, A. Laaziri, A. M. Papini, J. Uziel, S. Jugé, Tetrahedron: Asymm., 2003, 14, 2229; (b) F. Meyer, A. Laaziri, A. M. 
Papini, J. Uziel, S. Jugé, Tetrahedron, 2004, 60, 3593. 
60 F. Real-Fernandez, A. Colson, J. Bayardon, F. Nuti, E. Peroni, R. Meunier-Prest, F. Lolli, M. Chello, C. Daracel, S. Jugé, A. M. 
Papini, Peptide Science, 2008, 90, 488.  
61 G.G. Rajeshwaran, M. Nandakumar, R. Sureshbabu, A. K. Mohanakrishnan, Org. Lett., 2011, 13, 1270. 
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During the years prior to 1980 only few important methods for the C-P bong formation appeared. 
Starting with pioneering work of Hirao62 on palladium(0) catalyzed coupling of aryl and vinyl bromides 
with dialkyl phosphinites, many of new improved methods arose. Among them, the phospha-Michael 
reaction, the hydrophosphination reaction and the cross-coupling with the variety of nucleophilic 
phosphorus containing agents are considerable.  
 
I.2.2. Phospha-Michael reaction 
Similar to the Michaelis-Arbuzov and the Michaelis-Becker reaction (reaction of trialkyl 
phosphites with alkyl halides and of alkali salts of dialkyl phosphonates with alkyl halides, respectively), 
the phospha-Michael addition certainly represents versatile method for formation of P-C bonds. The 
phospha-Michael reaction is an addition of a phosphorus nucleophile to an olefinic acceptor. This 
reaction offers the possibility to access a number of diversely functionalized products, since many 
different electrophiles and P nucleophiles can be combined.  
Acceptors for phospha-Michael addition may be classified into five groups, depending on to the 
character of olefin, it may be: an acceptor bearing carbonyl or carboxyl group, an acceptor with a nitro 
group, with a sulfoxide or sulfone, with a phosphonate or phosphane oxide or alkynic acceptor. From 
the other hand, nucleophiles engaged in the reaction might be triaryl- or trialkylphosphines, 
phosphinites, phosphine boranes, etc…63 
The Michael addition of a trivalent phosphorus nucleophile to an acrylic acid leads to the 
phosphabetain (Fig.13), which could be isolated and its structure could be confirmed by X-ray 
analysis.64 The same results were obtained with cinammic acid and its derivatives, however with butyl 
methacrylate only anionic polymerization was observed, which means that the initially formed adduct 
is highly reactive and the polymerization step is faster than the addition itself. 
 
Fig. 13 Phospha-Michael addition between triphenylphosphine and acrylic acid  
In order to avoid the polymerization or degradation of obtained betain, the proton source is applied to 
trap this agent as a phosphonium salt. Cristau et al.65 reported a phospha-Michael addition of 
triphenylphosphine to the α,β-unsaturated ketones in the presence of hydrobromide (Fig. 14). 
                                                           
62 (a) T. Hirao, T. Masunaga, Y. Ohshiro, T. Agawa, Tetrahedron Lett., 1980, 21, 3595; (b) T. Hirao, T.Masunaga, N. Yamada, Y. 
Ohshiro, T. Agawa, Bull. Chem. Soc. Jpn., 1982, 55, 909. 
63 D. Enders, A. Saint-Dizier, M.-I. Lannou, A. Lenzen, Eur. J. Org. Chem., 2006, 29. 
64 C. Larpent, H. Patin, Tetrahedron, 1988, 44, 6107. 
65 H.-J. Cristau, J.-P. Vors, H. Christol, Tetrahedron Lett., 1961, 20, 2377. 
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Fig. 14 Phospha-Michael reaction  
Nucleophiles with P-H have also been used in the phospha-Michael addition. Among, them the 
phenylphosphines Ph2PH and PhPH2 are most often cited - either in form of their lithium salts or in the 
presence of KOtBu as a catalyst. Helmchen et al.66reported an addition of Ph2PLi to (-)-(1R)-tert-butyl 
myrtenate in a diastereoselective manner, providing chiral phosphine ligand in four steps with good 
yield (Fig. 15). 
 
Fig. 15 Phospha-Michael addition on (-)-(1R)-tert-butyl myrtenate 
The phospha-Michael addition of Ph2PLi to tert-butyl crotonate followed by cleavage of the ester gave 
the racemic mixture of acid, which can be separated by rectystallization with chiral salt (Fig. 16).67 
 
Fig. 16 Phospha-Michael addition with Ph2PLi 
Also, the phosphine-borane can act as nucleophile in phospha-Michael addition. The borane moiety is 
regarded as a protecting group, because it prevents oxidation of the phosphorus atom and can be 
cleaved in the presence of an excess of a highly nucleophilic amine (Et2NH, morpholine, DABCO). The 
1,4-addition to unsaturated amides using Ph2P(BH3)Li was studied by Quirion et al.
68 The nucleophilic 
attack of lithiated diphenylphosphine-borane to the double bond occurs to give tertiary phosphine-
boranes in good yields and with high diastereoisomeric excesses (Fig. 17). 
 
Fig. 17 Phospha-Michael addition with Ph2P(BH3)Li 
                                                           
66 G. Knühl, P. Sennhenn, G. Helmchen, J. Chem. Soc., Chem. Commun., 1995, 1845. 
67 T. Minami, Y.Okada, T. Otaguro, S. Tawaraya, T. Furuichi, T. Okauchi, Tetrahedron: Asymmetry, 1995, 6, 2469. 
68 M. Léautey, G. Castelot-Deliencourt, P. Jubault, X. Pannecoucke, J.-C. Quirion, Tetrahedron Lett., 2002, 43, 9237. 
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The asymmetric C-P bond formation was achieved under heterogenous conditions via a iron(III) oxide - 
mediated phospha-Michael conjugate addition of chiral phosphinite to alkylidene malonates69 (Fig.18).  
 
Fig. 18 Chiral phospha-Michael addition 
The use of a Brønsted base bicyclic guanidine catalyst was also reported for this reaction between 
aromatic phosphine oxides and nitrostyrene70 with very remarkable enantioselectivity. The same 
author studies the catalytic mechanism and origins of enantioselectivity of this kind of catalyst in 
phospha-Michael reaction.71 Examples of intermolecular phospha-Michael reaction of cyclic and acyclic 
alkenyl sulfoximines72 and α,β-unsaturated aldehydes73 exist in the recent literature.  
 
I.2.3. Hydrophosphonylation/hydrophosphorylation  
The addition reaction of H-phosphonates to activated double bond by electron withdrawing 
group is called hydrophosphonylation. This reaction is often promoted by transition metal catalysts, 
radical initiators, strong bases or Lewis acid-microwave initiation.74 In this group of transformations, 
we can distinguish Pudovik reaction,75 the conversion of dialkyl phosphites to α-hydroxy phosphonates 
in the presence of carbonyl compounds. The mechanism of this reaction involves the deprotonation of 
phosphorus agent forming a dialkyl phosphate anion, which reacts as a nucleophile toward 
electrophilic carbonyl carbon (Scheme 14). 
 
Scheme 14 Mechanism of Pudovik reaction 
                                                           
69 L. Tedeschi, D. Enders, Org. Lett., 2001, 22, 3515. 
70 X. Fu, Z. Jiang, C.-H. Tan, Chem. Commun., 2007, 5058. 
71 B. Cho, C.-H. Tan, M. W. Wong, Org. Biomol. Chem., 2011, 9, 4550. 
72 F. Lemasson, H.-J. Gais, J. Runsink, G. Raabe, Eur. J. Org. Chem., 2010, 2157. 
73 X. Luo, Z. Zhou, X. Li, X. Liang, J. Ye, RCS Adv., 2011, 1, 698. 
74 (a) C. Baillie, J. Xiao, J. Curr. Org. Chem., 2003, 7, 477; (b) M. Tanaka, Top. Curr. Chem., 2004, 232, 25; (c) J.-L.Montchamp, J. 
Organomet. Chem. 2005, 690, 2388; (d) D.Enders, A. Saint-Dizier, Lannou, M.-I.; Lenzen, A. Eur. J. Org. Chem.,2006, 29; (e) 
F.Alonso, I. P.Beletskaya, M.Yus, Chem. Rev. 2004, 104, 3079; (f) I. P. Beletskaya, M. A. Kazankova, Russ. J. Org. Chem. 2002, 
38, 1391; (g) L.Coudray, J.-L. Montchamp, Eur. J. Org. Chem. 2008, 3601. 
75 N. Pudovik, A. Arbuzov, Dokl. Akad. Nauk. SSSR, 1950, 73, 327. 
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Diverse metal complexes have been used as effective catalyst for this transformation, such as 
lanthanides or titanium.76 Recently, MoO2Cl2 has been reported as a novel catalyst for C-P bond 
formation during hydrophosphonylation of different aromatic and aliphatic aldehydes77 in solvent-free 
conditions with good to high yields.  
Furthermore, Balaraman et al. presented the protocol for regio-/stereo-selective hydro-/ 
hydrothiophosphonylation in ionic liquid medium.78 Several examples of Baylis-Hillman adducts in the 
presence of TBAF in [BMIM]+[PF6]
- were depicted in this work, leading to γ-hydroxyphosphonates with 
good yield (Fig.19). 
 
Fig. 19 Example of hydrophosphonylation 
The group of Knochel79 elaborated an application of t-BuOK - catalyzed addition of phosphines to 
fuctionalized alkenes, which allows an access to polyfunctional phosphine derivatives. Moreover, their 
methodology has been expanded to the preparation of novel chiral N,P-ligands, which were applied to 
enantioselective Ir-catalyzed hydrogenation.80  
The regio- and stereoselective hydrophosphination rea ction of alkynes with phosphine boranes was 
presented by A.-C. Gaumont.81 This methodology gives an access to vinylphosphines - a ligand building 
blocks for homogenous catalysis. 
The first asymmetric organocatalytic electrophilic phosphination has been reported by Nielsen et al.82 
as a reaction of α-substituted cyanoacetates with diarylphosphine chlorides with catalytic amounts of 
cinchona alkaloids (DHQD)2PYR as organocatalysts. Furthermore, obtained optically active α-
phosphinated cyanoacetates were transformed into protected chiral α-phosphino β-amino acids by 
using one-pot procedure (Fig.20). These products could be also regarded as precursors for new N,P-
ligands. 
 
Fig. 20 Asymmetric catalytic phosphination 
 
                                                           
76 F. Yang, D. Zhao, J. Lan, P. Xi, L. Yang, S. Xiang,  J. You, Angew. Chem. Int. Ed., 2008, 47, 5646. 
77 R. G. de Norohna, P. J. Costa, C. C. Romão, M. J. Calhorda, A. C. Fernandes, Organometallics, 2009, 28, 6206. 
78 E. Balaraman, V. Srinivas, K. C. Swamy, Tetrahedron, 2009, 65, 7603. 
79 T. Bunlaksananusorn, P. Knochel, Tetrahedron Lett., 2002, 43, 5817. 
80 T. Bunlaksananusorn, K. Polbron, P. Knochel, Angew. Chem. Int. Ed., 2003, 42, 3941. 
81 D. Mimeau, A.-C. Gaumont, J. Org. Chem., 2003, 68, 7016. 
82 M. Nielsen, C. B. Jacobsen, K. A. Jørgensen, Angew. Chem. Int. Ed., 2011, 50, 3211. 
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I.2.4. Carbon-phosphorus transition metal-catalyzed cross-coupling 
I.2.4.a. Historical introduction 
The group of cross-coupling reactions catalyzed by metal complexes is well-known in organic 
synthesis since the Cadiot-Chodkiewicz reaction between a terminal alkyne and halogen derivative in 
1957.83 Thereafter, plenty of new methods have been described, with different coupling partners and 
operating conditions. However, the issue of coupling between heteroatoms has been raised quite 
recently. Pioneering work in this field has been performed by the Hirao group63 and stated the 
palladium catalyzed couplings between aryl or vinyl halides and dialkyl phosphinites, affording dialkyl 
arylphosphonates and dialkyl vinylphosphonates (Fig. 21). The reaction conditions for these early 
experiments were: Pd(PPh3)4 in catalytic amount of 5 mol % and triethylamine as a base. Reactions 
were carried out neat or in toluene; the geometry of the double bond was maintained in the case of 
vinyl compound. 
 
Fig. 21 First examples of C-P coupling reaction 
The mechanism of this reaction proposed by the Hirao group states an oxidative addition of the Pd(0) 
complex to the aryl bromide bond (Scheme 15). Attack of the phosphinite forms expected product, 
while triethylamine liberates the Pd(0) from the complex HPd(II)Br. The significant amounts of salt 
(EtO)2PO
- Et3NH
+ are present in the reaction mixture; which lowers the yield.  
 
Scheme 15 Mechanism presented by Hirao 
Tunney and Stille84 were the first to describe direct phosphine synthesis using palladium catalyzed 
carbon-phosphorus bond formation. Diphenyl(trimethylsilyl)phosphine and 
                                                           
83 (a) W. Chodkiewicz, Ann. Chim. Paris, 1957, 2, 819; (b) P. Cadiot, W. Chodkiewicz, Chemistry of Acetylenes; H. G. Viehe Ed., 
Marcel Dekker: New York, 1969, 597. 
84 S. E. Tunney, K. J. Stille, J. Org. Chem., 1987, 52, 748. 
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diphenyl(trimethylstannyl)phosphine were brought into reaction with aryl halides in the presence of 
PdCl2(PPh3)2 or PdCl2(MeCN)2 as catalyst in benzene (Fig.22). 
 
Fig. 22 Phosphine synthesis presented by Tunney and Stille 
The mechanism presented by Stille is comparable to the Hirao catalytic cycle; it is more advanced due 
to recognition of probable intermediates in palladium chemistry and their role in steps of oxidative 
addition, transmetalation and reductive elimination (Scheme 16). 
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Scheme 16 Mechanism presented by Tunney and Stille 
Modern methods of organic synthesis might consider these two protocols somewhat outdated with 
quite toxic solvents and harsh thermal conditions, however a contribution of these strategies in a C-P 
bond formation is significant and enable a great progress in this area. 
Below, most significant examples of C-P metal catalyzed cross-coupling will be presented with 
the division of phosphorus-containing agents on the phosphines and phosphine oxides, phosphine 
boranes, triphenylphosphine, phosphine chlorides, and also to form the C(sp)-P bond, C(sp3)-P bond 
and some asymmetric examples. 
I.2.4.b. Phosphine oxides and phosphines as coupling agents 
Herein, some examples of phosphine synthesis from phosphine oxides and lower phosphines 
will be presented. The ability to convert phenol into phosphorus species by the aryl triflates 
intermediates was first presented by Morgans in 199085 and has been widely exploited by numbers of 
researcher for the preparation of chiral phosphines. Morgans and co-workers showed that 3-4 equiv. 
of a phosphoarylating agent such as diphenylphosphine oxide and 6 equiv. of diisopropylethylamine 
combined with the catalytic system of Pd(OAc)2/dppp/HCOONa carries out the stereospecific 
                                                           
85 L. Kurz, G. Lee, D. Morgans Jr., M. J. Waldyke, T. Ward, Tetraheron Lett., 1990, 31, 6321. 
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conversion of (-)-BINOL ditriflate to its monophosphorylated derivative in good yield. After hydrolysis 
of second triflate and phosphorus deoxygenation step, this methodology gives an access 
stereospecifically to triarylphosphines. 
A synthesis of one of the most efficient phosphorus-containing chiral ligand BINAP (2,2’-
bis(diphenylphosphino)-1,1’-binaphthyl) is a good example of direct arylation of secondary and 
primary amines. BINAP was synthesized for the first time by Noyori in early 1980s.86 Since this time 
many attempts have been undertaken, one of them is catalytic pathway proposed by Merck,87 starting 
from BINOL ditriflate with diphenylphosphine and NiCl2/dppe in DMF in the presence of DABCO as a 
base (Fig.23). 
 
Fig. 23 BINAP synthesis presented by Noyori 
Another interesting example of direct phosphination is synthesis of phosphine-containing amino 
acids57 described already in the paragraph I.1.3c. The catalytic transformation of tyrosine and 
hydroxyphenylglycine derivatives, and also thyrosine-containing peptides was effected by cross-
coupling of the corresponding trifluoromethylsulfonates with diphenyl phosphine in DMSO. 
I.2.4.c. Phosphine boranes as coupling agents 
Some phosphines oxidize easily in the presence of O2 from the air and they are difficult to 
handle. In order to circumvent this objection, the protection of phosphorus atom with borane group 
was undertaken. The phosphine-borane adducts are solid substances stable in air, where phosphorus 
atom is protected from oxidation. However, various transformations, like arylation or vinylation, on 
the P-center or in the α- or β-position of one of the phosphorus substituents, are possible. The 
approach was introduced by Imamoto and Oshiki in 199288 who showed that (S)P - and (R)P - 
menthyloxyphenylphosphine-boranes can undergo palladium catalyzed C-P bond formation with o-
iodoanisole. The reaction conditions provoke either retention or inversion of phosphorus 
configuration. Fig.24 presents experimental prove, that in the case of acetonitrile solution, the chiral 
center remains intact, but using ethereal solvents (i.e. THF) or toluene, the inversion of configuration 
occurs. 
                                                           
86 A. Miyashita, A. Yasuda, H. Takaya, K. Toriumi, T. Ito, T. Souchi, R. Noyori, J. Am. Chem. Soc., 1980, 102, 7932. 
87 D. Cai, J. F. Payack, D. R. Bender, D. L; Hughes, T. R. Verhoeven, P. J. Reider, J. Org. Chem., 1994, 59, 7180. 
88 T. Imamoto, T. Oshiki, T. Onozawa, M. Matsuo, T. Hikosaka, M. Yanagawa, Heteroat. Chem., 1992, 3, 563. 
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Fig. 24 Stereoselectivity depending on the solvent in the reaction with phosphine-boranes 
Aryl triflates and nonaflates are reactive with secondary phosphine-boranes (Fig.25).89 However, the 
authors describe that this procedure cannot be applied to compounds containing heterocyclic nitrogen 
because the presence of N-atom decomplexes the phosphine of its borane. 
 
Fig. 25 Cross-coupling with aryl triflates and nonaflates with phsophine-boranes 
Apart from palladium catalyst, mild arylation of phosphine-boranes is favored by addition of a catalytic 
amount of copper(I) iodide.90 Yields of this reaction are high, even at room temperature, which is 
explained by the formation of stable intermediate - copper phosphide. Moreover, mild conditions 
ensure arylation of a chiral phosphine-borane with a high enantioselectivity (ee 94.5-99%).91 
Other example of secondary phosphine functionalisation includes the conversion of vinyl triflates to 
vinylphosphines, which can be transformed to the more stable borane complex (Fig.26).92 
 
Fig. 26 Synthesis of vinylphosphine-boranes by Starkley 
Lately, the group of Gaumont showed that vinylphosphine-borane complexes are accessible directly by 
the cross-coupling with secondary phosphine-boranes.93 Series of experiments with different bases 
(K2CO3, K3PO4) and different heating conditions have been undertaken to choose the best ones (Fig. 
27). Also, some examples showing enantioselectivity of this reaction was presented.94 
                                                           
89 B. H. Lipshutz, D. J. Buzard, C. S. Yun, Tetrahedron Lett., 1999, 40, 201. 
90 M. Al-Masum, T. Livinghouse, Tetrahedron Lett., 1999, 40, 7731. 
91 M. Al-Masum, G. Kumaraswamy, T. Livinghouse, J. Org. Chem., 2000, 65, 4776. 
92 S. R. Gilbertson, Z. Fu, G. W. Starkley, Tetrahedron Lett., 1999, 40, 8509. 
93 D. Julienne, J.-F. Lohier, O. Delacroix, A.-C. Gaumont, J. Org. Chem., 2007, 72, 2247. 
94 D. Julienne, O. Delacroix, A.-C. Gaumont, C. R. Chimie, 2010, 13, 1099. 
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Fig. 27 Synthesis of vinylphosphine-boranes by Gaumont 
The borane protecting group is very convenient for phosphorus compounds, because its 
deprotection can be easily achieved to give quantitatively P(III) compound with complete retention of 
configuration on the phosphorus center.95 
I.2.4.d. Triphenylphosphine as coupling agents 
Chan96 has proved that triphenylphosphine might play a role in the direct formation of tertiary 
phosphorus ligands as the diarylphosphinating agent (Fig. 28).  
 
Fig. 28 Cross-coupling with triphenylphosphine 
In fact, palladium catalyzes in this reaction an aryl exchange on the phosphorus atom, attaching a 
functionalized aryl part to the expense of a phenyl group. The conversion of aryl bromides or triflates 
to phosphines offers products in the 25-50% yield, however application of this methodology to the 
synthesis of atropoisomeric biaryl N,P-ligands increases the recovery of product to 50-68%, 
presumably due to implication and coordinative interaction of the pyridyl nitrogen in the catalytic 
mechanism (Scheme 17). 
                                                           
95 (a) J. Uziel, C. Darcel, D. Moulin, C. Bauduin, S. Jugé,  Tetrahedron: Asymmetry, 2001, 12, 1441 ; (b) S. Jugé, M. Stephan, J. A. 
Laffitte, J. P. Genêt, Tetrahedron Let., 1990, 31, 6357. 
96 F. Y. Kwong, K. S. Chan, Organometallics, 2001, 20, 2570. 
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Scheme 17 Mechanism proposed by Chan 
According to Chan, the proximal nitrogen participates in complexation of palladium(II) and also 
provokes the oxidative addition of the palladium into existing P-C bond. It was shown that more than 
two equivalents of triarylphosphine are required for a complete transformation. The liberation of P,N-
ligand causes a formation of Pd phenyl complex, the last one undergoes reductive elimination and 
releases tetraphenylphosphonium triflate (which could be isolated from the reactional mixture) and 
regenerates the palladium(0) complex. 
I.2.4.e. Phosphine chlorides as coupling agents 
Other alternative partners for C-P cross-coupling are phosphine chlorides. First attempts of an 
application of diphenylphosphine chloride in the nickel-catalyzed cross-coupling are reported by 
Cristau.97 An improvement to his methodology has been brought by Laneman by the addition of 
stoichiometric amounts of zinc.98 Aryl and vinyl halides as well as sulfonates and benzylic halides can 
react with diphenylphosphine chloride to yield the corresponding tertiary phosphines in good yields 
(Fig. 29). The role of zinc is, from one hand, to reduce Ni(II) to Ni(0) but also, to form the intermediate 
Ph2PZnCl prior to the transmetalation step. 
 
Fig. 29 Cross-coupling reaction with phosphine chloride 
The methodology presented by Laneman provides the opportunity to the preparation of wide range of 
phosphines starting from sterically hindered aryl halides or sulfonates. Better yields are obtained with 
aryl triflates than with aryl halides.  
                                                           
97 H.-J. Cristau, A. Chêne, H. Christol, J. Organomet. Chem.,1980, 185, 283. 
98 D. J. Ager, B. E. East, A. Eisenstadt, S. A. Laneman, Chem. Comm., 1997, 23590. 
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I.2.4.f. Alkyl sp derivatives as coupling partners 
Cross-coupling reaction catalyzed by transition metals providing to C(sp2)-P bond formation is by 
far the most widespread, however some examples of coupling between C(sp)-P appeared in recent 
years. Beletskaya presented nickel-, palladium- and copper-catalyzed couplings of terminal alkynes 
with chlorophosphines.99 The mechanism of this transformation is similar to the Sonogashira cross-
coupling; here the initial step is the oxidative addition of the chlorophosphine to the metal complex, 
forming phosphido complex. After the exchange on the aforementioned complex, the 
phosphinioalkyne is liberated. The copper-catalyzed reaction can be applied to alkynes with heteroaryl 
substituents.100b This reaction works also with weaker electrophiles such as (RO)2P or (R2N)nPCl3-n. 
The second example of this type of coupling is work of Yamaguchi100 on reactions with terminal alkynes 
and diphosphines under rhodium catalysis in the presence of nitrobenzenes (Fig.30). The role of 
nitrobenzene is here to activate P-P bond for the transition metal catalysis.  
 
Fig. 30 Cross-coupling reaction C(sp)-P 
I.2.4.g. Alkyl sp3 derivatives as coupling partners 
In order to perform C(sp3)-P couplings, benzylic halides can be applied. Laneman et al.79 
presented the coupling reaction with benzylic bromide and diphenylphosphine chloride under nickel 
catalysis in the presence of zinc dust. Montchamp et al. 101 utilized benzylic and heterobenzylic 
chlorides in the Pd-catalyzed coupling with the anilinium salt of hypophosphorus acid to give 
substitued phosphinates with good to moderate (in case of heterobenzylic substrates) yields. Also 
phosphination of allylic alcohols and allylic chlorides with hypophosphorus acid was reported by the 
same group. C-H bond activation and subsequent C(sp3)-P coupling under rhodium catalyst102 was 
observed by Glueck using 2,4,6-tri(tert-butyl)phenyl phosphacumulenes and by Brookhart using 
phosphines (Scheme 18). 
                                                           
99 (a) I. P. Beletskaya, M. A. Kazankova, I. V. Efimova, Org. Lett., 2003, 5, 4309; (b) V. V. Afanasiev, I. P. Beletskaya, M. A. 
Kazankova, I. V. Efimova, M. U. Antipin, Synthesis, 2003, 2835. 
100 M. Arisawa, M. Onoda, C. Hori, M. Yamaguchi, Tetrahedron Lett., 2006, 47, 5211. 
101 K. Bravo-Altamirano, Z. Huang, J.-L. Montchamp, Tetrahedron, 2006, 61, 6315. 
102 (a) M.-A. David, S. N. Paisner, D. S. Glueck, Organometallics, 1995, 14, 17; (b) V. P. W. Böhm, M. Brookhart, Angew. Chem. 
Int. Ed., 2001, 40, 4694. 
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Scheme 18 Cross-coupling reaction C(sp
3
)-P 
 
I.2.4.h. Asymmetric examples 
The last part discussed here will concern asymmetric cross-coupling reactions with racemic 
phosphines and phosphorus-containing compounds. The first example of C-P coupling between 
secondary phosphine and phenyl iodide was reported by Glueck,103 catalyzed by the Pd-complex of 
(R,R)-MeDuPHOS (Fig. 31). The chiral product was obtained with 78% of enantiomeric excess; detailed 
studies of the reaction kinetics suggest that enantiodetermining step occurs after Pd-P bond 
formation. 
 
Fig. 31 Asymmetric C-P coupling 
The interconversion of diastereoisomers through inversion at the phosphorus atom was proven to be 
much more fast than C-P bond formation by reductive elimination (Keq>>kR and kS). The reaction 
depends on both the equilibrium ratio and the relative rates of the reductive elimination. It was shown 
that the major enantiomer (PS) is formed from the major diastereoisomer (PR), but also it was found 
that minor enantiomer suffers reductive elimination three times faster, though this slightly diminishes 
enentioselectivities (Scheme 19). 
                                                           
103 J. R. Moncarz, N. F. Laritcheva, D. S. Glueck, J. Am. Chem. Soc., 2002, 124, 13356. 
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Scheme 19 Stereoselectivity of C-P coupling 
Also phosphine boranes were tested in asymmetric cross-couplings starting from racemic product. 
Intensive mechanistic studies were performed by Glueck104, however in this case enantiomeric excess 
was lower. An intramolecular variant of asymmetric C-P bond formation was presented by the same 
authors,105 giving an access to benzophospholanes with moderate level of enantioselectivity. Also 
racemic silylphosphines106 served as substrate for this type of reaction, giving products with high ee. 
Other transition metals than Pd such as Pt or Ru were also tested for asymmetric couplings of C(sp3)-
hybridized coupling partners. Glueck107 showed that platinum(II) Me-DuPHOS reacts similar to 
palladium complex; from the other hand, Bergman and Toste108 have introduced ruthenium catalyst to 
the enantioselective preparation of P-stereogenic phosphines from para- and ortho-substituted 
benzylic chlorides, heteroaryls and non-benzylic electophiles. 
I.3. Summary 
In this bibliographic part, we have presented the importance of phosphorus-containing 
compounds in the field of organic synthesis (as organocatalyst and ligands for transition-metal 
asymmetric reactions) and in the domain of biologically active products. We have depicted possible 
strategies of synthesis of mentioned products, putting emphasis particularly on the cross-coupling 
reaction and the versatility of possible coupling partners.  
On the next pages of this dissertation, we will describe the preparation of original compounds 
containing phosphorus atom, applying two methodologies depicted previously: the C-P coupling of 
asymmetric phosphorus-containing compounds on N-heterocycles and the nucleophilic addition of the 
lithium phosphide on the acyclic enecarbamates. 
                                                           
104 J. R. Moncarz, T. J. Brunker, D. S. Glueck, R. D. Sommer, A. L. Rheingold, J. Am. Chem. Soc., 2003, 125, 1180. 
105 T. J. Brukner, B. J. Anderson, N. F. Blank, D. S. Glueck, A. L. Rheingold, Org. Lett., 2007, 9, 1109. 
106 V. S. Chan, R. G. Bergman, F. D. Toste, J. Am. Chem. Soc., 2007, 129, 15122. 
107 C. Scriban, D. S. Glueck, J. Am. Chem. Soc., 2006, 128, 2788; C. Scriban, D. S. Glueck, J. A. Golen, A. L. Rheingold, 
Organometallics, 2007, 26, 1788. 
108 V. S. Chan, I. C. Steward, R. G. Bergman, F. D. Toste, J. Am. Chem. Soc., 2006, 128, 2786.  
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II. Results and discussion 
II.1. C-P cross-coupling reaction 
II.1.1. Introduction 
As it was described before in the bibliographic part, the transition metal cross-coupling reaction 
plays a major role for construction of C-P bond. It exist vast number of literature examples of different 
electrophiles as partners for coupling reaction, such as halogenated derivatives and triflates, or even 
tosylates. The group of Gaumont94 has reported the palladium-catalyzed C-P coupling between vinyl 
triflates and phosphine-boranes providing vinylphosphine-boranes in efficient way (Fig. 32).  
 
Fig. 32 
They expand their methodology to the vinyl tosylates (Fig. 33) as a less expensive and more stable 
counterparts.109 The presented systematical work on activated and unactivated vinyl tosylates showed 
the usefulness of their approach. 
 
Fig. 33 
Considering the nucleophilic partners for C-P coupling, the oxidized species are also available. Equally, 
the cyclic phospholane moiety elaborated and largely studied by the group of Toffano in the cross-
coupling between the diphenylphospholane oxides and boranes and aryl triflates (Fig. 34).110 
 
Fig. 34  
For the best of our knowledge, any citation of phosphates as substrates for C-P cross-coupling 
reaction was given. That was the reason to test the vinyl phosphate – derivatives into the reaction of 
direct C-P coupling. 
                                                           
109 D. Julienne, O. Delacroix, A.-C. Gaumont, Phosphorus, Sulfur and Silicon, 2009, 184, 846. 
110 (a) C. Dobrota, A. Durand, M. Toffano, Eur. J. Org. Chem., 2008, 14¸2439;(b) J.-C. Fiaud, M. Toffano, C. Dobrota, J.-C. Fiaud, 
Eur. J. Org. Chem., 2006, 650; (c) F. Guillen, M. Rivard, M. Toffano, J-Y. Legros, J-C. Daran, J-C. Fiaud, Tetrahedron, 2002, 58, 
5895. 
 46
Only few examples of C-P coupling with electrophiles containing N-atom incorporated into 
heterocycles is reported. Notably, this arises from the reactivity of these substrates in cross-coupling 
reaction. With our investigation, we wanted to fill this gap and show the potential of N-containing vinyl 
phosphates as a substrate in palladium catalyzed cross-coupling reaction.  
 
II.1.2. Objectives of the project 
In the aim of the construction of novel alkenyl α-amidophosphines via a direct C-P cross-
coupling reaction, we envisage a three-step methodology. First, the starting lactam would be 
protected permitting the possibility to form the enol ether which would be trapped by 
chlorophosphate to furnish the corresponding enol phosphate. Finally, the palladium catalyzed 
reaction of C-P cross-coupling could occur to get the desired phosphine borane or phosphine oxides 
(Scheme 20). 
 
Scheme 20 
We envisage introducing phosphines with chiral phosphorus and then, conducting the structural 
investigations determining the stereospecificity of reactions. Therefore, final part of this project will be 
devoted to the X-ray diffraction studies of obtained products. 
 
II.1.3. The interest of enol phosphates in Pd-catalyzed couplings 
For several years, in order to develop synthetic routes to original nitrogen-containing 
derivatives, the laboratory of Pr. I. Gillaizeau has undertaken a research program directed toward 
expanding the range of lactam- and imide-derived vinyl phosphates available to the organist chemist. 
The ability to easily convert alkenyl phosphates into a myriad of functional motifs of synthetic 
relevance is well-known. In particular, this moiety has proved to be a robust and versatile partner for a 
range of cross-coupling reactions mediated by Pd(0) and Ni(0) (Heck, Hiyama, Negishi, Sonogashira, 
Stille and Suzuki-Miyaura reactions). Enol phosphates have in fact, in a few cases, proved to work 
better in such reactions than their triflate counterparts owing to higher stability, higher reaction yield, 
and easier work up. Even if the oxidative addition step to the catalyst is less favorable with this 
reagent, use of electron rich tertiary phosphines can provide yields comparable to those obtained with 
the traditional electrophiles. The ability of these synthetic intermediates to undergo cross-coupling 
reactions in the presence of various heteroatoms makes them indeed attractive functional groups for 
the construction of various substituted heterocyclic systems.7,8,111Enol phosphate has thus become a 
                                                           
111 (a) C. Buon, P. Bouyssou, G. Coudert, Tetrahedron Lett., 1999, 40, 701; (b) F. Lepifre, C. Buon, R. Rabot, P. Bouyssou, G. 
Coudert, Tetrahedron Lett., 1999, 40, 6373. 
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powerful tool and has engendered a number of versatile methods for the total synthesis of natural 
products and other biologically active targets. This methodology allowed to prepare a range of original 
privileged heterocyclic structures with high diversity (e.g. 1,4-dihydropyridines, 1,4-oxazines, 1,4-
dihydropyrazines) and which are advanced synthetic intermediate for the synthesis of biologically 
active derivatives (Scheme 21).112 
 
Scheme 21  
The first application of enol phosphates was reported by Nicolaou et al.113 in 1997 for the synthesis of 
cyclic ethers by the mean of palladium-catalyzed cross couplings of lactones via their enol derivatives 
(Fig. 35). 
  
Fig. 35 
Another example is the coupling of enol phosphates synthesized from 4-piperidinone with arylboronic 
acids in the Suzuki-Miyaura coupling to give an access to 4-substituted tetrahydropyridines (Fig. 36).114 
 
Fig. 36 
 
                                                           
112 (a) D. Mousset, I. Gillaizeau, A. Sabatié, P. Bouyssou, G. Coudert, J. Org. Chem., 2006,71, 5993; (b) E. Cleaveau, I. Gillaizeau, 
J. Blu, A. Bruel, G. Coudert, J. Org. Chem. , 2007, 72, 4832; (c) M. Chaignaud, I. Gillaizeau, N. Ouhamou, G. Coudert, 
Tetrahedron, 2008, 64, 8059. 
113 K. C. Nicolaou, G.-Q. Shi, J. L. Gunzner, P. Gärtner, Z. Yang, J. Am. Chem. Soc., 1997, 119, 5467. 
114 U. S. Larsen, L. Martiny, M. Begtrup, Tetrahedron Lett., 2005, 46, 4261. 
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II.2. Results of C-P coupling reaction 
II.2.1. Protection step 
In order to apply lactams to the preparation of enol phosphates, it is necessary to protect the 
NH function. We predicted to block this group with a carbamate, an electron withdrawing group 
activating the α-proton near to a carbonyl function. 
Starting materials for the construction of new P-containing compounds were commercially 
available 6- and 7-membered ring lactams, respectively δ-valerolactam and ε-caprolactam. The 
standard method with di-tert-butyl dicarbonate in the presence of catalyst DMAP gave satisfactory 
results, however to enlarge the scope, the corresponding methyl carbamates were also synthesized. In 
order to optimize reaction conditions with methyl chloroformate as electrophile, several different 
bases and solvents were tested (Table 1) with ε-caprolactam. 
Table 1 Protection of ε-caprolactam 
 
Entry Base (Equiv.) Solvent Temp. Time Yield [%] 
1 NaH (2.2) DMF RT 20 h 0% 
2 TEA (2.0) THF RT 20 h 0 % 
3 tBuOK (1.6) Et2O 0 ˚C 16 h 32% 
4 n-BuLi (1.1) THF -78 ˚C 2 h 66% 
 
The best result of protection for 7-membered lactam was n-BuLi as a base at -78 °C yielding expected 
carbamate 4 with 66% yield. The same conditions were also applied to the 6-membered counterpart, 
yielding the methyl 2-oxopiperidine-1-carboxylate 3 (68%). Tert-butyl carbamates of 6- and 7-
membered ring lactames were obtained with good yields (70% and 65%, respectively) after 
purification by column chromatography (Table 2). 
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Table 2 Protection of lactames 
 
Entry Conditions R, n Product. Yield [%] 
1 
(a) 
R=tBu, n=1 1 70% 
2 R=tBu, n=2 2 65 % 
3 
(b) 
R=Me, n=1 3 68% 
4 R=Me, n=2 4 66% 
 
II.2.2. Preparation of enol phosphates 
The formation of enol phosphates from starting carbamates was conducted in reaction 
conditions described in the literature.112-113 
 
The reaction of deprotonation of protected lactames 1-4 was carried out under anionic 
condition in anhydrous tetrahydrofuran at -78 °C, in the presence of 1.2 equiv. of LDA. 1.2 equiv. of 
electrophile were then introduced to trap the created lithiated anion. Diphenylchlorophosphate was 
chosen as an electrophile for this reaction due to the high stability of enol phosphates of our products 
during purification by column chromatography and the storage. These conditions already tested for 
Boc-protected derivatives gave very good results with methyl carbamates (Table 3).  
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Table 3 Formation of enol phosphates 
 
Entry Substrate R, n Product Yield [%] 
1 1 R=tBu, n=1 5 90* 
2 2 R=tBu, n=2 6 58 
3 3 R=Me, n=1 7 83 
4 4 R=Me, n=2 8 89 
* Product decomposes immediately after reaction so the yield is calculated from the conversion of starting 
material 
 
Results depicted in the Table 3 show that vinyl phosphates with methyl carbamate protecting group 
give better yields (83% and 89% yields) and they are more stable during the purification (the product 5 
- vinyl phosphate of 6-membered lactam was degradating during the chromatography on neutralized 
silica gel).  
 
II.2.3. C-P cross-coupling reaction 
II.2.3.a. The first approach and optimization of conditions 
In order to obtain original alkenyl-α-amidophosphines, cross-coupling reaction was performed 
on the enol phosphate intermediates (5-8). We intended first to test the reaction with the achiral 
diphenylphosphine borane substrate and then move to the series with chiral phosphorus atom. The 
coupling with the cyclic phospholane oxide or boranes was also predicted (Scheme 22). 
 
Scheme 22 
Although some examples of coupling between vinyl triflates and phosphine boranes exist in the 
literature, to the best of our knowledge any of them was given for the vinyl phosphate. The major 
advantage of our strategy lies in the fact that direct precursors of the free phosphine function can be 
easily introduced in the α-position to the nitrogen-containing heterocycle. 
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Using conditions similar to those reported for triflate rea gents94 we conducted preliminary 
essays onto the 7-membered ring phosphate 8 and diphenylphosphine borane - commercial product. 
The first coupling was carried out in DMSO, in the presence of 2.0 equiv. of potassium carbonate and 
5mol% of dppfPdCl2 as a catalyst, at 60 °C for 3 hours yielding desired phosphine with 38% efficiency. 
This reaction was the starting point to improve the yield and shorten the time of reaction. All tested 
conditions were presented in the Table 4. 
 
Table 4 Optimization of cross-coupling conditions 
 
Entry Base Solvent Temp. / time Yield [%]
a
 
1 K2CO3 DMSO 60°C / 3h 38 
2 K2CO3 DMSO 60°C (MWI) / 15 min. 11 
3 K2CO3 DMSO 60°C (MWI) / 30 min. 0 
4 K2CO3 CH3CN 60°C / 24h 51 
5 Cs2CO3 DMSO 60°C / 24h 60 
6 Cs2CO3 CH3CN 60°C / 2h 95 
7 Cs2CO3 CH3CN
b 60°C / 1h 90 
(a) Isolated yields after purification by column chromatography in air. MWI = microwave irradiation. (b) Reaction 
carried out with a catalyst (IMes)Pd(η3-2-methylallyl)Cl116 
 
As we can see in the Table 4, the change of weak inorganic base K2CO3 for a stronger one Cs2CO3 
increases the yield of reaction almost twice (Entry 5). Comparing tested solvents, the best results were 
obtained in polar solvent with high dielectric constant, acetonitrile (Entry 6) instead of DMSO (Entry 5). 
We performed reactions with classical thermal heating and microwave irradiation activation (MWI), 
however in this case, contrary to what we could expect, the lower yield was observed (Entry 2 and 3); 
due to the significant decomposition of starting phosphate. Using another catalyst - (IMes)Pd(η3-2-
methylallyl)Cl developed by Nolan et al.,115 our result was the same as with dppfPdCl2 (Entry 7). 
Therefore, the best operational conditions were: the reaction of 1.0 equiv. of enol phosphate with 2.0 
equiv. of phosphine borane, then the addition of 2.0 equiv. of Cs2CO3, 5 mol% of dppfPdCl2 and heating 
for 2 hours at 60 °C.  
These optimized conditions were then applied to other vinyl phosphates 5-7 to afford products with 
moderate yields 75% and 28 % (Scheme 23). In the case of tert-butyl 6-(diphenoxyphosphoryloxy)-3,4-
                                                           
115 O. Navarro, Y. Oonishi, R. A. Kelly, D. E. Stevens, O. Briel, S. P. Nolan, J. Organomet. Chem., 2004, 689, 3722. 
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dihydropyridine-1(2H)-carboxylate 5 desired product was not formed, probably because of the low 
stability of phosphate in reaction conditions. 
 
Scheme 23 
The first attempt showed that enol phosphate derivatives might be a potential substrate in the C-P 
cross-coupling reaction with phosphine boranes. In the next part of this chapter we will describe the 
extension of our methodology for the chiral secondary phosphines. 
We predicted also that decomplexation could occur during the coupling reaction, therefore the 
supplementary BH3∙Me2S was also added in order to increase the amount of attempted phosphine 
borane 9-12. Unfortunately, only unsubstituted enecarbamates resulting from the reduction of the 
enol phosphate moiety and degradation products were recovered. 
 
II.2.3.b. C-P cross-coupling reaction on the chiral phosphine boranes 
The next step of our investigation was an application of enol phosphates to the cross-coupling 
with asymmetric phosphine boranes and phosphine oxides. The partners for the coupling were 
enantiomerically pure (S)-(ortho-anisyl)phenylphosphine borane 13a largely studied by the group of 
Jugé116 and phospholane borane 13b and oxide 13c elaborated by the group of Fiaud and Toffano.111  
 
 
Scheme 24 
The product 13a is an example of P-chirogenic compounds and 13b-13c presents the asymmetry 
placed on carbon center which provoke the reorganization around the phosphorus atom (Scheme 24).  
II.2.3.c. Reaction with the (S)-(ortho-anisyl)phenylphosphine borane 13a 
The first attempt was undertaken with phosphine borane 13a and 7-membered ring enol 
phosphate 8 in the already elaborated conditions (Table 5); however the expected product was 
isolated with poor yield 18%. After increasing the time of reaction from 5h15 to 22h only 
                                                           
116 C. Bauduin, D. Moulin, El B. Kaloun, C. Darcel, S. Jugé, J. Org. Chem., 2003, 68, 4293. 
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decomposition of starting phosphate occurred (Entry 2). Finally, decreasing the quantity of catalyst to 
5 mol% we obtained better yield (Entry 3).  
Table 5 
 
Entry Time dppPdCl2 [mol%] Yield 
1 5h15 10 % 18 % (racemisation) 
2 22h 5 % 0 % (decomposition) 
3 2h 5 % 58 % (racemisation) 
 
Unfortunately, the reaction in thermal condition provokes the racemisation of P-atom. It may be 
explained by an inversion, under basic conditions, of the phosphide borane anion before ligand 
exchange in the coordination sphere of the palladium.117 The enantiomeric excess was verified before 
and after reaction by SFC chromatography on a chiral column, and showed that obtained product is a 
racemic mixture of enantiomers.  
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15 n=2, R=tBu (42%)
16 n=1, R=Me (42%)
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Fig. 37 
The same situation was observed for the other phosphates 5-7 (Fig. 37). The racemic phosphine 
boranes 15 and 16 from enol phosphates with 6-membered ring N-COOMe and 7-membered ring N-
Boc were acquired with 42% yields each. It was impossible to obtain tert-butyl 6-(diphenylphosphino)-
3,4-dihydropyridine-1(2H)-carboxylate borane 14 in used conditions. Only the product of hydrolysis of 
phosphate was recovered. Considering the presented results of C-P coupling with chiral phosphine 
borane 13a, the racemisation of products occurs in the case of coupling reaction in thermal conditions. 
In addition, obtained yields of isolated compounds are much lower, than in achiral series, probably due 
to the lesser reactivity of the phosphine 13a, owing to the inductive donor effect of the methoxy 
group.  
 
                                                           
117 J. S. Harvey, V. Gouverneur, Chem. Commun., 2010, 46, 7477. 
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II.2.3.d. Reaction with the (2S,5S)-2,5-diphenylphospholane borane complex 13b 
In this paragraph, we will consider the coupling reaction with phospholane bearing the chirality 
on two carbon center in α position to phosphorus atom. We anticipate, that this type of compound 
should not racemise under reaction conditions.  
 
Scheme 25 
With the coupling partner 13b, the initial reaction condition has been taken from the previous 
work;111 a reaction was carried out first with 7-membered ring enol phosphate 8 in acetonitrile at  
40 °C, in the presence of K2CO3 as a base and dppfPdCl2 as a catalyst, but only traces of good product 
were isolated. After changing the base for cesium carbonate and slightly increasing the time of 
reaction from 2 to 3 hours, desired products were obtained in moderate yields (Table 6). 
Table 6 Cross-coupling reaction with 13b 
 
Entry Substrate R, n Product Yield [%] ee [%] 
1 5 R=tBu, n=1 18 0 - 
2 6 R=tBu, n=2 19 35 99.5 
3 7 R=Me, n=1 20 30 99.5 
4 8 R=Me, n=2 21 46 99.5 
As in previous case, the product 18 from 6-membered ring enol phosphate could not be obtain, even 
traces of expected product were not isolated, probably due to low stability of this phosphate in 
reaction conditions. Moreover, as reported by Toffano et al.,111 the observed low yield could be 
explained by a lack of reactivity of the secondary phosphine 13b and the possible decomplexation of 
the borane group. Other compounds 19-21 were afforded in moderate yields (30-46% yield) after 
purification by column chromatography on neutralized silica gel. Enantiomeric excess were established 
by chiral SFC analysis, they show that this time coupling reaction permitted to retain the chirality in the 
reaction. 
 
II.2.3.e. Reaction with the (2S,5S)-2,5-diphenylphospholane oxide 13c 
Finally, (S,S)-2,5-diphenylphospholane oxide 13c was applied to the cross-coupling with enol 
phosphates. This phosphine oxide is characterized by higher stability and reactivity than phosphine 
boranes due to its oxidation state and more acidic P-H hydrogen. The starting coupling conditions were 
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taken from the literature: diisopropylethylamine as a base, dppfPdCl2 in distilled DMSO  
at 100 °C.111  
 
Scheme 26 
It appeared that this procedure was appropriate for desired products, giving chiral phospholane 
oxide derivative with good yields (Table 7). The coupling reaction was performed on the enantiomer 
pairs (S,S) and (R,R) showing similar results in both cases.  
Table 7 Cross-coupling reaction with 13c 
 
Entry Substrate R, n Product Yield [%] ee [%] 
1 5 R=tBu, n=1 22 28* 99.4 
2 6 R=tBu, n=2 23 70 >99.5 
3 7 R=Me, n=1 24 64 99.4 
4 8 R=Me, n=2 25 70 99.7 
* Yield was calculated for starting carbamate, because the enol phosphate after reaction was directly used for 
coupling. 
 
All conducted reactions were clean and showed the whole transformation of starting enol phosphate 
within 2 hours. We were also pleased to to observe that the higher reactivity of the phospholane oxide 
13c ensures the accomplishment of the C-P coupling with the hindered 6-membere ring phosphate 5, 
although with a low yield (Entry 1). In the case of compound 24 X-ray diffraction analysis revealed that 
no epimerization at the benzylic carbon atom occurred. 
In order to study the scope of this methodology and apply it to another N-containing 
heterocycles, we adopted the coupling reaction with (S,S)-2,5-diphenylphospholane oxide 13c to bis-
enol phosphates of dihydropyrazine. Based on the previously reported results of the functionalization 
of the dihydropyrazine ring and its possible aromatization into pyrazine,113c we anticipated obtaining a 
diphosphine with a dihydropyrazine moiety as a bridge. To date, only a few papers have reported the 
synthesis of pyrazinyl phosphine derivative.118 To prove our concept we engaged bis enol phosphate in 
                                                           
118 (a) F. Palacios, A. M. O. de Retana, J. I. Gil, R. L. de Munain, Org. Lett., 2002, 4, 2405; (b) M. E. Fox, M. Jackson, I. C. Lennon, 
J. Klosin, K. A. Abboud, J. Org. Chem., 2008, 73, 775; (c) E. L. Deal, C. Petit, J. L. Montchamp, Org. Lett., 2011, 13, 3270. 
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optimized conditions to yield bis-phospholane oxide derivative with good yield (75%) in an 
enantiomerically pure form(Fig. 38). 
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Fig. 38 
This product was also sensitized with both enantiomers (S,S) and (R,R) giving similar results in both 
cases. The high enantiomeric excess was obtained in this reaction. 
 
II.2.4. Conclusion and perspectives of C-P coupling reaction 
This part of thesis dissertation presents a formation of novel products containing C-P bond in 
direct C-P cross-coupling reaction between vinylphosphates of corresponding 6- and 7-membered ring 
carbamates leading to original alkenyl-α-amidophosphines.119 This approach is showing the possibility 
of cross-coupling between secondary phosphine boranes or phospholane derivative and N-containing 
non-aromatic heterocycles in mild conditions with short reaction times. First attempts were conducted 
onto achiral phosphines in order to optimize the conditions and then, the methodology was spread 
onto the series of chiral phosphines, with chirogenic phosphorus and a chirality bearing on the C-
atoms in α position to phosphorus.  
 
Scheme 27 
During the optimization of reaction conditions we have met with some difficulties of 
racemisation of chiral phosphine borane 13a. Nevertheless, in the series of asymmetric phospholane 
derivatives 13b and 13c, we managed to obtain the desired products with high enantiomeric excesses 
established by chiral SFC analysis (up to 99.7%) with fair to good yields. These products were used to 
optimized the condition of chiral separation in the Supercritical Fluid Chromatography.  
                                                           
119 M. Cieslikiewicz, A. Bouet, S. Jugé, M. Toffano, J. Bayardon, C. West, K. Lewinski, I. Gillaizeau, Eur. J. Org. Chem., 2012, 
1101. 
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In a perspective to this project, the racemisation problem encountered in the case of carbon-
phosphorus coupling could be elude by using the chiral catalyst for cross-coupling such as (R)-Tol-
BINAP or (S,S)-Me-DuPHOS. The group of Gaumont et al.94 presented recently the application of these 
catalytic systems to the enantioselective palladium C-P coupling between alkenyltriflate and secondary 
phosphine-borane complex.  
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II.3. Nucleophilic addition onto acyclic enecarbamates - an access to P-containing 
non-natural amino acids 
 
II.3.1. Bibliographic background 
Previous works in the laboratory were focused on the carbolithiation reaction onto acyclic 
enecarbamates derived from the vinylphosphates via a cross-coupling reaction.8 The key step in this 
methodology is the spontaneous internal migration of the alkyloxycarbonyl group from nitrogen atom 
to the quaternary carbon leading to aminoesters (Table 8). This approach gives an access to derivatives 
of amino acids with varied alkyl and N-containing substituents on β position.8  
Table 8 
 
Entry Ar Ar' R Yield [%] 
1 Ph Ph Me 75 
2 Ph Ph Ph 78 
3 Ph Ph N(iPr)2 89 
4 Ph Ph N(Me)(Bz) 51 
5 o-MePh Ph Me 80 
6 o-MePh Ph Ph 81 
7 m-MeOPh Ph Me 68 
8 m-MeOPh Naph Me 56 
9 o-MePh Ph n-Bu 89 
10 o-MePh Ph N(iPr)2 86 
 
Theoretical investigations reported by Houk120 and Bailey121 show that the initial step of intermolecular 
carbolithiation is an energetically favorable coordination of the lithium atom to π-system. This can be 
supported also by the concept of Complex-Induced Proximity Effect (CIPE), which elucidates the role of 
carbamate in the reaction mechanism.122 The lithiated intermediate provokes a spontaneous internal 
migration of tert-butyloxycarbonyl group via the formation of a strained aziridine cycle. As depicted in 
the Fig. 39, the equilibrium of the reaction is shifted into the direction of the aminoester creation 
when reaction is warmed up. After hydrolysis and work-up, desired products can be isolated. 
                                                           
120 K. N. Houk, N. G. Rondan, P. V. R. Schleyer, E. Kaufman, T. J. Clark, J. Am. Chem. Soc., 1985, 107, 2821.  
121 W. F. Bailey, A. D. Khnaolkar, K. Gavaskar, T. V. Ovaska, K. Rossi, Y. Thiel, K. B. Wiberg, J. Am. Chem. Soc., 1991, 113, 2925. 
122 (a) D. R. Anderson, N. C. Faibish, P. Beak, J. Am. Chem. Soc., 1999, 121, 7553; (b) K. M. Gross, P. Beak, J. Am. Chem. Soc., 
2001, 123, 315.  
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Fig. 39 
According to theoretical calculations realized by Arnaud Martel from University of Le Mans, we have 
well distinguished three transition states during the reaction: (i) the lithium derivative addition, (ii) the 
formation of aziridine and (iii) opening of aziridine cycle and the same time, the intermolecular 
migration. As presented on the energetic schema below, the intermediate int1 is energetically 
preferable than intermediate int2. The addition of lithiated agent is not a limiting step in this reaction. 
As well, the racemisation step is correlated with the aziridine cycle opening, which is not 
regioselective. 
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II.3.2. Objectives 
Based on the above mentioned results, we envisage thus to introduce the phosphorus atom via 
phospholithiation reaction into the β position to quaternary carbon in order to enlarge the family of 
non-natural amino acids. This strategy is expected to offer the potential advantage of directly 
introducing further molecular diversity as a result of the original choice of the starting primary amine, 
the phosphorus reagent or the palladium coupling catalyst. The first part of this work will concern the 
preparation of acyclic enecarbamates from the corresponding vinylphosphates via a palladium cross-
coupling reaction. The nucleophilic addition of lithiated phosphines onto the latter will be investigated 
in the second stage (Scheme 28). 
 
Scheme 28 
This methodology will give an access to phosphine-containing amino acid, which can be 
valorized not only in the domain of biological compounds, but also as a useful building blocks for the 
synthesis of N,P-heterocycles and hybrid ligands. 
 
 
II.3.3. Results of the nucleophilic addition 
II.3.3.a. Synthesis details 
Based on the results from anterior investigations on nucleophilic additions,8 we decided to 
synthesize a family of enecarbamates from commercially available anilines and benzylamines in three 
step transformation, going through vinylphosphates and palladium-catalyzed cross-coupling reaction.  
 
Scheme 29 
The series of enecarbamates with different aryl and heteroaryl substituents would be synthesized via 
this methodology. The vinylphosphates obtained from amides could be isolated with high yields. They 
are very convenient electrophilic partners for both Suzuki-Miyaura and Stille couplings. The last step - 
nucleophilic addition of lithiated phosphine would be carried out according to conditions established 
in our team (Scheme 29). 
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II.3.3.b. Preparation of acyclic enecarbamates 
The first step consisted of the acylation of primary amine in acidic conditions in the presence of 
acetic anhydride, followed by the protection of the nitrogen atom with a Boc group in classical 
conditions(Fig. 40).  
 
Fig. 40 
Equally, the benzylamine was converted into the acetamide by refluxing in acetic anhydride, and after 
work-up, protected by Boc as previously described (Fig. 41). 
 
Fig. 41 
Obtained acetylated carbamates were treated with LDA at -78 °C in anhydrous THF to give lithium 
enolates, which were quenched with diphenylchlorophosphate. This transformation gave an access to 
stable intermediates for numerous palladium-catalyzed cross-coupling reactions with excellent yields 
(Fig. 42). 
 
Fig. 42 
Vinylphosphates 28-30 were subjected to the cross-coupling reaction as previously demonstrated8 to 
extend the scope of synthesized acyclic enecarbamates. Derivatives with various substituents on α 
position to the N-atom were synthesized, both heteroaryl such as benzothiophenyl, benzofuranyl or 
pyridinyl and aryl with ortho-fluoro group. Standard conditions for Suzuki-Miyaura and Stille cross-
coupling reaction have been applied (Table 9). 
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Table 9 Cross-coupling reactions leading to acyclic enecarbamates 
 
Entry Substrate Product Product / Yield [%] 
1 
  
31 / 86 
2 
  
32 / 46 
3 
  
33 / 88 
4 
 
 
34 / 74 
5 
  
35 / 81 
6 
  
36 / 90 
7 
  
37 / 64 
8 
 
 
38 / 89 
9 
  
39 / 94 
10 
  
40 / 78 
11 
 
 
41 / 81 
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Applied reaction conditions were not optimized, however acyclic enecarbamates were obtained in fair 
to good yields. The best results were observed in the case of phenyl 36 and benzofuranyl moiety 38 
(90 and 94% respectively), probably due to the palladium activation in the reactional system. The 
lowest yield was observed in the fluoro-substituted compounds 32 and 37 because of electron 
withdrawing character of substituent, as we suppose. Ten synthesized derivatives have been tested in 
the phospholithiation reaction presented above. 
 
II.3.3.c. Literature examples of nucleophilic addition onto double bond 
In the literature, only few examples of the nucleophilic addition of phosphines onto the 
unactivated double bond have been reported. One of them is the treatment of pyridines bearing 
unsaturation with diphenylphosphane (Ph2PH) in the presence of a catalytic amount of potassium tert-
butyloxide in DMSO or N-methylpyrrolidinone (NMP). This strategy gave an access to the new family of 
N,P-ligands for asymmetric Ir-catalyzed reactions (Fig. 43).81  
 
Fig. 43 P,N - ligands for asymmetric Ir-catalyzed reactions 
Also, an organocatalytic asymmetric direct ortho phosphonylation of α,β-unsaturated aldehydes has 
been reported.123 The catalytic reaction affords the phosphonates in good yields and high 
enantioselectivities for a broad range of enals, such as aliphatic, aromatic and heteroaromatic α,β – 
unsaturated aldehydes (Fig. 44). 
 
Fig. 44 Organocatalyc asymmetric phosphonylation of α,β-unsaturated aldehydes 
Chiral β-phosphinocarboxylic acids can be obtained by addition of lithium diarylphosphides to α,β-
usaturated carboxylic esters.124 Trofimov et al. 125 reported nucleophilic additions of phosphines and 
phosphine chalcogenides onto alkenes and alkynes in the superbasic system such as KOH/DMSO (Fig. 
45).  
                                                           
123 E. Maerten, S. Cabrera, A. Kjærsgaard, K. A. Jørgensen, J. Org. Chem., 2007, 72, 8893. 
124 G. Knühl, P. Sennhenn, G. J. Helmchen, Chem. Comm., 1995, 1845. 
125 S. N. Arbuzova, N. K. Gusarova, B. A. Trofimov, Arkivoc, 2006, V, 12. 
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Fig. 45 Nucleophilic addition of phsophines to alkenes 
II.3.3.d. Nucleophilic addition reaction 
As previously reported, acyclic enecarbamates belong to the group of convenient electrophiles 
for nucleophilic addition.8 In our interest was to introduce the phosphorus atom in β-position to 
nitrogen and owing to the internal (N->C) alkyloxycarbonyl group migration, to synthesize the 
phosphine-containing non-natural α-amino acids.126 This methodology permits to perform at the same 
time the addition of phosphine moiety and the reorganization in the starting molecule. Our approach 
is beneficial from the point of view of atom economy and allows the reduction of steps of reaction. As 
a model molecule, tert-butyl phenyl(1-phenylvinyl)carbamate 30 was chosen. In order to get 
nucleophilic phosphorus agent, diphenylphosphine was treated with lithium base such as nBuLi at  
-78°C. This diphenylphosphanide lithium was introduced by cannula to the degassed anhydrous 
solution of enecarbamate 31 at -78 °C and left to react for 15 minutes during warming up to room 
temperature. The reaction was completed after this time, no starting material was observed in the 
reaction mixture and desired compound was isolated in 43% yield (Fig. 46). At the same time, some 
part of product with oxidized phosphine was recovered (confirmed by 31P NMR). 
 
Fig. 46 
Three equivalents of lithiated phosphine were used as an optimum to make a complete conversion of 
starting material in the shortest time. 
As presented on the Fig. 46, during the spontaneous Boc transfer, the quaternary center is 
formed, notwithstanding the reaction is not enantioselective and we obtain the racemic mixture. In 
order to induce the stereoselectivity during the nucleophilic attack onto the double bond, the 
synthesized phosphinide anion was first complexed with (-)-sparteine. Nonetheless, also in these 
conditions, racemic mixture was obtained. These may testify that the carbanion formation is not 
regioselective and that the Boc is equally transferred on both sites on this anion. 
                                                           
126 A. Bouet, M. Cieslikiewicz, K. Lewinski, G. Coudert, I. Gillaizeau, Tetrahedron, 2010, 66, 498. 
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Fig. 47 
Following the first results on the nucleophilc addition onto acyclic enecarbamate 30, the same 
reaction conditions were applied for the rest of the products (Table 10). This gave a range of 
phosphine-containing aminoesters in fair to good yields. 
Table 10 Phospholithiation reaction 
 
Entry Substrate Product Product/ Yield [%] 
1 
 
 
43 / 41 
2 
 
 
44 / 95 
3 
 
 
45 / 0 
4 
  
46 / 47 
5 
  
47 / 43 
6 
 
 
48 / 55 
7 
  
49 / 54 
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8 
 
 
50 / 0 
9 
 
 
51 / 0 
 
The best conversion was observed for the derivatives with benzo[b]thiophenyl group 44 (95%) and 49 
(54%). However, yields of other transformation were quite moderate (41-55%). The phospholithiation 
reaction did not give expected product in the case of benzo[b]furanyl derivatives 45 and 50 and 
pyridinyl 51, presumably due to the decomposition of starting enecarbamate in basic conditions.  
In the case of tert-butyl benzyl(1-phenylvinyl)carbamate 40 only one product was observed - 
here the complete oxidation of phosphine occurred without the Boc migration (Fig. 48). 
 
Fig. 48 
Obtained results confirm the hypothesis of a possible nucleophilic addition of phosphide agents onto 
the double bond of enecarbamates and permit to enlarge the family of non-natural amino acids with 
the β-phosphino counterparts. 
 
II.3.3.e. Oxidation of phosphine-based derivatives 
A spontaneous oxidation of phosphine-based derivatives 43-51 was observed during the 
hydrolysis process, the purification step by column chromatography or simply while the contact with 
the air. It is well-known that stability for oxidation of mixed aryl-alkyl phosphines is lower than purely 
aryl one. However, the reduction of phosphine oxide may be performed in the presence of 
trichlorosilane/triethylamine in toluene.127 
This partial oxidation was responsible for lower yield of isolation of phosphine-derivatives. 
Notwithstanding, the benzyl enecarbamate 40 gave only the oxidized product without the tBoc group 
transfer. These results show that migration of alkyloxycarbonyl group and oxidation of phosphorus 
atom may be co-notated and may influence one to another. In the purpose of rationalizing these 
observations, we studied the ratio of free and lithiated phosphine and its effect on the conversion of 
starting enecarbamate (Table 11).  
                                                           
127 Y. Uozumi, T. Hayashi, J. Am. Chem. Soc., 1991, 113, 9887. 
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Table 11 
 
Entry 
Ratio 
LiPPH2/HPPh2 
Starting 
enecarbamate 
Ar Ar' 
Product ratio A/B/C/D [%] 
A B C D 
1 3/0 
30 
Ph Ph 100 0 0 0 
2 1.5/1.5 Ph Ph 39 0 35 (42a) 26 (42b) 
3 1/2 Ph Ph 30 0 62 8 
4 3/0 
34 
Ph Py 100 0 0 0 
5 2/1 Ph Py 0 0 0 100 (46a) 
6 3/0 40 Bz Ph 0 0 0 100 
 
We started with tert-butyl phenyl(1-phenylvinyl)carbamate 30 limiting the quantity of the base and 
therefore introducing to the milieu the free phosphine, we observed the apparition of the non-
transferred product 41a almost in the same quantity of non-transferred oxidized one 41b. By using 
more equivalents of free phosphine than lithiated phosphanide we increased the quantity of non-
transferred product 41a (Table 11, Entry 3). For pyridinyl derivative 34 the presence of only one 
equivalent of free phosphine was sufficient to provoke the formation of non-transferred oxidized 
product 45b. Benzylic derivative 40 gives oxidized untransferred product even in the absence of free 
phosphine (Table 11, Entry 6). These results may be explained by the kinetic influence of in situ 
reprotonation which is significantly faster than the intermolecular migration of Boc group.  
 
II.3.3.f. Attempts with chiral phosphines 
At the end of our investigation, we wanted to introduce the chiral center to the system by the 
nucleophilic addition of chiral phosphine borane 13a or phospholane oxide 13c. The pyridinyl 
derivative 35, chosen as a model, was treated with chiral phosphine borane in different conditions (n-
BuLi, THF, -78 °C or tBuOK, DMSO, 50 °C as reported in the literature80,81) but did not give any results. 
Only degradation of starting material was observed (Fig. 49).  
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Fig. 49 
At the same time, the phospholane oxide 13c was tested in the nucleophilc addition reaction. However 
it was impossible to deprotonate this compound. Probably the acidity of hydrogen attached to 
phosphorus is not high enough to be deprotonated in applied reaction conditions (Fig. 50). 
 
Fig. 50 
Unfortunately, both envisaged reaction did not provide chiral phosphines and phospholane oxide. For 
the moment, the stereospecifity could not be introduce into the synthesized phosphine-derivatives. 
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II.3.4. Conclusion and perspectives of C-P coupling reaction 
This part of thesis dissertation presents the formation of novel products containing C-P bond: β-
phosphino α-amino acid derivatives on the way of nucleophilic addition onto the double bond of 
acyclic enecarbamates with concomitant spontaneous (C->N) alkyloxy group migration. 
 
Scheme 30 
Phosphine-containing amino acid derivatives extended the family of non-natural amino acids already 
elaborated in our laboratory (Scheme 30). The reaction of phospholithiation permits to introduce the 
nucleophile phosphorus agent to the studied scaffold in good to excellent yields. In the course of these 
investigations, we have envisaged carrying out the phospholithiation in the enantioselective manner; 
however, the transition state postulated for the mechanism precludes the possibility of 
enantiocontrol. Moreover, the application of (-)-sparteine as a chiral ligand for lithium complex during 
the nucleophilic addition did not avoid the racemisation of products. 
In perspectives to nucleophilic addition onto the double C=C bond of enecarbamates, we have 
anticipated to extend this reaction by using other nucleophilic heteroatom species such as silicon 
derivatives. The preliminary studies were encouraging (Fig.51). 
 
Fig. 51 
Also, in order to deal with the enantioselectivity of internal migration during nucleophilic addition, the 
chirality could be introduced by protection of the amide within an asymmetric protecting group. 
Recently, the group of Clayden128 showed that carbamate directed lithiation can be conducted in an 
enantioselective way.  
 
 
 
                                                           
128 A. Page, J. Clayden, Beilstein J. Org. Chem., 2011, 7, 1327. 
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III. Crystal structure determination 
The determination of the structure by the X-ray diffraction comprises four steps: 
 crystallization, 
 collection and processing of diffraction data, 
 solution of the phase problem, 
 refinement and analysis of structure. 
Each step will be briefly described here.  
III.1. Introduction 
III.1.1. Crystallization and quality of crystals 
This is a crucial step for structure determination because without well diffracting crystals, X-ray 
diffraction methods cannot be applied. Several methods of crystallization exist, although in this work 
we will focus only on those that are most popular for small molecules, such as slow evaporation and 
the vapour diffusion.  
The crystallization by slow solvent evaporation is a simple and efficient method for crystallization 
of small molecules. The crystal growth is controlled by choosing type of solvent, initial concentration, 
temperature of crystallization and rate of evaporation. If a crystallization solvent is too volatile, rapid 
evaporation leads to creation of many nuclei and crystals are too small or results in aggregation of the 
material. The evaporation can be slowed down by sealing the crystallization dish or lowering the 
temperature however, for some organic compounds this method still does not allow to obtain single 
crystals of sufficient size. 
For molecules having mixed polar and non-polar character, the vapour diffusion method has 
been adapted. The compound has to be dissolved in the good solvent, placed in the open dish in the 
larger container next to reservoir containing other solvent poorly dissolving the compound. This 
container should be tightly closed in order to allow these two solvents to equilibrate. The non-solvent 
diffuses through vapour phase to the solvent and lowers solubility, which leads to crystallization of the 
compound.  
The diffraction-quality crystal should be a single crystal without any occlusions or crystallization 
faults. In order to estimate quality of the crystal, we examine it under microscope using polarized light. 
If the ideal single crystal is not available, the fragment mechanically separated from larger sample 
might be used.  
The size of crystal is also an important parameter, generally it should be large enough to give a 
high intensity of diffraction pattern, but not larger than the diameter of X-ray beam. It is important to 
correct the effect of absorption that increases with the size of the crystal. Absorption of X-rays, much 
like other forms of electromagnetic radiation, depends on the path length (crystal size) and the 
absorption coefficient. The absorption coefficient μ, depends both on the absorbing species present in 
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the crystal and the wavelength of X-rays used. The absorption of X-rays by matter in general decreases 
with decreasing wavelength, meaning that MoK0 radiation will be less absorbed than CuKα radiation 
and reflections intensity will be less affected by absorption. The effect of absorption is corrected either 
by analytical methods that require indexing the faces of the crystal or by comparing intensities from 
redundant measurements. Because of its simplicity, the second method is now method of choice for 
data collected on CCD detectors.  
Other than absorption reason for using MoK0 radiation is higher efficiency of data collection. Use 
of CuKα radiation requires much larger angular θ range for collecting high-angle reflections necessary 
to determine the structure with atomic resolution and that makes data collection very time 
consuming. For all structures described here diffraction data were collected using MoK0 radiation.  
 
III.1.2. Data collection and data reduction 
In order to get the best quality of diffraction data, during data collection crystal samples are 
cooled to temperature about 100 K (which equals -173°C) using a dry nitrogen stream. At low 
temperatures, crystals (especially those of macromolecules) are more stable, they do not lose solvent 
and are resistant to the effects of X-ray radiation. At the same time, the low temperature reduces 
dynamic disorder and atomic thermal vibrations, facilitating their subsequent location within the 
crystal structure. 
During data collection the crystal is mounted on the goniometer head, which enables perfect 
positioning on the intersection of rotation axes and in the X-ray beam (Figure 52). The crystal is fixed 
to the tip of tiny glass needle with silicon grease or glue. In case of very little or very fragile crystals, 
they can be mounted on the nylon loop in a drop of mother liquor.  
 
Fig. 52 Positioning of crystal in the X-ray beam 
The diffraction pattern resulting from a scattering of X-rays on the crystal can be described in 
terms of geometrical distribution and intensity of diffraction spots. The description of diffraction 
conditions and interpretation of diffraction pattern geometry was proposed in 1913 by P. P. Ewald on 
the base of introduced by him reciprocal lattice and is known as a Ewald construction. Each reciprocal 
lattice point described by coordinates (h, k, l) corresponds to the set of lattice planes (hkl). The Ewald 
sphere with a center C is a sphere of radius 1/λ passing through the origin O of the reciprocal lattice. 
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When the crystal is rotated, the crystal lattice as well as the reciprocal lattice rotates in the same way. 
The diffraction conditions for a plane (hkl) are satisfied when during the rotation a reciprocal lattice 
point (h, k, l) goes through the surface of Ewald sphere in point marked as P on the Figure 53a. This 
results in a Bragg reflection in the direction CP.  
a 
       b 
Fig. 53 Ewald sphere 
As can be seen on Figure 53b, the diffraction pattern is a projection of reciprocal lattice points 
passing through the Ewald sphere when the crystal is rotated. Using reverse projection it is possible 
from positions of diffraction spots on detector to reproduce the position of reciprocal lattice points in 
3-dimensional space and to determine lattice parameters and h, k, l indices corresponding to each 
diffraction spot. 
The intensity I(hkl) of reflection is proportional to the square of amplitude of the structure 
factor F(hkl). The structure factor F(hkl) can be described as a Fourier transform of electron density 
distribution ρ(xyz) in the unit cell: 
 
 
dxdydzlzkyhxixyzVhklF )}(2exp{)()( ++= ∫∫∫ πρ
Equation 1 
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In order to solve the crystal structure, the intensity of reflections must be determined with high 
accuracy. It is done by program that integrates intensity of signal for each pixel on CCD detector in the 
region where diffraction spot is expected and makes corrections for background level.  For reflections 
that were recorded on several frames, average intensity is calculated. Corrections corresponding to 
absorption and measurement conditions are also introduced.  
 
III.1.3. Structure determination 
The electron density distribution can be calculated from the structure factors using reverse 
Fourier transform: 
 
 
 
Unfortunately, from diffraction data only amplitude |F(hkl)| of the structure factor can be 
determined experimentally. The phase angle must be determined in indirect way using some other 
method. For small organic compounds the most popular and efficient is application of so called “direct 
methods”. 
Direct methods are based on two assumptions: 
 The electron-density function calculated from deduced phase angles should never be 
negative, 
 The electron density map should have high values at/near the atomic position and have 
nearly zero value everywhere else. 
First of all, normalized structure factors E need to be calculated from the observed magnitude |F| of 
structure factors. Only reflections with high values of |E| will be used to assign preliminary phases. 
The set of three reflections is selected for which indices satisfy the triplet relationship  
'
)'()'()(
h
hhhh −+≈ ααα  
Equation 3 
From this relationship, given the two phases in the righ-hand side, we can calculate an estimate of 
third phase. This method requires approximate values of phases for at least some reflections, so called 
starting set. Several strategies have been adopted for setting starting phases, including random choice. 
Probabilities for every triplet are calculated using the tangent formula and the most probably phases 
are used to calculate the E map that is the first approximation of the electron-density map (replacing 
|F(hkl)| by |E(hkl)|). Distances between peaks are analysed for evidence of atomic connectivity and 
molecular fragments. The coordinates of these peaks represent the position of atoms and are used as 
an initial trial structure.  
 
 
)}(2exp{)(
1
)( lzkyhxihklF
V
xyz
h k l
++−= ∑∑∑ πρ
Equation 2 
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III.1.4. Structure refinement and analysis  
Positions of atoms based on the Fourier maps are only approximate and therefore they need to 
be optimised by the refinement process. The method usually applied for structure of small organic 
compounds is the least squares method. The process is done by minimizing the sum of differences 
between structure factors calculated from the model and determined experimentally.  
 
 
 
The individual terms of the sum are usually weighted to take into account the precision of the 
observation. Each structure factor is a function of atomic coordinates and displacement parameters. 
The function Q has minimum when its derivative is equal zero. Because this function is non-linear, to 
find out best set of atomic parameters, the structure factors are expanded in a Taylor series, from 
which only linear terms are used.  
 
 
 
Each structure factor is approximated by equation that linearly depends on small differences ε 
between current value of parameter u0 and its correct value u. Least squares method is applied to 
obtain the change ε of each parameter. As this value is only an approximation of real difference 
between current and correct value of the parameter, the procedure must be repeated iteratively until 
parameter changes are very small or zero. For successful refinement there should be at least 5 to 10 
observations for each refined parameter. Progress of refinement and correctness of the model are 
reflected by decreasing differences between observed and calculated structure factors expressed by 
the R-factor: 
 
 
 
For well determined and refined structure the value of R should be close to 0.03 (3%). Higher values 
are also acceptable for structures containing disorder, partially occupied solvent and other 
irregularities. Low quality of crystal and errors during data collection also affect R-factor value. 
For chiral molecules an important issue is determination of absolute structure.  It is possible 
when the crystal contains atoms for which the anomalous dispersion effect is observed and Friedel’s 
law is no longer satisfied. By comparing intensities of reflections with opposite hkl indices (Bijvoet 
pairs), it is possible to determine correct enantiomer. Another approach was introduced by H. D. 
Flack1. Two structures corresponding to two enantiomers are refined simultaneously with weights x  
and 1-x. 
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Equation 6 
 
The value of x called the Flack parameter indicates correctness of model. 
with a small standard uncertainty, the absolute structure given by the structure refinement is likely 
correct, and if the value is near 1, then the inverted structure is likely correct. If the value is near 0.5, 
the crystal may be racemic or twinne
confirming correctness of structures with non
for MoKα radiation the anomalous dispersion from light atoms is very weak and this method do not 
give reliable results. 
 
III.2. Crystal structure of products after direct C
Two products, 16 and 25, 
tert-butyl 7-((methoxyphenyl)(phenyl)phosphino)
complex 16, was dissolved in organic solvent
evaporation and phase diffusion. Crystallization conditions are presented in the Table 1
Entry Solvents,
1 DMSO:EtOAc (2:1), rt
2 MeOH, 4 °C
3 Acetone, 4 °C
 
The best crystals were obtained at 
in 2:1 ratio. Prismatic crystals were observed after two weeks, for X
0.20x0.17x0.05 mm3 was selected (Fig. 54). 
 
The diffraction data for compound 
100 K using a graphite monochromatized MoK
(hklI
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Equation 7 
d. This parameter, became one of a standard parameters 
-centrosymmetric space group symmetry. Unfortunately, 
-P coupling 
were crystallized in order to determine their structure
-2,3,4,5-tetrahydro-1H-azepine
s having different polarities and crystallized by slow 
Table 12 
 temp. Time of crystallization Observations
 two weeks orange prismatic 
crystals
 one month orange plate crystals
 one month orange prisms, 
aggregated
room temperature from crystallization in DMSO and EtOAc 
-ray experiment the crystal of size 
 
 
Fig. 54 The crystal form of product 16 
16 were collected on Nonius KappaCCD diffractometer at 
α (45 kV, 20 mA) radiation, λ
22
)()()1() lkhFxhklFx −−−+−=
1 mm 
If the value is near 0 
.  First product, 
-1-carboxylate borane 
2. 
 
 
 
 
 = 0.7107 Å. For cell 
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refinement and data reduction, the Denzo/Scalepack program package129 was used. The multiscan 
absorption correction was applied to the data. The structure was solved by direct methods using 
SIR92130 and refined by full-matrix least-squares on F2 using the program SHELXL-97.131 Anisotropic 
displacement parameters were applied for non-hydrogen atoms. The hydrogen atoms were refined 
with isotropic displacement parameters set at 1.5 times that of bonded atoms for methyl or BH3 
groups and 1.2 times for ring atoms. Because high-angle reflections were on the level of noise, only 
reflections from Θ range up to 22.5° were used in the refinement. Hydrogen atoms bonded to the 
carbon skeleton were added on calculated positions, however H-atoms in the boron group were 
located on the electron density map and refined with restrained distances and angles. The crystal data 
and refinement parameters are presented in Table 14.  
 
 
Fig. 55 Chemical structure and ORTEP presentation of compound 15 with displacement ellipsoids at 20% probability level 
 
The crystal structure of desired product 16 and the arrangement of phenyl groups around P-
atom is presented on Fig. 54. The presence of BH3 group attached to the phosphorus atoms that has 
been confirmed by the structure, could not be determined reliably using spectroscopy. The crystals of 
compound 16 were centrosymmetric and contained racemic mixture of two enantiomers. 
The product from the family of phospholane oxides – 7-((2S ,5S) -1-oxo-2,5-diphenyl-λ5-
phosphan-1-yl)-2,3,4,5-tetrahydro-azepine-1-carboxylic acid methyl ester 25 gave single crystal under 
crystallization conditions presented in the Table 13. 
                                                           
129 (a) Z. Otwinowski, W.Minor, Macromolecular Crystallography, Part A; (b) C. W. Jr. Carter, R. M. Sweet, Eds.; Academic 
Press: New York, 1997; Methods in Enzymology, Vol. 276, 307.  
130 A. Altomare, G. Cascarno, G. Giacovazzo, A. Guagliardi, M. C. Burla, G. Polidori, M. Camalli, J. Appl. Cryst., 1994, 27, 435. 
131 G. M. Sheldrick, Acta Crystallogr., 2008, A64, 112. 
 
Entry Solvents, temp.
1 DMSO:EtOAc (2:1), rt 
2 Chloroform, rt
3 Acetone, 4 °C
4 Toluene: acetone, 4 °C
 
The best single crystals of product 
chloroform at room temperature after 7 days of slow evaporation (Fig.5
Fig. 56 The picture of crystal forms of product 24, the single crystal chosen for experiment is marked with an arrow
 
A single crystal (0.50 x 0.30 x 0.25 mm
cyanopropane glue. The diffraction experiment 
collected and processed as described above for compound 
was determined on the base of s
using SIR92.130 The initial solution revealed
atoms. The remaining atomic positions were determined from sub
and the refinement was performed as described above using reflections 
27.5°. Details of crystal structure and refinement
O
N
P
O
O
Fig. 57 The structure and an ORTEP presentation of compound 2
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Table 13 
 Time of crystallization Observations
 one month brown film
 one week brown plates
 one month brown needles 
 one week brown film and
needles 
25, light-brown plates, were obtained from 
6).   
 
3) was selected and attached to a tip of glass fiber with 
was carried out at room temperature.
16. The symmetry of 
ystematic absences. The structure was solved by direct methods 
 positions of the P atom and the most of non
sequent difference Fourier maps. 
from the 
 parameters are presented in Table 1
5 in RT with displacement ellipsoids at 20% probability 
level. 
0.5 mm
 
 
 
 
 
saturated solution in 
 
 The data were 
space group P212121 
-hydrogen 
Θ range up to 
4.  
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The crystal structure analysis gave an evidence for the absolute structure of product 25. On the 
Fig. 57, carbon atoms attached to the phosphorus in the phospholane cycle are in the S configuration 
(as in staring phosphine 13c), what means that during the applied cross-coupling reaction the 
stereoselectivity is retained. The value of Flack parameter equal 0.07 confirms that the absolute 
structure given by the structure refinement is likely correct. 
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Table 14 Crystallographical parameters 
Product 16 25 
Empirical formula  C24 H33 B N O3 P C24 H28 N O3 P 
Formula weight  425.29 409.44 
Temperature  113(2) K 293(2) K 
Wavelength  0.71070Å 0.71070 Å 
Crystal system  Monoclinic Orthorhombic 
Space group  P 21/n P212121 
Unit cell dimensions a = 10.093(1)Å α= 90° a = 9.501(5) Å α= 90° 
b = 14.074(2)Å β= 92.048(9)°. b = 12.105(5) Å β= 90° 
c = 16.437(3)Å γ= 90° c = 19.615(5) Å γ = 90° 
Volume 2333.4(6)Å3 2256(2) Å3 
Z 4 4 
Absorption coefficient 0.142 mm-1 0.145 mm-1 
F(000) 912 872 
Crystal size 0.20 x 0.17 x 0.05 mm3 0.50 x 0.30 x 0.25 mm3 
Reflections collected 14659 19074 
Independent reflections 2064 [R(int) = 0.0608] 5173 [R(int) = 0.0476] 
Data / restraints / parameters 2064 / 6 / 273 3971 / 0 / 264 
Goodness-of-fit on  F2(S)  1.144 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0620, wR2 = 0.1252 R1 = 0.0437, wR2 = 0.1090 
R indices (all data) R1 = 0.0933, wR2 = 0.1447 R1 = 0.0668, wR2 = 0.1213 
Flack parameter - 0.07(13) 
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III.3. Crystal structure of compounds from the family of P-containing non-natural 
amino acids 
The synthesized products, analogues of β-phosphino non-natural amino acids, were racemic 
mixtures and in this form they were crystallized. Compounds were dissolved in acetonitrile and 
crystallized by slow evaporation of solvent from saturated solutions at temperature 4 °C. The 
crystallization gave only aggregated crystals, from which parts of single crystals were mechanically 
separated and used for X-ray experiments. The diffraction data for 47 were collected on Nonius 
KappaCCD diffractometer using the same procedures as described above. For compound 52 data were 
collected on Oxford Diffraction SuperNova diffractometer using CuKα radiation (λ = 1.5418 Å) while for 
46 the diffractometer was Oxford Diffraction Xcalibur with Mo X-ray source. The structures were 
solved by direct methods using SIR-92 software and refined by full-matrix least squares on F2 using the 
program SHELXL-97.  
The first crystallized compound in the family of phosphine non-natural amino acids analogues was tert-
butyl 3-(diphenylphosphino)-2-phenyl-2-(o-tolylamino)propanoate 47. A single crystal selected for the 
diffraction experiment was colorless plate with dimensions 0.5x0.25x0.25 mm3. The systematic 
absences indicated symmetry of space group P21/c which was confirmed by subsequent solution and 
refinement of the structure. The initial solution revealed positions of only P atoms and C atoms from 
the phenyl rings, the remaining atomic positions were determined from difference Fourier maps. The 
final refinement included anisotropic temperature factors of all non-hydrogen atoms. The H-atoms 
were refined using the riding model with isotropic displacement parameters set at 1.5 times that of a 
bonded atoms for methyl groups and 1.2 times for ring atoms. The crystal structure confirmed the 
presence of trivalent phosphorus atom and showed the arrangement of phenyl rings around the 
quaternary carbon. This structure was deposited in the Cambridge Crystallographic Data Center with 
the entry 748012.  
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Fig. 58 The structure and ORTEP representation of compound 46 (ellipsoids drawn at 50% probability level) 
 
The single crystals of product 52 were very thin needles, nevertheless it was possible to obtain 
diffraction pattern at 100 K using SuperNova diffractometer and CuKα radiation. The data collection 
and processing were performed in Oxford Diffraction headquarter with kind help of dr. Zoltan Gal from 
Oxford Diffraction Ltd, Yarnton, UK. This compound crystallizes in P21 space group, and contains two 
molecules in the asymmetric part of the unit cell. Its crystal structure enables unambiguously to 
confirm the oxidation of phosphorus atom. This structure was deposited in the CCDC with the 
accession number 748216. 
 
 
  
Fig. 59 Crystal of product 51 on the nylon loop 
 
   0.5 mm 
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Fig. 60 The structure and ORTEP representation of compound 51 (ellipsoids drawn at 50 % probability level) 
 
The last presented structure is a pyridine-derivative 46. The piece of single crystal used for the 
diffraction experiment was obtained by slow diffusion between two solvents: acetonitrile and 
methanol at 4 °C. It was very small and of low quality (Fig. 61) but after the data collection at 100 K 
and data processing with omitting high-angle reflections, it was possible to solve the structure in 
monoclinic crystal system.  The data collection and processing were performed in Oxford Diffraction 
headquarter with kind help of dr. Zoltan Gal from Oxford Diffraction Ltd, Yarnton, UK. After refinement 
process the reliable structure was obtained that has confirmed the chemical structure of expected 
product. 
 
 
Fig. 61 Crystal of product 45 on the nylon loop 
   0.25 mm 
 83
N
H
P
O O
N
 
Fig. 62 The structure and ORTEP diagram of compound 45 (ellipsoids at 50 % probability level) 
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Table 15 
Compound 47 52 46 
Empirical 
formula  
C32 H34 N O2 P C32 H34 N O3 P C30 H31 N2 O2  P 
Formula weight  495.57 511.61 482.54 
Temperature  100(2) K 100(2) K 100(2) K 
Wavelength  0.7107 Å 1.5418 Å 0.7107 Å 
Diffractometer Nonius KappaCCD Oxford Diffraction 
SuperNova 
Oxford Diffraction Xcalibur 
Crystal system  monoclinic monoclinic monoclinic 
Space group  P 21/c P 21 P 21/n 
Unit cell 
dimensions 
a = 19.798(2) 
Å 
α= 90° a = 5.8788(5) 
Å 
α= 90° a = 22.176(1) 
Å 
α= 90° 
b = 11.805(2) 
Å 
β=94.025(10)° b = 36.672(2) 
Å 
β= 90.42(1)° b = 11.575(4) 
Å 
β= 
115.608(6)° 
c = 11.620(4) 
Å 
γ = 90° c = 12.357(8) 
Å 
γ = 90° c = 22.4137(1) 
Å 
γ = 90° 
Volume 2709.07(11) Å 3 2663.9(3) Å3 5188.0(4) Å3 
Z 4 4 8 
Density (calc.) 1.215 Mg/m3 1.275 Mg/m3 1.236 Mg/m3 
Absorption 
coefficient 
0.130 mm-1 1.181 mm-1 0.135 mm-1 
Crystal size 0.5 x 0.25 x 0.25 mm3 0.47 x 0.23 x 0.04 mm3  0.25 x 0.17 x 0.05 mm3  
Reflections 
collected / 
unique / obs 
[I>2sigma(I)] 
11487 / 6191 / 4846 6743 / 5724 / 5518 16981 / 11106 / 5844 
R [I>2sigma(I)] R1 = 0.0404, wR2 = 0.1012 R1 = 0.0477, wR2 = 0.1310 R1 = 0.0415, wR2 = 0.0565 
R (all data) R1 = 0.0585, wR2 = 0.1179 R1 = 0.0492, wR2 = 0.1294 R1 = 0.0979, wR2 = 0.0632 
Flack parameter  0.09(3)  
Goodness-of-fit 
on F2 
1.079 1.045 0.758 
Largest diff. 
peak and hole 
0.284 and -0.342 e. Å -3 0.732 and -0.443 e.Å-3 0.257 and -0.274 e.Å-3 
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Chapter 2 
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I. Bibliography 
I.1. Lanthanides - introduction 
 
Lanthanides or lanthanoids (according to IUPAC nomenclature) are metallic elements of the f 
block of periodic table, comprising 15 species from lanthanum La (atomic number 57) through 
lutetium Lu (71). Etymology of their name comes from Greek and it means "lying hidden" (lanthanein), 
therefore their common name is "the rare-earth elements". In fact, the less abundant lanthanide - 
thulium occurs in the amount greater than arsenic or mercury and neodymium is more abundant than 
gold. However, the rarity of lanthanides is understood not in the term of scarcity, but with regard to 
difficulty in isolating certain elements in their pure form. The similarity of ionic radius between 
adjacent lanthanide metals makes it difficult to separate them from each other in naturally occurring 
ores or other mixtures. 
The luminescent properties of several lanthanides have been investigated and put into practice in 
lighting and light conversion technologies such as lasers (Nd:YAG laser), cathode-ray and plasma 
displays or light-emitting diodes (cerium or europium doped LED). Recently, it appeared that particular 
luminescent properties of lanthanide ions could be exploited in applications ranging from biomedical 
to sensing areas and luminescence imaging. This opens a great possibility for the coordination 
chemistry of these ions.132 Stable trivalent lanthanide complexes are of considerable interest owing to 
their magnetic133 and luminescent features.134 Gd3+ complexes are paramagnetic at room temperature 
and they serve as contrast agents in magnetic resonance imaging (MRI). Also, a novel class of contrast 
based on the transfer of magnetization properties to the bulk water signal provides high sensitive Ln3+ 
based probes for MRI. This phenomenon called Chemical Exchange Saturation Transfer (CEST) permits 
to use the different contrast agents in the same MR-image to distinguish them by activation with 
characteristic irradiation frequency.135 
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824; (c) J.-C. G Bünzli,  Chem. Rev. 2010, 110, 2729; (d) C. P. Montgomery, B. S. Murray, E. J. New, R. Pal, D. Parker, Acc. Chem. 
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Fig. 63 Emission spectra of lanthanides com
The luminescent properties of lanthanides give a range of applications from biomedical, through 
sensing area to optical imaging of cells and tissues 
complexes of europium and terbium exhibiting quite intense visibl
Notwithstanding, the photophysical properties of near infrared (NIR) lanthanide emitters such as Sm
Dy3+, Pr3+, Ho3+, Yb3+, Nd3+ and Er
Lanthanide cations emitting in near infrared are more efficient 
probes in visible range because they
much more important than for visible photons
biological tissues137 and they can pass through the tissue up to centimeters without harming it
absorption and less diffusion). Similarly, NIR luminescence from ions such as Nd
a useful application as optical signal amplifier in telecommunication network.
Fig. 64 Type of emission and related applications of lanthanides
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I.2. Lanthanide complexes 
The coordination numbers of Ln3+ are in the range 3 - 12 depending on the steric requirement of 
the ligand and the size of the lanthanide cation, although the number 8 and 9 are the most frequent. 
Aqua ions of crystalline compounds are generally 9-coordinated with the tricapped trigonal prism as 
favored structure.  
The choice of ligand for lanthanide complexation is very important. Aqueous solutions of non-
complexed lanthanides are toxic for living organisms (because of accumulation in the lung tissue and 
bones)140, therefore for the in vivo application, it is necessary to create complexes with high kinetic 
stability to avoid cation's liberation in aqueous media. The trivalent lanthanide ions are hard acceptors 
(according to the HSAB theory) and they form more stable complexes with O- and N-donor ligands. The 
most efficient coordination site for lanthanides needs to be formed by a number of donor atoms or 
groups arranged in a covalently organized structure. In relation to the dimensionality, they may be: 
 monodimensional, like acyclic linear ligands (podands) or branched ones (polypodands), 
 bidimensional macrocyclic ligands (coronands), 
 tridimensional macrobicyclic and macropolycyclic ligands (cryptands). 
A very important group of acyclic ligands is based on the polyaminopolycarboxylate system with 
four or more acetic groups covalently attached to a polyamino skeleton such as 
ethylenediaminetetraacetic acid EDTA or diethylentriaminepentaacetic acid DTPA. This kind of 
lanthanide chelates found an application in Magnetic Resonance Imaging (MRI) commercialized as 
MagnevistTM or OmniscanTM (Fig. 64)141 and biological assays by means of Dissociation-Enhanced 
Lanthanide Fluorescence ImmunoAssay (DELFIA).142 
 
Fig. 65 Examples of Gd
3+
 chelates currently used as MRI agents 
Cryptands are excelent candidates for the coordination of spherical lanthanide cations as long as 
they show complementarity of the dimension of the coordinating cavity with the size of metal cation 
(the "lock and key" criterion). Notwithstanding the control of the ligand topology based on this 
principle may fail in controlling the stability and selectivity of complexation with Ln3+. Therefore, 
                                                           
140 S. Hirano, K. T. Suzuki, Environ. Health. Perspect., 1996, 104, 85. 
141 K. W.-Y. Chan, W. T. Wong, Coord. Chem. Rev., 2007, 251, 2428. 
142 P.G. Sammes, G. Yahioglu, Nat. Prod. Rep., 1996, 13, 1.  
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ligands showing intermediate character between highly organized "lock and key" based 
macropolycycles and the preorganized "induced fit" systems are very useful for lanthanide 
complexation. These ligands contain polyaza-macrocycle core with pending anionic binding sites 
covalently linked to the secondary amine nitrogen atom of the ring. The stability of these complexes 
may be controlled by adjusting the ring size and the number and nature of binding arms to surround 
the lanthanide cation. Among all known lanthanide ligands, 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid (DOTA) shows the highest stability constant (log KML in the range of 22-29). Four 
nitrogens of the cyclen ring bind cooperatively to the face of the square antiprism; they possess the 
same quadrangular conformation either in the free or complexed state.143 Other aza-macrocycles such 
as 1,4,7-triazacyclononane or 1,4,8,11-tetraazacyclotetradecane (cyclam) having acetic pending groups 
are also applied in the lanthanide chelation, even if their thermodynamic and kinetic stability constants 
are lower than for cyclen (Fig. 66).  
These complexes are used as contrast agents or luminescent labels for biological assays, depending on 
the lanthanide cation. Gadolinium DOTA complexes are efficient contrast agents for MRI.144 
 
Fig. 66 Examples of polyaza-macrocycle ligands 
I.3. Jablonski Diagram and antenna effect 
The luminescence activity of molecules can be described schematically by the energy diagram, 
presented for the first time at 1935 by Polish physicist Aleksander Jablonski, and after that called the 
Jablonski's diagram. This diagram illustrated the electronic states of the molecule and the transition 
between them (Scheme 31).  
The absorption of energy by the chromophore system leads to the excitation on the higher vibrational 
level S1 or S2. In a typical system, irradiation with a wide range of wavelengths (the UV or visible part) 
will generate an entire range of possible transitions and therefore, will populate the various vibrational 
energy levels of the excited state. The intensity of absorption represents the degree of probability of 
certain transitions and combined lines of these transitions construct the absorption spectrum of the 
molecule. Immediately after absorption of a photon, several processes can occur with different 
probabilities, but the most likely will be the relaxation to the lowest vibrational energy level of the first 
                                                           
143 S. Aime, A. S. Batsanov, M. Botta, J. A. K. Howard, D. Parker, K. Senanayake, G. Williams, Inorg. Chem., 1994, 33, 4696.  
144 (a) D. Meyer, M. Sheafer, B. Bonnemain, Invest. Radiol., 1988, 23, S232; (b) K. Nwe, M. Bernardo, C. A. Regino, M. Williams, 
M. W. Brechbiel, Bioorg. Med. Chem., 2010, 18, 5925. 
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excited state S1. This process is known as internal conversion or vibrational relaxation (loss of energy in 
the absence of light emission) and generally occurs in a picosecond's range or less. Due to fact that a 
significant number of vibration cycles may occur during the lifetime of excited state, all molecules 
virtually always undergo the complete vibrational relaxation during their excited states. An energy 
liberated over vibrational relaxation is converted into heat, which is absorbed by neighboring solvent 
molecules upon collisions with the excited state molecule. 
The lifetime of excited electronic state S1 is around a few nanoseconds. An excited molecule 
exists in the lowest excited singlet state S1 for this time before finally it comes back to the ground 
state. If relaxation from this excited state is accompanied by emission of a photon, the process is 
formally known as fluorescence. The closely spaced vibrational energy levels of the ground state, when 
coupled with normal thermal motion, produce a wide range of photon energies during emission. As a 
result, fluorescence is normally observed as emission intensity over a band of wavelengths rather than 
a sharp line. Most fluorophores can repeat the excitation and emission cycle many hundreds to 
thousands of times before the highly reactive excited state molecule is photobleached, resulting in the 
destruction of fluorescence.  
However, several other relaxation pathways that have varying degrees of probability compete 
with the fluorescence emission process. The excited state energy can be dissipated non-radiatively as 
heat, the excited fluorophore can collide with another molecule to transfer energy in a second type of 
non-radiative process, or a phenomenon known as intersystem crossing to the lowest excited triplet 
state can occur. The latter event is relatively rare, but ultimately results either in emission of a photon 
through phosphorescence or a transition back to the excited singlet (T->S1) state that yields delayed 
fluorescence. The phosphorescence and delayed fluorescence are phenomena much more slow than 
fluorescence; they may last even few seconds. The difference between them is the characteristic 
emission spectrum: for delayed fluorescence this spectrum is similar to the "normal" fluorescence one, 
while, because the triplet state has lower energy, the phosphorescence spectrum will be located at 
higher wavelengths. 
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Scheme 31 Jablonski Diagram 
The luminescence of lanthanide complexes results from the oscillator strength of the 
 f-f transitions (forbidden by the Laporte's rule) and even if many lanthanide containing compounds 
display a reasonable quantum yield, the direct excitation of Ln3+ ions is almost impossible (the 
absorption coefficients for such trivalent cations is ε≈1-10 M-1cm-1). Therefore, the indirect excitation 
(called sensitization or antenna effect) needs to be adopted by the means of the chromophore 
(antenna). This proceeds in three steps: 
 absorption of light by a chromophore and population of the lowest-lying singlet 
excited state (S), 
 intersystem crossing (ISC) to the chromophore triplet level (T), 
 energy transfer (ET) to the excited lanthanide state Ln3+* which provokes its 
luminescence.  
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Fig. 67 The antenna effect for senitization of the lanthanide luminescence 
As presented on the schematic Jablonski Energy Diagram (Fig. 67), both the singlet and triplet 
states may transfer energy onto the metal ion, however, the singlet state S1 is short lived and this 
process is therefore less efficient. The energy proximity between the chromophore triplet state and 
lanthanide excited state is taking into account. The overall efficiency of sensitized emission φSE is 
regulated by the intersystem crossing efficiency φISC, the energy transfer efficiency φISC and the 
intrinsic metal center quantum yield of the lanthanide ion φlum
MC (Equation 8) 
 = 	

  
Equation 8 
Besides, in aqueous solutions, in order to avoid non-radiative deactivation by quenching with O-
H oscillators, the 8-9 coordination positions of Ln3+ should be shielded from solvent molecules. For this 
purpose, the comparison of luminescence results in water and deuterated water solutions need to be 
done to estimate the number of water molecules close to the lanthanide center. For example, for the 
Nd(III)145and Yb(III)146 complexes following equations could be applied, where q is the number of 
coordinated water molecules and τ is the lifetime of complex: 
CkAq obs −∆= )(   for Nd
3+ 
Equation 9 
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3+ 
Equation 10 
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Where A = 130 ns for Nd3+ and 1 µs for Yb3+, B = 0.2 µs-1 and C = 0.4. Δkobs is described in ns
-1 for Nd3+ 
and in µs-1 for Yb3+ complex. 
                                                           
145 (a) A. Beeby, B. P. Burton-Pye, S. Faulkner, G. R. Motson, J. Jeffery, J. A. McCleverty, M. D. Ward, Dalton Trans., 2002, 19, 
1923; (b) Faulkner, A. Beeby, M. C. Carrie, A. Dadabhoy, A. M. Kenwright, P. G. Sammes, Inorg. Chem. Commun., 2001, 4, 187. 
146 A. Beeby, I. M. Clarkson, R. S. Dickins, S. Faulkner, D. Parker, L. Royle, A. S. de Sousa, J. A. G. Woods, J. Chem. Soc., Perkin 
Trans., 1999, 3, 493. 
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Therefore, in order to ensure efficient lanthanide sensitization the sensitizer-ligand must fulfill 
several requirements. From the one hand, thermodynamic, kinetic and structural features (complex 
stability, saturation of the coordination position of lanthanide) must be considered, but also the 
electronic properties of the sensitizer must be tuned with, to obtain effective energy transfer to the 
lanthanide metal center.  
 
I.4. Antennae for lanthanide sensitization 
 
The antenna for lanthanide sensitization might be an organic molecule or the system (the 
nanocrystal, the metal-organic framework or the dendrimer) collecting the energy and transferring it 
directly to the metal center, provoking the emission of lanthanide.147 In this work, we will focus on the 
organic sensitizers.  
In general, the organic antenna can be any aromatic or hetero-aromatic compound with highly 
π-conjugated system and superior absorption coefficient ε responsible for high light absorption. Also, 
it should be characterized by energy of triplet excited state that should be located at sufficient energy 
in respect to the lowest emitting level of the Ln3+ cation.148 When the energy gap is smaller, the 
thermal deactivation occurs due to the back energy transfer towards the chromophore triplet level. 
The excitation wavelengths of chromophore should be above ~350 nm to facilitate the use of 
inexpensive excitation sources and avoid the harmful for biological tissues UV irradiation. Taking into 
account the position and nature of the chromophore, the energy transfer may occur either by Förster 
(FRET), Dexter and electron transfer mechanisms.149 The difference between these types of energy 
transfer is the distance from donor to acceptor: in the Dexter and electron transfer mechanisms, the 
overlap of orbitals is needed, whereas in the Förster mechanism the transfer is through the space and 
it depends strongly on the spectral overlap of the emission of the donor and the absorption of the 
acceptor. An energy transfer by the Dexter and electron transfer mechanisms is efficient only at very 
small distances (< 10 Å), when the Förster energy transfer has been reported to occur over much 
longer distances.150 In order to avoid the dissipation of energy in the system, the distance between the 
sensitizer and lanthanide cation should be short enough; the most efficient energy transfer can be 
obtained when the chromophore directly coordinates the metal centre. This goal can be achieved 
when antenna contains binding sites for the Ln3+ such as aza-aromatic compounds (bipyridine, 
phenantroline) or phenolate aromatics (2-hydroxyisophtalamide or 1-hydroxypyridin-2-one).151 
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However, the too short distance between the triplet state of chromophore and the accepting level of 
the lanthanide cation may provoke the back energy transfer without efficient sensitization process.  
 
 
Fig. 68 The Dieke energy diagram of emissive levels of some lanthanide cations (Nd, Gd, Yb) and chromophores
139
 
 
Emissive levels of some chromophores were presented in comparison with the Dieke energy diagram 
of three of lanthanide cations particularly used in the medical imaging (Fig. 68). As presented on figure 
abve, the lowest excited state of Gd3+ is about 32 000cm-1, which corresponds to energy in UV region. 
For gadolinium complexes containing chromophores with excitation band higher than 300 nm any 
transfer of energy cannot occur, for this reason the Gd3+ compounds are used to determine the triplet 
state of complex.  
I.5. Advantage of lanthanide markers for biological applications 
 
Fluorescence detection is among the most sensitive, versatile and least expensive techniques for 
biological applications. In the field of the fluorescence microscopy, there is a strong demand for 
luminescent imaging agents with advanced properties. Lanthanides are very promising for biological 
imaging for the following reasons:  
 Most described lanthanide complexes do not photobleach.136 This prevents irreversible 
photoreactions when complex is irradiated. 
 Lanthanide luminescence can be spectrally discriminated from other luminescent 
reporters (biological autofluorescence).They have a number of excited states allowing 
their emission to appear as sharp bands in the visible  and near-infrared regions. This 
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advantage allows the individual detection of several lanthanide emitters during the 
same experiment (multiplex assay). 
 Biological tissues do not have significant native NIR fluorescence, therefore the use of 
NIR eliminates background fluorescence, one of the most important issues for biological 
imaging. The use of NIR photons is also a good strategy to obtain higher resolution 
pictures than visible photons, as NIR light scatters less than visible light. 
 
I.6. Lanthanide sensitizers based on cyclen derivatives 
 
In the recent literature, a vast number of lanthanide sensitizers have been presented, however 
in this chapter we will focus on the lanthanide sensitizers bearing heterocycle framework and with 
cyclen chelating core, because of their applications in near-infrared optical imaging.152 As it was 
already stated, the DOTA complexes are kinetically and thermodynamically stable in aqueous 
conditions and furthermore, the substitution of one of the pending arm with organic aromatic 
molecule enables the formation of the sensitizer.  
 
Scheme 32 The concept of lanthanide sensitizer based on DOTA complex 
The first lanthanide sensitizers were absorbing in the UV region. The phenantroline153 
chromophore is an example of molecule that permits the efficient energy transfer to the lanthanide 
center and at the same time enters in the coordination sphere of the metal ion (Fig. 69). The limitation 
of this system was the excitation band at 280 nm, which exclude this compound from use for biological 
application. 
                                                           
152 (a) J.-C. G. Bünzli, Chem. Rev., 2010, 110, 2729, (b) S. Faulkner, S. J. A. Pope, B. P. Burton-Pye, Appl. Spectr. Reviews, 2005, 
40, 1. 
153 S. Quici, G. Marzanni, M. Cavazzini, P. L. Anelli, M. Botta, E. Gianolio, G. Accorsi, N. Armaroli, F. Barigelletti, Inorg. Chem., 
2002, 41, 2777. 
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Fig. 69 The phenantroline sensitizer 
Some inorganic transition-metal complexes have been used as sensitizers for lanthanide 
complexes. Beeby et al.154 reported a porphyrin core with Pd(II) covalently bound to the chiral 
lanthanide complex, which effectively sensitizes the near-IR emission of Yb3+ and Nd3+ and has also a 
specific affinity to the nucleic acids. At the same time, the group of Klink155 presented ferrocene and 
ruthenium tris(bypiridine) complexes as light-harvesting units for sensitization of lanthanide 
luminescence. 
 
Fig. 70 The palladium porphyrin sensitizer for lanthanides 
Investigations in the field of organic sensitizers with the absorption in the visible were pioneered 
by Li and Selvin156 by the application of carbostyril-124 chromophore (Fig. 71). This compound is 
attached to polyaminocarboxylate chelates for lanthanide cations such as DPTA, DOTA or TETA and 
shows a good efficiency of energy transfer to the metal center, both europium and terbium. 
                                                           
154 A. Beeby, R. S. Dickins, S. FitzGerald, L. J. Govenlock, C. L. Maupin, D. Parker, J. P. Riehl, G. Siligardi, J. A. G. Williams, Chem. 
Commun., 2000, 1183. 
155 S. I. Klink, H. Keizer, F. C. J. M. van Veggel, Angew. Chem. Int. Ed., 2000, 39, 4319. 
156  M. Li, P. R. Selvin, J. Am. Chem. Soc., 1995, 117, 8132. 
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Fig. 71 The carbostyril chromophores incorporated into DOTA complex 
Another example is the complex of Eu3+ based on acridone derivatives (Fig. 72a) reported by 
Sammes et al.157 This sensitizer shows high quantum yields after excitation with the visible light (λexc = 
380 nm). Faulkner158 also presented efficient excitation of several lanthanides with the use of 
triazolophthalazine as an antenna (Fig. 72b). The observation of lanthanide emission has been made in 
visible (for Eu3+) and near-infrared (Yb3+, Nd3+, Er3+) part of spectrum. 
 
Fig. 72 Acridone and triazolophthalazine based sensitizers for lanthanides 
The attachment of 8-hydroxyquinoline159 and 8-benzyloxyquinoline160 moiety to DOTA 
derivatives has been reported. The additional benzyloxy group displaces the water molecules from the 
lanthanide coordination sphere; however it does not improve the efficiency of sensitization. 
                                                           
157 A. Dadabhoy, S. Faulkner, P. G. Sammes, J. Chem. Soc., Perkin Trans. 2, 2002, 348. 
158 B. P. Burton-Pye, S. L. Heath, S. Faulkner, Dalton Trans., 2005, 146. 
159 F. Rizzo, A. Papagni, F. Meinardi, R. Tubino, M. Ottonelli, G. F. Musso, G. Dellapiane, Synthetic Metals, 2004, 147, 143. 
160 D. Maffeo, J. A. G. Williams, Inorg. Chimica Acta, 2003, 355, 127. 
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Fig. 73 8-hydroxyquinoline and 8-benzyloxyquinoline sensitizers for europium 
Other organic chromophore - quinoxaline - proved to be a good sensitizer for lanthanide ion 
luminescence.161 In the case of this complex, the coordination of lanthanide cation is provided by 
carbonyl groups of amides replacing triacetic acids. Emission spectra of lanthanides after excitation at 
320-390 nm were recorded. Also xanthone derivatives have been tested for the sensitization of 
terbium luminescence at 355 nm with cell permeable pyrazoyl-1-azaxanthone macrocyclic 
complexes.162 
 
Fig. 74 Quinoxaline and xanthone-based sensitizer 
The heterometallic lanthanide complex containing Yb3+ and Tb3+ cations has been reported by Faulkner 
et al.
163
 This approach was achieved by sequential controlled deprotection (one DOTA unit was 
protected with tert-butyl esters and the second one - with ethyl esters) and complexation of 
orthogonally blocked ligand. The compound (Fig. 74) showed sensitized luminescence from both the 
Tb3+ and Yb3+ metal center in the visible and near-infrared, respectively. 
 
Fig. 75 Heterometallic lanthanide complex 
                                                           
161 M. Andrews, L. H. Laye, L. P. Harding, S. J. A. Pope, Polyhedron, 2008, 27, 2365. 
162 C. P. Montgomery, D. Parker, L. Lamarque, Chem. Commun., 2007, 3841. 
163 L.S. Natrajan, A.- J. L. Villaraza, A. M. Kenwright, S. Faulkner, Chem. Commun., 2009, 6020. 
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Alternatively, the building blocks containing various lanthanide cations may be connected by the 
simple organic reaction of diazotization and therefore enhance the wavelengths of excitation by 
increasing the conjugation of the system.164 This methodology allows not only the preparation of 
heterometallic systems containing different lanthanides but also the simultaneous incorporation of a 
sensitizing chromophore (Fig. 76). 
 
Fig. 76 Azo-dye derivatives of polymetallic lanthanide complexes 
Aita et al.165 reported the NIR fluorescent ytterbium complex based on the pyridin-2-yl-diazenyl-5-
amino-naphthalen-2-ol (PAN) (Fig. 77), which gives efficient lanthanide emission upon excitation at 
530 nm. This complex is not fluorescent and has negligible fluorescence in the red to NIR region, which 
allows the complete energy transfer to the lanthanide chelate. In addition, this compound is stable in 
the large range of pH, therefore it reports high in vivo stability. 
 
Fig. 77 Yb complex with pyridine-2-yl-diazenyl-5-amino-naphthalen-2-ol 
 
Examples presented above did not cover whole literature in this domain; they are depicted here 
in order to illustrate the versatility of the approach and a vast possibility to extend this field.  
 
I.7. Examples of lanthanides application in NIR probing 
 
Some demonstrations of the application of NIR luminescent lanthanide complexes in 
bioanalytics and molecular imaging have appeared in recent years. This development is due to the 
                                                           
164 M.P. Placidi, A-J.L. Villaraza, L.S. Natrajan, D. Sykes, A.M. Kenwright, S. Faulkner, J. Am. Chem. Soc. 2009, 131, 9916. 
165 K. Aita, T. Temma, Y. Kuge, K. Seki, H. Saji, Luminescence, 2010, 25, 19. 
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great progress in the domain of optoelectronics, with light sources and detectors suitable to work in 
the near-infrared region.  
Lanthanide complexes can be pH, temperature or oxygen166 sensitive and therefore may 
become useful sensors for cell imaging. A crown ether-modified Nd3+ cryptand167 was proposed for 
barium ion detection. Unfortunately, this complex works as probe only in one organic solvent - 
acetonitrile and it requires UV excitations. 
 
Fig. 78 Barium ion sensor based on lanthanide luminescence 
The detection of nucleic acid strands by NIR luminescence is possible by the tuning of ytterbium 
emission in Pd-porphyrin-containing complexes (prevoiusly described in this document) or by the 
sensitivity of the intramolecular energy transfer in coumarin-rhodamine-modified Yb3+ complex.168 The 
lanthanide is sensitized by rhodamine, which in turn is excited by energy transfer from a coumarin 
moiety. These three compounds operate on the principle of energy transfer cascade, spanning the UV-
visible-near IR region of the spectrum, resulting in the large Stokes shifts. When double stranded DNA 
is interacting with coumarin, this system is disturbed and only NIR signal is observed. 
 
Scheme 33 Principle of NIR-emitting DNA-probe 
The europium(III) complex containing diaza-18-crown-6 ether and diaryl-alkyne-antenna-part reported 
by He et al.169works in the similar way as described earlier. This compound was demonstrated to be a 
specific fluorescence probe for the toxin isolated from the paralytic shellfish (saxitoxin). The binding of 
the toxin to the crown ether triggers a two-photon induced f-f emission of europium complex. 
                                                           
166 D. Parker, P. K. Senanayake, J. A. G. Williamms, J. Chem. Soc., Perkin Trans. 2, 1998, 2129. 
167 J. B. Coldwell, C. E. Felton, L. P. Harding, R. Moon, J. A. Pope, C. Rice, Chem. Commun., 2006, 5048. 
168 A. Bodi, K. E. Borbas, J. I. Bruce, Dalton Trans., 2007, 4352. 
169 S. He, H. Li, Y.-W. Yip, C.-T. Yeung, Y. O. Fung, H.-K. Kong, H.-L. Yeung, G.-L. Law et al., Org. Lett., 2011, 13, 5036. 
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Fig. 79 Mechanism of saxitoxin detection 
In addition, the lanthanide complexes have found applications in the domain of live cell imaging 
and in vivo detection. The particular Yb3+ complex with porphyrin chelate170 has amphiphilic properties, 
which allow molecule to cross the membrane barrier and target the tumor cell by NIR luminescence. 
Furthermore, this molecule may act as dual-function probe, combining near-infrared luminescence for 
detecting and imaging with a singlet oxygen generation for photodynamic therapy on malignant cells. 
 
Fig. 80 Amphiphilic bisporphyrin Yb(III) complex 
Another example of connection both bioanalysis and bioimaging applications with photodynamic 
therapy of cancer is photosensitizer with Yb3+ and Er3+ (Fig. 80).171 Upon irradiation at a specific 
wavelength, the sensitization of nanoparticles occurs and the singlet oxygen is produced at the same 
time, provoking the destruction of cancerous cells. This system has been tested on the breast cancer 
cells.  
The lanthanide cations may be likewise complexed by dendrimers (repetitively branched 
molecules) type PAMAM (polyamidoamine). This kind of compounds allows the incorporation of many 
Ln3+ ions (7-8 cations with the coordination number equals 9) and naphtalimide molecules branched at 
the end of dendrimers to sensitize cations and therefore enhance the emission signal (Fig. 81). 
                                                           
170 F.-L.Jiang, C.-T. Poon, W.-K. Wong, H.-K. Koon, N.-K. Mak, C. Y. Choi, D. W. J. Kwong, Y. Liu, Chem. Bio. Chem., 2008, 9, 
1034. 
171 P. Zhang, W. Steelant, M. Kumar, M. Scholfield, J. Am. Chem. Soc. , 2007, 129, 4526. 
 
Recently, luminescent dendrimer europium(III) complexes
preferentially within rat liver tumors. This imaging agent seems
photobleaching than organic sensitizers.
Lanthanide complexes have found commercial use as highly sensitive and selective probes in 
immunoassays and DNA assays such as DELFIA a
Förster resonance energy transfer (TR
FQA) are also commercially available. The new challenge is the construction of responsive lanthanide 
luminescent probes for cellular imaging.
Scheme 34 The possible ways of lanthanide luminescence modulation 
Several possibilities exist for 
distance separating the sensitizer from the chelating center
                                                          
172 M. A. Alcala, C. M. Shade, H. Uh, S. Y. Kwan, M. Bishhof, Z. P. Thompson, K. A. Gogick, A. R. Meier, T. G. Strein, D. L. 
Bartlett, R. A. Modzelewski, Y. J. Lee, S. Petoud, C. K. Brown, 
173 A. Thibon, V. C. Pierre, Anal. Bioanal. Chem.
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Fig. 81 PAMAM dendrimer 
nd FIAgen probes. Complexes for time
-FRET) and time-resolved fluorescence quenching assays (TR
173  
the modulation of the luminescence of lanthanide sensor by the 
 (Scheme 34): 
Biomaterials, 2011, 32, 9343. 
, 2009, 394, 107. 
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a. binding the analyte to the spacer arm brings lanthanide in close proximity to the Ln3+ and 
switches on the luminescence, 
b. the analyte provokes the conjugation of the antenna to the lanthanide complex and therefore 
enables the sensitization process, 
c. direct coordination of the analyte to the lanthanide removes a weakly coordinated antenna 
and turns off the lanthanide's luminescence. 
An interesting example for lanthanide sensors for protease activity is antenna-chelator 
conjugate, which acts by emitting the strong luminescence signal once the protease cleaves the amide 
bond in the complex.174 Also, the application of peptide bound DOTA[Tb3+] complex for cyclin A probe 
was reported.175 The concept of this sensor is based on the intermolecular lanthanide sensitization 
through the tryptophan residue placed in the surface of the peptide. 
  
                                                           
174 S. Mizukami, K. Tonai, M. Kaneko, K. Kikuchi, J. Am. Chem. Soc., 2008, 130, 14376.  
175 E. Pazos, D. Torrecilla, M. V. López, L. Castedo, J. L. Mascareñas, A. Vidal, M. E. Vásquez, J. Am. Chem. Soc., 2008, 130, 
9652. 
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II. Result and discussion: chromophores based on pyrazinic core 
II.1. Background 
The preparation and the valorization of new chromophores is a challenging task nowadays, 
taking into account the requirements that need to be fulfilled. The efficient sensitizer for lanthanide 
complexes needs to have well defined excitation and emission bands tailored for the lanthanide 
excitation. The synthesis pathway of this molecule should be simple and reproducible. Besides, it 
needs to be easily changeable giving access to different derivatives. From the photophysical point of 
view, it must be photostable to give a constant signal during the time of the experiments. 
In the course of investigation on the synthesis of original N-containing heterocycles conducted in 
our laboratory, we were interested in the 1,4-dihydropyrazines motif. This moiety gives a direct access 
to a range of 2,5-disubstituted pyrazines after deprotection/aromatization step and ipso facto opens a 
great possibility to synthesize various pyrazinic chromophores with a broad variety of electronic 
structures.9 
We can find some significant examples of the pyrazine ring system in biological organisms 
showing the luminescence properties. One of them is a coelenterazine isolated from marine 
organisms, including the sea pansy Renilla, the jellyfish Aequorea and the hydroid Obelia.176 This 
pyrazinic framework is responsible for the chemiluminescence of these animals by reaction with 
oxygen and formation of coelenteramide anion in the excited state (Fig. 82). 
 
Fig. 82 The chemiluminescence of coelenterazine 
The pyrazinic moiety has interesting photophysical properties, which have been proven useful in 
different fields of science. The photophysical features of pyrazine and its methylated derivatives at 
high pressure were examined first by Mitchell.177 They showed that when the pressure increases, the 
intensity of π -> π* transition increases and at the same time, the fluorescence intensity increases. 
Also, the effect of substituents linked to the pyrazine in the position 2 and 5 were investigated178 in 
series of polar and apolar solvents. One of tested molecules – dibenzofuran-2,2’-pyrazine in 
acetonitrile solution showed very high fluorescence quantum yields (more than 90 %) after excitation 
at 390 nm and with emission maximum above 410 nm (Fig. 83). 
                                                           
176 (a) K. Hori,M. J. Cormier, Proc. Natl. Acad, Sci. U.S.A., 1973, 14, 120; (b) O. Shimomura, F. H. Johnson, Proc. Nat. Acad. Sci., 
1975, 72, 1546; (c) C. M. Thomson, P. J. Herring, A. K. Campbell, J. Biolumin. Chemilumin., 1997, 8, 87; (d) K. Jones, F. Hibbert, 
M. Keenan, Trends Biotechnol., 1999, 17, 477; (e) J. W. Hastings, C. H. Johnson, Methods Enzymol., 2000, 305, 75.  
177 D. J. Mitchell, G. B. Schuster, H. G. Drickamer, J. Chem. Phys., 1979, 70, 2443. 
178 Z. Li, S. Wu, J. Fluorescence, 1997, 7, 237. 
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Fig. 83 Photophysical properties of pyrazine derivatives in acetonitrile solution 
178 
Moreover, the pyrazine may play a role as a ligand for transition metals such as ruthenium or rhodium 
(Fig. 84). One of the applications is construction of a light-absorber – electron-acceptor dyads with 
tridentate-bridge Ru-Rh complex of 2,3,5,6-tetrakis(2-pyridyl)pyrazine).179 This system enables a 
construction of a wide assortment of supramolecular arrangements.  
 
Fig. 84 Tridentate-bridged ruthenium-rhodium complex 
The pyrazinic ring has been incorporated into the porphyrin system in order to create the light-
harvesting assembly.180 This structure is able to enhance the fluorescence of porphyrin about 77 times. 
The introduction of pyrazine moiety in the polymer structure such as polyfluorene has been reported 
lately181 as an efficient polymer light-emitting diod (PLED). 
Recently, the pyrazine moiety has been applied as an original bis-pyridinylpyrazine chromophore 
for efficient sensitizing of Eu (III) and Sm (III) cations.182 This complex shows the red-shift of the 
maximum absorption wavelength compared to the usual terpyridine-based Ln(III) chelates. Moreover, 
a bioconjugation of non-symmetrical chelate provided a labelling marker for peptides (Fig. 85). 
                                                           
179 J. D. Lee, L. M. Vrana, E. R. Bullock, K. J. Brewer, Inorg. Chem., 1998, 37, 3575. 
180 K. Sugou, K. Sasaki, K. Kitajima, T. Iwaki, Y. Kuroda, J. Am. Chem. Soc., 2002, 124, 1182. 
181 W. Ming, L. Ying, X. ZhiYuan, W. LiXiang, Science China, chemistry, 2011, 54, 656. 
182 N. Maindron, S. Poupart, M. Hamon, J.-B. Langlois, N. Plé, L. Jean, A. Romieu, P.-Y. Renard, Org. Biomol. Chem., 2011, 9, 
2357.  
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Fig. 85 Bis pyridinylpyrazine chromophores 
Despite the relevant potential of pyrazine, its chemistry is under-developed in comparison with 
that of its isomers (i.e. dihydropyrazines) and pyridine. Given that non-flexible dimerization approach 
is the most often reported for the preparation of substituted 1,4-dihydropyrazines183 and pyrazines, 
the development of new methods of their synthesis and their functionalization is still a great 
challenge. 
II.2. Previous work  
 
The antennae, that we propose to construct, are based on pyrazinic heterocyclic frameworks chosen 
as a luminescent moiety. This molecule is indeed hypothesized to emit a significant amount of photons 
in the red/ near-infrared region of electromagnetic spectrum. In previous investigation, realized in our 
laboratory,9 we have demonstrated that this diazinic skeleton could be functionalized in a controlled 
and selective way, which appears as a main advantage in term of flexibility. Taking advantage of our 
previous works, the original 1,4-dihydropyrazine bis-vinyl phosphate A was synthesized in good yields 
from piperazine-2,5-dione (Fig. 86). This vinyl phosphate A became a starting point for the numerous 
palladium catalyzed cross-coupling reactions in order to obtain "symmetrical" 2,5-disubstitued 1,4-
dihydropyrazines. First, the reaction of Suzuki-Miyaura was tested with different boronic acids in the 
presence of 10 mol% of PdCl2(PPh3)2, aqueous Na2CO3 (2M) and few drops of EtOH in the reflux of THF. 
Products with different heterocyclic substituents were obtained with good yields. Then, the Stille 
cross-coupling with tin reagents was performed, providing the 1,4-dihydropyrazines with heterocyclic 
and vinylic substituents. 
                                                           
183 (a) X. Zhang, Z. Sui, Tetrahedron, 2006, 47, 5953;  (b) D. Aparicio, O. A. Attanasi, P. Filippone, R. Ignacio, S. Lillini, F. 
Mantellini, F. Palacios, J. M. de los Santos, J. Org. Chem., 2006, 71, 5897. 
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Fig. 86 
The treatment of 2,5-disubstituted dihydropyrazines with anhydrous trifluoroacetic acid in 
dichloromethane for 2h afforded desired pyrazines with fair to good yields. The using TMSI instead of 
TFA improved the time of reaction providing the same conversion of starting dihydropyrazines (Fig. 
87).  
 
Fig. 87 
The presented original strategy permits to synthesize 2,5-disubstitued pyrazines in three step 
synthesis starting from easily accessible products in a modulable methodology. 
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II.3. Spectroscopic properties  
 
The fluorescence properties of new synthesized pyrazines were tested and one of these 
compounds was selected for further investigation. These values may be compared to the derivative 
with benzofuranyl substituent presented before178; where excitation on the maximum of the band at 
390 nm leads to an emission band at 432 nm. A high quantum yield of fluorescence is observed (φf = 
90 %) in acetonitrile solution.  
Table 16 The comparison of photophysical properties of pyrazine derivatives
9
 
Molecule 
 
 
2,5-diphenylpyrazine 
 
 
2,5-dithiophenylpyrazine  
2,5-dibenzo[b]thiophenylpyrazine 
λabs [nm] 326 367 390 
λem [nm] 374 417 418 & 433 
ε [M
-1
cm
-1
] 12000 94200 8300 
φf [%] 
(CHCl3 solution) 
5 15 40 
 
Results presented in Table 16 signify that among three synthesized pyrazine derivatives, the one 
bearing benzo[b]thiophenyl group possesses the best photophysical properties for the lanthanide 
sensitization, which means the lowest energy of excitation and emission with the highest quantum 
yield of fluorescence. This molecule became for us a starting point for the preparation of various 
dihydropyrazine systems.  
 
II.4. Reactivity of 2,5-dibenzo[b]thiophenyl-pyrazine and construction of sensitizers 
for lanthanides with pyrazinic core 
 
II.4.1. Objectives of project 
 
Based on previous encouraging results and with the perspective of the valorization of pyrazine 
frameworks as a new NIR antenna, our objective was to introduce onto the dihydropyrazine moiety 
various relevant functional groups enabling to anchor via simple steps (e.g. click chemistry, 
nucleophilic substitution) the lanthanide chelator (DOTA). For our investigation, we have chosen the 
di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)pyrazine-1,4-dicarboxylate as the common moiety as it 
allows the preparation of various dihydropyrazinic systems (Scheme 35). In this aim, we have 
envisaged two possible routes for the preparation of the sensitizer: first via the Diels-Alder 
cycloaddition reaction using dihydropyrazine substituted with aryl group as a dienic partner and the 
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second one – via the functionalization of dihydropyrazine system under anionic conditions and by 
using standard transformations. A final step of deprotection/aromatization might be conducted to 
afford desired pyrazine moiety. As a system chelating lanthanides, we have chosen substituted cyclen 
derivative, taking into account the great stability of these complexes. With cyclen derivatives, the 
coordination cavity is achieved by the four nitrogen atoms of the ring and by four additional donor 
atoms located on each dangling arm. Moreover, this chelate is easily modulable, relatively stable on air 
and commercially available. 
 
 
Scheme 35 
 
II.4.2. DO3A derivative as a convienient chelator for lanthanides 
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (also known as DOTA) is an organic 
compound derived from cyclen. This 12-membered tetraaza macrocycle is usually applied as a 
complexing agent, especially for lanthanide ions. The transition metal and lanthanide DOTA complexes 
have medical applications as contrast agents and cancer treatments. 
N N
NN
HO
O
HO
O
OH
O
OH
O
 
Fig. 88 DOTA 
In our synthesis we used the three substituted cyclen moiety, in abbreviation DO3A, in order to have 
the possibility to attach our chromophore to the fourth N-atom. We have carried out the nucleophilic 
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substitution with 3.3 equiv. of tert-butyl bromoacetate, which was slowly added drop by drop to the 
mixture of cyclen with NaHCO3. This method permitted us to substitute only three nitrogens and purify 
the product 53 as a free secondary amine after filtration and crystallization from toluene.184  
 
Fig. 89 The synthesis of DO3A 
 
 
II.5. First approach - Construction of sensitizers via cycloaddition reaction 
II.5.1. Bibliographic background: Diels-Alder reaction  
Diels-Alder reaction is a [4+2] cycloaddition of a conjugated diene with a double or triple bond 
(the dienophile).185 This electrocyclic reaction involves the 4 π-electrons of the diene and 2 π-electrons 
of the dienophile. The driving force of the reaction is the formation of new σ-bonds, which are 
energetically more stable than the π-bonds.  
 
Scheme 36 Diels-Alder cycloaddition 
With its broad scope and simplicity of operation, the Diels-Alder is the most powerful synthetic 
method for unsaturated six-membered rings. The Diels-Alder reaction occurs via single cyclic transition 
state with redistribution of bonding valence electrons. The cisoid conformation of the diene is a 
prerequisite for the cycloaddition step. Favored by a fixed cisoid geometry are those substrates where 
the diene is fitted into a ring (i.e. cyclopentadiene). 
 
Scheme 37 Mechanism of Diesl-Alder reaction 
Overlap of the molecular orbitals (MOs) is required: 
                                                           
184 S. Mizukami, K. Tonoi, M. Kaneko, K. Kikuchi, J. Am. Chem. Soc., 2008, 130, 14376. 
185 O. Diels, K. Alder, Justus Liebigs. Ann. Chem., 1928, 460, 98. 
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Fig. 90 Orbital explanation of Diels-Alder reaction 
Overlap between the highest occupied MO of the diene (HOMO) and the lowest unoccupied MO of the 
dienophile (LUMO) is thermally allowed in the Diels-Alder reaction, provided the orbitals are of similar 
energy. The reaction is facilitated by electron-withdrawing groups on the dienophile, since this will 
lower the energy of the LUMO. Good dienophiles often bear one or two of the following substituents: 
CHO, COR, COOR, CN, C=C, Ph, or halogen. The diene component should be as electron-rich as 
possible. 
There are “inverse demand” Diels Alder reactions that involve the overlap of the HOMO of the 
dienophile with the unoccupied MO of the diene. This alternative scenario for the reaction is favored 
by electron-donating groups on the dienophile and an electron-poor diene. 
 
Fig. 91 Orbital explanation of "inverse demand" Diels-Alder reaction 
From reaction of an unsymmetrically substituted diene and dienophile, different regioisomeric 
products can be formed. The so-called ortho and para isomers are formed preferentially. The observed 
regioselectivity can be explained by taking into account the frontier orbital coefficients of the 
reactants.186 
 
Scheme 38 Regioselectivity of Diels-Alder reaction 
                                                           
186 I. Fleming, Frontier Orbitals and Organic Chemical Reactions, Wiley, London, 1976, p.110, 161. 
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II.5.2. Objectives 
Based on the anterior work conducted in our team on the Diels-Alder cycloaddition of 
benzoxazines and benzodioxanes, which notably conducted to new heterocyclic compounds exhibited 
antitumor activity,187 we have focused on the valorization of substituted dihydropyrazine derivative as 
a diene. The Diels-Alder cycloaddition followed by the complete aromatization of ring system will give 
an access to highly conjugated compound II. The deprotection and aromatization of cyclic scaffold 
provides to the pyrazino[d]naphto[1,2-b]thiophen system, which is highly conjugated therefore 
promising from the photophysical point of view. Indeed, the naphthalimide motif present in this 
structure has found an application as an antenna for dendrimers PAMAM.188 Therefore, we decided to 
elaborate the sensitizer based on the cycloadduct attached to the cyclen chelate. 
The spacer arm can be introduced to the system via trans-imidation step. Further modification 
of spacer and nucleophilic substitution with DO3A will afford the compound III, which after 
deprotection of tert-butyl esters may complex various lanthanide cations. The retrosynthetic pathway 
to obtain these molecules is presented on the Scheme 39. 
Scheme 39 
II.5.3. Results and discussion of Diels-Alder reaction  
Our starting molecule - dihydropyrazine substituted with benzo[b]thiophenyl groups shows a 
potential diene-character. A free rotation around the single bond is possible, however, the steric 
hindrance near the tert-butyl group favors the trans conformation (Fig. 91). We predicted that this 
dienic system may work well in thermal conditions.189 We have started the screening process with 5 
equiv. of N-methylmaleimide as a dienophile, heating the solution in toluene for several hours.  
                                                           
187 (a) G. Coudert, F. Lepifre, D. H. Caignard, P. Renard, J. Hickman, A. Pierré, L. Kraus-Berthier, FR 2002-12964 A 18 oct. 2002 
– WO 2003-FR3068 W 17 oct. 2003; (b) G. Coudert, N. Ayerbe, F. Lepifre, S. Routier, D. H. Caignard, P. Renard, J. Hickman, A. 
Pierré, S. Léonce, FR 2002-12965 A 18 oct. 2002 – WO 2003-FR3069 W 17 oct. 2003.  
188M. A. Alcala, S. Y. Kwan, C. M. Shade, M. Lang, H. Uh, M. Wang, S. G. Weber, D. L. Bartlett, S. Petoud,  Y. J. Lee, 
Nanomedicine, 2011, 7, 249. 
189 (a) A. Bourderioux, V. Bénéteau, J.-Y. Mérour, B. Baldeyrou, C. Ballot, A. Lansiaux, C. Bailly, R. Le Guével, C. Guillouzo, S. 
Routier, Org. Biomol. Chem., 2008, 6, 2108; (b) N. Ayerbe, S. Routier, I. Gillaizeau, S. Tardy, G. Coudert, Lett. Org. Chem., 2010, 
7, 121. 
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Fig. 92 Diels-Alder reaction with N-methylmaleimide 
 
First, this reaction was tested under classical thermal conditions. The mixture was heated in toluene 
solution and with micro-wave activation in the sealed tube. Tested conditions of reaction were 
depicted in Table 17 (Entry 1-5). The structure of compound 54 was assigned as presented on Fig. 91, 
however, an isomer with aromatized benzo[b]thiophen is also possible. The two-dimensional NMR 
investigation (HSQC, HMBC) were performed, but results did not enable to clearly determine if this 
structure is correctly represented. Then, the methodology was extended for other dienophiles 
(maleimide, ethyl acrylate, acrylonitrile, dimethyl acetylenedicarboxylate (DMAD) and diethyl 
acetylenedicarboxylate (DEAD)). 
Table 17 Diels-Alder reaction with dihydropyrazine as diene 
 
Entry Substrate Conditions Time Product Yield 
1 
 
(5.0 equiv.) 
Toluene,  
140 °C 
24 h 
 
58 % 
2 Toluene,  
110 °C 
24 h 95 % 
3 µ-waves, 
toluene, 
160 °C, 140 W 
45 min. 55 % 
4 µ-waves, 
toluene, 
160 °C, 140 W 
1 h 41 % 
5 
 
(5.0 equiv.) 
Toluene,  
110 °C 
72 h 
 
62 % 
6 
 
(excess) 
110 °C, neat, 
sealed tube 
48 h 
 
47 % 
 115 
7 
 
(excess) 
110 °C, neat, 
sealed tube 
5 days 
 
19 % 
8 
 
(5.0 equiv.) 
Toluene,  
150 °C 
48 h 
 
37 % 
9 
 
(5.0 equiv.) 
Toluene,  
150 °C, 
5 days 
N
N
S
Boc
Boc
59
CO2Et
CO2EtS
EtO2C
EtO2C
 
23 % 
As we can notice, the optimal conditions were obtained with thermal heating at  
110 °C for 24h (Table 17, Entry 2). In other applied conditions, remaining starting material was present 
in the reaction mixture and some part of degradation was observed. The microwave activation did not 
improve the yield of reaction; at the same time, the increase of the time of reaction (Table 17, Entry 4) 
decreased the yield of conversion, provoking the degradation of some starting material.  
Interestingly, even using 5 equiv. of dienophile we did not observe the product of double cycloaddition 
(our starting material is a double dienic system). Probably, the energy delivered for this reaction is not 
sufficient or the double cycloadduct is too much constrained to be a stable molecule. Moreover, the 
steric hindrance play a role of constrain for the double cycloaddition. 
Encouraged with the satisfactory results obtained with N-methylmaleimide, we have moved our 
investigation to other dienophiles. We have enlarged the scope of the Diels-Alder cycloaddition for 
dienophilic systems which permit the further modification of inserted groups in order to attach the 
chelate system for lanthanides. For this goal we have chosen maleimide, ethyl acrylate, acrylonitrile, 
and the activated dienophiles - dimethyl acetylenedicarboxylate (DMAD) and diethyl 
acetylenedicarboxylate (DEAD). We predicted to modifiy the ester and nitrile groups into the easily 
functionalizable alcohol or primary amine counterparts. The imide-moiety can be substituted by trans-
imidation reaction leading to the product with longer terminal chain and a new functional group. 
The results presented in Table 17 show that the most reactive dienophile in Diels-Alder reaction 
with our compound is N-methylmaleimide. Other products give much lower yields and the time of 
reaction was much longer. These may signify that starting dihydropyrazine derivative is not very active 
diene and it reacts well only with activated dienophile. In the case of non-substituted maleimide (Entry 
5), the yield is much lower and the complete conversion of starting materials requires longer heating. 
Moreover, the resulted product is less stable due to free NH bond. Low yields of isolation of products 
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56 and 57 result from the lack of regioselectivity of reaction (Entry 6 and 7), these reactions gave the 
mixture of products of mono- and di-addition very difficult to separate by the column 
chromatography. Dimethyl and diethyl acetylenedicarboxylates showed only double cycloaddition with 
moderated yields, probably due to the steric hindrance.  
Among all synthesized cycloadducts, the derivative with N-methylmaleimide has been involved in the 
further investigation, because of the great repeatability of the synthesis and the high yield of 
conversion. The compound 54 is stable in the air yellow solid, which allows easy storage and handling. 
 
II.5.4. Cleavage of tert-butoxycarbonyl groups 
The cleavage of N-Boc groups was carried out in acidic conditions in the presence of TFA at 0 °C in 
CH2Cl2. By using TMSI, a strong electrophile, instead of TFA, we managed to improve the yield of 
reaction. Both reactions gave the expected product 60 but the second method (using TMSI) was much 
more efficient (98 % in comparison with 32 % obtained after deprotection with TFA). During the 
deprotection, the aromatization step occurs with migration of the double bond. The structure of 
compound 60 was confirmed by the two-dimensional NMR experiments. 
 
Fig. 93 
The proposed mechanism is based on the stability of 1,4-dihydropyrazine moiety after elimination of 
tert-butyloxy carbamate group. This dihydropyrazine undergoes spontaneously the 
dehydrogenation/aromatization after aqueous work-up and provides the pyrazine scaffold directly. 
 
Scheme 40 
In order to validate the strategy for other cycloadducts, reaction of deprotection of the double adduct 
58 has been carried out in the presence of TMSI in dichloromethane, and the elimination of tBoc group 
with complete aromatization of the 7-membered cyclic system occurred (Fig. 94). 
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Fig. 94 
 
 
II.5.5. Aromatization of the polycyclic system 
In the aim to get the tetracyclic polyaromatic target compounds, a further aromatization step is 
needed. This transformation was carried out in the presence of 2 equiv. of DDQ (2,3-dichloro-5,6-
dicyano-1,4-benzoquinone) as a mild oxidizing agent in toluene at 90 °C. However, as remaining 
starting material was present in the reaction mixture, additional of 2 equiv. of DDQ allowed the 
completion of reaction within 18 h to give after isolation and purification the desired product 62 on a 
quantitative way (Fig. 95). 
 
Fig. 95 
In order to introduce the diversity on the maleimide nitrogen, we have envisaged to perform trans-
imidation reaction in the presence of aminoalcohol or diamine derivative in order to introduce the 
aminopropyl or hydroxypropyl-group. According to the literature,189 this reaction is possible for N-
methyl imides constructed into the cyclic systems (Fig. 96). 
 
Fig. 96 
In this aim, we have conducted the reaction of trans-imidation with N-methyl imide 62 in thermal 
conditions (110 °C) using 3-aminopropanol as solvent. The reaction took 3 hours and converted 
completely the starting material. The product isolated after precipitation and filtration appeared to be 
a double hydroxyamide formed by the double nucleophilic attack of the amine group on the open 
 118 
diamide. By carring out the reaction at 110 °C under classical heating in the presence of 3-
aminopropanol used as solvent, after 3 hours we isolated the difunctionalized adduct in 86 % yield. 
 
Fig. 97 
By using 1,3-diaminopropane, similar results were obtained and the difunctionalized adduct was 
isolated with 53 % yield (Fig. 97). 
In the aim to valorize these results, attempts were made to substitute both primary amine and 
hydroxyl-functions. We have predicted two possibilities: either the sunstitution of the hydroxyl groups 
by the halogen or the formation of esters from alcohols and amides from amino group with 
bromoacetic bromide. These envisaged products could be attached to the cyclen moiety by the 
nucleophilic substitution.  
II.5.6. Attempts to attach the DO3A moiety 
The first tested reaction was the Appel reaction190 with carbon tetrabromide and triphenylphosphine 
in toluene at 60 °C. This reaction did not give expected product, only the degradation of starting 
alcohol. Also, the application of NBS (N-bromo succinimide) with PPh3 in toluene was unsuccessful (Fig. 
98).  
 
Fig. 98 
From the other hand, we predicted the formation of the ester with bromoacetic bromide, this reaction 
should provide an ester with bromide terminal function. Tested condition (2.5 equiv. of bromoacetic 
bromide, 5 equiv. Et3N, CH2Cl2 or THF as solvents at 50 to 80 °C) did not lead to the expected product; 
we observed the decomposition of starting alcohol 62. 
                                                           
190 R. Appel, Angew.Chem. Int. Ed., 1975, 14, 801. 
 119 
 
Fig. 99 
The same situation was observed in the case of amino derivative 64. The applied reaction conditions 
gave only decomposition of starting material (Fig. 99). 
II.5.7. Summary 
This part of dissertation was devoted to the construction of original antenna systems for lanthanide 
sensitization based on the condensed polycyclic systems. We were able to develop the synthesis of 
new polycyclic systems and valorize our starting dihydropyrazine as a valuable diene for the Diels-
Alder reaction. Unfortunately, we did not manage to accomplish the goal due to the difficulties arising 
at the last step of undertaken strategy. We met the problem during the functionalization of hydroxy 63 
and amino 64 derivatives to attach them to the DO3A moiety. However, we hope that this reaction 
may be substituted by other transformation making our polycyclic system valuable chromophore 
system. 
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II.6. Second approach 
 
In order to valorize the pyrazinic scaffold in the domain of chromophores for lanthanide 
sensitization, we wanted to introduce an "easy-to-modulate function", which would serve to construct 
the spacing arm between the light harvesting center and the chelator of lanthanide. Two different 
pathways were envisaged. 
First, we could introduce a iodide atom, which could be advantageously used in the reaction of 
palladium-catalyzed cross-coupling (i.e. type Sonogashira). The Sonogashira cross-coupling could give 
an access to compounds with triple bond, which could be involved in a “click reaction”. 
Second, an aldehyde function could be submitted to further synthetic transformations (oxidation or 
reduction, olefination, reductive amination, etc.) and provides hydroxyl, amino, ester, nitrile groups for 
further modifications. 
The both strategies were designed to provide a linkage between the chromophore center and a ligand 
for lanthanide cations. 
 
Scheme 41 Possible functionalization of 1,4-dihydropyrazine 
II.6.1. Construction of spacing arm via cross-coupling reaction 
In order to construct the spacer by the cross-coupling reaction, the first step requires the 
introduction of a iodide atom onto the 1,4-dihydropyrazine derivative. The reaction of iodation was 
conducted under anionic conditions (-78 °C) in anhydrous THF in the presence of an excess of iodide 
(2.5 equiv.). This reaction provided uniquely to the mono-iodated product 65 in an efficient way  
(91 %). It is noteworthy that in the presence of HMPA used to stabilize formed anion, we obtained the 
3,6-diiodo derivative (66) with an excellent yield (93 %).  
The elaborated methodology enables to control the synthesis of dihydropyrazines substituted on 
three of four positions in the case of iodide derivatives. It is worth mentioning that the mixture of 
mono- and di-iodo-products is impossible to separate by the column chromatography. 
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Fig. 100 Regioselective synthesis of mono- and diiodo- derivatives of 1,4-dihydropyrazine 
These iodo-derivatives may be applied in the palladium-catalyzed cross-coupling reaction, i.e. 
Sonogashira type to introduce the triple bond useful from the point of view of cycloaddition reactions.  
II.6.1.a. Bibliographic background: Sonogashira cross-coupling 
This cross-coupling reaction between terminal alkyne and vinyl or aryl halides was first reported in 
1975 by Japanese chemists Sonogashira and Hagihara.191  
 
Scheme 42 Sonogashira coupling 
The Sonogashira coupling requires Pd(0) complex as catalyst and Cu(I) as co-catalyst. The mechanism 
of this reaction is not fully understood but theoretical predication indicates an existence of two 
catalytic cycles (palladium cycle and copper-involved cycle).192  
                                                           
191 K. Sonogashira, Y. Tohda, N. Hagihara, Tetrahedron Lett., 1975, 16, 4467. 
192 R. Chinchilla, C. Nájera, Chem. Rev., 2007, 107, 874. 
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Scheme 43 Proposed mechanisms of Sonogashira reaction with copper co-catalyst (a) and without (b) 
The main catalytic cycle starts with an oxidative addition to a pre-formed Pd(0) catalyst. 
Simultaneously, a copper acetylide is believed to be generated in a separate cycle through an 
activation of the alkyne by coordination of the copper catalyst to form a π-alkyne – Cu complex 
followed by deprotonation by a base (usually amine bases are applied for Sonogashira coupling). 
Generally the base is not sufficiently basic to deprotonate the alkyne on its own (pKa of the base has to 
be greater than 25), thus a pre-coordination of the alkyne to the metal to form a π-alkyne – Cu 
complex is probably occurring prior to the formation of the copper acetylide. Formation of a π-alkyne 
complex facilitates deprotonation of the alkyne due to an increase of the acidity of the C-H bond. This 
copper acetylide is involved in the transmetalation step with Pd(II) complex. Organic ligands on the Pd 
center are in the trans orientation and they convert to the cis isomer. In the final step, the product is 
released in a reductive elimination, what regenerated Pd(0). The organocopper compound is formed 
after reaction with a base and continues to react with palladium complex to reconstitute copper halide  
It exists also a "copper-free" variant of Sonogashira reaction, called the Heck-Cassar coupling.193 In the 
mechanism of this transformation, the alkyne can be deprotonated by base, and the catalytic cycle can 
be proceeded as for copper version. However, this reaction depends strongly on the electronic 
properties of the employed alkyne and the choice of base. 
The Sonogashira reaction is very useful transformation to construct the triple bond in complicated 
systems, enynes and enediynes, which serve as starting materials for cyclizations and synthesis of 
natural products. 
                                                           
193 (a) H. A. Dieck, F. R. Heck, J. Organomet. Chem., 1975, 93, 259; (b) L. Cassar; J. Organomet. Chem, 1975, 93, 253. 
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II.6.1.b. Application of Sonogashira coupling on the compounds 65 and 66 
The Sonogashira coupling was carried out in standard conditions in the presence of 
trimethylsilylacetylene. The free terminal alkyne may be obtained after desilylation with TBAF.  
We conducted our first attempt with PdCl2(PPh3)2 (10 mol%) as catalyst and CuI (25 mol%) as co-
catalyst in freshly distilled triethylamine as solvent with mono-iodide derivative 65. The reaction 
mixture was heated at 50 °C and after 40 hours gave complete conversion of starting material. The 
acidic aqueous work-up and purification by column chromatography provided expected alkyne 67 in 
excellent yield 91 %. 
N
N
Boc
Boc
I
S
S
10 mol% PdCl2(PPh3)2,
25 mol% CuI, Et3N, 50 °C, 40 h
H
N
N
Boc
Boc S
S
TMS
TMS
65 67 (91 %)
 
Fig. 101 Sonogashira coupling on the compound 66 
Starting from the diiodo derivative 66 and by doubling the quantity of reactants, we obtained the bis-
trimethylsilanylethynyl derivative 68 with good yield (79 %). The reaction was completed after only 4h, 
the transformation appeared to be very clean and we did not observe any traces of mixed products. 
N
N
Boc
Boc
I
S
S
20 mol% PdCl2(PPh3)2,
50 mol% CuI, Et3N, 50 °C, 4 h
H
N
N
Boc
Boc S
S
TMS
TMS
66 68 (79 %)
I
TMS
 
Fig. 102 Sonogashira coupling on the compound 67 
It should be noted that unsuccessful attempts were conducted in order to functionalize only one 
iodide atom by using 1 equiv. of alkyne derivative. However, in this case, only bis-coupled compound 
was isolated with unreacted starting material. 
 
II.6.1.c. Background of copper-catalyzed cycloaddition - application "click reaction" 
"Click Chemistry" is a term introduced by K. B. Sharpless in 2001 to describe reactions that are 
high yielding, wide in scope, create only by-products that can be removed without chromatography, 
are stereospecific, simple to perform, and can be conducted in easily removable or benign solvents. 
This concept was developed in parallel with the interest within the pharmaceutical, materials, and 
other industries in capabilities for generating large libraries of compounds for screening in discovery 
research. 
Although meeting the requirements of a "click" reaction is a tall order, several processes have 
been ascribed to this category. Among them, we can mention nucleophilic ring opening reactions: 
epoxides, aziridines; non-aldol carbonyl chemistry: formation of ureas, oximes and hydrazones; 
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addition to carbon-carbon multiple bonds: especially oxidative addition and Michael additions of Nu-H 
substrates; and cycloaddition reactions: especially 1,3-dipolar cycloaddition. In this work, we will focus 
on the last transformation. 
 
Fig. 103 
The Huisgen 1,3-dipolar cycloaddition between azide and terminal alkyne often provides a 
mixture of two regioisomers of triazole (1,4 and 1,5 substituted) and it requires elevated 
temperatures. However, it is considered as an example of click chemistry just after one small 
modification: an application of metal catalysts. The copper(I)-catalyzed variant was first reported in 
2002 in independent publications by Meldal
194
 and Sharpless.
195
 This reaction is better termed the 
Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC). A copper-catalyzed variant can be conducted 
under aqueous conditions, even at room temperature. 
 
Fig. 104 
The ruthenium-catalysed 1,3-dipolar azide-alkyne cycloaddition (RuAAC)
196
 gives the 1,5-triazole. 
Unlike CuAAC in which only terminal alkynes reacted, in RuAAC both, terminal and internal alkynes can 
participate in the reaction. This suggests that ruthenium acetylides are not involved in the catalytic 
cycle. 
 
Fig. 105 
Mechanism of CuAAC was first established by Sharpless et al.
197 based on the DFT calculations. 
The copper (I) species generated in situ forms a π complex with the triple bond of a terminal alkyne. In 
the presence of a base, the terminal hydrogen, being the most acidic is deprotonated first to give a Cu 
acetylide intermediate. The ligands employed are labile and are weakly coordinating. The azide 
displaces one ligand to generate a copper-azide-acetylide complex. At this point cyclization takes 
place. This is followed by protonation; the source of proton being the hydrogen which was pulled off 
from the terminal acetylene by the base. The product is formed by dissociation and the cooper catalyst 
complex is regenerated for further reaction cycles. 
                                                           
194 C. W. Tornøe, C. Christensen,, M. Meldal, J. Org. Chem., 2002, 67, 3057. 
195 V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, Angew. Chem. Int. Ed., 2002, 41, 2596. 
196 B. C. Boren, S. Narayan, L. K. Rasmussen, L. Zhang, H. Zhao, Z. Lin, G. Jia and V. V. Fokin, J. Am. Chem. Soc., 2008, 130, 8923. 
197 F. Himo, T. Lovell, R. Hilgraf, V. V. Rostovtsev, L. Noodleman, K. B. Sharpless, V. V. Fokin, J. Am. Chem. Soc., 2005, 127, 210. 
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In the reaction without the catalyst, the alkyne remains a poor electrophile. Thus high energy 
barriers lead to slow reaction rates. The reaction is assisted by copper, which, when coordinated with 
the acetylide lowers the pKa of the alkyne C-H by up to 9.8 units. Under certain conditions, the 
reaction may be carried out even in the absence of a base. 
 
Scheme 44 
The cooper(I)-catalyzed cycloaddition is considered as bioorthogonal reaction due to the high specifity 
and the biocompability of reactants. It may be carried out in aqueous media; respective triazols may 
be obtained from biomolecules after simple modification. Neither azides nor alcynes react with other 
functional groups commonly present in biomolecules, there is no need for protecting groups.  
In the course of our investigation, we envisaged the introduction of spacing arm by applying the “click 
reaction” with alkyne function already introduced onto the dihydropyrazine moiety, in order to insert 
different functional groups and then to attach the DO3A ligand.  
 
II.6.1.d. Attempts of alkyne deprotection and click reaction 
In the first attempt, we predicted the deprotection of the dihydropyrazine moiety, followed by 
the deprotection of TMS group, however this synthetic pathway could not be achieved. The complete 
degradation of starting product 67 was observed. We tested the deprotection of tert-butoxycarbonyl 
groups in acidic conditions in the presence of TFA (10 equiv.) in CH2Cl2 at room temperature and at  
0 °C. 
 
Scheme 45 
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Thus, we decided first to deprotect the TMS group and after the “click reaction”, and to remove the 
tBoc group to have an access to pyrazines. The trimethylsilyl group can be cleaved in the presence of 
tetrabutylammonium fluoride (TBAF) in mild conditions (0 °C to room temperature). We have tested 
this deprotection step on the compound 67 with 2.2 equiv. of TBAF, but even after long time of 
contact (3 days) we observe only partial conversion of starting material. 
 
Fig. 106 Deprotection of compound 66 
According to recent results described in the literature, we thought to perform a direct “click reaction” 
on the TMS-protected alkynes with the deprotection step in situ,198 in order to optimize this step. 
 
Scheme 46 Click reaction with TMS-protected alkyne 
We decided to apply the same methodology to our compounds. We wanted to test the copper-
catalyzed cycloaddition reaction on the easy to synthesized model compounds and at the same time, 
introduce the functional group at the end of chain. The azide from 2-(2-benzyloxy-ethoxy)-ethanol and 
3-aminopropanol were formed in two-step synthesis. These compounds were predicted to introduce 
the hydroxy- and amino group to our dihydropyrazine derivatives. 
We have started from 2-(2-benzyloxy-ethoxy)-ethanol, which was first treated with methanesulfonyl 
chloride in the presence of triethylamine to form mesylate, a good nucleofuge. This mesylate was used 
without any purification and submitted to nucleophilic substitution in the presence of sodium azide. 
This two-step synthesis gave a desired azide 70 in good yield (52 %).  
 
Fig. 107 Formation of [2-(2-azido-ethoxy)-ethoxymethyl-benzene 70 
                                                           
198 C. Li, E. Henry, N. K. Mani, J. Tang, J.-C. Bronchon, E. Deprez, J. Xie, Eur. J. Org. Chem., 2010, 2395. 
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The same procedure was applied to 3-aminopropanol. In this case, we observed the formation of 
mesylate and of methylsulfonamide from the primary amino group 71. This synthesis yielded only  
20 % of good product. 
 
Fig. 108 Synthesis of N-(3-azidopropyl)methanesulfonamide 71 
These products are good partners of copper-catalyzed cycloaddition reaction, because they are water-
soluble, potentially easy to deprotect giving access to free alcohol or amine possible to functionalize 
via DO3A substitution. 
 
II.6.1.e. Tests of copper-catalyzed cycloaddition 
The obtained products 67 and 68 were subsequently used in the “click reactions” with azides in 
the aim to create the linkage for the DO3A attachment. The copper-catalyzed cycloaddition was 
preferably chosen in view of its great bioavailability, the aqueous operational conditions and the 
possibility to introduce the diverse functional groups. 
As it was previously presented, TMS-protected alkyne derivatives 67 and 68 were cleaved with 
difficulty. Notwithstanding we decided to use them directly in the click reaction, trying the in situ 
deprotection with an excess of TBAF (4 equiv. for one TMS group). Effectively, this procedure applied 
to the products 68 and 69 which provided respectively the cycloadducts 70 and 71 with mild yields (53 
% and 45 %).  
 
Fig. 109 
The same strategy was applied to the double substituted alkyne 67 providing double cycloadducts 72 
and 73 with lower yields (35 % and 30 % respectively). This was probably due to the steric hindrance 
around the pyrazinic core and the difficulty to form the catalytic copper-complex. From the other 
hand, we did not use any ligands for copper and that could also affect the results. These reactions 
should be optimized in order to improve the yield of the double cyclization. 
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Fig. 110 
II.6.1.f. Attempts of deprotection 
The step leading to the antenna system is a deprotection of benzyl or mesyl group and tert-
butyloxycarbamates. First, we tried to perform the deprotection step starting from compound 74 in 
the presence of 10 % Pd/C using an atmospheric pressure of H2 at room and at elevated temperature. 
In each case, only starting materials were recovered; no trace of the expected product was observed.  
 
Fig. 111 
At the same time, we were testing the deprotection reaction in acidic conditions, hoping that we 
would manage to unprotect two blocking functions in one step. The triisopropyl silane (TIS) was used 
as scavenger for free radicals. Unfortunately, this reaction also did not resulted in deprotection, even 
by using a large excess (10 and 45 equiv.) of trifluoroacetic acid at 0 °C or ambient temperature. The 
last attempt was to treat the cycloadduct 74 with the electrophile TMSI at 0 °C. This reaction provided 
complete decomposition of the starting product.  
 
Fig. 112 
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These failed attempts did not allow achieving the construction of the spacing arm, to attach DO3A 
moiety. However, the application of other protecting functions may be considered. At the same time, 
we proved that the copper-catalyzed cycloaddition is possible for our model compounds. The proper 
protecting group should be applied. 
 
II.6.2. Summary 
In the above paragraph we were considering the usefulness of our dihydropyrazine system in the 
reaction of copper-catalyzed cycloaddition. Indeed, this molecule could be transformed after the 
iodation reaction into the alkyne - derivative and then directly used in the “click reaction” with diverse 
azides. However, we did not manage to unprotect our pyrazinic core. In the perspective of this part of 
project, we envisage to connect the derivatized cyclen molecule (53).  
II.7. Construction of the spacing arm starting from a key aldehyde function 
 
The formylation reaction permits the introduction of an aldehyde group onto the 1,4-
dihydropyrazine system in the chosen position. This reaction was conducted under anionic conditions, 
treating the starting dihydropyrazine with 4.0 equiv. of LDA in the presence of 2.0 equiv. of HMPA. 
Introduction of DMF (5.0 equiv.) provided the aldehyde derivative 76 after a 5h reaction. 
 
Fig. 113 Formylation reaction 
We did not observe any product resulting of a double insertion of the aldehyde function, neither the 
deprotonation of thiophenic positions. The only by-product of this transformation was the carboxylic 
acid, which degraded directly after purification by flash chromatography. The aldehyde 74 was then 
subjected to Wittig-Horner-Emmons olefination reaction. 
 
II.7.1. Wittig-Horner-Emmons olefination reaction 
The Wittig - Horner reaction (called also Horner-Wadsworth-Emmons reaction) is the variant of the 
Wittig reaction for aldehydes or ketones with stabilized phosphorus ylides (phosphonate carbanions), 
which leads to olefins with excellent E-selectivity (Scheme 47).  
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Scheme 47 
As first reported by Horner,199 carbanionic phosphine oxide can be used; today carbanions from alkyl 
phosphonates are most often used. The latter are easily prepared by application of the Arbuzov 
reaction. The reactive carbanionic species are generated by treatment of the appropriate phosphonate 
with base (i.e. sodium hydride).  
The reaction mechanism is similar to the mechanism of the Wittig reaction. The stereochemistry 
is set by a steric approach control, where the antiperiplanar approach of the carbanion to the carbon 
of the carbonyl group is favored when the smaller aldehydic hydrogen eclipses the bulky phosphoranyl 
moiety. This places the ester group syn to the aldehyde R group, but the incipient alkene assumes an 
E-orientation of these groups after rotation to form the oxaphosphetane.  
The reaction of Wittig-Horner-Emmons is a very convenient transformation to get olefins with various 
terminal chains. Because of the reliability and wide applicability, the Wittig reaction and variations has 
become a standard tool for synthetic organic chemists. They are used as key steps in many organic 
syntheses of natural products,200 in the late stage of multi-step synthetic sequences.201 A real 
advantage of this transformation is that both Z and E isomers of alkene are available by choosing the 
reaction conditions.  
In the course of our work, diethylcyanomethyl phosphonate and triethyl phosphonoacetate has been 
chosen as active substrates for Horner-Wadsworth-Emmons (HWE) reaction because of their very 
active carbanions in α position to the phosphonate. As well, these substrates allow different 
modifications on the terminal functions leading to possible connection with the chelating system for 
lanthanides - DO3A. 
First, the appropriate carbanion was formed in the presence of NaH, then the addition of aldehyde 76 
provided after several hours desired products bearing a nitrile (77) and ester (78) group in a very 
efficient way (92 % and 80 %, respectively) (Fig. 114). 
                                                           
199 L. Horner, H. Hoffmann, H. G. Wippel, G. Klahre, Chem. Ber., 1959, 92, 2499. 
200 K. C. Nicolau, M. W. Härter, J. L. Gunzner, A. Nadin, Eu. J. Org. Chem., 1997, 7, 1283. 
201 G. Pattenden, A. Walter, S. J. Woodhead, Natural Product Synthesis, 2004, 101, 12024. 
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Fig. 114 
The following step of spacing arm formation involves the deprotection of dihydropyrazine moiety 
leading to free pyrazine core. 
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II.7.1.a. Formation of pyrazinic core 
 
The removal of tert-butylcarbamate function was undertaken in order to form aromatized pyrazinic 
core. Two possible protocols were tested: the treatment of TMSI (4.8 equiv.) at 0 °C and ambient 
temperature, and the deprotection in the presence of trifluoroacetic acid at 0 °C. The reaction in acidic 
conditions did not provide the good product in both cases, but the attack of strong electrophile TMSI 
led to the good unprotected pyrazine. The application of TMSI in anhydrous conditions on ester 78 
gave the pyrazine 79 with reduced double bond in a 76 % yield.  
 
Fig. 115 
However, in the case of nitrile derivative 77 we noticed a partial reduction of the double bond, 
depending on the quality of TMSI, the time of contact, and the temperature of reaction.  
 
Table 18 Optimization of the deprotection reaction of nitrile 
Entry TMSI (equiv.)  Temp. Time Yield [%] (ratio 80:81) 
1 4.8 rt 30 min. 72 (50:50) 
2 4.8 rt 60 min. 76 (40:60) 
3 6.0 0 °C 60 min. 61 (60:40) 
4 6.0 0 °C 3 h 53 (100:0) 
5 2.4 rt 60 min. 16 (50:50) 
 
As it was presented in Table 18, the obtainment of reduced product varied largely in the applied 
conditions. Increasing the time of contact (Table 18, Entry 1 and 2), we observed the increase of 
quantity of unsaturated nitrile 81. From the other hand, the increase of number of equivalents of TMSI 
provoked the reduction of double bond and provided the product 80 (Table 18, Entry 3 and 4). At the 
same time, the lower number of equivalents of TMSI gave equimolar mixture of products 80 and 81. 
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The best results were obtained with freshly open bottle of TMSI, after stirring for 60 minutes at room 
temperature (Table 18, Entry 2). 
Trying to understand the mechanism of deprotection and partial reduction of the double bond in 
the presence of TMSI, we found some examples in the literature, which describe similar 
phenomenon.202 In the case of an α,β-unsaturated ester, the reaction is initiated by 1,4-addition of 
TMSI to produce a β-iodo enol silyl ether intermediate, whose allylic and benzylic iodo substituent will 
be extremely labile and attacked by an iodide anion existing in milieu, to generate the iodine molecule. 
 
Scheme 48 
Also we have described an experiment which proves that, by using the reactant TMSI, we can 
have a liberation of HI in these reaction conditions. To prove the presence of HI, we carried out an 
experiment with norbornen. We added the same number of equivalents of TMSI (4.8 equiv.), as in the 
typical deprotection reaction, to the solution of norbornen in CH2Cl2 and we observed the addition of 
HI onto the double bond. The same situation took place with freshly prepared TMSI from TMSCl and 
NaI in acetonitrile (Fig. 116).203 
 
Fig. 116 
Thus, the reaction of deprotection of ester 78 was carried out in the presence of norbornen. Taking 
into account that in the case of deprotection of this ester, the complete reduction of the double bond 
occurred, we wanted to trap the HI by addition of an equimolar amount of norbornen. However, the 
reaction of ester 78 with norbornen provided only the saturated pyrazinic ester 79 in 40 % yield and 
the iodo – bicycle[2.2.1]heptane. In the case of in situ produced TMSI from TMSCl and NaI, we 
obtained also the ester 79 in 51 % yield and a product of complete addition of HI to norbornen.  
 
                                                           
202 (a) J. M. Robinson, G. T. Daniel, S. J. Hale, J. Org. Chem., 1986, 51, 109; (b) T. Sakai, K. Miyata, M. Utaka, A. Takeda, Bull. 
Chem. Soc. Jpn., 1987, 60, 1063. 
203 S. Irifune, T. Kibayashi, Y.Ishii, M. Ogawa, Synthesis, 1988, 5, 366. 
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Fig. 117 
These experiments proved that we have got a hydroiodide in the reaction, which is responsible for the 
reduction of the double bond. In the same time, we did not manage to avoid this reaction by addition 
of norbornen as a "sponge" for created HI. 
 
II.7.1.b. Reduction of ester and formation of compatible function to attach the DO3A 
The reduction of ester 79 was first conducted with DiBAL (1.2 equiv.) at 0 °C, but in these conditions, 
the starting material remained intact. After increasing the temperature to 20 °C, a mixture of aliphatic 
alcohol 82, traces of aldehyde and an ester were obtained. The ratio of each compound was 
determined by 1H NMR of the crude, but the isolation of an aldehyde derivative was not possible by 
column chromatography. Then, the complete reduction of α,β-unsaturated ester was conducted in 
anhydrous THF in the presence of LiAlH4 (2.0 equiv.) at 0 °C to give quantitatively the alcohol 82.  
Scheme 49 
For the next investigations, we focused on the alcohol 82, which can be modified in the reaction of 
exchange of hydroxyl group to halogen (Br, I) or the esterification reaction with bromoacetic bromide. 
Our aim was to introduce a functional group compatible with the DO3A attachement.  
The bromide derivative 83 was obtained using standard conditions (PPh3, NBS, DMF, 30 min., 60 °C) or 
in the Appel conditions (PPh3, CBr4, DMF, 18h, rt) with respective yields (66 % and 80 %). The iodide 84 
was isolated in 67 % yield by reacting the compound 82 in the presence of PPh3, imidazole and I2 in 
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toluene at 60 °C. As well, the treatment of alcohol 80 with bromoacetic bromide in the presence of 
Et3N gave the bromo - ester 85 with correct efficiency (79 % yield). 
 
Fig. 118 
Having in hand these newly synthesized electrophilic derivatives, they were submitted to nucleophilic 
substitution in the presence of cyclen DO3A derivative 53. According to the literature conditions,157 a 
first attempt was carried out in the presence of Et3N (2.0 equiv.) in acetonitrile with bromide derivative 
83. A reaction was carried out for 60 h at 80 °C and with complete consumption of starting material 83. 
However, after work-up and purification by column chromatography, only starting cyclen and the by-
product were obtained. We supposed that bromide derivative 83 eliminates HBr in the long heating 
reaction and forms the (dibenzo[b]thiophen-2-yl)pyrazine bearing an allylic chain. We decided 
therefore to change the base for Na2CO3 and solvent for THF.
204 However, in these conditions we 
observed also the formation of by-products instead of expected one. The same situation was observed 
with a stronger base K2CO3.
205 That is why we abandoned the nucleophilic substitution with bromide 
derivative 83 and moved to the iodide 84, supposed to show higher reactivity. First we attempted the 
substitution with triethylamine under reflux of acetonitrile, but without success. Next, we tested 
inorganic base K2CO3 and here, once again, we observed the elimination of halogen and we recovered 
intact DO3A product. These reactions failed because of the low nucleophily or the hindrance of the 
secondary amine - DO3A, and at the same time, the low stability of tested halogens' derivatives 83 and 
84 in applied conditions.  
                                                           
204 M. Botta, S. Quici, G. Pozzi, G. Marzanni, R. Pagliarin, S. Barra, S. G. Crich, Org. Biomol. Chem., 2004, 2, 570 
205 N. Raghunami, G. P. Guntle, V. Gokhale, G. S. Nichol, E. A. Mash, B. Jagadish, J. Med. Chem., 2010, 18, 6746 
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Table 19 
 
Entry X Base Solvent Temp. Time 
1 Br Et3N Acetonitrile 80 °C 60 h 
2 Br Na2CO3 THF 66 °C 16 h 
3 Br K2CO3 THF 66 °C 16 h 
4 I Et3N Acetonitrile 80 °C 60 h 
5 I K2CO3 THF 66 °C 60 h 
 
Finally, we decided to apply brominated ester 85, a better source of electrophilic bromine, to carry out 
the nucleophilic substitution with the secondary amine. According to the literature,206 we dissolved the 
DO3A derivative in THF and suspended Na2CO3 to activate the secondary amine. Then, the solution of 
ester 85 was added and the mixture was heated for 20 h under reflux of THF. After this time, complete 
consumption of both starting materials was observed and desired DOTA derivative 86 was isolated in a 
good yield 73 %. This product was subjected to the deprotection of tert-butyl esters in order to liberate 
the acid functions, necessary for the metal complexation. 
 
Fig. 119 
                                                           
206 C. Tu, E. A. Osborne, A. Y. Louie, Tetrahedron, 2009, 65, 1241. 
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II.7.1.c. Reduction of nitrile, formation of amide and SN on cyclen derivative 
At the same time, we have envisaged the connection of cyclen moiety via an amide bond. In this aim, 
we wanted to reduce the nitrile derivative 81 to obtain a primary amine. However, the reduction 
appeared to be more complicated than it was supposed. As it was explained in the paragraph II.7.1.a, 
after the deprotection of dihydropyrazine moiety with terminal nitrile group, the mixture of reduced 
and non-reduced product, impossible to separate by the column chromatography, was obtained. In 
the first approach, this mixture was directly applied to the reduction step in the presence of LiAlH4 in 
THF at room temperature.  
 
Fig. 120 
We observed that some part of mixture (the unsaturated nitrile) undergoes the reduction, giving the 
amine 87. Saturated nitrile 80 does not react in these conditions. However, during all the test of 
deprotection, we recovered much more of the saturated nitrile, than unsaturated one. Thus, we 
wanted to use this product in the reduction step, testing different conditions, presented in Table 20. 
Table 20 
 
Entry Conditions Time Results 
1 
1) LiAlH4 (2 equiv.), THF, t.a. 
2) H+, H2O 
16h No reaction 
2 H2, Pd/C, MeOH, rt 72h Degradation 
3 
1) CoCl2, MeOH, 0 °C 
2) NaBH4, 0 °Crt 
3) H+, H20 
30 min. 
1h 
Degradation 
4 
NH2NH2∙H2O, Ni Raney 
EtOH, 50 °C 
18h Degradation 
5 H2 (80 psi), (CF3CO)2O, Ni Raney, THF, 30 °C 18h Not isolable 
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The degradation of starting material was observed by using hydrogen under atmospheric pressure 
with Pd/C catalyst, using NaBH4 with CoCl2 and also in the presence of hydrazine with Ni Raney catalyst 
(Entry 2, 3 and 4). The reduction with Ni Raney in the presence of trifluoroacetic acid anhydride gave a 
non-isolable product.  
The amine derivative 87, obtained from the reduction of the mixture of nitrile derivatives (Fig. 120), 
was transformed into the amide 88 in a good yield (75 %) by reaction with bromoacetic bromide, 
according to conditions already described for ester derivative 85. This amide was subjected to the 
nucleophilic substitution with DO3A, giving product 89 isolated in good yield (75 %) – Fig. 121.  
 
 
Fig. 121 
II.7.1.d. Deprotection and complexation step 
According to the literature,158,160 the cleavage of tert-butyl esters may be conducted in an excess of 
trifluoroacetic acid in dichloromethane at 0 °C. We applied these conditions to ester derivative 84. 
After overnight stirring, we did not observe any conversion of starting materials. Therefore, we 
warmed the reaction to room temperature without any success. By increasing the temperature to 
reflux of CH2Cl2, the cleavage of pyrazinc ester was observed. The use of formic acid at room 
temperature afforded a complete decomposition of starting material. 
 
Fig. 122 
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These results indicate that the ester derivative 86 will be difficult to unprotect without the cleavage of 
molecule and a change of protecting group in cyclen derivative should be envisaged. 
Subsequently, we moved forward to the amide product 89 regarding the higher stability of amide 
bond to the cleavage in acidic conditions. The product 89 was dissolved in a mixture TFA/CH2Cl2 (50/50 
% vol) with 2%vol of triisopropylsilane as scavenger for formed carbocations. The reaction took 16 
hours and gave expected triacetic acid 90 in an excellent yield (94 %). 
 
 
Fig. 123 
This product was directly involved in the complexation reaction with triflate salts of neodymium, 
ytterbium and gadolinium in order to get lanthanide complexes. The complexation reaction was 
carried out in methanol, in equimolar amounts of chelate and lanthanide salt, by heating at 50 °C for 
16 hours. 
 
Fig. 124 
The lanthanide complexes were obtained in high yields 85 % (for Nd3+), 82 % (for Yb3+) and 83 % (for 
Gd3+). The structures of obtained products were confirmed by high resolution mass spectrometry 
(HRMS). Their absorption and emission spectra were measured in order to confirm the presence of 
metal in the chelation center and to estimate the ability of complexes to sensitize the lanthanides (see 
paragraph II.8).  
 
II.7.2. Reduction of aldehyde and reactivity of obtained alcohol 
We envisaged enlarging the scope of possible sensitizers by introduction of a shorter arm based 
on the ether or ester function. To reach this aim, we need to transform the aldehyde 76 to alcohol, 
which presumably will react with propargyl bromide to give a terminal alkyne or bromoacetic bromide 
providing bromated ester. 
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Scheme 50 
As mentioned before, the aldehyde function of the dihydropyrazine derivative 76 may be reduced to 
give appropriate alcohol derivative 94. We tested the reduction reaction with two reducing agents 
(LiAlH4 and NaBH4) and better yield was obtained in the first case (quantitative compared to 90 %). 
 
Fig. 125 
The predicted reaction of transformation of alcohol derivative 94 into an ester or ether gave only 
products of degradation. Any traces of expected products were observed. Therefore, we first 
anticipated the reaction of deprotection and then, the further modification of alcohol. At the first 
attempt, the deprotection with TMSI was applied to give a product, which appeared to be 2,5-
di(benzo[b]thiophen-2-yl)-3-methylpyrazine 95, the product of deprotection of carbamate and 
elimination of hydroxyl group in an excellent yield of 90 %. The change of reaction conditions to 
TFA/TIS did not permit to get expected product. We isolated the same product 95, but with lower yield 
(33 %). 
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Fig. 126 
We abandoned this pathway of synthesis and we tried to undertake the Dield-Alder reaction on 
alcohol 94 in order to get possibility to link the spacing arm on this system. The same conditions of 
reaction were applied as for dihydropyrazine derivative (see paragraph II.5.3). The cycloadduct 96 was 
obtained in low yield (34 %), probably due to the deactivation of diene character by the introduction of 
a methylhydroxy group.  
 
Fig. 127 
The deprotection of nitrogen atoms of dihydropyrazine moiety with TMSI or TFA led to the elimination 
of a water molecule and gave similar to methyl derivative, product 97 (34 %).  
 
Fig. 128 
Unfortunately, this access to construct the spacing arm on the methylhydroxy group had to be 
abandoned, from one hand due to the difficulty of functionalization of protected compounds and from 
the other hand, because of the deprotection stage the hydroxyl group is eliminated, required for 
further modifications. However, this synthetic pathway is not closed and a trans-imidation step could 
be envisaged in order to introduce functional groups allowing the attachment to the cyclen moiety. 
 
 
 
 
 142 
II.7.3. Reductive amination 
II.7.3.a. Short introduction 
Afterwards, we have envisaged the introduction of the spacing arm to the pyrazinic core by a 
reductive amination. This reaction involves the conversion of carbonyl group (most commonly a 
ketone or an aldehyde) to an amine via an imine intermediate reduced by the use of reduction agents; 
such as sodium borohydride (NaBH4) or sodium cyanoborohydride (NaBH3CN) or sodium 
triacetoxyborohydride (NaBH(OAc)3).  
 
Scheme 51 Reductive amination 
The amine first reacts with the carbonyl group to form a hemiaminal species, which 
subsequently loses one molecule of water in a reversible manner by alkylimino-deoxo-bisubstitution to 
form the imine. The equilibrium between the carbonyl compound and the imine can be shifted toward 
the imine formation by removal of water. The imine intermediate can be isolated and reduced with 
suitable reducing agent. However, the direct reductive amination may also take place with reductors, 
more reactive toward protonated imines than ketones and stable in moderately acidic conditions, such 
as NaBH3CN or NaBH(OAc)3. 
II.7.3.b. Examples of reductive amination onto the aldehyde 76 
We tested several primary amines to check the reactivity of our aldehyde 76 in the reductive 
amination reaction. First, we applied 3-aminopropanol as a substrate offering the free hydroxyl group 
for further modifications. We used the particular conditions described in a recent publication.207 The 
solution of aldehyde in MeOH was prepared, then 3-aminopropanol and Et3N was added, followed by 
catalyst Ti(iPrO)4. After 60 h of stirring at room temperature, NaBH4 was added to reduce an imine. 
After work-up, the crude product was verified by 1H NMR to be unreduced imine. The purification by 
column chromatography resulted in the decomposition of product. Therefore, the reaction was 
repeated without addition of reducing agent and at the end, the crude was reduced in the presence of 
H3BO3 and sodium borohydride to give expected secondary amine with 30 % of global yield after two 
steps. 
                                                           
207 A. Novoa, N. Pellegrini-Moïse, D. Bechet, M. Barberi-Heyob, Y. Chapleur, Bioorg. Med. Chem., 2010, 18, 3285. 
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Fig. 129 
This reaction gave a secondary amine with a very poor yield. Therefore, we decided to test another 
reactions with primary amines, such as 2-aminobenzylamine or N-benzylethylenediamine. Tested 
reduction agents were: NaBH(OAc)3 and NaBH4 to conduct to the direct reductive amination without 
the step of isolation of imine. Unfortunately, the reaction between aldehyde derivative 74 and N-
benzylethylenediamine did not work in both conditions, the formation of imine did not occurred and 
aldehyde was reducted to the alcohol. At the same time, with 2-aminobenzylamine, we managed to 
isolate expected product after reduction with NaBH(OAc)3 with excellent yields.  
 
Fig. 130 
This reaction shows an opportunity to enlarge the scope of possible reaction of aldehyde 74 and 
introduce a more complicated molecule by mean of reductive amination in relatively mild conditions. 
In perspectives, the deprotection of dihydropyraznic moiety and further functionalization of the 
aromatic amine and the alcohol are envisaged in order to anchor the cyclen derivative and construct 
the lanthanide complex. 
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Scheme 52 
Notably, the following paragraph will be dedicated the formation of particular chromophores 
based on azo dyes, which can be attached to the pyrazinic system by the reductive amination. 
 
 145 
II.8. Spectroscopic properties of compounds 91 and 92 
II.8.1. Absorption and emission spectra 
The UV-Vis absorption spectra of the lanthanide complexes were measured in solution DMSO/ H2O 
(1/9) in concentration 100 µg/mL at room temperature and they are presented in Fig.131. 
 
 
Fig. 131 
Both spectra of absorption show apparent maxima at 380 nm. The absorption coefficient ε, which 
quantifies the ability of complex to absorb the light, is equal 8 700 M-1cm-1 for the complex with 
neodymium (91) and 8 800 M-1cm-1 for the ytterbium complex (92) – for organic chromophores this 
coefficient is usually in range 5 000 - 100 000 [M-1cm-1]. 
 
Fig. 132 
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The Yb3+ complex displays a unique NIR emission band ranging from 920 nm to 1050 nm, which is 
assigned to the 2F5/2→
2F7/2 transition. The relative intensities of the components of this band reflect 
the particular symmetry around the metal center. Respectively, for the Nd3+ complex, two 
characteristic bands were observed at 900 nm and 1064 nm. These emission bands are assigned to the 
transition from the level 4F3/2 to the level 
4I9/2 and 
4I11/2. The excitation spectra for the respective 
lanthanide complexes 91 and 92 with the emission monitored at the respective maxima of each 
lanthanide show the presence of one band with a maximum at 370 nm, which matches the position of 
the maximum of absorption of both compounds. These results indicate that the electronic levels 
associated with this band that are located on the chromophore are used for the sensitization of the 
lanthanide cations. In short, these results demonstrate that this sensitizer can act as an antenna for 
the sensitization of both Nd3+ and Yb3+ metal ions. 
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Fig. 133 
II.8.2. Emission spectra and determination of energy levels 
In the aim of analysis of the photophysical and energy processes occurring in these complexes, 
energies of the singlet and triplet states located on the ligand bound to the lanthanide cations have 
been measured. We have recorded the steady-state fluorescence and time-resolved phosphorescence 
spectra for the ligand coordinated to Gd3+ that act as silent metal center. Indeed, the electronic levels 
of gadolinium complex are too high in energy to allow ligand to lanthanide energy transfer. 
The excited chromophore may be in the state S1 or T1, however the experiment in the cool conditions 
permits to "freeze" the transfer and to increase the signal of phosphorescence. Fluorescence spectrum 
recorded at room temperature (Fig. 134) shows the presence of a broad band assigned to the S1→S0 
transition with apparent maximum at 450 nm. The phosphorescence spectra recorded at 77K with 50 
µs and 100 µs delay after flash (Fig. 135) indicates a presence of a broad band with maximum at 498-
503 nm, which is assigned to the transition T1→S0. The average energy of triplet state is estimated for 
19900 cm-1, which makes our complex preferable for the energy transfer to the Yb3+ cation. 
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Fig. 134 Fluorescence of gadolinium complex 
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Fig. 135 The comparison of steady state and delayed emission of complex 93. 
Having in hand results of our sensitizing system for the energy of singlet and triplet state, we 
compared them to the sensitizer formed with phenantroline chromophore.153 The energy level of 
triplet states is comparable for both molecules (19 900 cm-1 for our pyrazinic system versus 21 200 cm-
1 for phenantroline). However, the energy of singlet is completely different: a cited molecule has a 
high-energetic level at 29 200 cm-1 and the pyrazinic derivative shows a singlet at 23 000 cm-1, which 
makes it more valuable in the domain of biological application with lower energy required for the 
excitation (340 nm).  
Table 21 
 Compound 93 Reference – phenantroline153 
λexc [nm] 370 264 
Singlet state [cm-1] 23 000 29 200 
Triplet state [cm-1] 19 900 21 200 
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II.8.3. Quantum yields and luminescence lifetimes 
In order to quantify the ability of our sensitizers to transfer energy to the metal center, we made 
an experiment to quantify the quantum yield of luminescence emitted via the lanthanide. This 
experiment was carried out in the integration sphere on the Fluorolog - 322. Collecting NIR quantum 
yields (φ) requires the use of both a visible and a NIR detector. A relative quantum yield is measured 
using a reference sample with a known value (ytterbium tropolonate [Yb(trop)4]
- φYb = 1.9∙10
-2 and 
neodymium tropolonate [Nd(trop)4]
- φNd = 2.1∙10
-3).136  
In the case of our samples, we were measuring the emission of solutions of lanthanide complexes in 
DMSO/H2O (1/9) at two excitation wavelengths (340 nm and 380 nm) corresponding to our sensitizer 
and the tropolonate complexes. In order to get a statistical approval, we have made three repetition of 
every experiment. The results were placed in Table 22.  
Table 22 Relative quantum yields of Nd and Yb complexes 
Excitation at 340 nm QY Excitation at 380 nm QY 
Nd3+ complex 1 2.03∙10-5 Nd3+ complex 1 1.08∙10-5 
Nd3+ complex 2 3.73∙10-5 Nd3+ complex 2 1.05∙10-5 
Nd3+ complex 3 1.97∙10-5 Nd3+ complex 3 2.56∙10-5 
Average value 2.6∙10-5(±1.0∙10-5) Average value 1. 6∙10-5(±0.9∙10-5) 
Yb3+ complex 1 3.14∙10-5 Yb3+ complex 1 3.28∙10-5 
Yb3+ complex 2 2.80∙10-5 Yb3+ complex 2 2.94∙10-5 
Yb3+ complex 3 - Yb3+ complex 3 2.74∙10-5 
Average value 3.0∙10-5 (±0.2∙10-5) Average value 3.0∙10-5 (±0.3∙10-5) 
 
The quantum yield of Nd3+ complex equals 2.58∙10-5 at 340 nm and 1.56∙10-5 at 380 nm and for Yb3+ 
complex is slightly higher: 2.97∙10-5 (340 nm) and 2.99∙10-5 (380 nm). The quantum yields, for each 
case, are higher for the ytterbium than for the neodymium complex, which means that our 
chromophore sensitize more efficiently Yb3+. The obtained results show that quantum yields of both 
complexes can appear as low, but are relatively comparable to those obtained with several complexes 
of DOTA incorporating organic antenna.208 
Luminescence lifetimes monitoring the emission of the lanthanide cations were determined in order to 
analyze the protection of the lanthanide center against non-radiative deactivation and quantify the 
number of inner sphere water molecules. The analysis of the experimental luminescence decays 
obtained upon excitation of the complexes at 355 nm in the solution of H2O/DMSO (9/1) and 
                                                           
208 (a) J.-C. G. Bünzli, A.-S. Chauvin, H. K. Kim, E. Deiters, S. V. Eliseeva, Coord. Chem. Rev., 2010, 254, 2623; (b) M. V. López, S. 
V. Eliseeva, J. M. Blanco, G. Rama, M. R. Barnejo, M. E. Vázquez, J.-C. G. Bünzli, Eur. J. Org. Chem., 2010, 4532, (c) S. Comby, D. 
Imbert, C. Vandevyver, J.-C. G. Bünzli, Chem. Eur. J., 2007, 13, 936. 
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D2O/DMSO (9/1) revealed the best fittings as single-exponential functions. The fitted lifetimes upon 
monitoring Nd(4F3/2) and Yb(
2F5/2) bands are placed in Table 23. 
Table 23 
Complex λexc [nm] 
for quantum 
yield 
measurement 
φ, H2O/DMSO (9/1) τ [µs] 
H2O/DMSO 
(9/1) 
D2O/DMSO 
(9/1) 
q 
91 (Nd3+) 340 2.6∙10-5 0.089(2) 0.364(1) 0.7 
92 (Yb3+) 340 3.0∙10-5 2.48(1) 7.4(2) 0.1 
 
The luminescence lifetime is significantly longer for the Yb3+ complex than for Nd3+ which is consistent 
with the literature results; Faulkner158 reports for example the hydralazine-derived chromophore 
values 1.87 µs for Yb3+ and 0.09 µs for Nd3+ in H2O and respectively higher values in the D2O solution 
(7.88 µs and 0.33 µs). The q parameter for neodymium complex (0.7) means that this lanthanide has 
one molecule of water coordinated to the metal, however, the value of the q for ytterbium complex 
(0.1) signifies that no water molecule is complexed to the coordination sphere of this lanthanide. This 
phenomenon may be explained by the size of ionic radius of Ln3+, which equals 116.3 pm for nine-
coordinated Nd3+ and 98.5 pm for Yb3+, thus the smaller ytterbium cation is better shielded in the 
coordination cativity of cyclen and water molecules have greater difficulty to approach the lanthanide 
cation.209 
 
II.8.4. Conclusion 
The spectroscopic features of an originally synthesized ligand for lanthanide cations show that our 
system satisfies the condition of a sensitizer for lanthanides. We have quantified and identified the 
principal properties such as excitation and emission energy, the energy of singlet and triplet state as 
well as the energy transfer to the metal center (quantum yield). Our molecule is a promising prototype 
for a family of sensitizers, and its flexible synthetic pathway gives an opportunity to create a library of 
sensitizers with different spacing arms in order to test the influence of diversity in the system for the 
lanthanide emission. 
  
                                                           
209 (a) R. D. Shanon, Acta Cryst., 1976, A23, 751, (b) S. Faulkner, A. Beeby, R. S. Dickins, D. Parker, J. A. G. Williams, Journal of 
Fluorescence, 1999, 9, 45. 
 150 
III. Results and discussion: Sensitizers based on azo compounds 
III.1. Bibliography 
Azo compounds are chemicals consisted of aryl or alkyl part linked by N=N double bond. 
According to IUPAC terminology, these compounds are derivatives of diazene (diimide) HN=NH 
wherein both hydrogens are substituted by hydrocarbone groups, e.g. PhN=NPh azobenzene or 
diphenyldiazene. The first example of azo compounds - azobenzene was obtained by Alfred Noble in 
1856210 by heating nitrobenzene with iron filings and acetic acid at the reflux of methanol. This product 
has an intensive red-yellow color as a consequence of π-delocalized electrons.  
 
Fig. 136 Azobenzene and its chemical aspect 
Therefore, the azo compounds found an application as organic dyes and pigments. They have very 
vivid, intensive colors, which last for a long time. Many of pH indicators are azo compounds, due to 
their different colors at the basic and acid form. For example, the acid indicator - methyl orange 
chemically is p-dimethylamino-azobenzenesulfonic acid, which in the pH below 3.1 has red color and 
above 4.4 it takes yellow color. 
 
Fig. 137 The acid-base equilibrium in methyl orange 
Another azo dye known under name Congo red has not only pH-indication properties, but also it 
serves as a dye for the cellulose industry owing to its great affinity to cellulose fibers by the hydrogen 
bonding. Moreover, it is used as a stain for a visual detection of amyloids in muscle and nerve fresh 
frozen sections in patients who have amyloidosis. In the 1920s Benhold211 and Divry212 established that 
Congo red bound to amyloid in tissue sections and demonstrated its characteristic yellow-green 
birefringence under crossed polarizers. The linearity of the dye configuration permits hydrogen 
bonding of the azo and amine groups of the dye to similarly spaced carbohydrate hydroxyl radicals of 
the amyloid substance. Since then this birefringence has been used as a diagnostic for amyloid 
fibrils.213 
                                                           
210 A. Nobel, Justus Liebigs Annalen der Chemie, 1856, 98, 253. 
211 H. Benhold, München. Med. Wochenschr., 1922, 69, 1537. 
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Fig. 138 Congo red 
Additionally, Congo red is used in microbiological epidemiology to rapidly identify the presence of 
virulent serotype 2a Shigella flexneri by the binding to the bacterium's unique lipopolysaccharide (LPS) 
structure.214 
Non-aromatic azo compounds are noted as radical reaction initiators, because they are unstable at 
elevated temperature or upon irradiation and they liberate N2 and free radicals. The very well-known 
example is azobisisobutylonitrile (AIBN) widely used in industrial scale as initiator of polymerization 
reaction. Recently, azobenzenes have shown the potential application in the field of nonlinear optics, 
liquid crystals,215 nanotubes,216 photochemical molecular switches217 and molecular shuttles.218Also in 
the field of medicine, they supposed to be a therapeutic agents and prodrugs to carry the therapeutic 
agents.219 
One of the most intriguing properties of azo compounds is the photoisomerization of trans and cis 
isomers. The two isomers can be switched with particular wavelengths of light: ultraviolet light, which 
corresponds to the energy gap of the π-π* (S2 state) transition, for trans-to-cis conversion, and blue 
light, which is equivalent to that of the n-π* (S1 state) transition, for cis-to-trans isomerization. The cis 
isomer is less stable due to steric hindrance than the trans, it has a distorted configuration and is less 
delocalized than the trans configuration. Thus, cis-azo compound will thermally relax back to the trans 
via cis-to-trans isomerization. The trans isomer is more stable by approximately 50 kJ/mol, and the 
barrier to photoisomerization is approximately 200 kJ/mol.220 
 
Fig. 139 Photoisomerization of azobenzene 
The photoisomerization of azobenzene is extremely rapid, occurring on picosecond timescales. The 
rate of the thermal back-relaxation varies, greatly depending on the compound: usually hours for 
azobenzene-type molecules, minutes for aminoazobenzenes, and seconds for the pseudo-stilbenes. 
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This feature makes from azo compounds potential candidates to modulate relative movement of 
different moieties. It has been proven that the motion of one molecule containing an azobenzene 
group can control the movement of a complementary substrate non-covalently bound to the 
azobenzene fragment.221 In the biological system, this photoisomerization may enable the control of 
biomolecules as enzymes of nucleic acids. Liang et al.222reported that this process of the azobenzene 
tethered to the third strand of nucleic acid assists a formation and dissociation of DNA triplex.  
 
Fig. 140 Photoregulation of formation of DNA triplex 
III.2. The synthesis of azo compounds 
Several methods of synthesis of azo compounds exist. The classical one is the azo coupling reaction 
between diazonium salt and electron-rich aromatic compound, the Mills and the Wallach reactions. 
Recently, some more efficient strategies have been reported by Len et al.223 with particular emphasis 
to the carbohydrate domain. In this work, we will focus on the specified methods and we will point out 
other more particular strategies. 
 
III.2.1. Formation of diazonium salt and azo coupling 
Azo coupling is the most widely used industrial reaction in the production of dyes, lakes and pigments. 
An aromatic diazonium ion acts as electrophile in coupling reactions with activated aromatics such as 
anilines or phenols. The substitution normally occurs at the para position, except when this position is 
already occupied; in this case ortho position is favored. The diazonium salt formation is called 
diazotation; this process requires aromatic amines (anilines) and the presence of nitrous acid. Usually 
the nitrous acid is generated in situ from sodium nitrite and mineral acid. In aqueous solution 
diazonium salts are unstable at temperatures above +5 °C; the -N+≡N group tends to be lost as N2 
(nitrogen gas). Diazonium compounds can be isolated as tetrafluoroborate salts, which are stable at 
room temperature. Often, diazonium compounds are not isolated and once prepared, used 
immediately in further reactions. 
                                                           
221 T. Muraoka, K. Kinbara, T. Aida, Nature, 2006, 440, 512. 
222 X. Liang, H. Asanuma, M. Komiyama, J. Am. Chem. Soc., 2002, 124, 1877. 
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Scheme 53 Mechanism of diazotation 
The reaction of diazotation is very pH dependant. For the formation of diazonium salt from an 
aromatic amine, an acid is indispensable to liberate in situ nitrous acid from sodium nitrite(III). Further 
protonation and water elimination provides the nitrosation agent (+N=O), which reacts with the amine 
group forming N-nitroso derivative, the tautomer of diazohydroxide. After a second protonation and 
H2O elimination, the diazonium salt is created (Scheme 53); this species is stabilized by resonance.
224 
 
Fig. 141 Mezoforms of arenediazonium ion 
Due to the positive charge, diazonium ions, participate in an electrophilic aromatic substitution 
as an electrophile. The electrophilic reaction center is the terminal nitrogen from the –N=N group. The 
electrophilicity of this group is relatively weak because of the delocalized positive charge. The 
unsubstituted benzenediazonium ion may react only with strongly activated aromatic compounds, 
such as phenolates or amines.  
The optimal pH for the coupling reaction depends on the nature of reactant. Phenols usually 
react in slightly alkaline solutions in order to activate the phenol moiety to the highly reactive 
phenoxide.  
 
Fig. 142 Diazo coupling with phenol 
For aryl amines, the reaction mixture should be considerably acidic or neutral to maintain a high 
concentration of free amine as well as arenediazonium ions in the solution, because aryl ammonium 
species are unreactive. When aromatic amines are the nucleophilic reagents, two pathways are 
possible: the N-N bond formation providing the amino diazo compound, further transformed into the 
azo compound by rearrangement in acidic media.225 As the reactivity of the aryl group is increased by 
                                                           
224 I. Svele, H. Zollinger, Top. Curr. Chem., 1983, 112, 1. 
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the presence of electron-donating group or fused ring, the direct C-N bond formation occurs (Scheme 
54). 
 
Scheme 54 Diazo coupling with amines 
By introducing electron-withdrawing substituents in ortho or para position regarding the azo group, 
the diazonium ions' electrophilicity may be increased to such a degree that diazonium coupling also 
occurs with phenols and phenolic ethers, such as anisole.  
The azo coupling reaction has been carried out with specialized macrocyclic systems such as 
porphyrins,226 metacyclophanes227 and calixarenes.228 One of examples is coupling between 
substituted calixarene with diazonium tetrafluoroborate giving the azo product with 23% isolated yield 
(Fig. 143). This compound shows the UV band splitting of chromogenic azo-coupled calix[4]crown upon 
cation complexation. 
 
Fig. 143 
III.2.2. The Mills reaction 
The synthesis of dissymmetrical azobenzenes by aromatic nitroso derivatives with anilines in glacial 
acetic acid is known as Mills reaction.229 The aromatic nitroso species can be prepared by oxidation of 
an aromatic methylhydroxylamine with tert-butyl hypochloride at temperature -78 °C. Other oxidation 
agents may be used: FeCl3, Caro's acid (H2SO5), sodium or potassium dichromate and sulfuric acid, 
AcOH/H2O2, m-chloroperbenzoic acid, KMnO4, diethyl azodicarboxylate, I2/NaI/NaOAc, Ag2CO3, DDQ 
and peroxyformic acid. 
                                                           
226 C. H. Hunter, L. D. Sarson, Tetrahedron Lett., 1996, 37, 699. 
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Fig. 144 Example of Mills reaction 
Overall yields of this reaction are good to excellent; it depends on the stability of nitroso compound. It 
is noteworthy that, applying the Mills reaction, different electron-withdrawing and -donating groups 
could be present in the ortho-, meta- and para-positions of both aromatic nitroso compounds and the 
aromatic amines.  
The mechanism of Mills reaction involves the attack of aniline onto the nitroso derivative in acidic 
media. This leads to the azobenzene after dehydration of the intermediate (Scheme 55).230 
 
Scheme 55 Mechanism of Mills reaction 
The nitroso derivative may be obtained by deoxygenation of nitrobenzene. This allows the preparation 
of asymmetrically substituted azo compounds from the nitro compound and an aromatic N-acylamine 
in the basic conditions (Scheme 56). 231 
 
Scheme 56 Mills reaction in basic conditions 
Recently, the Mills reaction was applied to synthesized ferrocenylazobenzenes232 from 3-
ferrocenylaniline and nitrosobenzene in acetic acid. It was notable that 2-ferrocenylazobenzene 
without substituents was obtained in the Z configuration.  
Also, this method served to synthesize the altering sequences of pyridine-2,6-dicarboxamides and 3-
(phenylazo)-azobenzenes, assembled into oligomers of four and eight azobenzene linkages. 233 X-ray 
crystallography confirmed a two-turn helical conformation with a helical pitch of approximately 3.4 Å 
in the solid state. 
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III.2.3. The Wallach reaction
The Wallach reaction, called also Wallach rearrangement,
azoxybenzene in the presence of sulfuric acid (60% to 100% are required) to an azo compound with 
one arene ring substituted by a hydroxyl group in the 
related to Fries rearrangement or benzidine rearrangement. An azoxybenzene is accessible from the 
reduction of nitrobenzene with alcoholic KOH/CH
equally from the oxidation of aniline with hydrogen peroxide or permanganic acid/formaldehyd
N
The mechanism of this reaction is not completely known, but several experimental evidences 
exist showing the possibility of occurrence this kind of arrangement
NNPh
O
HSO4 H
NNPh
OH
HSO4 H
NNPh
-HSO
-HS
-H2O
In the first part of the reaction, two equivalents of acid split the oxygen atom off the azoxy group. The 
resulting dicationic intermediate 
by proton NMR in a system of fluoroantimonic acid and azoxybenzene at 
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Fig. 145 
 
234 involves the conversion of an 
para-position. Conceptually, this reaction is 
3CHO, sodium amalgam, hydrogen/PbO or MeONa or 
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Scheme 57 Mechanism of Wallach reaction 
C with an unusual R-N+=N+-R motif in this scheme has been observed 
-50°C.235
, 13, 525. 
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 In the second part of 
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the reaction the HSO4
- anion is a nucleophile in a nucleophilic aromatic substitution to E followed by 
hydrolysis to F. 
Shemyakin et al. described that the formation of 2-hydroxyazobenzene occurs via an intermolecular 
oxygen shift.236 Also, it was proven that UV irradiation provokes this rearrangement.237 According to 
this mechanism, the oxygen atom from the azoxy group is transferred to the benzene ring attached to 
the fragment -N=N- upon exposure to light. The 5-member ring may be formed and its opening leads 
to 3 different pathways. One of them is ring opening accompanied with deprotonation by basic solvent 
(A), second is the formation of ketone in ortho-position followed by tautomerization (B). The third one 
is the intramolecular H-migration by the [1,5]-sigmatropic rearrangement.  
 
Scheme 58 Formation of 2-hydroxyazobenzene according to Shemyakin 
Studies of the Wallach reaction controlled by the presence of Lewis acid were carried out.238 The 
formation of Lewis complex was observed and after thermolysis of this complex, desired products with 
hydroxy-group in the ortho-position were obtained. This situation occurred only with SbCl5, with other 
Lewis acids (AlCl3, TiCl4, FeCl3 or ZnBr2) did not give the ortho-hydroxy derivatives.  
The thermal Wallach reaction is not synthetically useful since, the mixture of products is obtained. At 
the same time, this reaction is not very efficient and it requires the thermally stable substrate. 
Therefore, it has not found any application in preparative organic chemistry. 
 
III.2.4. Other reaction providing the azo compounds 
Azobenzenes can be also prepared by the reduction of azoxy derivatives in the presence of aluminium 
in MeOH under reflux or with microwave irradiation.239 This reaction is very fast and provides 
azoarenes in excellent yields. Another method is the reductive coupling of aromatic nitro derivatives, 
such as LiAlH4, NaBH4, etc. 
240 It is a useful way to obtain exclusively symmetrical aromatic azo 
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compounds. The reductive coupling of 2-nitrotoluene with magnesium/HCO2H
.NEt3 in methanol in 
room temperature gives 2,2'-dimethyl azobenzene in 90 % yield (Fig. 147).241  
 
Fig. 147 Reduction of azoxy derivatives 
The electrolytic oxidation of anilines is the next method of azobenzene formation. However, the first 
applied procedure did provide to desired product with low yield,242 the further modification by 
addition of different oxidizing agent (such as H2O2/Na2WO4) much improves this methodology (Fig. 
148).243 
 
Fig. 148 Oxidation of anilines providing to azo compounds 
Several examples exist of azobenzene formation by the dehydrogenation of arylhydrazines. One of 
them is the reaction of hydrazobenzene with periodate containing polyethylene imine resin.244  
Also, dimerization reaction of stable diazonium salts (Fig. 149) is possible in the presence of metallic 
copper and an acid or with copper(I) salts.245 The mechanism of dimerization probably involves free 
radicals formed with the aid of copper salts. This process is highly dependent on the nature of the aryl 
group. If the substrate has electron-withdrawing groups, mainly the C-C coupling will take place. With 
electron-donating groups only azo compound will be isolated.  
 
Fig. 149 Dimerization of diazonium salts  
Another example is triazene rearrangement, first proposed by Nietzki in 1877. Also, a thermolysis of 
azides or decomposition of N,N'-p-benzoquinonediimine dioxide under the light are particular method 
for azo compounds formation. An interesting pathway is the reaction of arylcalcium derivatives with 
nitrous oxide (Fig. 150).246   
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Fig. 150 Arylcalcium derivative forming azo compound 
Recently, the metal catalyzed coupling reaction of arylhydrazines became the method of choice for the 
azo compound's formation. The first described reaction was coupling between N-Boc arylhydrazine 
and aryl halide with Pd(OAc)2/P(
tBu)3 as catalyst. The resulting diaryl hydrazines were directly oxidized 
with NBS/Py to give azobenzenes with good yields (Fig. 151).247 
 
Fig. 151 Palladium catalyzed reaction of azo compound formation 
Also, the Cu(I) salts may be applied to oxidize obtained arylhydrazines.248 
Ziegler et al.249 has described a direct approach of preparation of 2-hydroxyazobenzenes from 
benzotriazoles by reaction with phenols. Owing to the presence of strongly electron-withdrawing 
group, the opening of the cycle occurs easily. The azobenzene is obtained after acid hydrolysis with fair 
to excellent yields (Fig. 152). 
 
Fig. 152 Application of benzotriazols in azo compound synthesis 
Two last particular methods are: the reaction of quinone with arylhydrazines in acidic conditions and 
reaction of quinone acetals with arylhydrazines. The reaction between quinone and phenylhydrazine 
was reported for the first time at 1941 (Fig. 153).250 
 
Fig. 153 Application of arylhydrazines to form azo compounds 
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Since this time, some modification has been applied like addition of thallium acetate or nitrate251 to 
give rise to desired azo compounds with excellent yields. 
Carreño et al.252 have presented the formation of azobenzenes from quinone acetals (provided from 
anodic oxidation of 1,4-dimethoxybenzenes) with aryl hydrazines. The presence of catalytic amounts 
of cerium ammonium nitrate (CAN) much reduce the reaction times (Fig. 154). 
 
Fig. 154 Carreño approach to azo compounds 
III.3. Objectives 
 
Reactions presented above are showing the versatility of synthetic pathways leading to the azo 
compounds. The interest of formation of new azo derivatives takes its origins in the diversity of 
application and interesting photophysical properties.  
In our strategy of synthesis of azo derivatives, we were focused onto the formation of diazonium ions 
and subsequent coupling with aromatic amines because of great accessibility of starting materials 
(aniline derivatives) and short reaction times. Moreover, the isolation of azo compounds from aqueous 
media by precipitation and filtration was a great advantage. We started with simple diazonium salts 
with electron withdrawing groups like halides or NO2 then we moved to more complicated 
aminobenzylanilines to construct the desired azo compounds with amine group in the para-position. 
This amino group will permit us to perform the reductive amination between azo derivative and our 
pyrazinic aldehyde in order to get more complex antenna systems where, at the same time, the azo 
function and pyrazinic core are present. The goal of this part of thesis was to synthesize the original 
chromophores for lanthanides with cyclen as chelating part and azo compound as an antenna (Fig. 
155).  
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Fig. 155 The scheme of azo sensitizer for lanthanides 
III.4. Formation of azo compounds 
As a molecule-model, we have chosen the (E)-4-((4-bromophenyl)diazenyl)aniline because of the 
accessibility of starting material, in order to check the regioselectivity of reaction (ortho or para 
isomer). The standard condition was the preparation of diazonium salt from 4-bromoaniline in the 
presence of sodium nitrate and the concentrated hydrochloric acid. This reaction was carried out for 
30 min. at 0 °C, till the moment of disappearing of solid in mixture and the change of color of solution 
from colorless to orange. Then, this diazonium salt was directly introduced drop by drop to the cooled 
suspension of aniline in the acetic buffer (120 M, pH = 6) (Fig. 156).  
 
Fig. 156 
Unfortunately, in the case of this coupling, the mixture of products was obtained. Moreover, the 
expected para isomer 101 was isolated as a minor fraction (7 %). From this reasons, we moved 
forward with other nucleophilic aromatic amines. We were searching substrates with blocked ortho-
position to the amine group and at the same time, with potential increased photophysical properties. 
One of them is 2,5-dimethoxyaniline, the analogue of hydroquinone. The reaction of diazo coupling 
was tested with the same para-bromo diazonium chloride.  
 
Fig. 157 
For this substrate, the aromatic nucleophilic substitution takes place only in preferential para position, 
and we did not have any problems with isolation or purification step. The product 100 was isolated in 
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58 % yield. The same procedure was repeated for the para-chloro and para-methoxyanilines to test 
the reactivity of obtained diazonium salts and to synthesize the diverse chromophores.  
 
Fig. 158 
Finally, 2-aminobenzylaniline was subjected to the formation of diazonium and coupled with 2,5-
dimethoxyaniline in order to get the chromophore with the aromatic and aliphatic amino group at the 
same time. The amino azo compound 105 was obtained with 81 % yield. 
 
Fig. 159 
The last azo compound, which has been envisaged, was product with terminal alkyne. Two synthetic 
pathways leading to this product were predicted: one through the diazo coupling of activated 
nitrobenzene and then reduction of obtained azo compound or the synthesis of 4-(prop-2-
ynyloxy)aniline 106 and formation of diazonium anion from this product (Scheme 59). 
 
Scheme 59 
The starting material para-nitro phenol was transformed into alkyne ether in the presence of propargyl 
bromide and K2CO3 in DMF. The product was applied for the reduction step without purifying and gave 
the 4-(prop-2-ynyloxy)aniline 106 with good yield (66 % after two steps).253 
 
Fig. 160 Preparation of 4-(prop-2-ynyloxy)aniline 106 
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This aniline 106 was used in the diazotation reaction in the conditions already stated (NaNO2, HClconc., 
30 min., 0 °C) and then coupled with aniline, giving the mixture of isomers ortho and para. We tried to 
separate mixture by column chromatography; however products were not stable in the 
chromatography conditions.  
 
Fig. 161 
Simultaneously, we were carring out the reaction of azo coupling between para-nitroaniline and 
phenol, which provided expected para-isomer 107 in 57 % yield. Then, this azo compound was 
subjected the Wiliamson ether synthesis with propargyl bromide to give (E)-1-(4-nitrophenyl)-2-(4-
(prop-2-ynyloxy)phenyl)diazene 108 (81 %). 
 
Fig. 162 
Unfortunately, the last step of synthesis - the reduction of nitro group in the presence of tin chloride 
and hydrochloric acid did not work and provided only decomposed product (Fig. 163). 
 
Fig. 163 
From the one hand, the application of first pathway seemed to be more accessible, however, the 
reduction step conferred a problem, therefore the desired product was synthesized via the amino 
alcyne, coupled with 2,5-dimethoxyaniline. We have obtained desired product - the para-isomer with 
46 % of yield after purification by column chromatography. 
 
Fig. 164 
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III.5. Reductive amination with pyrazinic aldehyde 
This reaction will permit us to construct the antenna system with pyrazinic core and azo derivative as a 
spacing arm between the chromophore center and lanthanide chelate. For the best our knowledge, 
there are no literature examples of this reaction and our approach is completely original. Therefore, 
we based our first attempt on some examples already conducted with simple primary amines (see 
paragraph II.7.3). We mixed our product 105 with aldehyde 76 in equimolar amounts in 
dichloroethane and then reducing agent, NaBH(OAc)3 (1.4 equiv.) was introduced. Unfortunately, even 
after overnight vigorous stirring, we did not obtain any traces of expected product. Only both starting 
materials were recuperated. If so, we changed our strategy, and we used sodium borohydride instead 
of sodium triacetoxyborohydride. This reaction provided the reduction of aldehyde; therefore we 
concluded that the nucleophilic attack of the primary amine onto the carbonyl carbon is not 
spontaneous and needs to be forced by addition of acid.254 We conducted first the formation of imine 
between an aldehyde and amine (1.2 equiv.) in the presence of acetic acid (1.0 equiv.) for 15 min. at rt 
and then a reduction agent - NaBH3CN (1.2 equiv.) -.was introduced. Reaction was carried out for 1h at 
rt and gave a compound 110 with 22% of yield. 
 
Fig. 165 
After optimization of reaction conditions and longer time of stirring with reducing agent, we managed 
to improve yield of reaction to 54%. 
This first attempt showed that the reductive amination of aliphatic group of azo compound 105 is 
possible. However, the deprotection of the Boc group was not succeed for a moment, tested both in 
acid conditions using TFA at 0 °C and in the presence of TMSI. The further assays are pursuing in the 
laboratory resulting in a pyrazine derivative with azo spacing arm.  
                                                           
254 (a) A. F. Abdel-Magid, K. G. Carson, B. D. Harris, C. A. Maryanoff, R. D. Shah, J. Org. Chem., 1996, 61, 3849; (b) D. C. 
Beshore, C. J. Dinsmore, Org. Lett., 2002, 4, 1201. 
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III.6. Creation of the spacing arm 
The expected final complex should possess the function of attachment with derivatized cyclen 
molecule. This macrocycle is protected in three positions with acetic acid, but its fourth position stays 
non-blocked and the connection may be conducted by the secondary amine function. Therefore, the 
construction of short spacing arm with terminal halogen as candidate for nucleophilic substrate was 
designed. Besides, this spacing arm should have the carbonyl group in the β position to the nitrogen 
atom from cyclen in order to provide the oxygen to chelate the metal placed into the center of 
complex and at the same time to prevent an access for water molecules to the lanthanide center and 
quenching of fluorescence.  
 
Fig. 166 
Bromoacetic bromide was selected as the best spacer. In many synthetic strategies considering the 
attachment of cyclen moiety to the chromophore, this kind of spacer is used.255 In case of azo 
derivatives, it suffices to add bromoacetic bromide to the amine compound in the presence of organic 
base to form the amide with Br-terminal atom. Moreover, the presence of amide bond in the spacing 
arm gives the possibility to coordinate the eighth position of lanthanide and form the complex 
insusceptible for quenching in aqueous milieu.  
Herein, we report the results of formation of amides from azo derivatives (Table 24). 
Table 24 
 
Entry Substrate Reaction 
time 
Product Yield 
[%] 
1 
102 
30 min. 
111 
95 
                                                           
255 (a) S. Mizukami, K. Tonai, M. Kaneko, K. Kikuchi, J. Am. Chem. Soc., 2008, 130, 14376; (b) K. N. Green, S. Viswaiathar, F. A. 
Rojas-Quijano, Z. Kovacs, D. Shermy, Inorg. Chem., 2011, 50, 1648. 
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2 
103 
30 min. 
112 
94 
3 
104 
60 min. 
113 
97 
4 
109 
30 min. 
114 
81 
 
As presented in the Table 8 this reaction gives expected products with excellent yields after 1 hour 
maximum (Entry 1-3). The product 114 was isolated with 81 % but we suppose that it was due to the 
lower stability of alkyne in basic conditions. All obtained products were subjected to the nucleophilic 
substitution with cyclen moiety. 
 
III.7. Nucleophilic substitution with DO3A 
The substitution of bromoacetamide of azo compounds by fourth nitrogen atom in DO3A was 
undertaken in endothermic conditions in the presence of sodium carbonate. First, DO3A was 
deprotonated by stirring for 30 min. at room temperature in the flask equipped with CaCl2 trap to 
avoid the humidity. Then solution of appropriate bromoacetamide was introduced dropwise and the 
mixture was stirred at the reflux of tetrahydrofuran for several hours. Owing to this methodology, we 
have obtained expected chromophores in a quantitative manner. 
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Table 25 Nucleophilic substitution with DO3A 
  
Entry Substrate Time Product/ Yield [%] 
1 111, X = Br 20h 115 / 98 
2 112, X = Cl 18h 116 / 98 
3 113, X = OMe 16h 117 / 57* 
4 114, X = OCH2C≡CH 18h 118 / 95 
* The complete transformation of starting material, the product partially degraded during purification by column 
chromatography 
Results depicted in Table 25 show the high efficiency of this reaction, all products reacted in the 
quantitative way; however, the methoxy derivative 117 was isolated with lower yield (57% yield) due 
to the decomposition on the silica gel in chromatography conditions. 
 
III.8. Deprotection of acetic acid groups in DO3A 
 
The great advantage of application of tert-butyl ester group to protect the acetic acid pending 
arm of cyclen is that this group is stable in nucleophilic substitution condition but also that it is 
relatively easy to remove in acidic conditions. First, we tested the deprotection in the presence of 
formic acid in toluene at room temperature. Only the degradation of product and the starting material 
DO3A were recuperated after this reaction. Afterwards, trifluoroacetic acid was applied in combination 
with triisopropyl silane (TIS) as a scavenger to trap the free radicals formed during deprotection. This 
methodology gave a rapid (1 hour of stirring) access to desired acids in a quantitative way. 
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Table 26 Deprotection of tert-butyl esters 
 
 
Entry Substrate Product/ Yield [%] 
1 115, X = Br 119 / quant. 
2 116, X = Cl 120 / quant. 
3 117, X = OMe 121 / 88 
4 118, X = OCH2C≡CH 122 / 87 
 
The same conditions were applied to the all compounds giving satisfactory results in every case. 
Compounds 119 and 120 (halogen derivatives) yielded desired acid in quantitative way and 
compounds 121 (OMe) and 122 (OCH2C≡CH) showed lower yield, probably due to the difficulty of 
isolation of products. These products have an aspect of hygroscopic solids and in contact with the air 
take a form of gum. From these reason, all products were directly used to the step of complexation 
with corresponding lanthanide salts.  
III.9. Formation of lanthanide complexes 
 
The stability of complex is described by the equilibrium constant of formation of complex. 
Mt+ + nLu-⇆ [M(L)n]t-nu+ 
 
 =
[()]
[][]
 
Equation 12 
Stability constants defined in this way, are association constants. This can lead to some confusion as 
pKa values are dissociation constants. The relationship between the two types of constant is given in 
association and dissociation constants. 
 =
1

 
Equation 13 
It is known that the stability of the metal complexes with the macrocyclic ligands are much greater 
than expected in comparison to the stability of the complex with the corresponding open-chain 
ligands. This phenomenon was named "the macrocyclic effect" and it was also interpreted as an 
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entropy effect. For the lanthanide complexes of DOTA, the value pKa is very high
256 and that indicates 
the great stability of these assemblies. 
As a labile lanthanide complex, we have chosen the trifluoromethanesulfonate salts Ln(OTf)3 and we 
conducted the complexation reaction in endothermic conditions (50 °C) in methanol as a solvent. We 
were using the chromophore triacetic acid derivative without preliminary deprotonation and we 
recovered the expected complex after precipitation from the mixture with diethyl ether. This method 
was widely used by the group of Faulkner.257 
  
                                                           
256 M. F. Loncin, J. F. Desreux, E. Merciny, Inorg. Chem., 1986, 25, 2646. 
257  A. Dadabhoy, S. Faulkner, P. G. Sammes, J. Chem. Soc., Perkin Trans.2, 2002, 348. 
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Table 27 
 
 
Entry Substrate Lanthanide complex Product/Yield [%] 
1 
119 
Nd3+ 123 (92) 
2 Yb3+ 124 (73) 
3 Eu3+ 125 (71) 
4 
120 
Nd3+ 126 (82) 
5 Yb3+ 127 (75) 
6 Eu3+ 128 (81) 
7 
121 
Nd3+ 129 (90) 
8 Yb3+ 130 (75) 
9 Gd3+ 131 (82) 
10 
122 
Nd3+ 132 (81) 
11 Yb3+ 133 (quant.) 
12 Gd3+ 134 (quant.) 
 
We have obtained 12 new complexes of lanthanides with different metals and different substituents in 
para position to azo bond. All complexes were characterized by high resolution mass spectrometry and 
absorption and emission spectra, their purity were checked by reversed phase HPLC. In our interest 
was to create the complexes of ytterbium(III) and neodymium(III) in order to observe the 
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luminescence in the region of near-infrared. The complex of gadolinium serves to verify energy of 
triplet state of molecule and therefore fully characterize the new sensitizers. 
 
III.10. Vectorization of lanthanide complex by the mean of cyclopeptide RGD 
The final aim of this project was to introduce a particular biomolecule to the lanthanide 
complex, which will show a great affinity to cancer cells and therefore, enables the specific detection 
of cancerous cells. The biomolecule possessing these features is a cyclopeptide containing a triad RGD. 
 
III.10.1. Cyclopeptide RGD and its role in cancer cell vecorization 
Integrines are a family of heterodimeric transmembrane glycoproteins involved in the wide 
range of cell-to-membrane and cell-to-cell interactions. In general, this kind of biomolecules belongs to 
the group of cell adhesion molecules (CAM). They play a major role in cell morphology, locomotion, 
mitosis, phagocytosis and cytokinesis. It is known also that CAMs are responsible for various disease 
states such as cancer,258 thrombosis,259 rheumatoidal arthritis260 and diabetes.261  
The motif of three amino acids: arginine (R), glycine (G) and aspartic acid (D) has been 
discovered to be recognizable by the cell adhesion sequence in fibronectin.262 The RGD sequence is the 
cell attachment site of a number of adhesive surface proteins. It has been proven that nearly half of 
over 20 integrins recognize this motif in their cell adhesion protein ligands. One of them – integrin αvβ3 
is expressed on the cell membrane of various tumor cell types such as late stage glioblastoma, 
melanoma, ovarian, breast and prostate cancer.263 An integrin αvβ3 was shown to play a crucial role in 
tumor invasion and metastasis resulting from the ability to recruit and activate matrix metalloprotease 
(MMP), which can degrade components of the basement membrane and interstitial matrix.264  
Many of modified structures of molecules containing sequence RGD have been synthesized and 
valorized since last ten years. Among them, linear and cyclic RGD peptides have been developed as 
ligands preferentially bound to integrin αvβ3, such as c(RGDfK) and c(RGDyK), presented below (Fig. 
167). 
                                                           
258 (a) G. Christifori, EMBO J. , 2003, 22, 2318; (b) K. Maaser, K. Wolf, C. E. Klein, B. Niggemann, K. S. Zanker, E. B. Brocker et 
al., Mol. Biol. Cell., 1999, 10, 3067; (c) E. Ruohslahti, Nat. Rev. Cancer., 2002, 2, 83. 
259 (a) R. K. Andrews, M. C. Berndt, Thromb. Res., 2004, 114, 447; (b) J. M. Gibbins, J. Cell. Sci., 2004, 117, 3415. 
260 X. Banquy, G. Leclair, J. M. Rabanel, A. Argaw, J. F. Bouchard, P. Hildgen et al., Bioconjug. Chem., 2008, 19, 2030. 
261 K. Ichinose, E. Kawasaki, K. Eguchi, Am. J. Nephrol., 2007, 27, 554.  
262 (a) M. D. Pierschbacher, E. Ruoslahti, Nature, 1984, 309, 30; (b) E. Ruoslahti, Matrix Biol., 2003, 22, 459. 
263 (a) W. Cai, X. Chen, Agents. Med. Chem., 2006, 6, 407; (b) G. J. Mizejewski, Proc. Soc. Exp. Biol. Med., 1999, 222, 124; (c) H. 
Jin, J. Varner, Br. J. Cancer., 2004, 90, 561. 
264 P. C. Brooks, S. Stromblad, L. C. Sanders, T. L. von Schalscha, R. T. Aimes, W. G. Stetler-Stevenson et al., Cell., 1996, 85, 683. 
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Fig. 167 
Cyclopeptides c(RGDyK) and c(RGDfK) are showing high binding affinity and selectivity particulary for 
this integrin αvβ3, thus these peptides are applied as target delivery of therapeutics or diagnostic to 
tumors.265 Moreover, this kind of peptides may be easily modified by the introduction of azide group in 
the place of lysine residue, and thus they became interesting substrates in relation to the click 
reactions.  
Taking into account the great affinity of cyclopeptides to integrins, they have found an important 
application to prepare probes for non-invasive visualization by different media: nuclear media such as 
SPECT (Single Electron Emission Computed Tomography) and PET (Positron Emission Tomography),266 
magnetic resonance (MRI)267 and optical methods dyes (FMT – Fluorescent Mediated Tomography). 
 
III.10.2. Cycloaddition reaction with peptide RGD 
Our intention was to use this modified cyclopeptide attached to the lanthanide complex as a 
marker for cancer cells. Some molecules connected to the macrocycle DO3A have been reported, but 
they do not serve as chelators for lanthanide emitting in near-infrared, but as a ligands for radiometals 
such as [111In].268 Also, these complexes are chelates for paramagnetic Gd3+ as a probe for MRI. To the 
best of our knowledge, no examples of cyclopeptide RGD attached to the lanthanide complex emitting 
in near-infrared exist. For the synthesis of biovector for the cancerous cells, we have envisaged to 
construct the chromophore already complexed with lanthanide, which will have the terminal alkyne to 
perform cycloaddition reaction with azide-derived cyclopeptide RGD.  
 
Fig. 168 Cyclopentapeptide RGD 
                                                           
265 K. Temming, R. M. Schiffelers, G. Molema, R. J. Kok, Drug Resist Updat., 2005, 8, 381. 
266 Z.-B. Li, Z. Wu, K. Chen, F. T. Chin, X. Chen, Bioconjugate Chem., 2007, 18, 1987. 
267 P. Verwilst, S. V. Eliseeva, S. Carron, L. V. Elst, C. Burtea, G. Dehaen et al., Eur. J. Inorg. Chem., 2011, 3577. 
268 (a) I. Dijgraaf, A. Y. Rijnders, A. Soede, A. C. Dechesne, G. W. van Esse, A. J. Brouwer et al., Org. Biomol. Chem., 2007, 5, 
935; (b) Y. Zhou, S. Chakraborty, Theranostics, 2011, 1, 58. 
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The modified cyclopeptide RGD has been furnished by Dr. V. Aucagne (CBM, Orléans)269 and 
chromophores containing different lanthanide cations (Yb3+, Nd3+ and Gd3+) were synthesized 
according to our original pathway. The reaction of cycloaddition was carried out in HEPES buffer (pH = 
7.5) at room temperature in aqueous solution in the presence of CuSO4
.5H2O, THPTA as a ligand for 
Cu(I), sodium ascorbate and aminoguanidine hydrochloride to protect the peptidic part.270 This 
methodology has been elaborated and evaluated by equipe of V. Aucagne and A. Delmas for 
cyclopeptides RGD with terminal azide function. The progress of reaction and purification of products 
were conducted by HPLC reversed phase. 
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Fig. 169 
 
Fig. 170 
We have obtained three complexes of target molecules (Fig. 170) with satisfactory yields (up to 40 % 
after isolation by preparative RP-HPLC) and high purity (99.8%). The structure of products was 
confirmed by high-resolution mass spectrometry (HRMS), absorption and emission spectra. During the 
cycloaddition reaction, we did not observe any decomplexation of lanthanide or the cleavage of the 
azo bond. 
 
                                                           
269
 V. Aucagne, A.F. Delmas, unpublished results 
270 I. E. Valverde, A. F. Delmas, V. Aucagne, Tetrahedron, 2009, 65, 7597. 
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III.11. Spectroscopic properties of azo compounds 
III.11.1. Absorption spectra 
In order to identify the maximum of excitation wavelength of lanthanide sensitizers, we have 
collected the absorption spectra in the UV-visible region (Fig. 171). We have worked with diluted 
aqueous solution of complexes (100 µg/mL for Br-substituted, Cl-substituted and those with 
cyclopeptide, 50 µg/ mL for OMe-substituted). For the ytterbium and neodymium complexes formed 
with the ligands that incorporate halogen atom in the position para to the azo group 123, 124, 126 and 
127, we observed two maxima of absorption at 338 nm and 414 nm. The coefficient of absorption of 
these compounds is in the range of 6900-9000 [M-1cm-1] (see Table 28). For the compounds containing 
the methoxy substituent 129 and 130, two maxima are present and are localized at 350 nm and 410 
nm. The highest value if coefficient of absorption equals 9000 [M-1cm-1] for the complex 127 with Nd3+. 
Whereas, for the lanthanide complexes formed with the cyclopeptide 135 and 136, we have obtained 
slightly more elevated (11000-11500 M-1cm-1) values. Also maxima of absorption are slightly shifted 
compared to halogen derivatives: with two apparent maxima located at 350 nm and 410 nm. These 
values of absorption coefficient are in accordance with those reported for azamacrocyclic europium 
complexes (11 000-16 000 M-1cm-1).271 In comparison with other antennae for lanthanides, they are 
twice lower than for quantum dots,272 and few-folds smaller than for PAMAM dendrimers273 due to 
high concentration of chromophore groups in one molecule. 
  
                                                           
271 A. Bourdolle, M. Allali, J.-C. Mulaer, B. Le Guennic, J. M. Zwier, P. L. Baldeck, J.-C. G. Bünzli, C. Andraud, L. Lamarque, O. 
Maury, Inorg. Chem., 2011, 50, 4987. 
272 D. Geißler, L. J. Charbonnière, R. F. Zeissel, N. G. Butlin, H.-G. Löhmannsröben, N. Hildebrandt, Angew. Chem. Int. Ed., 
2010, 49, 1396. 
273 (a)I. Grabchev,J.-M. Chovelon,V. Bojinov, G. Ivanova, Tetrahedron, 2003, 59, 9591; (b) M. A. Alcala, C. M. Shade, H. Uh, S. Y. 
Kwan, M. Bischof, Z. P. Thompson, K. A. Gogick, A. R. Meier, T. G. Strein, D. L. Bartlett, R. A. Modzelewski, Y. J. Lee, S. Petoud, 
C. K. Brown, Biomaterials, 2011, 32, 9343. 
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Table 28 
 
 
 
Entry Ligand Complex Conc. [mmol/L] λmax [nm] A ε[M
-1
cm
-1
] 
1 
L1 
123 (Nd3+) 0.115367 
338 1.014 8800 
414 
0.958 8300 
2 124 (Yb3+) 0.111657 
338 1.003 9000 
414 
0.947 8500 
3 
L2 
126 (Nd3+) 0.1221 
338 0.931 7600 
414 0.848 6900 
4 127 (Yb3+) 0.117925 
338 1.043 8800 
414 0.967 8200 
5 
L3 
129 (Nd3+) 0.061497 
350 0.480 7800 
410 0.553 9000 
6 130 (Yb3+) 0.05926 
350 0.420 7100 
410 0.498 8400 
7 
L4 
135 (Nd3+) 
0.06824 
350 0.664 9900 
410 0.770 11500 
8 136 (Yb3+) 
0.06678 
350 0.635 9300 
410 0.750 11000 
X Ligand Ln
3+ 
Product 
Br L1 Nd 123 
Yb 124 
Cl L2 Nd 126 
Yb 127 
OMe L3 Nd 129 
Yb 130 
cyclopeptide L4 Nd 135 
Yb 136 
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Fig. 171 
The tendency can be observed between the different complex containing halogen atom (123, 124, 
126, 127) and methoxy group and cyclopeptide, that the first maximum of absorption exists for 
wavelength (λ = 338 nm) corresponding to higher energies for halogen derivatives and is shifted 
toward lower energies for other products. However, the second maximum of absorption is located at 
almost the same wavelength for the different complexes: 410-414 nm and it is significantly shifted 
toward the red part of spectrum. This observation permits the use of higher wavelengths 
corresponding to lower energy to induce the sample excitation. 
Making comparison between these four groups of chromophores, we can say that the highest 
efficiency to absorb light (the highest molar absorptivity ε) and transfer the energy to the lanthanide 
cation is found for the compound 135 (cyclopeptide), probably owing to an assembly of chromophore 
parts (the azo part and triazole moiety joining with the cyclopeptide RGD) in one molecule. 
Subsequently, we have tested the photostability of complexes by irradiation in the region of UV-Vis 
and observation of absorption spectra. We were recording absorption spectra every 15 minutes. The 
solution of halogenated ligand 123 showed a significant decrease of absorption signal after each 15 
minutes of data collection in the maxima of absorptions (indicated by arrows). In the case of the 
sample test (a green line), the solution was prepared a day before experiment and stored in a dark 
place. No decrease of signal in the sample test was observed, which means that the irradiation by the 
excitation source, not the time of storage, is responsible for the decomposition. 
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Fig. 172 
On the Fig. 172 we can notice a significant decrease of absorption signal after each irradiation. A signal 
loss of about 20% was observed after four consecutive irradiations. We suppose that this decrease is 
due to the slow degradation of the chromophore. At the same time, absorption spectra of compound 
129 (OMe) counterpart of previously tested product do not show any change of intensity on the 
absorption spectrum after the repetition of irradiation every 15 min (Fig. 173). That may explain our 
hypothesis of partial decomposition of complexes containing halides during the irradiation process. 
 
Fig. 173 
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III.11.2. Emission spectra in the NIR region – luminescence of lanthanide 
 
The emission spectra were recorded on the Fluorolog 322 apparatus in order to quantify the 
energy which is transferred to the lanthanide chelating system. The stock solution of compounds were 
prepared prior to use at the concentration 1mg/mL of ultrapure water MiliQ (in the case of 
compounds 123 and 124) and in the buffer PBS (pH = 7.5) in the case of products linked to the 
cyclopeptide RGD (products 135 and 136). Then these solutions were diluted ten times to the 
concentration 100 µg/mL to avoid the saturation of the signal on the detector. 
At room temperature and upon broad band excitation at 465 nm (123 and 124) and 460nm (135 and 
136), the luminescence spectra display the bands corresponding to the expected emissions. The Nd3+ 
complex 123 displays NIR luminescence in the 800-1200 nm range, the main band being centered at 
1064 nm and with a band of lower intensity in the range 875-940 nm, which corresponds to transitions 
from 4F3/2 level to the 
4I9/2 sublevel (for lower wavelengths) and to the 
4I11/2 sublevel (for the higher 
wavelengths). Under the same conditions, the Yb3+ complex 124 emits in the 920-1000 nm range, with 
a band at 950 nm assigned to the 2F5/2→
2F7/2 transition and a broaden vibronic component at shorter 
wavelengths.  
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Fig. 174 
The compounds 135 and 136 (with cyclopeptide) were equally tested for the energy transfer to the 
lanthanide center. For the proper acquisition of lanthanide emission spectra, samples were excited at 
460 nm, with slit opening 14 nm and 30 nm and integration time 0.5 s. The filter LP700 was applied to 
remove the contribution of visible photons.  
Excitation at 460 nm gave the typical sharp emission bands corresponding to the maxima of Nd3+ and 
Yb3+ cations. For the complex 135 (Nd3+) two individual apparent emission maxima were observed for 
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915 nm and 1064 nm attributed to the transitions between 4F3/2 level to the 
4I9/2 and 
4I11/2 sublevels, 
respectively. At the same time, Yb3+ complex shows the emission band ranging from 920 to 1050 nm 
(2F5/2→
2F7/2 transition). 
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Fig. 175 
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Fig. 176 
Excitation spectra for products 135 and 136 presented on Fig. 176 prove that the both complexes can 
be excited in the range 370 – 500 nm. These excitation spectra can be compared to the absorption 
spectra of the chromophore 135 and 136, showing a correct overlap of the chromophore absorption 
with the excitation spectrum when observing the luminescence of the lanthanide. The red shift of 
maximum of excitation in comparison to maximum of absorption of ca. 40 nm is probably due to 
different efficiency of the energy transfer depending on the excited state of the chromophore. 
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The complexes with cyclopeptide 135 and 136 were synthesized in concept of creation a 
luminescent biomarkers for tumor cell due to high affinity of cyclopeptide RGD part to the membrane 
integrines of cancerous cells, as it was described in the introduction. Therefore, we wanted to 
determine the maximum wavelength of excitation for both complexes, which is still capable to 
generate the emission of lanthanide cation. Indeed, higher excitation wavelength corresponds to 
lower energy, and hence provokes less damage in the tested biological material and is preferable for 
biological tests. Lanthanide emission spectra were recorded with excitation at 370, 410, 460 and 520 
nm for solutions of 100µg/mL of complexes in PBS buffer (pH = 7.5, physiological conditions) and are 
presented on the Fig. 177 for Nd3+ and Fig. 178 for Yb3+ complex. We can notice that at the range of 
excitation from 370 to 460 nm, the lanthanides have good emission intensities in both cases and the 
high wavelengths excitation at 520 nm gives some low signal for Nd3+ complex 135, but for Yb3+ 
compound 136 the limit of excitation has been reached, since very low signal can be seen. 
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Fig. 177 Emission spectra of the Nd complex 135 
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Fig. 178 Emission spectra of the Yb complex 136 
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In order to establish a proof of principle of the ability of complexes 133 and 134 to act as a 
luminescent marker for biological imaging, we have decided to record images using Nikon AZ-100 
macroscope. However, even the concentrated solution did not allow the recording of an image due to 
the insufficient number of photons. 
III.11.3. Emission spectra in UV-Vis – fluorescence of chromophore 
It is noteworthy that the solution of product 136 (Yb3+ complex) in cold conditions (77K) changes 
significantly color from yellow to dark violet, indicating a clear change of its absorbance spectrum, 
which is co-notated with the change of the emission spectrum of chromophore. 
 
Fig. 179 Change of color of the aqueous solution of compound 134 at -20 °C (on the right) 
This red shift of the fluorescence spectrum is presented on Fig. 180. The normalized emission 
spectra show that at room temperature the maximum of emission is assigned at 550 nm and at the 
temperature of liquid nitrogen – 594 nm. Moreover, the intensity of this band is about hundred times 
higher than the intensity at room temperature. 
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This is an example of thermochromism, explained as reversible color change of a substance induced by 
a temperature change. Some examples of this effect were described for compounds with azo bond,274 
however, to the best of our knowledge, not with lanthanides complexes.  
III.11.4. Lifetime measurements 
The lifetime of luminescence of lanthanide complexes for aqueous solutions of compounds 129, 130, 
135 and 136 were measured to establish the number of inner sphere water molecule, and therefore to 
consider the protection of lanthanide cation against non-radiative deactivation (Chapter 2, Paragraph 
I.3).  
The analysis of the experimental luminescence decays obtained upon excitation of the complexes at 
355 nm revealed the best fittings as single-exponential functions as an indication of the presence of a 
single-species. The fitted lifetimes upon monitoring Nd(4F3/2) and Yb(
2F5/2) bands are placed in Table 29. 
Table 29 
Complex λexc [nm] τ [µs] 
H2O D2O q 
129 (Nd3+) 355 0.064(5) 0.230(1) 1.1 
130 (Yb3+) 355 0.708(10) 5.85(5) 1.0 
135 (Nd3+) 355 0.069(10) 0.238(3) 1.0 
136 (Yb3+) 355 0.793(10) 5.84(3) 0.9 
 
The presented luminescence lifetimes are roughly 11-times longer for both Yb3+ complexes for the H2O 
solutions and about 25-times in the D2O solution, which is consistent with observations for similar 
sensitizers.166 Lifetimes in H2O solutions are significantly shorter that those reported by Faulkner (1.95 
µs and 1.75 µs in water, 5.12 µs and 5.17 µs in the D2O solution), where the azo sensitizer neodymium 
complex shows 0.112 µs and our compounds 129 -0.064 µs and 135 - 0.069 µs. The same tendency 
occurs for Yb3+ complex; the value reported by Faulkner is 1.41 µs and our - 0.708 µs (130) and 0.793 
µs (136). However, in the case of deuterated solutions, values are much closer: the literature ones 
0.355 µs (Nd3+) and 4.02 µs are close to ours 0.230 (129), 0.238 (135), 5.853 (130) and 5.843 (136). In 
our case, the q parameter is convergent to the unity, which means that we can expect one water 
molecule in the inner sphere of coordination of the lanthanide cation in synthesized complexes. In the 
literature this value is rather lower than one, but still means that one molecule is inserted in the 
coordination sphere of metal center. 
 
 
                                                           
274 (a) G. S. Kikot', M. I. Cherkashin, B. S. Kikot', Russ. Chem. Bull., 1981, 5, 783; (b) U. Oertel, H. Mart, H. Komber, F. Böhme, 
Optical Materials, 2009, 32, 54. 
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III.11.5. Summary 
In conclusion, the spectroscopic features of a newly synthesized chromophore based on azo 
compounds were presented. These compounds were predicted to sensitize the lanthanide cations and 
presented results show that our system satisfies the condition of an antenna for lanthanides. The 
principal properties such as excitation and emission energy were determined. The presented 
molecules are novel and original examples of azo chromophores linked with cyclen chelate. In our 
synthetic strategy we have envisaged the attachment of this azo system to the pyrazinic moiety, 
described before, and this approach will permit to complete studies on original sensitizers. 
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IV. Conclusion and perspectives 
This doctoral dissertation has been devoted to the two complementary topics revolved around 
the synthesis, reactivity and applications of enecarbamates or enamides and N-heterocycles derived 
from them. The contribution to the valorization of heterocyclic systems containing the nitrogen atom 
has been presented on the pages of this thesis. In the first part, the synthesis and evaluation of new 
organophosphorus compounds starting from enol phosphates was described. Two different synthetic 
pathways were considered: the first one based on the C-P cross-coupling palladium catalyzed reaction 
leading to original α-enamido phosphane derivatives and the second one, the nucleophilic addition of 
phosphides anions to non-activated acyclic enecarbamates. The second part of thesis, in the same 
assumption of evaluation and valorization of N-heterocycles, was dedicated to the synthesis of original 
chromophores with pyrazinic core as sensitizers for lanthanide cations emitting in near-infrared.  
The lactam derived enol phosphates were starting materials for original C-P cross coupling 
reaction with borane protected secondary phosphines and phospholane oxides.119 This approach gave 
us an access to 6- and 7-membered ring α-enamido phosphane products with fair to good yields. 14 
novel organophosphorus compounds were obtained: first the strategy was optimized on the achiral 
series and then, we moved to chiral substrates for coupling (Scheme 60). 
 
Scheme 60 
Unfortunately, we encountered the difficulties on the stage of cross-coupling with enantiopure 
secondary phosphine borane, where the chiral phosphorus center racemized in the applied thermal 
conditions. However, in the case of phospholane substrate with chirality placed on two carbons at α 
position to P-atom, we managed to obtain expected products in an enantioselective way (up to 99.7% 
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ee). A variety of phosphine derivatives as well as different enol phosphates was coupled, showing the 
efficiency of this cross-coupling reaction. This strategy may thus provide an access to 
phosphinoheterocyclic compounds based on privileged substructures with potential biological interest.  
In perspectives, the problem of racemization could be overcome by using chiral catalysts such as (R)-
Tol-BINAP or (S,S)-Me-DuPHOS, which was recently decribed in the literature by the team of A.-C. 
Gaumont. 
 
The second strategy of the synthesis of new organophosphorus compounds was based on the 
reaction of the nucleophilic addition of lithiated phosphines onto the double bond of acyclic 
enecarbamates, providing analogues of non-natural amino acids with phosphorus atom in the β 
position. First, starting from commercial available anilines and benzylamine, after the protection step, 
we obtained the range of variously substitued enol phosphates. Then, we performed reactions of 
cross-coupling type Suzuki and Stille on enol phosphates leading to the acyclic enecarbamates with 
different aryl and heteroaryl groups in an efficient way (46-94% yield for 10 examples).  
 
Scheme 61 
These compounds became a starting point for the phospholithiation reaction. The reaction of 
nucleophilic addition of phosphide anions was inspired by the methodology already elaborated in our 
laboratory with other nucleophilic agents (RLi, organic bases) and concerned the addition to the 
double bond of the enecarbamate with concomitant migration of the alkyloxycarbonyl group leading 
to the derivatives of β-phosphino amino acids. This strategy gave an access to 7 derivatives with 
moderate to excellent yields (41-95%) (Scheme 62). 
 
Scheme 62 
As it is presented on Scheme 62, the quaternary center is created during this reaction, however, the 
transformation itself is not enantioselective. In order to induce the enantioselectivity during the 
phospholithation, we conducted the reaction in the presence of (-)-sparteine as a chiral bidentate 
ligand to protect the formed carbanion. Nonetheless, even with this modification, we did not manage 
to obtain the enantiomerically pure compounds. This result signifies that the carbanion formation is 
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not regioselective and that the alkyloxycarbonyl is equally transferred on both sites on this anion. Also, 
some attempts with chiral phosphines were undertaken, however in this case, the nucleophilic 
phosphorus agent could not be formed. In the perspective to this project, the enantiocontrol of this 
reaction, either by the application of chiral protecting group, or by the chiral organocatalyst or by the 
application of chiral deprotonation, system is envisaged. 
Furthermore, the spontaneous oxidation of the phosphorus atom was observed during the reaction. 
We tested the influence of the quantity of the nucleophile in the relation to the free phosphine on the 
tert-butyl phenyl(1-phenylvinyl)carbamate. The presence of free phosphine provokes the apparition of 
non-transferred oxidized and non-oxidized product (Fig. 181), and the excess of the phosphine 
increases the percentage of this products.  
 
Fig. 181 
It means that kinetic influence of reprotonation is much faster than the intramolecular migration of 
the alkyloxycarbonyl group. 
Finally, the structure of five among twenty five novel organophosphorus compounds were determined 
by structural analysis based on X-ray crystallography.  
 
The second chapter of this dissertation was devoted to the construction of sensitizing systems 
for lanthanide cations based on pyrazinic chromophores. The pyrazine derivatives were obtained in 
the reaction of cross-coupling of bisvinyl phosphate of dihydropyrazine with range of aryl and 
heteroaryl derivatives.  
 
Scheme 63 
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Considering the photophysical properties of new compounds, a target molecule - 2,5-
dibenzo[b]thiphenyl dihydropyrazine was chosen for further investigation. Two distinct methodologies 
were applied in order to functionalize this dihydropyrazine. From the one hand, the reaction of 
cycloaddition type Diels-Alder was tested with different dienophiles (Scheme 63). This transformation 
showed that our system is moderate diene and requires an electron-withdrawing dienophile such as N-
methylmaleimide. 
 
Scheme 64 
Therefore, the cyclization with N-methylmaleimide led to the monocycloadduct on quantitative 
manner, which was involved in the reaction of the Boc deprotection and aromatization with DDQ. This 
compound was further functionalized in the trans-imidation reaction providing amino- and hydroxyl-
derivatives with fair yields (53 and 62%, respectively). The last step of predicted strategy was the 
attachment with the chelating molecule for lanthanide complexation, either by the halogen derivative 
or by bromoacetyl function. Notwithstanding, the provided reactions were unsuccessful, making this 
step impossible (Fig. 182). 
 
Fig. 182 
 
Based on the literature and experiments conducted in the laboratory, we assumed the 
functionalization of the last free position of dihydropyrazine to construct the additional spacer serving 
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as an attachment for the biomolecule. We envisaged the introduction of the function compatible with 
the attachment of the biomolecule to the sensitizer. In this aim, we performed the Diels-Alder reaction 
on the alcohol derivative, which provides, from the one side, a construction of the spacing arm, and 
from the other side - the connection to the biomolecule. However, provided pathway was blocked on 
the deprotection step, preventing the anchoring the active compound. 
 
Scheme 65 
 
The second pathway to functionalize pyrazinic moiety was to introduce the iodide under anionic 
conditions and next, to apply the reaction of Sonogashira cross-coupling leading to TMS protected 
alkyne derivatives. These compounds were tested in the copper-catalyzed cycloaddition reaction 
("click reaction") with the deprotection step in situ. This strategy had as an aim the valorization of our 
system in this type of transformation making the field for further application of click reaction to attach 
the lanthanide chelating system. In the perspective to this pathway, the further deprotection and 
attachment to the cyclen moiety were predicted. This methodology allows the insertion of two 
different lanthanide cations as well as the lanthanide and the biomolecule in order to construct the 
specific bio probe (Scheme 66). 
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Scheme 66 
In the third strategy, we predicted the introduction of aldehyde functional group, a useful 
intermediate for the olefination reaction. We applied the Wittig-Horner-Emmons reaction in order to 
obtain the nitrile and ester derivatives, which were further modified, first by Boc deprotection, then by 
reduction, to give an access to pyrazines with hydroxyl group and primary amine (Scheme 67). 
 
Scheme 67 
The substitution of an alcohol by different halogens were performed in order to carry out the 
nucleophilic substitution with cyclen derivative, however, this reaction did not yield an expected 
product. The amino and hydroxyl derivatives were applied in the esterification or amidation reaction 
leading to respective brominated ester or amide useful for the DO3A linkage. This methodology 
permitted to introduce the chelating system for lanthanides in two steps, moreover it gave an access 
for stable systems for the luminescent experiments.  
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Scheme 68 
The complexes of Nd3+, Gd3+ and Yb3+ were obtained and tests for their ability to sensitize 
lanthanide cations were performed, showing that our chromophore system possesses the electronic 
structures compatible with lanthanides. In conclusion, a new sensitizing system for near-infrared 
lanthanides was constructed in an original and flexible strategy that offers the possibility to modulate 
the electronic structure of this system. Pyrazinic sensitizers showed an efficient energy transfer to the 
lanthanide cation, resulting in emission in the near-infrared region with quantum yield comparable to 
other luminescent lanthanide complexes emitting in the NIR and the moderate lifetimes of the 
emission. The presented sensitizer is the first example of this type of chromophores, not yet described 
in the literature. Our preliminary studies constitute a proof of principle for the construction of 
pyrazinic chromophores and open the range of possibilities to versatile modification of synthetic 
pathways and further functionalizations of these compounds. 
 
Finally, the new family of azo compounds was synthesized and valorized as an original sensitizer 
alone or in the linkage with the pyrazinic core. These compounds were obtained in the reaction of 
diazotation of different aromatic amines, followed by the diazo coupling with 2,5-dimethoxyaniline. 
The resulted products were functionalized to attach the DO3A system in the reaction of nucleophilic 
substitution and then deprotected and complexed with different lanthanide cations.  
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Scheme 69 
Also, a reaction of copper-catalyzed cycloaddition with the alkyne derivative and cyclopeptide RGD 
was performed in order to furnish our system with the highly specific for the cancerous cells’ 
biomolecule and hence to make an original near-infrared marker for tumors. This work gives a huge 
opportunity to valorize the properties of novel systems in cellulo. 
 
Scheme 70 
 
The series of azo chromophores were tested for the spectroscopic properties in the visible and 
near-infrared region. They absorb light in the visible range and transfer energy through the conjugated 
system to the lanthanide center, provoking an intensive luminescence of metal. Luminescence 
lifetimes of lanthanide emission are consistent with values reported in the literature. 
This original and innovative methodology based on azo dyes permits to apply our sensitizers alone or 
in the combination with cyclopeptides or other biomolecules. Starting from versatile aromatic amines, 
the formation of desired sensitizers could be obtained. Moreover, the azo derivatives might be 
introduced to the pyrazinic system, enhancing thus the spectroscopic properties of the latter. 
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I. General methods 
 
A) Solvents and reagents 
THF was purified with a dry station GT S100 immediately prior to use. Dichloromethane was distilled 
over CaH2. Other anhydrous solvents and reagents were distilled according to procedures commonly 
described. All anionic and moisture-sensible reactions were carried out in the flame-dried glassware 
under an argon atmosphere. All reagents were obtained from commercial suppliers unless otherwise 
stated. 
 
B) Chromatography 
Thin layer chromatography (TLC) 
The reactions were monitored by thin-layer chromatography (TLC) analysis using silica gel (60 F254) 
plates. Compounds were visualized by UV irradiation (254 and 365 nm) and/or spraying with a solution 
of potassium permanganate or cerrium amonium nitrate (CAN), followed by charring at 150 °C. 
 
Column chromatography on silica gel 
Flash column chromatography was performed on silica gel 60 (230-400 mesh, 0.040-0.063 mm). Ethyl 
acetate, dichloromethane, acetonitrile and methanol used as eluents are technical grade. Petroleum 
ether is at 40-60 °C boiling point range. 
 
Determination of enantiomeric excess 
Enantiomeric excesses and purity were determined by chiral SFC measurement on a Waters 
Investigator SFC (Waters, Guyancourt, France) equipped with a Waters 2998 Photodiode Array 
detector with high-pressure resistant cell. The column was a Lux Cellulose-1 (250 x 4.6 mm, 5 µm) from 
Phenomenex (Torrance, CA). Operating conditions were always isocratic, with methanol or ethanol 
modifier. Flow rate was 3 mL/min, outlet pressure 15 MPa, column oven temperature 25°C. Retention 
times (tR) are given in minutes. Enantiomers were identified by comparison of retention times, 
whenever the second enantiomer could be synthesized, and by comparison of UV spectra as provided 
by the photodiode-array detector. 
 
C) Analysis and identification 
Melting points 
Melting points (Mp) of solid compounds were determined with WME Kofler apparatus and they are 
uncorrected. 
 
Infrared spectoscopy 
IR spectra were recorded on PERKIN ELMER IRTF spectrometer. Liquids and oils were applied as film 
between KBr windows and solids were dispersed in a NaCl pastille. Some spectra were recorded with 
Attenuated Total Reflectance (ATR) device. Absorption bands were given in cm-1. 
 
Nuclear Magnetic Resonance 
1H and 13C NMR spectra were recorded on a Brüker Avance spectrometer at 250 MHz (13C, 62.9 MHz) 
or 400 MHz (13C, 100 MHz). Chemical shifts were reported in ppm (δ) relative to tetramethylsilane 
(TMS) as internal reference (δ = 0.0 ppm). 31P NMR was recorded on spectrometer Brüker 400 MHz 
(160 MHz) with complete proton decoupling. The corresponding chemical shifts were reported in 
[ppm] (δ) relative to external standard – 85% solution of phosphoric acid. The following abbreviations 
are used for the proton spectra multiplicities: s: singlet, d: doublet, t: triplet, q: quartet, qt: quintuplet, 
m: multiplet, br: broad signal. Coupling constants (J) are reported in Hertz (Hz).  
Optical rotations 
Optical rotations were recorded at the sodium D line with a Perkin-Elmer 341 polarimeter.  
 
Mass spectrometry 
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Low resolution mass spectra (MS) were recorded on a Perkin-Elmer SCIEX API 3000 spectrometer. 
Ionspray methodology was used to record mass spectra. High-resolution mass spectra were obtained 
with a Varian MAT 311 spectrometer using electrospray analysis. 
 
D) Luminescence measurements 
Absorption spectra 
UV-Vis absorption spectra were recorded at room temperature using Perkin-Elmer Lambda 9 
spectrophotometer in quartz cuvette (1 cm).  
 
Emission and excitation 
Emission and excitation spectra were measured using a modified Jobin-Yvon Horriba Fluorolog-322 
spectrofluorimeter equipped with an Electro-Optical System, Inc. DSS-IGA02TL cooled to 77 K, near-
infrared detector. Singlet and triplet states were measured for the Gd3+ complexes with excitation at 
room temperature (fluorescence mode) and at 77 K (phosphorescence mode with 100 and 50 µs 
delay). 
 
Quantum yields 
Luminescence quantum yields were collected with an integration sphere developed by Frédéric Gumy 
and Prof. Jean-Claude G. Bünzli (Laboratory of Lanthanide Supramolecular Chemistry, École 
Polytechnique Féderale de Lausanne (EPFL), BCH 1402, CH- 1015 Lausanne, Switzerland) and 
manufactured by GMP SA (Renens Switzerland), using a quartz tube sample holder. Spectra were 
corrected for variations in excitation lamp output, spectral responses of the excitation and emission 
gratings, response of the detector, and the use of neutral density filters, when applicable. The 
calculated values were determined by integrating the emission profiles, averaged from three 
independent trials, and substitution into the ratio of emitted photons over absorbed photons. 
Luminescence quantum yields were determined with an integration sphere using a quartz tube sample 
holder. Collecting NIR quantum yields (φ) requires the use of both a visible and a NIR detector. A 
relative quantum yield is measured using a reference sample with a known value (ytterbium 
tropolonate [Yb(trop)4]
- φYb = 1.9∙10
-2 and neodymium tropolonate [Nd(trop)4]
- φNd = 2.1∙10
-3).136 The 
following steps for collecting a relative quantum yield using the integration sphere are: 
1) Emission spectra of the lamp (Rayleigh bands) are collected for the sample (RS+SB), the sample 
solvent (RSB), the reference (RR+RB) and the reference solvent (RRB). The resulting integration values are 
used to determine the amount of light absorbed by the sample and the reference. 
2) Emission spectra of the sample (IS+SB), the sample solvent (ISB), the reference (IR+RB) and the reference 
solvent (IRB) are collected in the NIR range. Emission spectra are corrected for the lamp variation, the 
solvent spectra are subtracted from the appropriate sample and reference spectra, the resulting 
spectra are corrected for detector response. 
3) The known quantum yield of the reference is used to create a scalar (XNIR-VIS) which accounts for the 
use of two different detectors: 
 =
Φ

 
4) The quantum yield of the sample is calculated using the following equation: 
 =


 
Lifetime determination 
Lanthanide-centered luminescence lifetimes were measured at room temperature using Quantel YG 
980 (355 nm, third harmonic) as the excitation source. Emission was collected at a right angle to the 
excitation beam, and wavelengths were selected by an interferential filter (990BP20 for Yb3+ and 
1063BP175 for Nd3+). The signal was monitored by a Hamamatsu H10330-45 near-infrared detector, 
and was collected on a 500 MHz band-pass digital oscilloscope (Tektronix TDS 724C). The experimental 
luminescence decay curves were treated with Origin 8.0 software using exponential fitting model. 
Three decay curves were collected for each sample and fitted separately. The lifetime values were 
averaged and presented with the calculated error. 
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II. General procedures 
General procedure (A) for the preparation of enol phosphates:  
 
To a solution of the appropriate N-COOMe or N-Boc protected lactam (1-4) (14.6 mmol) in THF (c = 0.32M) at -
78°C was added dropwise LDA (1.8 M in THF, 1.20 equiv.). The mixture was stirred for 2h at -78 °C and 
diphenylchlorophosphate (1.20 equiv.) was subsequently introduced. After stirring for 2 h at – 78°C (TLC control), 
the reaction was quenched by slow addition of distilled water. The resulting mixture was extracted with ethyl 
acetate. The organic phase was washed with distilled water and brine, dried over MgSO4 and concentrated. The 
residue was purified by flash chromatography (silica gel, petroleum ether/ethyl acetate with 0.1 % triethylamine) 
to provide the desired vinyl phosphates. 
 
General procedure (B) for palladium-catalyzed C-P cross-coupling reaction: 
 
Under argon, enol phosphate 5-8 (120 mg, 0.30 mmol) was dissolved in distilled CH3CN (2.5 mL) and secondary 
phosphine borane (diphenylphosphine borane or 13a) (0.60 mmol, 2.00 equiv.) was added. The content of the 
flask was evacuated and backfilled with argon three times. Subsequently, dppfPdCl2 (5 mol% yield) and Cs2CO3 
(0.60 mmol, 2.00 equiv.) were introduced and the Procedure: of degassing was repeated. Reaction was carried 
out in a oil bath (65–70˚C) for 2 h. The reaction mixture was filtered through Celite®, washed with CH3CN and the 
filtrate was evaporated. The crude product was purified by flash column chromatography (silica gel) to yield the 
expected alkenylphosphines. 
 
General Procedure (C) for palladium-catalyzed cross-coupling reaction of phospholane borane complex  
 
Under argon, enol phosphate 5-8 (100 mg, 0.248 mmol) was dissolved in CH3CN (2.1 mL) and chiral phosphine 
13b (0.496 mmol, 2.00 equiv.) was added. The content of the flask was evacuated and backfilled with argon three 
times. Subsequently, dppfPdCl2 (10 mol% yield) then Cs2CO3 (161.6 mg, 0.496 mmol, 2.00 equiv.) were 
introduced, and the Procedure: of degassing was repeated. Reaction was carried out in an oil bath (40°C) for 3 h 
(TLC control). After cooling down the mixture to room temperature, content of flask was filtrated through Celite®, 
washed with CH3CN and the filtrate was evaporated. The crude product was purified by flash column 
chromatography (silica gel, petroleum ether/ethyl acetate: 7/3 with 1% triethylamine). 
 
General Procedure (D) for palladium-catalyzed cross-coupling of phosphine oxide (4m-q).  
 
Under argon, enol phosphate 5-8 (40 mg, 0.09 mmol) was dissolved in DMSO (0.4 mL) and secondary phosphine 
oxide (13c) (0.18 mmol, 2.00 equiv.) was added. The content of the flask was evacuated and backfilled with argon 
three times. Subsequently, dppfPdCl2 (10 mol% yield) then N,N-diisopropylethylamine (0.06 mL, 0.36 mmol, 4.00 
equiv.) were introduced, and the Procedure: of degassing was repeated. Reaction was carried out in an oil bath 
(100 ˚C) for 2h (TLC control). After cooling down the mixture to room temperature, water and dichloromethane 
were added. The resulting mixture was extracted with dichloromethane. The organic phase was washed with 
brine, dried over MgSO4 and concentrated. The crude product was purified by flash column chromatography 
(silica gel) to yield the expected alkenylphosphine oxides. 
 
General Procedure for the preparation of acyclic ene-carbamates 4 via Suzuki coupling (E) 
Phosphate (3.2 mmol) was dissolved in degassed THF (10 mL) under argon. Dichloro-bis(triphenylphosphine) 
palladium (II) (0.32 mmol, 10% mol) was then added and the mixture was degassed and flushed under argon. 
Boronic acid (8.0 mmol, 2.50 equiv.), aqueous sodium carbonate solution (2M, 3.2 mL) and EtOH (3 drops) were 
added at once. The reaction mixture was then rapidly degassed, flushed under argon and heated at 60°C for 30 
minutes. After cooling, the reaction mixture was filtered through Celite, and was washed with EtOAc (50 mL). The 
organic phase was washed with brine, dried over MgSO4 and concentrated. Flash chromatography (silica gel, 
petroleum ether/EtOAc: 9/1) afforded the desired the pure product. 
 
General Procedure for the synthesis of the ene-carbamates via a Stille cross coupling (F) 
Phosphate (3.2 mmol) was dissolved in degassed toluene (10 mL) under argon. The dichloro-
bis(triphenylphosphine) palladium (II) (0.32 mmol, 10% mol) was added and the mixture was degassed and 
flushed under argon. 2-tributylstannylpyridine (8.0 mmol, 2.50 equiv.) and lithium chloride (6.2 mmol) were 
added. The reaction mixture was quickly degassed and flushed under argon. The mixture was then heated at 
90°C for a night. Brine (50mL) and EtOAc (50mL) were added. The organic phase was separated and the aqueous 
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phase was extracted with 20 mL of EtOAc. Combined organic phases were dried over MgSO4 and evaporated 
under vacuum. Flash chromatography of the crude (silica gel, petroleum ether then petroleum ether/EtOAc: 9/1) 
provided the pure product. 
 
General Procedure: (G) for the nucleophilic addition of lithiated phosphine onto acyclic ene-carbamates. 
 
Ene-carbamate (0.40 mmol) was dissolved in dry THF (2 mL) and was degassed. The solution was cooled at -78°C. 
In a separated dried flask, to a degassed solution of diphenylphosphine (1.20 mmol) in dry THF (2 mL) was added 
n-butyllithium (1.20 mmol, 1.6M solution in hexanes) which leeds to the apparition of an intense red color. This 
red solution was slowly canulated into the first flask cooled at -78°C. The cold bath was removed, letting the 
reaction mixture warm up to room temperature for 15 minutes. The reaction mixture was then quenched with 
saturated aqueous ammonium chloride (5 mL). EtOAc (5 mL) was added. The organic phase was separated and 
the aqueous phase was extracted with 20 mL of EtOAc. Combined organic phases were dried over MgSO4 and 
evaporated under vacuum. Flash chromatography of the residue (silica gel, PE then PE/EtOAc: 9/1) provided the 
pure product. 
 
 
Tert-butyl 2-oxopiperidine-1-carboxylate (1) 
 
Colorless solid 
Rf = 0.58 (PE/EtOAc: 6/4) revelator KMnO4 
 
Procedure: 
 
A solution of δ-valerolactam (2.00 g, 20.18 mmol, 1.00 equiv.) was prepared in distilled acetonitrile (30 mL) at 
room temperature, then DMAP (123 mg, 1.01 mmol, 0.05 equiv.) and Boc2O (4.85 g, 22.20 mmol, 1.10 equiv.) 
were added. The mixture was stirred at room temperature for 4 h. The solvent from mixture was evaporated 
under vacuum and residues were taken up in 20 mL of EtOAc, washed with distilled water (2x15 mL) and brine, 
dried over MgSO4 and concentrated. The residue was purified by flash chromatography (silica gel, PE/EtOAc: 7/3 
then 6/4) to provide 2.80 g (70 % yield) of the carbamate 1 as a colorless solid.  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 3.86 (t, J = 6.0 Hz, 2H), 2.62 (t, J = 6.3 Hz, 2H), 1.93-1.90 (m, 4H), 1.51 (s, 9H). 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 171.4 (C=O), 153.2 (C=O), 82.9 (C
IV), 47.1 (CH2), 35.2 (CH2), 28.3 (3xCH3), 22.8 
(CH2), 20.7 (CH2). 
MS (ESI) [m/z]: 200.5 [M+H]+, 222.5 [M+Na]+. 
IR (ATR, neat) ν [cm-1]: 2944, 1777, 1676, 1589, 1485, 1454. 
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Tert-butyl 2-oxoazepane-1-carboxylate (2) 
 
Colorless oil 
Rf = 0.59 (PE/EtOAc: 7/3) revelator KMnO4 
 
Procedure: 
 
A solution of ε-caprolactam (5.00 g, 44.18 mmol, 1.00 equiv.) was prepared in distilled acetonitrile (60 mL) at 
room temperature, then DMAP (270 mg, 2.21 mmol, 0.05 equiv.) and Boc2O (10.89 g, 49.91 mmol, 1.10 equiv.) 
were added. The mixture was stirred at room temperature for 18 h. The solvent from mixture was evaporated 
under vacuum and residues were taken up in 20 mL of EtOAc, washed with distilled water (2x15 mL) and brine, 
dried over MgSO4 and concentrated. The residue was purified by flash chromatography (silica gel, PE/EtOAc: 
7/3) to provide 6.14 g (65 % yield) of the carbamate 2 as a colorless oil.  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 3.76 (m, 2H), 2.65 (m, 2H), 1.73 (m, 6H), 1.52 (s, 9H). 
 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 175.9 (C=O), 153.1 (C=O), 82.9 (C
IV), 46.3 (CH2), 39.7 (CH2), 29.4 (CH2), 28.8 
(CH2), 28.2 (3xCH3), 23.7 (CH2). 
MS (ESI) [m/z]: 214.0 [M+H]+. 
IR (NaCl film) ν [cm-1]: 2979, 2933, 1768, 1715, 1569, 1285. 
 
Methyl 2-oxopiperidine-1-carboxylate (3) 
 
Colorless oil 
Rf = 0.43 (PE/EtOAc: 4/6) revelator KMnO4 
 
Procedure: 
 
To the solution of δ-valerolactam (1.00 g, 10.09 mmol, 1.00 equiv.) in THF (c = 0.25 M) at -78°C, a solution of n-
BuLi (1.6M in hexane, 6.9 mL, 11.10 mmol, 1.1 equiv.) was added dropwise. After stirring at -78°C for 30 
minutes, methyl chloroformate (0.86 mL, 11.10 mmol, 1.10 equiv.) was introduced to the yellow solution. The 
resulting mixture was stirred for an additional 1.5h at -78°C. The reaction was quenched with a saturated 
aqueous NH4Cl solution. The resulting mixture was extracted with ethyl acetate The organic phase was washed 
with distilled water and brine, dried over MgSO4 and concentrated. The residue was purified by flash 
chromatography (silica gel, petroleum ether/ethyl acetate: 6/4) to provide 1.59 g (52 % yield) of the methyl 
carbamate 2 as a colorless oil.  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 3.83 (s, 3H), 3.74 (t, J = 6.3 Hz, 2H), 2.54 (t, J = 7,1 Hz, 2H), 1.83 (qt, J =3.8 
and 3.1 Hz, 4H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 171.1 (C=O), 154.9 (C=O), 54.9 (CH3), 46.4 (CH2), 34.7 (CH2), 22.5 (CH2), 20.2 
(CH2). 
MS (ESI) [m/z]: 158.5 [M+H]+, 175.5 [M+NH4]
+. 
IR (ATR, neat) ν [cm-1]: 2953, 2875, 1775, 1706, 1436, 1282, 1247, 1142, 1059, 778. 
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Methyl 2-oxoazepane-1-carboxylate (4) 
 
 
Colorless oil 
Rf = 0.61 (PE/Acetone: 6/4) revelator KMnO4 
 
Procedure: 
 
To the solution of ε-caprolactam (2.00 g, 17.67 mmol, 1.00 equiv.) in THF (c = 0.25 M) at -78°C, a solution of n-
BuLi (1.6M in hexane, 12.15 mL, 19.44 mmol, 1.10 equiv.) was added dropwise. After stirring at -78°C for 30 
min., methyl chloroformate (1.50 mL, 19.44 mmol, 1.10 equiv.) was introduced to the yellow solution. The 
resulting mixture was stirred for an additional 1.75h at -78°C. The reaction was quenched with a saturated 
aqueous NH4Cl solution. The resulting mixture was extracted with ethyl acetate. The organic phase was washed 
with distilled water and brine, dried over MgSO4 and concentrated. The residue was purified by flash 
chromatography (silica gel, petroleum ether/acetone: 6/4) to provide 2.00 g (66 % yield) of the methyl 
carbamate 4 as a creamy oil.  
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3 δ [ppm]: 3.85 (s, 5H), 2.69 (m, 2H), 1.77 (s, 6H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]:  175.7 (C=O), 155.2 (C=O), 54.1 (CH3O), 46.5 (CH2), 39.6 (CH2), 29.3 (CH2), 
28.7 (CH2), 23.7 (CH2). 
MS (ESI) [m/z]: 172.5 [M+H]+, 194.5 [M+Na]+. 
IR (ATR, neat) ν [cm-1]: 2981, 2952, 2892, 1701, 1287, 1248, 1135, 1061, 854. 
 
Tert-butyl 6-(diphenoxyphosphoryloxy)-3,4-dihydropyridine-1(2H)-carboxylate (5) 
 
 
Colorless oil 
Rf = 0.50 (PE/EtOAc: 7/3) revelator KMnO4 
 
Procedure: 
 
Following the general procedure (A), vinylphosphate 5 was obtained and the crude product was directly used 
for coupling step, because degradation occurs during purification on column.  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.34-7.16 (m, 10 H), 5.12-5.08 (dd, J = 2.0 and 3.0 Hz, 1H), 3.60 (t, J = 11.0 
Hz, 2H), 2.50 (m, 2H), 1.80 (m, 2H), 1.43 (s, 9H).
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Tert-butyl 7-(diphenoxyphosphoryloxy)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate (6) 
 
 
Colorless oil 
Rf = 0.57 (PE/EtOAc: 7/3) revelator KMnO4 
 
Procedure: 
 
According to general procedure (A), after purification by flash column chromatography (petroleum ether/ethyl 
acetate: 6/4) vinylphosphate 6 was afforded (83% yield) as a colorless oil. 
 
Analyses: 
 
1
H NMR (400MHz, CDCl3) δ [ppm]: 7.40-7.19 (m, 10 H), 5.45 (td, J =7.0 and 3.0 Hz, 1H), 3.55 (m, 2H), 2.14-2.09 
(m, 2H), 1.80-1.67 (3, 2H), 1.56-1.47 (m, 9H+2H). 
13
C NMR (100MHz, CDCl3) δ [ppm]: 153.2 (C=O), 150.7, 150.6(C
IV), 145.3 (CIV), 129.9 (4xCH), 125.6 (2xCH), 120.2 
(4xCH), 109.7 (CH), 81.3 (CIV), 46.7 (CH2), 29.5 (CH2), 28.3 (3xCH3), 24.5 (CH2), 24.0 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: -16.50. 
MS (ESI) [m/z]: 445.0 [M]+, 468.0 [M+Na]+.  
IR (ATR, neat) ν [cm-1]: 3058, 2977, 2929, 2849, 1712, 1982, 1590, 1482, 1294, 1183, 944, 761. 
 
 
 
Methyl 6-(diphenoxyphosphoryloxy)-3,4-dihydropyridine-1(2H)-carboxylate (7) 
 
Colorless oil 
Rf = 0.43 (PE/EtOAc: 6/4) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (A), after purification by flash column chromatography (petroleum 
ether/ethyl acetate: 6/4 with 1% TEA) vinylphosphate 7 was obtained (83% yield) as a colorless oil.  
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.38-7.17 (m, 10H), 5.12 (dd, JH,P = 3.8 Hz and JH,H = 3.0 Hz, 1H), 3.65 (t, J = 
5.5 Hz, 2H), 3.56 (s, 3H), 2.17 (m, 2H), 1.74 (qt, J = 5.5 and 6.7 Hz, 2H). 
13
C NMR (100 MHz,CDCl3) δ [ppm]:  154.9 (C=O), 130.1 (C
IV), 129.9 (4xCHar), 125.6 (2xC
IV), 129.5 (2xCHar), 120.4 
(4xCHar), 99.6 (CHvinyl), 54.1 (CH3), 46.7 (CH2), 35.0 (CH2), 22.8 (CH2). 
31
P NMR (160 MHz,CDCl3) δ [ppm]: -16.11. 
MS (ESI) [m/z]: 390.5 [M+H]+, 412.5 [M+Na]+. 
IR (ATR, neat) ν [cm-1]: 3067, 2956, 2878, 1775, 1712, 1596, 1488, 1294, 1180, 1162, 968, 755. 
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Methyl 7-(diphenoxyphosphoryloxy)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate (8) 
 
Yellow oil 
Rf = 0.32 (PE/EtOAc: 7/3) revelator KMnO4 
 
Procedure: 
 
According to general procedure (A), after purification by flash column chromatography (petroleum ether/ethyl 
acetate: 8/2 to 7/3) the vinylphosphate 8 was obtained (58% yield) as a yellow oil.  
 
Analyses: 
 
1
H NMR (400MHz, CDCl3) δ [ppm]: 7.37-7.20 (m, 10H), 5.48-5.44 (td, JH,P = 1.8 Hz and JH,H = 6.8 Hz, 1H), 3.59 (s, 
5H), 2.08 (m, 2H), 1.74 (t, J = 3.3 Hz, 2H), 1.52 (m, 2H). 
13
C NMR (100MHz, CDCl3) δ [ppm]: 154.8 (C=O), 150.9 (2xC
IV) 150.8 (CIV), 130.2 (4xCHar), 125.9 (2xCHar), 120.5 
(2xCHar), 120.4 (2xCHar), 110.7 (CHvinyl), 53.5 (CH3O), 47.8 (CH2), 29.8 (CH2), 24.6 (CH2), 24.3 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: -17.34. 
MS (ESI) [m/z]: 404.5 [M+H]+, 426.5 [M+Na]+. 
IR (ATR, neat) ν [cm-1]: 3058, 2950, 2926, 2852, 1715, 1691, 1593, 1485, 1437, 1285, 1189, 944, 755. 
 
 
 
Tert-butyl 7-(diphenylphosphino)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate borane complex (10) 
 
Colorless oil 
Rf = 0.56 (PE/EtOAc: 8/2) revelator KMnO4 
 
Procedure: 
 
The general procedure (B) was applied. Purification by flash column chromatography (petroleum ether/ethyl 
acetate: 9/1) yielded 10 (67 mg, 75% yield) as a colorless oil. 
 
Analyses: 
1H NMR (400MHz, DMSO-d6) δ [ppm]: 7.55 (m, 9H), 7.40 (s, 1H) 6.52 (dd, JH,P = 7.5 Hz and JH,H = 1.3Hz, 1H), 2.26 
(m, 2H), 1.72 (m, 2H), 1.35 (m, 2H), 1.18 (m, 2H), 0.98 (s, 9H). 
13C NMR (100 MHz, DMSO-d6) δ [ppm]: 152.2 (C=O), 145.6 (CHvinyl), 136.5 (C
IV), 132.9 (4xCHar), 131.5 (2xCHar), 
128.8 (2xCHar), 128.7 (2xCHar), 79.7 (C
IV), 59.6 (CH2), 47.1 (CH2), 28.9 (CH2), 27.2 (3xCH3), 22.7(CH2). 
31P NMR (DMSO-d6, 160 MHz) δ [ppm]: 21.94. 
HRMS (ESI) [m/z]: calculated for C23H31
11BN23NaO2P [M+Na]
+ : 418.2082, found: 418.2084. 
IR (KBr) ν [cm-1]: 3442 (CON lactam), 3051, 2935, 2404, 1697 (C=O), 1435, 1389, 1157. 
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Methyl 6-(diphenylphosphino)-3,4-dihydropyridine-1(2H)-carboxylate borane complex (11) 
 
Yellow oil 
Rf = 0.56 (PE/acetone: 7/3) revelator KMnO4 
Procedure: 
 
Following the general procedure (B), after purification by flash column chromatography (petroleum 
ether/acetone: 8/2 to 7/3) phosphine borane 11 was obtained (30 mg, 28% yield) as a yellow oil.  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.60 (m, 4 H), 7.45 (m, 6 H), 5.59-5.51 (dt, JH,P = 10.8 Hz and JH,H = 3.8 Hz, 
1H), 3.72-3.67 (m, 2H), 3.11 (s, 3H), 2.25 (m, 2H), 1.88 (m, 2H), 1.00 (m, BH3). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.3 (C=O), 133.5 (2xC
IV), 132.8, 132.7 (4xCHar), 130.9 (2xCHar), 130.8 (C
IV), 
128.6 (4xCHar), 100.2 (CHvinyl), 52.0 (CH3O), 24.8 (CH2), 23.1 (CH2), 20.2 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 27.11. 
MS (ESI) [m/z]: 342.5 [M+NH4-BH3 ]
+, 364.5 [M+Na+NH4-BH3]
+. 
HRMS (ESI) [m/z]: calculated for C19H22NO2
11BP [M-H]+ : 338.1481, found: 338.1449. 
IR (NaCl) ν [cm-1]: 3446 (CON lactam), 3210, 2950, 2384, 1712 (C=O), 1438, 1061, 499. 
 
 
Methyl 7-(diphenylphosphino)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate borane complex (12) 
 
 
 
Colorless oil 
Rf = 0.56 (PE/acetone: 7/3) revelator KMnO4 
 
Procedure: 
 
Following the general procedure (B), after purification by flash column chromatography (petroleum ether/ethyl 
acetate: 95/5 to 85/15) product 12 was isolated (100mg, 95% yield) as a colorless oil.  
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3 δ [ppm]: 7.58-7.56 (m,4H), 7.40-7.35 (m, 6H), 6.33 (td, JH,P = 6.8 Hz and JH,H = 2.0 Hz, 
1H), 2.96 (s, 3H), 2.27 (q, JH,H = 6.0 Hz, 2H), 1.75 (t, JH,H = 5.4 Hz, 2H), 1.18 (m, 2H), 0.80 (m, BH3). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.5 (C=O), 144.5 (CHvinyl), 137.6 (C
IV), 133.0 (4xCHar), 131.2 (2xCHar), 129.3 
(2xCHar), 129.3 (C
IV),128.6 (2CHar), 52.0 (CH3), 48.6 (CH2), 29.7 (CH2), 28.7 (CH2), 23.4 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 24.106. 
MS (ESI) [m/z]: 355 [M+H]+. 
HRMS (ESI) [m/z]: [M–BH3]
+ calculated for C20H22NO2P: 339.1388, found: 339.1379. 
IR (KBr) ν [cm-1]: 3416 (CON lactam), 2946, 2389, 1706 (C=O), 1437, 1056, 740. 
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Methyl 6-((2-methoxyphenyl)(phenyl)phosphino)-3,4-dihydropyridine-1(2H)-carboxylate borane complex 
(15) 
 
Yellow oil 
Rf = 0.81 (PE/acetone: 6/4) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (B), after purification by flash column chromatography (petroleum 
ether/ethyl acetate: 7/3) product 15 (60 mg, 42% yield) was obtained as a yellow oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.44-7.39 (m, 4H), 7.34-7.24 (m, 5H), 5.75 (dt, JH,P =11.1 Hz and JH,H = 3.8 Hz, 
1H), 3.78 (s, 3H), 3.69 (m, 2H), 3.11 (s, 3H), 2.25 (m, 2H), 1.91 (m, 2H), 1.00 (m, BH3). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.3 (C=O), 150.9 (C
IV), 130.4 (2xCHar), 129.6 (CHar), 128.1 (CHar), 127.9 
(CHar), 124.7 (CHar), 120.6 (C
IV), 120.1 (2xCHar), 111.4 (CHvinyl), 55.5 (CH3O), 44.4 (CH3O), 25.0 (CH2), 24.4 (CH2), 
23.1 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 28.11. 
HRMS (ESI) [m/z]: calculated for C19H19NO3P [M–BH3–Me]
+: 340.1102, found: 340.1121. 
0% ee as determined by chiral SFC-DAD: CO2-methanol 91:9 (v/v), 3 mL/min, 25°C, 15 MPa.tR1=6.54 min., 
tR2=7.02 min. 
 
 
Tert-butyl 7-((2-methoxyphenyl)(phenyl)phosphino)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate borane 
complex (16). 
 
Yellow oil 
Rf = 0.23 (PE/EtOAc 8/2) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (B) and after purification by flash column chromatography (petroleum 
ether/acetone: 8/2 to 7/3) product 16 was obtained (40 mg, 42% yield) as a yellow oil. 
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6, 80°C) δ [ppm]: 7.62-7.47 (m, 7H), 7.09-7.05 (m, 2H), 6.48-6.44 (m, 1H), 3.62 (s, 
3H), 2.31-2.28 (m, 2H), 1.76 (m, 2H), 1.49 (m, 2H), 1.29 (m, 2H), 1.09 (s, 9H), 0.8-0.5 (m, BH3). 
13
C NMR (100 MHz, CDCl3 δ [ppm]: 154.9 (C=O), 133.7 (CHar), 131.6 (CHar), 131.5 (C
IV) 130.1 (2xCHar), 128.2 
(2xCHar), 120.8 (2xCHar), 120.7 (C
IV), 111.4 (CHvinyl), 99.9 (C
IV), 80.6 (CIV), 55.3 (CH3), 47.3 (CH2), 29.6 (CH2), 28.1 
(CH2), 27.8 (3xCH3), 23.8 (CH2). 
31
P NMR (160 MHz, CDCl3 δ [ppm]: 21.88. 
HRMS (ESI) [m/z]: calculated for C24H30NO3P [M–BH3]
+: 411.1963, found: 411.1944. 
0% ee as determined by chiral SFC-DAD: CO2-ethanol 93:7 (v/v), 3 mL/min, 25°C, 15 MPa. tR1 = 7.02 min., 
tR2=7.90 min. 
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Methyl 7-((2-methoxyphenyl)(phenyl)phosphino)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate borane 
complex (17). 
 
Yellow oil 
Rf = 0.49 (PE/acetone: 7/3) revelator KMnO4 
Procedure: 
 
According to the general procedure (B) and after purification by flash column chromatography (petroleum 
ether/acetone: 8/2 to 7/3) product 17 was isolated (55 mg, 58% yield) as a yellow oil.  
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.69 (m, 2H), 7.41 (m, 5H), 6.99-6.90 (m, 2H), 6.45-6.40 (dd, JH,H = 3.0 Hz and 
JH,P = 9.5 Hz, 1H), 3.70 (s, 3H), 3.05 (s, 3H), 2.34–2.33 (m, 2H), 1.83-1.82 (m, 2H), 1.26 (m, 2H), 0.89-0.85 (m, 
BH3). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.6 (C=O), 136.7 (C
IV), 133.6 (2xCHar), 132.4 (CHar), 132.3 (2xCHar), 
130.5(CHar), 130.4 (CHar), 128.2 (2xCHar), 128.1 (C
IV), 120.9 (CIV), 120.8 (CHar), 111.6 (CH), 111.5(C
IV), 55.5 (CH3), 
51.9 (CH3), 29.9 (CH2), 28.7 (CH2), 28.6 (CH2), 23.6 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 22.70. 
MS (ESI) [m/z]: 368.5 [M + NH4 –BH3 ]
+, 408.5 [M + NH4 –BH3+Na]
+. 
HRMS (ESI) [m/z]: calculated for C21H24NO3P [M–BH3]
+: 369.1494, found: 369.1476. 
IR (NaCl) ν [cm-1]: 3449 (CON lactam), 3056, 2940, 2385, 1709, 1479, 737, 508. 
0% ee as determined by chiral SFC-DAD: CO2-ethanol 80:20 (v/v), 3 mL/min, 25°C, 15 MPa. tR1=3.19 min., 
tR2=3.85 min. 
 
 
Methyl 6-((2S,5S)-2,5-diphenylphospholan-1-yl)-3,4-dihydropyridine-1(2H)-carboxylate borane complex (19) 
 
White semi-solid 
Rf = 0.76 (PE/EtOAc: 6/4) revelator KMnO4 
 
Procedure: 
 
Following the general procedure (C), the product 19 was isolated after purification as a white semi-solid (30 
mg, 30% yield).  
 
Analyses: 
 
1
H NMR (400 MHz,CDCl3) δ [ppm]: 7.35-7.57 (m, 5H), 7.29-7.27 (m, 5H) 5.28-5.22 (q, JH,P =7.2 Hz, 1H), 4.38-4.33 
(q, JH,P = 7.5 Hz, 1H), 3.95 (m, 2H), 3.67 (s, 1H), 3.52 (m, 3H), 2.63 (m, 2H), 2.24-2.22 (m, 4H), 1.00-0.50 (m, BH3). 
13
C NMR (100 MHz,CDCl3) δ [ppm]: 151.7 (C=O), 137.9 (2xC
IV), 136.7 (CIV), 129.2 (CHar), 128.8 (CHar), 128.7 
(CHar), 128.6 (CHar), 128.3 (CHar), 127.6 (CHar), 127.5 (2xCHar), 127.4 (2xCHar), 100.2 (CH), 44.8 (CH3), 44.5 (CH2), 
41.0 (CH2), 40.7 (CH2), 34.9 (CH2), 34.8 (CH2), 34.1 (2xCH). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 28.74. 
MS (ESI) [m/z]: 397.17 [M–BH3]
+, 402.16 [M+Na–BH3]
+. 
HRMS (ESI) [m/z]: calculated for C23H30NO2PB [M]
+ : 394.2106, found: 394.2104. 
IR (NaCl) ν [cm-1]: 3424, 2960, 2924, 2373, 1720, 1449, 1261, 1063, 801, 699. 
[ ]20Dα = -20.1 (c=1, CHCl3); > 99.5% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (S,S)=17.1 min., tR (R,R) not detected. 
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Tert-butyl 7-((2S,5S)-2,5-diphenylphospholan-1-yl)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate borane 
complex (20) 
N
O O
BH3
P
Ph
Ph
 
White semi-solid 
Rf = 0.80 (PE/EtOAc: 8/2) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (C), after purification by flash column chromatography 20 was isolated as a 
white semi-solid (30 mg, 35% yield). 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) (rotamers) δ [ppm]: 7.46-7.25 (m, 10H), 6.44-5.99 (m, 1H), 4.55 (m, 1H), 3.74 (m, 2H), 
2.50 (br t, 6H), 2.25 (m, 4H), 1.57 (s, 9H), 1.00-0.50 (m, BH3). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 160.9 (C=O), 128.8 (3xCHar), 128.4 (2xCHar), 128.0 (4xCHar), 126.6 (CHar), 
99.9 (CH), 80.5 (CIV), 43.8 (CH2), 33.8 (2xCH2), 30.7 (CH2), 28.5 (2xCH), 28.4 (3xCH3), 22.8(2xCH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 47.30. 
MS (ESI) [m/z]: 435.5 [M–BH3]
+. 
HRMS (ESI) [m/z]: calculated for C19H19NO2P [M-tBu-BH3]
+ 
: 324.1153, found: 324.1145. 
[ ]20Dα = -13.7 (c=1, CHCl3); > 99.5% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (S,S) = 5.9 min.; tR (R,R) not detected. 
 
 
Methyl 7-((2S,5S)-2,5-diphenylphospholan-1-yl)-2,3,4,5-tetrahydro-1H-azepine-1-carboxylate borane 
complex (21) 
 
Creamy semi-solid 
Rf = 0.69 (PE/EtOAc: 6/4) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (C), after purification by flash column chromatography 21 was obtained as 
a creamy semi-solid (45 mg, 46% yield).  
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) (rotamers) δ [ppm]: 7.36-7.34 (m, 10H), 5.95 and 5.76 (m, 1H), 3.93 (m, 2H), 3.76 (s, 
3H), 3.60 (m, 1H), 3.18 (s, 1H), 2.88 (m, 2H), 2.49 (m, 2H), 2.24-2.22 (m, 2H), 1.91 (m, 2H), 1.42 (m, 2H), 0.85 (m, 
BH3). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 155.3 (C=O), 141.9 (CHvinyl), 133.6 (C
IV), 129.0 (CHar), 128.8 (2xCHar), 128.5 
(2xCHar), 128.3 (CHar), 128.0 (CHar), 127.0 (CHar), 126.7 (2xCHar), 53.0 (CH3), 52.0 (CH), 50.7 (CH), 46.0 (CH2), 34.7 
(CH2), 30.4 (CH2), 28.2(CH2), 22.8 (CH2), 22.6 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 48.20. 
MS (ESI) [m/z]: 430.21 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C24H31NO2P
11B [M]+ : 407.2186, found: 407.2175.  
[ ]20Dα = -26.9 (c=1, CHCl3); > 99.5% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (S,S) = 18.08 min., tR (R,R) not detected. 
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6-((2S, 5S)-1-oxo-2,5-diphenyl-λ5-phospholan-1-yl)-3,4-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
(22) 
 
White semi-solid 
Rf = 0.2 (EtOAc) revelator KMnO4 
 
Procedure: 
 
Following the general procedure (D), after purification by flash column chromatography (petroleum ether/ethyl 
acetate: 5/5 to 0/1) yielded the product 22 (43 mg, 28% yield) as a white semi-solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.46-7.16 (m, 10H), 6.19-6.17 (dt, JHP = 11.7 Hz, 1H), 4.06 (m, 1H), 3.84-3.75 
and 3.59-3.57 (m, 2H), 3.26-3.23 (m, 1H), 2.51-2.43(m, 6H), 2.07 (m, 2H), 1.56 (m, 2H), 1.45 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 152.8 (C=O), 137.4 (C
IV), 136.9 (CIV), 132.1 (Cvinyl), 129.3 (CHar), 129.3 (C
IV), 
129.1 (CHar), 128.3 (CHar), 128.2 (CHar), 127.8 (CHar), 127.8 (CHar), 127.5 (CHar), 126.0 (CHar), 125.9 (CHar), 80.4 
(CIV), 50.9 (CH), 50.2 (CH), 31.5 (CH2), 28.3 (3xCH3), 27.3-27.2 (CH2), 23.8(CH2), 22.3 (CH2), 20.9 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 55.56. 
MS (ESI) [m/z]: 438.5 [M+H]+, 460 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C22H24NO3P [M–C4H8]
+: 381.1494, found: 381.1490. 
IR (KBr) ν [cm-1]: 3443, 2946, 2865, 1689, 1359, 1153, 768, 698. 
[ ]20Dα = -66.0 (c=1, CHCl3). 99.4% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (R,R) = 4.61 min., tR (S,S) = 5.14 min. 
 
 
1-(methoxycarbonyl)-6-((2S,5S)-1-oxo-2,5-diphenyl-λ5-phospholan-1-yl)-3,4-dihydro-2H-pyridine (23). 
N P
OO
O
 
Orange oil 
Rf = 0.27 (EtOAc) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (D) and after purification by flash column chromatography (petroleum 
ether/ethyl acetate: 5/5 to 0/10 with 1% triethylamine) product 23 was obtained as an orange oil (130 mg, 64% 
yield). 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.47-7.20 (m, 10H), 5.95 (m, 1H), 3.87-3.76 (m, 2H), 3.42 (s, 3H), 3.23 (m, 
1H), 2.61 (m, 1H), 2.49 (m, 2H), 2.42 (m; 2H), 1.99 (m, 2H), 1.58 (m, 2H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.3 (C=O), 137.6 (C
IV), 137.1 (CIV), 133.9 (CIV), 132. 9 (CIV), 129.3 (2xCHar), 
129.3 (2xCHar), 128.3 (CHar), 128.0 (CHar), 127.1 (CHar), 127.1 (CHar), 126.6 (CHar), 126.3 (CHar), 102.0 (CHvinyl), 
52.7 (CH3), 45.8 (2xCH), 43.7 (CH2), 23.7 (CH2), 23.6 (CH2), 22.2 (2xCH2). 
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31
P NMR (CDCl3) δ [ppm]: 54.45. 
MS (ESI) [m/z]: 396.0 [MH]+, 4180 [MNa]+, 434.0 [MK]+. 
HRMS (ESI) [m/z]: calculated for C23H26NO3P [M]
+ : 395.1650, found: 395.1649. 
IR (NaCl) ν [cm-1]: 3386, 2951, 2867, 2354, 1704, 1446, 758, 502. 
[ ]20Dα = -64.2 (c=1, CHCl3). 99.4% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (R,R) = 7.62 min., tR (S,S) = 9.14 min. 
 
 
7-((2S,5S)-1-oxo-2,5-diphenyl-λ5-phospholan-1-yl)-2,3,4,5-tetrahydro-azepine-1-carboxylic acid methyl ester 
(24) 
 
Orange oil 
Rf = 0.32 (EtOAc) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (D) and after purification by flash column chromatography (petroleum 
ether/ethyl acetate: 5/5 to 0/10) compound 24 was obtained (75 mg, 70% yield) as a brown oil.  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) (rotamers) δ [ppm]: 7.43-7.26 (m, 10H), 6.64-6.56 and 6.13 (s, 1H), 4.01 and 3.90 (m, 
2H), 3.75 (s, 3H), 3.25 (m, 1H), 3.12 (m, 1H), 2.99 (m, 1H), 2.61 (m, 2H), 2.30 (m, 2H), 2.04 (m, 2H), 1.52 (m, 2H), 
1.42 (m, 2H), 1.25 (t, 2H, J = 4.6 Hz). 
13
C NMR (63 MHz, DMSO-d6) δ [ppm]: 154.2 (C=O), 137.9 (CIV), 137.6 (CIV), 137.3 (CIV), 136.4 (CIV), 129.5, 129.3, 
128.4, 127.9, 127.4, 127.3, 126.4, 126.2 (10xCHar), 99.9 (CH), 51.7 (CH), 51.0 (CH), 46.6 (CH2), 45.3 (CH2), 36.7 
(CH2), 29.2 (CH2), 27.3 (CH2), 27.8 (3xCH2), 26.4 (CH2), 22.7 (CH3). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 53.769. 
MS (ESI) [m/z]: 410.5 [M+H]+, 432.5 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C24H31NO2
11BP [M]+ : 409.1807, found: 409.1799.  
IR (NaCl) ν [cm-1]: 3399, 3058, 2933, 2857, 1713, 1450, 1032, 699. 
[ ]20Dα = -31.0 (c=1, CHCl3). 99.7% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (R,R) = 9.64 min., tR (S,S) = 14.3 min. 
 
 
7-((2S,5S)-1-oxo-2,5-diphenyl-1 λ5-phospholan-1-yl)-2,3,4,5-tetrahydro-azepine-1-carboxylic acid tert-butyl 
ester (25) 
 
Light brown oil 
Rf = 0.31 (EtOAc) revelator KMnO4 
Procedure: 
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Following the general procedure (D) and after purification by flash column chromatography (petroleum 
ether/ethyl acetate: 5/5 to 0/10) compound 25 was isolated (71 mg, 70% yield) as a light brown oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) (rotamers) δ [ppm]: 7.46 (m, 2H), 7.39 (m, 6H), 7.26 (m, 2H), 6.60 (m, 1H), 4.05 (m, 
2H), 3.72 (m, 2H), 2.97 (m, 2H), 2.56 (m, 2H), 2.50 (m, 2H), 2.29 (m, 2H), 2.11 (s, 4H), 1.50 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.3 (C=O), 146.2 (CHvinyl), 129.5-126.0 (CH, ar), 80.4 (C
IV), 60.4 (CH), 50.3 
(CH), 48.2 (CH2), 44.9 (CH2), 31.4 (CH2), 29.7 (CH2), 28.4 (3xCH3), 26.7 (CH2), 22.8 (CH2). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 53.75. 
MS (ESI) [m/z]: 452.5 [M+H]+, 474.5 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C23H25NO3P [M–tBu]
+: 394.1572, found: 394.1564. 
IR (NaCl) ν [cm-1]: 3373, 3060, 2930, 2859, 2342, 1694, 1454, 1367, 1061, 699.  
[ ]20Dα = -39.4 (c=1, CHCl3). 99.5% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 mL/min, 
25°C, 15 MPa. tR (R,R) = 5.72 min., tR (S,S) = 5.35 min. 
 
 
Di-tert-butyl bis(2S,5S)-1-oxo-2,5-diphenyl-1λ5-phospholan-1-yl)pyrazine-1,4-dicarboxylate (26) 
N
N
P
OO
O
P
O
OO
 
Colorless oil 
Rf = 0.13 (EtOAc) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (D) by doubling the quantity of all reagents, after purification by flash 
column chromatography (petroleum ether/ethyl acetate: 5/5 to 0/10), product 26 was isolated (220 mg, 75% 
yield) as a colorless oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.41-7.21 (m, 10H), 6.75 (t, JH,P = 5.4 Hz, 1H), 4.67 (m, 1H), 3.95 (dd, J = 3.1 
Hz, J = 16.6 Hz, 1H), 3.77 (m, 1H), 2.44 (m, 2H), 2.09 (d, J = 16.6 Hz, 1H), 1.50 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 166.6 (C=O), 152.5 (CHvinyl), 136.5 (C
IV), 136.0(CIV),  132.3 (CHar), 129.2 
(2xCHar), 129.1 (2xCHar), 128.4 (CHar), 128.3 (CHar), 126.9 (CHar), 126.8 (CHar), 126.7 (CHar), 82.3 (C
IV), 50.3 (CH), 
49.7 (CH), 47.3 (CH2), 45.7 (CH2), 28.2 (3xCH3). 
31
P NMR (160 MHz, CDCl3) δ [ppm]: 56.83. 
MS (m/z): 791.33 [M+H]+, 813.8 [M+Na]+. 
[ ]20Dα = -26.4 (c=0.33, CH3OH). > 99.5% ee as determined by chiral SFC-DAD: CO2-methanol 90:10 (v/v), 3 
mL/min, 25°C, 15 MPa. tR (R,R) = 9.91 min., tR (S,S) = 11.07 min. 
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Tert-butyl acetyl-benzyl-carbamate (27) 
 
Colorless oil 
Rf = 0.30 (PE/EtOAc: 6/4) revelator KMnO4 
 
Procedure: 
 
Benzylamine (3.00 g, 27.98 mmol) was added to acetic anhydride (2.64 mL, 27.98 mmol, 1.00 equiv.) and this 
solution was refluxed 30 min. After coolong down, product was dissolved in dichloromethane and washed with 
the saturated solution of sodium carbonate, dried over MgSO4 and evaporated under vacuum. After 
crystallization in Et2O and drying under vacuum pump, product was taken up in THF (15 mL) and Boc2O (6.17 g, 
28.32 mmol, 1.10 equiv.) was added. Then, DMAP as organocatalyst (346 mg, 2.38 mmol, 10 mol% yield) was 
introduced and mixture was stirred for 3h ar room temperature. Residues were quenched with distilled water, 
the aqueous phase was extracted with 20 mL of EtOAc. Combined organic phases were dried over MgSO4 and 
evaporated under vacuum. Flash chromatography (silica gel, petroleum ether/EtOAc: 5/5) yielded carbamate 
27 (6.28 g, 90% yield) as a colorless oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.31-7.23 (m, 5H), 4.89 (s, 1H), 2.54 (s, 3H), 1.41 (s, 9H).  
13
C NMR (100 MHz,CDCl3) δ [ppm]: 173.3 (C=O), 153.3 (C=O), 138.4 (C
IV), 128.4 (CHar), 127.7 (CHar), 127.2 (CHar), 
83.4 (CIV), 47.2 (CH2), 28.0 (CH3), 26.9 (CH3). 
 
 
Tert-butyl benzyl(1-(diphenoxyphosphoryloxy) vinyl)carbamate (30) 
 
Colorless oil 
Rf = 0.20 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
Starting amide 27 (3.7 mmol) was dissolved in dry THF (15 mL) and the mixture was cooled down to -78°C 
under argon. A lithium diisopropylamine solution (5.6 mmol, 2 M in THF/n-Heptane, 1.50 equiv.) was then 
added dropwise and the mixture was stirred at -78°C for 90 minutes. Subsequently, diphenylchlorophosphate 
(5.6 mmol) was added. After 2h at -78°C, the mixture was quenched with water. The aqueous phase was 
extracted with 20 mL of EtOAc. Combined organic phases were dried over MgSO4 and evaporated under 
vacuum. Flash chromatography (silica gel, petroleum ether/EtOAc: 1/9) provided pure vinylphosphates 30 (98% 
yield) as colorless oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.19-7.36 (m, 15H), 4.97 (br s, 1H), 4.57 (s, 2H), 4.50 (br s, 1H), 1.42 (s, 9H).  
13
C NMR (100 MHz,CDCl3) δ [ppm]: 153.8 (C=O), 150.6 (C
IV), 146.4 (CIV), 137.7 (CIV), 130.0 (CHar), 128.2 (CHar), 
128.0 (CHar), 127.6 (CHar), 125.8 (CHar), 120.3 (CHar), 98.2 (CH2), 82.7 (C
IV), 51.7 (CH2), 28.3 (CH3). 
31
P NMR (162 MHz, CDCl3) δ [ppm]: -18.7. 
IR (ATR, neat) ν [cm-1]: 1488, 1193, 1146, 944, 753, 689. 
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Tert-butyl 1-(2-fluorophenyl) vinyl(phenyl) carbamate (32) 
 
White solid 
Rf = 0.57 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E) and after purification on the column, product 32 was isolated (46% 
yield) as a white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.25-7.42 (m, 6H), 7.03-7.20 (m, 3H), 5.42 (s, 1H), 5.16 (s, 1H), 1.25 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 160.4 (C=O), 157.9 (C
IV), 152.3 (CIV), 142.4-142.3(F-CIV), 128.6 (CH), 128.5 
(CH), 128.1 (CH), 128.0 (CH), 127.9 (CH), 125.2 (CH), 124.7 (CH), 123.2 (CH), 123.1 (CH), 114.9 (CH), 113.8 (CH2), 
80.3 (CIV), 27.0 (CH3). 
19
F NMR (376.5 MHz, CDCl3) δ [ppm]: -116.17. 
HRMS (ESI) m/z: [M+Na]+ calcd for C19H20FNO2
23Na: 336.1375, found: 336.1369. 
IR (neat) ν [cm-1]: 1712, 1365, 1491, 1336, 1218. 
Mp < 50°C. 
 
Tert-butyl 1-(benzo[b]thiophen-2-yl) vinyl (phenyl) carbamate (33) 
 
Yellow solid 
Rf = 0.50 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E), after purification by flash column chromatography, product 33 was 
isolated as a yellow solid (88% yield). 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.71 (m, 1H), 7.66-7.70 (m, 1H), 7.42-7.45 (m, 2H), 7.25-7.34 (m, 5H), 7.14-
7.17 (m, 1H), 5.69 (s, 1H), 5.23 (s, 1H), 1.36 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ[ppm]: 153.4 (C=O), 142.9 (C
IV), 142.7 (CIV), 139.9 (CIV), 139.4 (CIV), 128.9 (2CH), 
127.5 (CH), 124.9 (CH), 124.8 (CH), 124.7 (CH), 124.5 (CH), 123.1 (CH), 121.5 (CH),118.5 (CH), 114.5 (CH2), 81.5 
(CIV), 28.1 (CH3). 
HRMS (ESI) m/z [M-tBu]+ calcd for [C17H12NO2S]: 294.0589, found: 294.0593. 
IR (neat) ν [cm-1]: 1711, 1503, 1317, 1288, 1251, 1150.  
Mp = 117°C. 
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Tert-butyl 1-(benzofuran-2-yl) vinyl (phenyl) carbamate (34)  
 
Yellow solid 
Rf = 0.40 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E), after purification by flash column chromatography, product 34 was 
isolated (74% yield) as a yellow solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.14-7.55 (m, 9H), 6.70 (s, 1H), 6.00 (s, 1H), 5.34 (s, 1H), 1.39 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 153.9 (C=O), 152.8 (C
IV), 152.4 (CIV), 141.3 (CIV), 137.8 (CIV), 127.7 (CH), 
127.6 (CH), 124.5 (CH), 123.9 (CH), 122.0 (CH), 120.3(CH), 113.2 (CH2), 110.1 (CH), 103.2 (CH), 80.4 (C
IV), 27.1 
(CH3).  
HRMS (ESI) m/z: [M-tBu]+ calcd for [C17H12NO3]: 278.0817, found: 278.0827. 
IR (neat, ATR) ν [cm-1]: 1705, 1118, 1063, 988, 711 
Mp = 120°C. 
 
Tert-butyl phenyl(1-(pyridin-2-yl) vinyl) carbamate (35)  
 
Brown oil 
Rf = 0.15 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E), after purification by flash column chromatography, product 35 was 
isolated (81% yield) as a brown oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.60 (m, 1H), 7.65 (dt, J = 1.6 and 7.6 Hz, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.43 
(dd, J = 0.8 and 8.8 Hz,2H), 7.29 (dd, J = 8.4 Hz, 2H), 7.11-7.20 (m, 2H), 5.95 (s, 1H), 5.23 (s, 1H), 1.26 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 156.0 (C=O), 153.3 (C
IV), 149.2 (CH), 148.2 (CIV), 143.3 (CIV), 136.5 (CH), 
128.6 (2CH), 125.5 (2CH), 125.3 (CH), 122.7 (CH), 120.0 (CH), 114.4 (CH2), 81.0 (C
IV), 27.9 (CH3). 
HRMS (ESI) m/z: [M-tBu]+ calcd for [C14H11N2O2]: 239.0821, found:239.0838. 
IR (neat, ATR) ν [cm-1]: 1707, 1342, 1154, 1100, 746.  
 
Tert-butyl 1-phenylvinyl(o-tolyl)carbamate (36) 
 
Yellow oil 
Rf = 0.30 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
 213
According to the general procedure (E), after purification by flash column chromatography, product 36 was 
isolated (90% yield) as a yellow oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.55 (d, J = 7.0 Hz, 2H), 7.11-7.32 (m, 7H), 5.01 (s, 1H), 4.57 (s, 1H), 2.33 (s, 
3H), 1.16 (s, 9H).  
13
C NMR (100 MHz, CDCl3) δ [ppm]: 153.2 (C=O), 149.5 (C
IV), 142.5 (CIV), 135.7 (CIV), 131.1 (CH), 128.4 (2CH), 
128.1 (CH), 127.6 (CH), 127.2 (2CH), 126.0 (2CH), 107.6 (CH2), 80.9 (C
IV), 27.9 (3CH3), 18.2 (CH3). 
HRMS (ESI) m/z: [M+Na]+ calcd for C20H23NO2
23Na: 332.1626, found: 332.1633. 
IR (neat, ATR) ν [cm-1]: 1709, 1345, 1299, 1163, 768.  
 
Tert-butyl 1-(2-fluorophenyl)vinyl(o-tolyl) carbamate (37) 
 
Yellow oil 
Rf = 0.30 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E), after purification by flash column chromatography, product 37 was 
isolated (64% yield) as a yellow oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.47 (t, J = 7.7 Hz, 1H), 7.01-7.31 (m, 7H), 4.92 (s, 1H), 4.61 (s, 1H), 2.31 (s, 
3H), 1.18 (s, 9H).  
13
C NMR (100 MHz, CDCl3) δ [ppm]: 160.9 (C=O), 158.5 (C
IV), 152.7 (CIV), 143.7, 141.9 (CIV), 136.2 (CIV), 130.8 
(CH), 129.3 (2CH), 128.0 (CH), 127.4, (CH), 127.2 (CH), 124.0 (2CH), 115.7 (CH), 115.5 (CH), 109.1, 109.0 (CH2), 
80.9 (CIV), 28.4 (CH3), 27.8 (3CH3). 
19
F NMR (376.5 MHz, CDCl3) δ [ppm]: -116.1. 
HRMS (ESI) m/z: [M+H]+ calcd for C20H23NO2F: 328.1699, found: 328.1713.  
IR (neat, ATR) ν [cm-1]: 1709, 1307, 1218, 759.  
 
Tert-butyl 1-(benzo[b]thiophen-2-yl)vinyl(o-tolyl)carbamate (38) 
 
Yellow solid 
Rf = 0.55 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E), after purification by flash column chromatography, product 38 was 
isolated (89% yield) as a yellow solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.71 (m, 2H), 7.42 (s, 1H), 7.12-7.29 (m; 6H), 5.35 (s, 1H), 4.83 (s, 1H), 2.37 
(s, 3H), 1.28 (s, 9H). 
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13
C NMR (100 MHz, CDCl3) δ [ppm]: 1531 (C=O), 143.3 (C
IV), 141.8 (CIV), 139.7 (CIV), 135.3 (CIV), 131.0 (CH), 127.1 
(2CH), 126.9 (CH), 124.7 (CH), 124.5 (CH), 123.7 (CH), 122.1 (CH), 121.1 (CH), 110.5 (CH2), 81.1 (C
IV), 27.9 (3CH3), 
18.3 (CH3).  
HRMS (ESI) m/z: [M].calcd for C22H23NO2S: 365.1450, found: 365.1470. 
IR (neat, ATR) ν [cm-1]: 1707, 1102, 993, 728.  
Mp = 130°C. 
 
Tert-butyl 1-(benzofuran-2-yl)vinyl(o-tolyl)carbamate (39) 
 
Yellow solid 
Rf = 0.40 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (E), after purification by flash column chromatography, product 39 was 
isolated (94% yield) as a yellow solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.42-7.56 (m, 2H), 7.12-7.31 (m, 6H), 6.83 (s, 1H), 5.63 (s, 1H), 4.96 (s, 1H), 
2.38 (s, 3H), 1.30 (s, 9H).  
13
C NMR (100 MHz, DMSO-d6) δ [ppm]: 154.6 (C=O), 154.3 (CIV), 152.9 (CIV), 141.9 (CIV), 139.7 (CIV), 135.8 (CIV), 
131.4 (CH), 128.9 (CIV), 127.9 (CH), 127.2 (CH), 127.7 (CH), 125.4 (CH), 123.7 (CH), 121.8 (CH), 111.5 (CH), 111.0 
(CH2), 104.4 (CH), 81.0 (C
IV), 28.1 (3CH3), 18.1 (CH3).  
HRMS (ESI) m/z/ [M-tBu]+ calcd for [C18H14NO3]: 292.0974, found: 292.0953. 
IR (neat, ATR) ν [cm-1]: 1709, 1324, 1108, 994.  
Mp = 110°C. 
 
Tert-butyl 1-(pyridin-2-yl)vinyl(o-tolyl)carbamate (40) 
 
Yellow oil 
Rf = 0.25 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 40  was 
isolated (78% yield) as a yellow oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.50 (d, J = 4.7 Hz,1H), 7.57 (t, J = 7.8 Hz,1H), 7.45 (m, 1H), 7.06-7.25 (m, 
5H), 5.32 (s, 1H), 4.69 (s, 1H), 2.27 (s, 3H), 1.08 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 152.9 (C=O), 148.9 (CH), 148.9 (C
IV), 142.3(CIV), 136.2 (CH), 135.8 (CIV), 
130.8 (CH), 127.7 (CH), 127.1 (CH), 126.9 (CH), 122.5 (CH), 120.6 (CH), 109.9 (CH2), 80.7 (C
IV), 27.8 (3CH3), 17.9 
(CH3).  
HRMS (ESI) m/z: [M+H]+ calcd for C19H23N2O2: 311.1760, found: 311.1754.  
IR (neat, ATR)  ν [cm-1]: 1709, 1354, 1158, 1082. 
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Tert-butyl benzyl(1-phenylvinyl)carbamate (41) 
 
Colorless oil 
Rf = 0.60 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 41 was 
isolated (81% yield) as a colorless oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.11-7.22 (m, 10H), 5.13 (s, 1H), 4.85 (s, 1H), 4.62 (s, 2H), 1.13 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.7 (C=O), 147.8 (C
IV), 138.7 (CIV), 128.6 (CH), 128.5 (CH), 128.2 (CH), 
128.1 (CH), 127.5 (CH), 127.1 (CH), 125.8 (CH), 109.5 (CH2), 80.4 (C
IV), 53.2 (CH2), 27.9 (3xCH3). 
HRMS (ESI) m/z [M+Na]+ calcd for C20H23NO2
23Na: 332.1627, found: 332.1626. 
IR (neat, ATR) ν [cm-1]: 1695, 1366, 1153, 696. 
 
Tert-butyl 3-(diphenylphosphino)-2-phenyl-2-(phenylamino)propanoate (42) 
H
N
P
O O
 
White solid 
Rf = 0.70 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 42 was 
isolated (43% yield) as a white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ[ppm]: 7.57 (dd, J = 12.0 Hz, 2H,), 7.43 (dd, J = 12.0 Hz, 2H), 7.35 (m, 7H), 7.07 (m, 
3H), 6.97 (dd, J = 7.2 Hz,2H), 6.79 (dd, J = 7.2 Hz,2H), 6.47 (dd, J = 7.2 Hz,1H), 6.08 (d, J = 7.6 Hz,2H), 5.57 (s, 1H), 
3.42 (ddd, J = 4.4 and 14.1 and 26.8 Hz,2H), 1.22 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 209 (C=O), 172.2 (C
IV), 144.1 (CIV), 141.3 (CIV, J = 7 Hz), 139.6 (CIV), 137.3 
(CIV), 133.3 (CHar), 133.1 (CHar), 133.0 (CHar), 132.9 (CHar), 128.6 (2xCHar), 128.5 (CHar), 128.4 (CHar), 128.3 (CHar), 
128.1 (CHar), 128.0 (CHar), 127.5 (CHar), 127.0 (CHar), 116.9 (CHar), 115.0 (CHar), 82.8 (C
IV), 66.6 (CH2, J = 7 Hz), 
35.0 (CH2, J = 13 Hz), 27.6 (3xCH3). 
31
P NMR (162 MHz, CDCl3) δ [ppm]: -22.83.  
HRMS (ESI) m/z [M+Na]+ calcd for C31H32NO2
23NaP: 504.2068, found: 504.2063. 
IR (neat, ATR) ν [cm-1]: 1713, 1504, 1288, 1148, 737.  
Mp = 120°C. 
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Tert-butyl 3-(diphenylphosphino)-2-(2-fluorophenyl)-2-(phenylamino)propanoate (43) 
 
White solid 
Rf = 0.65 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 43 was 
isolated (41% yield) as a white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.56 (m, 3H), 7.48 (m, 4H), 7.11-7.33 (m, 6H), 6.89 (m, 3H), 6.57 (dd, J = 8.0 
Hz, 1H), 6.27 (d, J = 8.0 Hz, 2H), 5.13 (s, 1H), 3.38 (ddd, J = 4.0 and 12.0 and 36.0 Hz, 2H), 1.24 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 171.0 (C=O), 161.9 (C
IV), 159.5 (CIV), 145.205 (CIV), 144.7 (CIV), 139.4 (CIV), 
139.3 (CIV), 138.0 (CIV), 137.9 (CHar), 133.4 (CHar), 133.2(CHar), 132.9 (CHar), 129.8 (CHar), 129.7 (CHar), 128.9 
(CHar), 128.8 (CHar), 128.7 (CHar), 128.6 (CHar), 128.4 (CHar), 128.2 (CHar), 123.9 (CHar), 118.0 (CHar), 117.8 (CHar), 
116.5 (CHar), 116.2 (CHar), 115.7 (CHar), 115.5 (CHar), 82.9 (C
IV), 37.2 (CH2, J = 15 Hz ), 27.7 (3xCH3). 
19
F NMR (376.5 MHz, CDCl3) δ[ppm]: -109.9.  
31
P NMR (162 MHz, CDCl3) δ[ppm]: -25.0.  
HRMS (ESI) m/z [M+H]+ calcd for C31H32FNO2P: 500.2155, found: 500.2153.  
IR (neat, ATR) ν [cm-1]: 1720, 1602, 1503, 1281, 1146, 691.  
Mp = 120°C. 
 
Tert-butyl 2-(benzo[b]thiophen-2-yl)-3-(diphenylphosphino)-2-(phenylamino)propanoate (44) 
 
White solid 
Rf = 0.45 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 44 was 
isolated (95% yield) as a white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.72 (dd, J = 8.0 Hz, J = 21.0 Hz, 2H), 7.50 (m, 2H), 7.45 (s, 1H), 7.25 (m, 5H), 
7.02 (m, 5H), 6.84 (m, 2H), 6.54 (m, 1H), 6.30 (d, J = 7.8 Hz, 2H), 5.50 (s, 1H), 3.28-3.53 (ddd, J = 2.6 and 14.2 
and 80.6 Hz, 2H), 1.25 (s, 9H).  
13
C NMR (100 MHz,CDCl3) δ [ppm]: 170.7 (C=O), 148.2 (C
IV, J = 10 Hz), 144.0 (CIV), 140.4 (CIV), 139.9 (CIV), 138.5 
(CIV), 137.1 (CIV), 133.0 (4xCHar, J = 10 Hz), 132.8 (CHar, J = 10 Hz), 128.5 (2xCHar), 128.5 (CHar), 128.4 (CHar), 128.4 
(CHar), 128.1 (CHar), 128.0 (CHar), 124.0 (CHar), 123.7 (CHar), 122.2 (CHar), 117.8 (CHar), 115.4 (2xCHar), 83.4 (C
IV), 
65.2 (CH2, J = 20 Hz), 37.4 (CH2, J = 10 Hz), 27.5 (3xCH3).  
31
P NMR (162 MHz, CDCl3) δ [ppm]: -23.4.  
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HRMS (ESI) m/z [M+H]+ calcd for C33H33NO2PS: 538.1970, found: 538.1964.  
IR (neat, ATR) ν [cm-1]: 1715, 1602, 1501, 1433, 1288, 1149, 743. 
Mp = 178°C. 
 
Tert-butyl 3-(diphenylphosphino)-2-(phenylamino)-2-(pyridin-2-yl)propanoate (46) 
 
White solid 
Rf = 0.15 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 46 was 
isolated (47% yield) as white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.61 (d, J = 4.8 Hz, 1H), 7.51 (dt, J = 2.0, 8.0 Hz, 1H), 7.42 (m, 1H), 7.34 
(m,2H), 7.21 (m, 3H), 7.10 (m, 4H), 6.99 (m, 2H), 6.85 (m, 2H), 6.51 (dd, J = 7.2 Hz, 1H), 6.21 (d, J = 8.0 Hz, 2H), 
6.03 (s, 1H), 3.55 (ddd, J = 2.4 and 16.0 and 54.4 Hz, 2H), 1.27 (s, 9H).  
 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 210.1 (C=O), 172.3 (C
IV), 172.2 (CIV), 159.5 (CIV), 159.4 (CIV), 148.7(CHar), 
144.4 (CIV), 139.5 (CIV), 139.4 (CIV), 138.2 (CIV), 138.1 (CIV), 136.8 (CHar), 134.7 (CHar), 134.5 (CHar), 133.5 (CHar), 
133.3 (CHar), 133.0 (CHar), 132.9 (CHar), 128.8 (CHar), 128.4 (CHar), 128.3 (CHar), 128.3 (CHar), 128.2 (CHar), 128.1 
(CHar), 128.0 (CHar), 122.6 (CHar), 121.5 (CHar), 121.5 (CHar), 117.2 (CHar), 114.8 (CHar), 82.8 (C
IV), 68.1 (CH2, J = 20 
Hz), 34.4 (CH2, J = 10 Hz), 27.8 (3xCH3).  
31
P NMR (162 MHz, CDCl3) δ [ppm]: -25.0.  
HRMS (ESI) m/z [M+H]+ calcd for C30H31N2O2P: 483.2182, found: 483.2201.  
IR (neat, ATR) ν [cm-1]: 3329, 1729, 1600, 1280, 1147, 740.  
Mp = 146°C. 
 
Tert-butyl 3-(diphenylphosphino)-2-phenyl-2-(o-tolylamino)propanoate (47) 
 
Clear yellow solid 
Rf = 0.40 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 47 was 
isolated (43 % yield) as clear yellow solid. 
 
Analyses: 
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1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.59 (d, J = 7.9 Hz, 2H), 7.42 (m, 2H), 7.33 (m, 7H), 7.07 (m, 3H), 6.98 (m, 
2H), 6.78 (d, J = 7.9 Hz, 1H), 6.65 (t, J = 7.9 Hz, 1H), 6.45 (t, J = 7.3 Hz, 1H), 5.87 (d, J = 8.04 Hz, 1H), 5.54 (s, 1H), 
3.46 (ddd, J = 2.7 and 14.2 and 73.3 Hz, 2H), 2.03 (s, 3H), 1.29 (s, 9H).  
13
C NMR (100 MHz, CDCl3) δ [ppm]: 172.3 (C=O), 141.7 (C
IV), 141.2 (CIV, J = 7.0 Hz), 139.7 (CIV, J = 11.8 Hz), 136.3 
(CHar, J = 11.0 Hz), 133.0 (CHar), 132.8 (CHar), 132.8 (CHar), 132.6 (CHar), 129.9 (CHar), 128.5 (CHar), 128.4 (CHar), 
128.4 (CHar), 128.2 (CHar), 128.1 (CHar), 127.7 (CHar), 127.6 (CHar), 127.3 (CHar), 126.8 (CHar), 125.7 (CHar), 123.2 
(CIV), 116.6 (CHar), 112.8 (CHar), 82.7 (C
IV), 66.4 (CH2, J = 21.2 Hz), 34.2 (CH2, J = 13 Hz), 27.6 (3xCH3), 17.6 (CH3).  
31
P NMR (162 MHz, CDCl3) δ [ppm]: -22.6.  
HRMS (ESI) m/z [M+H]+ calcd for C32H35NO2P: 496.2413, found: 496.2405. 
IR (neat, ATR) ν [cm-1]: 1719, 1280, 1150, 734.  
Mp = 108°C. 
 
Tert-butyl 3-(diphenylphosphino)-2-(2-fluorophenyl)-2-(o-tolylamino)propanoate (48) 
 
White solid 
Rf = 0.56 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 48 was 
isolated (55% yield) as a white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.57 (t, J = 7.9 Hz, 1H), 7.47 (dt, J = 1.4 and 8.0 Hz, 2H), 7.08-7.35 (m, 7H), 
6.83 (d, J = 7.2 Hz, 1H), 6.70 (t, J = 7.6 H, 1H), 6.49 (t, J = 7.3 Hz, 1H), 6.14 (d, J = 8.1 Hz, 1H), 5.18 (s, 1H), 3.45 
(ddd, J = 2.1 and 14.4 and 60.0 Hz, 2H), 1.95 (s , 3H), 1.26 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 171.0 (C=O), 161.8 (C
IV), 159.3 (CIV),142.4 (CIV), 139.6 (CIV), 137.3 (CIV), 133.1 
(CHar), 132.9 (CHar), 132.8 (CHar), 132.6 (CHar), 130.3(CHar), 129.9 (CHar), 129.6 (CHar), 129.5 (CHar), 128.5 (CHar), 
128.1 (CHar), 127.9 (CHar), 127.8 (CHar), 125.8 (CHar), 123.7 (CHar), 123.6 (C
IV), 117.3 (CHar), 116.4 (CHar), 116.2 
(CHar), 112.9 (CHar), 82.8 (C
IV), 65.5 (CH2, J = 19 Hz), 36.5 (CH2, J = 11 Hz), 27.6 (3xCH3), 17.5 (CH3).  
31
P NMR (162 MHz, CDCl3) δ [ppm]: -24.3.  
19
F NMR (376.5 MHz, CDCl3) δ [ppm]: -109.7.  
HRMS (ESI) m/z [M+H]+ calcd for C32H34FNO2P: 514.2296, found: 514.2311. 
IR (neat, ATR) ν [cm-1]: 1731, 1279, 1150, 741, 695.  
Mp = 80°C. 
 
Tert-butyl 1-(benzo[b]thiophen-2-yl)-2-(diphenylphosphino)ethyl(o-tolyl)carbamate (49) 
 
Brown oil 
Rf = 0.25 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
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According to the general procedure (F), after purification by flash column chromatography, product 49 was 
isolated (54% yield) as a brown solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.69 (m, 2H), 7.00-7.39 (m, 13H), 6.81 (m, 1H), 6.67 (t, J = 7.5 Hz, 1H), 6.50 
(dt, J = 1.0 and 7.5 Hz, 1H), 6.2 (d, J = 8.0 Hz, 1H), 5.49 (s, 1H), 3.25-3.65 (ddd, J = 4.5 and 14.3 and 82.8 Hz, 2H), 
2.02 (s, 3H), 1.29 (s, 9H).  
13
C NMR (100 MHz, CDCl3) δ [ppm]: 170.9 (C=O), 148.5 (C
IV), 141.9 (CIV), 140.4 (CIV), 139.9 (CIV), 138.6 (CIV), 
136.4 (CIV), 132.9 (CHar), 132.7 (CHar), 130.1 (CHar), 128.6 (CHar), 128.5 (CHar), 128.3 (CHar), 127.9 (CHar), 127.8 
(CHar), 127.5 (CHar), 126.0 (CHar), 124.0 (CHar), 123.7 (CHar), 123.6 (C
IV), 122.3 (CHar), 122.1 (CHar), 117.6 (CHar), 
113.2 (CHar), 83.4 (C
IV), 65.2 (CH2, J = 20 Hz), 36.5 (CH2, J = 10 Hz), 28.3 (3xCH3), 17.5 (CH3). 
31
P NMR (162 MHz, CDCl3) δ [ppm]: -23.1.  
MS (ESI) m/z [M+H]+ C34H34NO2PS: 552. 
IR (neat, ATR) ν[cm-1]: 1729, 1243, 1045, 694.  
 
Tert-butyl benzyl(2-(diphenylphosphoryl)-1-phenylethyl)carbamate (52) 
 
White solid 
Rf = 0.30 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F), after purification by flash column chromatography, product 52 was 
isolated (50% yield) as white solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.92 (m, 1H), 7.76 (m, 2H), 7.73 (m, 2H), 7.45 (m, 7H), 7.30-7.12 (m, 8H), 
5.37 (dt, J = 8Hz and 4Hz, 1H), 4.46 (brs, 1H), 4.05 (brs, 1H), 2.95 (dt, J = 5.0 and 12.5 Hz, 1H), 1.27 (s, 9H).  
13
C NMR (100 MHz, CDCl3) δ [ppm]: 209.9 (C=O), 182.4 (C
IV), 154.9 (CIV), 138.9 (CIV), 131.6 (CHar), 130.8 (CHar), 
130.7 (CHar), 130.5 (CHar), 130.4 (CHar), 128.6 (CHar), 128.5 (CHar), 128.2 (CHar), 127.9 (CHar), 80.1 (C
IV), 59.0-
51.2(CH2), 43.6 (CH), 33.4 (CH), 32.7 (CH), 28.3 (3xCH3).  
31
P NMR (162 MHz, CDCl3) δ [ppm]: 28.5.  
MS (ESI) m/z [M+Na]+ C33H34NO2PNa: 518. 
Mp = 150°C. 
 
Tert-butyl 2-(diphenylphosphino)-1-phenylethyl(phenyl)carbamate (42a). 
 
 
Colorless oil 
Rf = 0.50 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 220
 
According to the general procedure (F) and after purification on the column, the by product 42a was isolated( 
35% yield) as a colorless oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.49-7.17 (m, 18H), 6.87 (m, 2H), 5.55 (m, 1H), 2.62 (m, 2H), 1.34 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 155.1 (C=O), 141.4 (C
IV), 139.4 (CIV), 133.4 (CIV), 130.3 (CIV), 130.2 (CHar), 
129.1 (CHar), 128.9 (CHar), 128.8 (CHar), 128.7 (CHar), 128.5 (CHar), 128.4 (CHar), 128.3 (CHar), 127.7 (CHar), 127.1 
(CHar), 80.3 (C
IV), 57.5 (CH, J = 18.1 Hz), 32.4 (CH2, J = 13.7 Hz), 27.0 (CH3). 
31
P NMR (162 MHz, CDCl3) δ [ppm]: -22.8. 
MS (ESI) m/z [M+H]+ C31H33NO2P: 482. 
 
Tert-butyl 2-(diphenylphosphoryl)-1-phenylethyl(phenyl)carbamate (42b). 
 
 
Colorless oil 
Rf = 0.10 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F) and after purification on the column, the by product 42b was isolated 
(26% yield) as a colorless oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.70-7.50 (m, 4H), 7.50-7.30 (m, 6H), 7.10 (m, 8H), 6.79-6.76 (m, 2H), 5.65 
(m, 1H), 3.36 (m, 1H), 2.86-2.78 (m, 1H), 1.22 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 171.1 (C
IV), 154.4 (C=O), 140.6 (CIV), 133.8 (CIV), 131.5 (CIV), 130.7 (CHar), 
129.1 (CHar), 128.5 (CHar), 128.3 (CHar), 126.6 (CHar), 114.3 (CHar), 80.3 (C
IV), 57.1 (CH), 33.4 (CH2, J = 69 Hz), 28.2 
(CH3). 
31
P NMR (162 MHz, CDCl3) δ [ppm]: 28.6. 
MS (ESI) m/z [M+H]+ C31H33NO3P: 498. 
 
Tert-butyl 2-(diphenylphosphoryl)-1-(pyridin-2-yl)ethyl(phenyl)carbamate (45a). 
 
 
Colorless oil 
Rf = 0.10 (PE/EtOAc: 9/1) revelator KMnO4 
 
Procedure: 
 
According to the general procedure (F) and after purification on the column, the by product 45a was isolated 
(100% yield) as a colorlessoil. 
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Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.37 (m, 1H), 7.70-7.20 (m, 16H), 6.94 (m, 2H), 5.93-5.86 (m, 1H), 3.57-3.49 
(m, 1H), 3.08 (br s, 1H), 1.32 (s, 9H). 
13
C NMR (100 MHz, CDCl3) δ [ppm]: 154.5 (C=O), 148.5 (C
IV), 140.9 (CIV), 132.0 (CHar), 131.1 (CHar), 128.7 (CHar), 
126.5 (CHar), 122.9 (CHar), 122.3 (CHar), 80.9 (C
IV), 57.9 (CH), 32.0, 31.3 (CH2), 28.4 (CH3). 
31
P NMR (162 MHz, CDCl3) δ [ppm]: 29.3. 
MS (ESI) m/z [M+Na]+ C31H33N2O3P: 499. 
 
Tert-butyl 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate (53)
184
 
N N
NNH
OtBu
OtBu
tBuO O
O
O  
White solid 
Rf = 0.37 (CH2Cl2/MeOH: 9/1) revelator KMnO4 
 
Procedure: 
 
A solution of cyclen (100 mg, 0.58 mmol, 1.00 equiv.) was prepared in distilled acetonitrile (4 mL), cooled down 
to 0 °C and NaHCO3 (244 mg, 2.90 mmol, 5.00 equiv.) was added. The mixture was stirred for 30 minutes at 0 
°C, then tert-butyl bromoacetate (0.28 mL, 1.91 mmol, 3.30 equiv.) was introduced drop by drop during 60 min. 
at 0 °C. The reaction mixture was left for gentle warming up to room temperature and stirred for next 22h. The 
residues were filtered through glass frit, washed abundantly with acetonitrile and the filtrate was 
concentrated. After crystallization in toluene 280 mg (94 % yield) of 53 as a white solid was obtained. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 3.38 (s, 4H), 3.30 (s, 2H), 3.11 (m, 4H), 2.92-2.89 (m, 12H), 1.47 (s, 27H). 
MS (ESI) [m/z]: 515.0 [M+H]+, 459.5 [M-tBu]+, 403.5 [M-2tBu]+, 347.5 [M-3tBu]+. 
 
8,11-di-tert-butyl 9-(1-benzothiophen-2-yl)-4-methyl-3,5-dioxo-14-thia-4,8,11-
triazapentacyclo[11.7.0.0
2,6
.0
7,12
.0
15,20
]icosa-1(13),9,15,17,19-pentaene-8,11-dicarboxylate (54) 
 
Yellow solid 
Rf = 0.52 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
A solution of 1,4-dihydropyrazine derivative9 (300 mg, 0.55 mmol, 1.00 equiv.) and N-methylmaleimide (305 
mg, 2.75 mmol, 5.00 equiv.) in distilled toluene (4 mL, c = 0.14 M) was heated for 24 h at 110 °C in the sealed 
tube. After cooling down solvent was removed under vacuum and the crude was purified by flash column 
chromatography (PE then PE/ EtOAc: 9/1) to isolate 360 mg (quantitative) of 54 as a yellow solid. 
 
Analyses: 
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1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.99 (d, J = 6.4 Hz, 1H), 7.83 (s, 1H), 7.36 (s, 1H), 7.67 (d, J = 8 Hz, 3H), 7.15 
(m, 6H), 6.72 (s br, 1H), 5.20 (d, J = 5.2 Hz, 1H), 4.34 (d, J = 7.2 Hz, 1H), 3.13 (m, 1H), 3.09 (s, 3H), 2.77 (t, J = 9.6 
Hz, 1H), 1.54 (s, 9H), 1.10 (s br, 1H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 177.6 (C=O), 175.2 (C=O), 139.9 (C
IV), 139.6 (CIV), 128.5 (CHar), 126.8 (CHar), 
125.6 (CHar), 125.0 (C
IV), 124.6 (CHar), 124.5 (CHar), 123.8 (CHar), 122.8 (CHar), 122.1 (CHar), 121.1 (CHar), 82.3 
(CIV), 60.2 (CH), 47.5 (CH), 46.0 (CH), 44.3 (CH), 28.2 (CH3), 27.8 (CH3), 25.1 (CH3N). 
MS (ESI) [m/z]: 680.5 [M+Na]+, 696.5 [M+K]+. 
HRMS (ESI) [m/z]: calculated for C35H35N3O6NaS2 [M+Na]
+: 680.1865, found: 680.1860. 
IR (neat, ATR) ν [cm-1]: 3056 (CH, sp2), 2974 (CH, sp3), 1700 (C=O), 1438, 1347, 1252, 1155, 748. 
Mp = 170 °C. 
 
8,11-di-tert-butyl 9-(1-benzothiophen-2-yl)-3,5-dioxo-14-thia-4,8,11-triazapentacyclo 
[11.7.0.0
2,6
.0
7,12
.0
15,20
]icosa-1(13),9,15,17,19-pentaene-8,11-dicarboxylate (55) 
 
Yellow solid 
Rf = 0.17 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
A solution of 1,4-dihydropyrazine derivative9(100 mg, 0.18 mmol, 1.00 equiv.) and maleimide (88 mg, 0.92 
mmol, 5.00 equiv.) in distilled toluene (1.5 mL, c = 0.12 M) was heated for 72 h at 110 °C in the sealed tube. 
After cooling down solvent was removed under vacuum and the crude was purified by flash column 
chromatography (PE/EtOAc: 9/1 then 8/2 then 7/3) to isolate 72 mg (62% yield) of 55 as a yellow solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 9.32 (s, 1H), 7.98 (d, J = 2.6 Hz, 1H), 7. 82 (s, 1H), 7.78 (d, J = 8.0 Hz, 2H), 
7.30-7.18 (m, 6H), 6.90 (s, 1H), 5.47 (s br, 1H), 4.52 (s br, 1H), 3.34 (t, J = 8.0 Hz, 1H), 2.93 (t, J = 8.0 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 178.2 (C=O),171.1 (C=O), 151.1 (C
IV), 139.9 (CIV), 139.6 (CIV), 138.5 (2xCIV), 
135.1 (2xCIV), 128.5 (CHar), 126.6 (CHar), 126.2 (CHar), 125.6 (CHar), 124.6 (C
IV), 122.8 (CHar), 122.1 (CHar), 121.1 
(2xCHar), 82.7 (C
IV), 60.3 (CH), 47.4 (CH), 47.2 (CH), 45.5 (CH), 28.2 (CH3), 27.7 (CH3). 
HRMS (ESI) [m/z]: calculated for C34H33N3O7NaS2 [M+Na]
+: 682.1658, found: 682.1660; calculated for 
C30H25N3O7NaS2 [M-tBu+Na]
+: 626.1032, found: 626.1007. 
IR (neat, ATR) ν [cm-1]: 3466 (NH imide), 3053 (CH, sp2), 2972 (CH, sp3), 1704 (C=O), 1445, 1347, 1252, 1156, 
748. 
Mp = 146 °C. 
 
3,6-di-tert-butyl 9-ethyl 5-(1-benzothiophen-2-yl)-17-thia-3,6-diazatetracyclo[8.7.0.0
2,7
.0
11,16
]heptadeca-
1(10),4,11,13,15-pentaene-3,6,9-tricarboxylate (56) 
 
Orange oil 
Rf = 0.21 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
In the sealed tube, a solution of starting 1,4-dihydropyrazine derivative9 (50 mg, 0.09 mmol, 1.00 equiv.) was 
prepared in ethyl acrylate (1.0 mL, 9.15 mmol, 100.00 equiv.). The mixture was stirred for 2 days at 110 °C. 
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After cooling down, the solvent was evaporated under vacuum and a brown oil was recuperated. The crude 
was purified by column chromatography (8/2) to yield 28 mg of product 56 as an orange oil (47% yield). 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.98 (m, 2H), 7.79 - 7.75 (m, 2H), 7.63 (s, 1H), 7.52 (m, 4H), 6.97 (s, 1H), 5.08 
(s, 1H), 4.59 (m, 1H),4.21 (q, J = 5.2 Hz, 2H), 3.60 (t, J = 4.0 Hz, 1H), 2.31 (m, 1H), 2.06 (m, 1H), 1.40 (s, 18H), 
1.29 (t, J = 2.5 Hz, 3H). 
MS (ESI) [m/z]: 647.0 [M+H]+, 669.0 [M+Na]+, 685.0 [M+K]+. 
IR (neat, ATR) ν [cm-1]: 3016, 2975 (CH, sp3), 2952 (CH, sp2),1725, 1706 (C=O), 1505, 1365, 1237, 1180, 730, 484. 
 
3,6-di-tert-butyl 5-(1-benzothiophen-2-yl)-9-cyano-17-thia-3,6-diazatetracyclo[8.7.0.0
2,7
.0
11,16
]heptadeca-
1(10),4,11,13,15-pentaene-3,6-dicarboxylate (57) 
 
Yellow oil 
Rf = 0.21 (PE/ EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
In the sealed tube, a solution of starting 1,4-dihydropyrazine derivative9 (100 mg, 0.18 mmol, 1.00 equiv.) was 
prepared in acrylonitrile (2.0 mL, 31.11 mmol, 170.00 equiv.). The mixture was stirred over 5 days at 110 °C. 
After cooling down, the solvent was evaporated under vacuum and a brown oil was recuperated. The crude 
was purified by column chromatography (9/1) to yield 21 mg of product 57 of a yellow oil (19% yield). 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.65 (m, 2H), 7.35-7.01 (m, 8H), 6.76 (s, 1H), 5.08 (s, 1H), 4.28 (s, 1H), 3.62 
(m, 1H), 2.72 (m, 1H), 2.53 (m, 1H), 1.55 (s, 9H), 1.19 (s, 9H). 
MS (ESI) [m/z]: 600.5 [M+H]+, 622.0 [M+Na]+, 638.0 [M+K]+. 
IR (neat, ATR) ν [cm-1]: 3006, 2975 (CH, sp3), 2951 (CH, sp2), 2245 (CN), 1710 (C=O), 1505, 1365, 1237, 1180, 
730, 484. 
 
2,16-di-tert-butyl 13,14,27,28-tetramethyl 5,19-dithia-2,16-
diazaheptacyclo[15.11.0.0
3,15
.0
4,12
}.0
6,11
.0
18,26
.0
20,25
]octacosa-3,6,8,10,13,17,20,22,24,27-decaene-
2,13,14,16,27,28-hexacarboxylate (58) 
 
Yellow solid 
Rf = 0.30 (PE/ EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
In the sealed tube, a solution of starting 1,4-dihydropyrazine derivative9 (200 mg, 0.37 mmol, 1.00 equiv.) was 
prepared in dry toluene (4 mL) and DMAD (0.22 mL, 1.83 mmol, 5.00 equiv.) was introduced. The mixture was 
stirred over 48 h at 150 °C. After cooling down, a solvent was evaporated under vacuum and a brown oil was 
recuperated. After trituration in diethyl ether, 117 mg of product 58 a yellow solid was obtained (37% yield). 
 
Analyses: 
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1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 9.71 (s, 1H), 8.18 (s, 1H), 8.15 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 
7.60 (m, 2H), 4.05 (s, 3H), 3.91 (s, 3H), 1.52 (s, 9H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 168.5 (C=O), 165.3 (C=O), 153.1 (CIV), 139.0 (CIV), 138.6 (CIV), 133.6 (CIV), 
132.0 (CIV), 131.5 (CIV), 128.2 (CHar), 126.6 (C
IV), 125.6 (CHar), 124.1 (CHar), 123.6 (CHar), 122.9 (CH), 121.1 (CH), 
80.2 (CIV), 53.1 (CH3), 52.9 (CH3), 28.1 (3xCH3). 
MS (ESI) [m/z]: 831.0 [M+H]+, 853.0 [M+Na]+. 
IR (neat, ATR) ν [cm-1]: 3305, 2978 (CH, sp3), 2950 (CH, sp2), 1717 (C=O), 1511, 1237, 1150, 730. 
Mp = 185 °C. 
 
2,16-di-tert-butyl 13,14,27,28-tetraethyl 5,19-dithia-2,16-
diazaheptacyclo[15.11.0.0
3,15
.0
4,12
.0
6,11
.0
18,26
.0
20,25
]octacosa-3,6,8,10,13,17,20,22,24,27-decaene-
2,13,14,16,27,28-hexacarboxylate (59) 
 
Yellow solid 
Rf = 0.31 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
In the sealed tube, a solution of starting 1,4-dihydropyrazine derivative9 (70 mg, 0.13 mmol, 1.00 equiv.) was 
prepared in dry toluene (2 mL) and DEAD (0.11 mL, 0.64 mmol, 5.00 equiv.) was introduced. The mixture was 
stirred for 5 days at 150 °C. After cooling down, the solvent was evaporated under vacuum and a brown oil was 
recuperated. The crude was purified by column chromatography (PE/ EtOAc: 8/2) to yield 26 mg of product 59 
of a yellow semi-solid (23% yield). 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 9.07 (s, 1H), 8.11 (d, J = 5.5 Hz, 1H), 7.93-7.82 (m, 4H), 7.52-7.45 (m, 2H), 
7.44-7.37 (m, 2H), 4.61 (q, J = 7.2 Hz, 2H), 4.46-4.40 (m, 4H), 4.30-4.25 (m, 2H), 1.48-1.40 (m, 12 H), 1.38-1.26 
(m, 18 H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 168.4 (C=O), 166.8 (C=O),165.0 (C=O), 164.9 (C=O), 155.7 (CIV), 151.2 
(CH), 142.1 (CIV), 141.8 (CIV),141.3 (CIV),140.3 (CIV), 139.7 (CIV), 135.2 (CIV), 134.3 (CIV), 129.5 (CIV), 125.0 (CHar), 
124.4 (CHar), 124.2 (CHar), 123.8 (CHar), 123.3 (CHar), 123.1 (CHar), 123.0 (CHar), 122.8 (CHar), 117.6 (CH), 80.2 
(CIV), 62.7 (CH2), 62.5 (CH2), 62.2 (CH2), 31.6 (CH3), 30.4 (CH3), 29.9 (CH2), 18.5 (CH3), 14.3 (3xCH3), 14.2 (CH3), 
14.2 (3xCH3). 
MS (ESI) [m/z]: 887.0 [M+H]+. 
IR (neat, ATR) ν [cm-1]: 3336, 2975 (CH, sp3), 2951 (CH, sp2), 1720 (C=O), 1511, 1237, 1150, 730. 
 
9-(1-benzothiophen-2-yl)-4-methyl-14-thia-4,8,11-triazapentacyclo[11.7.0.0
2,6
.0
7,12
.0
15,20
]icosa-
7,9,11,15,17,19-hexaene-3,5-dione (60) 
 
Red-orange solid 
Rf = 0.17 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
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A solution of adduct 54 (100 mg, 0.15 mmol, 1.00 equiv.) in anhydrous distilled dichloromethane (2.5 mL, c = 
0.06 M) was prepared at room temperature and degassed. Then TMSI (0.13 mL, 0.91 mmol, 6.00 equiv.) was 
introduced via syringe. The solution changed color from yellow to red. After 20 min. of magnetic stirring, the 
solution was diluted with 10 mL of dichloromethane, hydrolyzed with 10 mL of a saturated solution of NaHCO3 
and extracted three times with dichloromethane (15 mL). All organic phases were resembled and washed with 
distilled water (30 mL) and brine (20 mL), dried over anhydrous MgSO4, filtered and solvent was removed 
under reduced pressure. The crude was purified by precipitation in diethyl ether to yield 68 mg (98% yield) of 
60 as a red-orange solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.63 (s, 1H), 8.31 (d, J = 5 Hz, 1H), 7.78 (m, 3H), 7. 57 (d, J = 7.5 Hz, 1H), 7.47 
(m, 4H), 5.32 (d, J = 7.5 Hz, 1H), 4.82 (dd, J = 5 Hz, 2.5, 1H), 4.58 (dd, J = 7 Hz, 2.5, 1H), 4.27 (dd, J = 7.5 Hz, 2.5, 
1H), 3.05 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 176.5 (C=O), 175.1 (C=O), 152.3 (C
IV), 151.1 (CH), 141.6 (CIV), 141.5 (CIV), 
139.3 (CIV), 139.3 (CIV), 136.9 (CIV), 134.1 (CIV), 126.9 (CHar), 126.1 (CHar), 125.1 (CHar), 125.0 (CHar), 124.9 (C
IV), 
124.7 (CHar), 124.6 (CHar), 123.5 (CHar), 122.5 (CHar), 122.2 (CHar), 52.2 (CH), 50.5 (CH), 45.5 (CH), 40.0 (CH), 25.2 
(CH3N). 
MS (ESI) [m/z]: 456.5 [M+H]+. 
HRMS (ESI) [m/z]: calculated for C25H17N3O2NaS2 [M+Na]
+: 478.0660, found: 478.0654. 
IR (ATR, neat) ν = 3066 (CH, sp2), 2973 (CH, sp3), 1698 (C=O), 1345, 1254, 1156, 749, 697. 
Mp = 214 °C (decomposition). 
 
13,14,27,28-tetramethyl 5,19-dithia-2,16-diazaheptacyclo[15.11.0.0
3,15
.0
4,12
.0
6,11
.0
18,26
.0
20,25
]octacosa-
1,3,6,8,10,13,15,17,20,22,24,27-dodecaene-13,14,27,28-tetracarboxylate (61) 
 
Yellow solid 
Rf = 0.27 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
To the cooled solution of 58 (52 mg, 62.6 µmol, 1.00 equiv.) in the distilled CH2Cl2 (5 mL) under argon at 0 °C, 
TMSI (21 µL, 0.15 mmol, 2.40 equiv.) was introduced by syringe and the reaction was carried out for 30 min. 
Then reaction was warmed up and hydrolyzed by addition of 20 mL of a saturated solution of NaHCO3. The 
aqueous phase was extracted twice with CH2Cl2, all organic phases were collected and washed with distilled 
water and brine, dried over MgSO4, filtrated and concentrated. The crude was precipitated with diethyl ether 
to provide 30 mg of product 61 as a yellow solid (71% yield).  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.96 (m, 2H), 7.49 (m, 2H), 7.35 (s, 1H), 4.11 (s, 3H), 3.92 (s, 3H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 168.5 (C=O), 165.3 (C=O), 153.1 (CIV), 139.0 (CIV), 138.6 (CIV), 133.6 (CIV), 
132.0 (CIV), 131.5 (CIV), 128.2 (CHar), 126.6 (C
IV), 125.6 (CHar), 124.1 (CHar), 123.6 (CHar), 122.9 (CH), 121.1 (CH), 
80.2 (CIV), 53.1 (CH3), 52.9 (CH3), 28.1 (3xCH3).  
MS (ESI) [m/z]: 860.0 [M+H]+. 
IR (neat, ATR) ν [cm-1]: 3305, 2978 (CH, sp3), 2950 (CH, sp2), 1717 (C=O), 1511, 1237, 1150, 730. 
Mp = 185 °C. 
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9-(1-benzothiophen-3-yl)-4-methyl-14-thia-4,8,11-triazapentacyclo[11.7.0.0
2,6
.0
7,12
.0
15,20
]icosa-
1(13),2(6),7,9,11,15,17,19-octaene-3,5-dione (62) 
 
Brown solid 
Rf = 0.56 (DCM/EtOAc/MeOH: 6/2/2) revelator CAN 
 
Procedure: 
 
A solution of 60 (90 mg, 0.20 mmol, 1.00 equiv.) in distilled toluene (10 mL, c = 0.02 M) was prepared at room 
temperature and DDQ (202 mg, 0.75 mmol, 4.50 equiv.) was added. Then solution was heated to 90 °C for 18h. 
After cooling down, a red precipitate was observed. The volume of solvent was reduced under vacuum to 2 mL 
and solid was precipitated with diethyl ether, filtered through Milipore and washed twice with diethyl ether to 
yield after drying 88 mg (98% yield) of 62 as brown solid. 
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 9.85 (s, 1H), 9.68 (m, 1H), 8.69 (s, 1H), 8.50 (m, 1H), 8.10 (m, 1H), 8.00 
(m, 1H), 7.68 (m, 2H), 7.48 (m, 2H), 3.20 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 168.2(C=O), 168.0 (C=O), 153.2 (C
IV), 149.0 (CH), 143.4 (CIV), 141.9 
(CIV),140.7 (CIV), 140.3 (CIV), 139.9 (CIV), 139.6 (CIV), 137.9 (CIV),136.6 (CIV), 134.1 (CIV), 128.0 (CIV), 126.1 (CHar), 
124.9 (CIV), 124.5 (CHar), 124.4 (CHar),124.3 (CHar), 123.2 (CHar), 123.0 (CHar), 122.8 (CHar), 122.5 (CHar), 122.1 
(CHar), 25.0 (CH3N). 
MS (ESI) [m/z]: 452.5 [M+H]+, 474.5 [M+Na]+.  
HRMS (ESI) [m/z]: calculated for C25H13N3O2NaS2 [M+Na]
+: 474.0347, found: 474.0346. 
IR (neat, ATR) ν [cm-1]: 3058 (CH, sp2), 2919 (CH, sp3), 1699 (C=O), 1436, 1391, 1252, 1038, 743. 
Mp > 250 °C. 
 
5-(1-benzothiophen-2-yl)-8-N,9-N-bis(3-hydroxypropyl)-17-thia-3,6-
diazatetracyclo[8.7.0.0
2,7
.0
11,16
]heptadeca-1(10),2,4,6,8,11,13,15-octaene-8,9-dicarboxamide (63) 
 
Orange-brown solid 
 
Procedure: 
 
The product 62 (100 mg, 0.22 mmol, 1.00 equiv.) was added at room temperature to distilled 3-aminopropanol 
(7.25 mL, 85.0 mmol, 390 equiv.). The mixture was heated at 110 °C for 3h. After cooling down, an orange 
precipitate was observed. 20 mL of distilled water were added to precipitate the product. Residues were 
filtered through Milipore and washed twice with distilled water to remove an excess of 3-aminopropanol. After 
drying under vacuum, 80 mg (62% yield) of 63 were obtained as a brown solid. 
 
Analyses: 
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1
H NMR (400 MHz, DMSO-d6) δ [ppm]: 9.79 (s, 1H), 8.66 (m, 1H), 8.63 (s, 1H), 8.32 (m, 1H), 8.17 (m, 1H), 8.06 
(m, 1H), 7.99 (m, 1H), 7.64 (m, 2H), 7.46 (m, 2H), 3.63 (m, 2H), 3.57 (m, 4H), 3.49 (m, 6H), 1.87 (t, J = 8 Hz, 2H), 
1.80 (t, J = 8 Hz, 2H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 166.0 (C=O), 165.0 (C=O), 148.1 (CIV), 142.2 (CH), 141.6 (CIV), 141.3 (CIV), 
140.3 (CIV), 138.8 (CIV), 137.5 (CIV), 136.2 (CIV), 134.3 (CIV), 133.6 (CIV), 130.7 (CIV), 127.6 (CHar), 126.6 (CHar), 
126.0 (CHar), 125.3 (CHar), 125.2 (CHar), 124.3 (CHar), 123.6 (CHar), 123.1 (CHar), 65.1 (CH2), 59.0 (CH2), 58.8 (CH2), 
36.8 (CH2), 32.8 (CH2), 32.2 (CH2). 
MS (ESI) [m/z]: 452.5 [M+H]+, 474.5 [M+Na]+.  
HRMS (ESI) [m/z]: calculated for C30H26N4O4NaS2 [M+Na]
+: 593.1293, found: 593.1278. 
IR (neat, ATR) ν [cm-1]: 3265 (CONH), 3056 (CH, sp2), 2938 (CH, sp3), 1636 (C=O), 1523, 1327, 1061, 748, 726. 
Mp = 256 °C (decomposition). 
 
8-N,9-N-bis(3-aminopropyl)-5-(1-benzothiophen-2-yl)-17-thia-3,6-diazatetracyclo[8.7.0.0
2,7
.0
11,16
]heptadeca-
1(10),2,4,6,8,11,13,15-octaene-8,9-dicarboxamide (64) 
 
Orange-brown solid 
 
Procedure: 
 
The product 62 (53 mg, 0.12 mmol, 1.00 equiv.) was added at room temperature to diaminopropane (2 mL, 
24.0 mmol, 200 equiv.). The mixture was heated at 110 °C for 3h. After cooling down, an orange precipitate 
was observed. 20 mL of distilled water were added to precipitate the product. Residues were filtered through 
Milipore and washed twice with distilled water to remove an excess of diaminopropane. After drying under 
vacuum, 32 mg (53% yield) of product 64 was obtained as an orange-brown solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.17 (d, J = 8.0 Hz, 1H), 8.08 (m, 1H), 7.93 (s, 1H), 7.85-7.76 (m, 3H), 7.60 (m, 
1H), 7.40-7.36 (m, 5H), 3.82 (m, 2H), 3.72 (m, 4H), 2.92 (t, J =6.5 Hz, 2H), 2.89-2.84 (m, 4H), 1.94 (t, J = 6.3 Hz, 
2H), 1.85-1.80 (m, 4H). 
MS (ESI) [m/z]: 569.5 [M+H]+, 591.5 [M+Na]+.  
IR (neat, ATR) ν [cm-1]: 3264 (CONH), 3056 (CH, sp2), 2933 (CH, sp3), 1635 (C=O), 1529, 1433, 1327, 748, 726. 
Mp = 224 °C. 
 
2,5-Bis-benzo[b]thiophen-2-yl-3-iodo-pyrazine-1,4-dicarboxylic acid di-tert-butyl ester (65) 
 
Yellow solid 
Rf = 0.43 (PE/EtOAc: 9/1) revelator CAN 
 
Procedure: 
 
 228
To a solution of starting dihydropyrazine9 (570 mg, 1.04 mmol,1.00 equiv.) in anhydrous THF (30 mL) at -78°C 
under argon was added dropwise 1.04 mL of LDA (2M in THF, 2.08 mmol, 2.00 equiv.) and the solution was 
stirred for 45 minutes. The solution of I2 (662 mg, 2.60 mmol, 2.50 equiv.) in THF was prepared under argon 
with activated molecular sieves (4A) at room temperature, and after 45 min of stirring, was introduced to the 
first solution at -78°C. After 1h of reaction, residues were diluted with EtOAc and hydrolyzed with saturated 
solution of NH4Cl. Then, the mixture was extracted with EtOAc, washed with a saturated solution of Na2S2O3, 
distilled water and brine. All organic phases were resembled, dried over MgSO4, filtred and concentrated. The 
crude was purified by column chromatography (PE/ EtOAc: 95/5) to yield 635 mg (91% yield) of product 65 as a 
yellow solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.85-7.64 (m, 4H), 7.50 (s, 1H), 7.42-7.27 (m, 4H), 7.24 (s, 2H), 1.41 (s, 9H), 
1.16 (s, 9H). 
13
C NMR (63 MHz, CDCl3) δ [ppm]:151.53 (C=O), 149.38 (C
IV), 140.19 (CIV), 139.74 (CIV), 139.03 (CIV), 138.97 (CIV), 
137.55 (CIV), 136.58 (CIV), 135.89 (CIV), 127.66 (CHar), 125.28 (CHar), 124.79 (CHar), 124.73 (CHar), 124.68 (CHar), 
124.52 (CIV), 124.19 (CHar), 123.62 (CHar), 122.39 (CHar), 122.25 (CHar), 121.16 (CHar), 83.94 (C
IV), 83.56 (CIV), 
28.14 (CH3), 27.67 (CH3). 
IR (neat, ATR) ν [cm-1]: 3061 (CH sp2), 2974 (CH sp3), 2926 (CH sp3), 1718 (C=O), 1308, 1153, 745 (C-S). 
MS (ESI, m/z): 673.0 [M+H]+, 695.0 [M+Na]+. 
Mp = 87°C. 
 
2,5-Bis-benzo[b]thiophen-2-yl-3,6-diiodo-pyrazine-1,4-dicarboxylic acid di-tert-butyl ester (66) 
 
 
Yellow powder 
Rf= 0.52 (PE/ EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
To a solution of starting dihydropyrazine9 (250 mg, 0.46 mmol, 1.00 equiv.) in anhydrous THF (14 mL) at -78°C 
under argon, was added dropwise 1.02 mL of LDA (1.8 M in THF, 1.83 mmol, 4.00 equiv.). The solution was 
stirred for 45 minutes and HMPA (0.16 mL, 0.87 mmol, 1.90 equiv.) was introduced to the solution. The 
reaction was stirred for 10 min. The solution of I2 (580 mg, 2.29 mmol, 5.00 equiv.) in anhydrous THF was 
prepared under argon, with activated molecular sieves (4A) at room temperature and was introduced to the 
first solution at -78°C via canulla. After 1h of reaction, residues were diluted with EtOAc and hydrolyzed with a 
saturated solution of NH4Cl. The mixture was extracted with EtOAc, washed with a 20 % solution of Na2S2O3, 
distilled water and brine. All organic phases were resembled, dried over MgSO4, filtered and concentrated. The 
crude was purified by column chromatography (PE/EtOAc: 95/5 to 90/10) to yield 340 mg (93% yield) of 
product 66 as a yellow powder. 
 
Analyses: 
 
1
H NMR (400 MHz, DMSO) δ [ppm]: 8.07 – 7.89 (m, 2H), 7.74 (s, 1H), 7.41 (d, J = 4.4 Hz, 2H), 1.22 (s, 9H). 
13
C NMR (101 MHz, DMSO) δ [ppm]: 149.17 (C=O), 139.22 (CIV), 138.96 (CIV), 136.41 (CIV), 136.28 (CIV), 126.22 
(CHar), 125.47 (CHar), 124.89 (CHar), 124.27 (CHar), 122.44 (CHar), 83.29 (C
IV), 27.36 (CH3). 
IR (neat, ATR) ν [cm-1]: 3064 (CH sp2), 2974 (CH sp3), 2932 (CH sp3), 1719 (C=O), 1299, 1154, 747 (C-S). 
MS (ESI, m/z): 821.0 [M+Na]+. 
Mp = 195°C. 
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2,5-Bis-benzo[b]thiophen-2-yl-3-trimethylsilanylethynyl-pyrazine-1,4-dicarboxylic acid di-tert-butyl ester (67) 
 
 
Yellow-orange oil 
Rf = 0.53 (PE/EtOAc: 9/1) revelator CAN 
 
Procedure: 
 
To a solution of starting iodide 65 (200 mg, 0.29 mmol, 1.00 equiv.) in an freshly distilled triethylamine (8 mL) 
was added trimethylsilylacetylene (0.09 mL, 0.65 mmol, 2.20 equiv.). The solution was degassed and backfilled 
with argon for three times. Then, catalysts PdCl2(PPh3) (21 mg, 0.029 mmol, 0.10 equiv.) and CuI (14 mg, 0.074 
mmol, 0.25 equiv.) were introduced and the reaction was carried out for 40 h at 50°C. The content of flask was 
filtered through a fritted glass, washed with diethyl ether and concentrated. Then, residues were taken up into 
diethyl ether, washed with a 5% solution of HCl, distilled water, saturated solution of NaHCO3 and brine. After 
drying over MgSO4, filtration and concentration, the crude was purified by column chromatography (silica gel, 
PE/EtOAc: 95/5) to give 160 mg (91% yield) of product 67 as a yellow-orange oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.85-7.64 (m, 5H), 7.42-7.22 (m, 5H), 7.18 (s, 1H), 1.48 (s, 9H), 1.29 (s, 9H), 
0.19 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 151.60 (C=O), 149.63 (C
IV), 140.02 (CIV), 139.82 (CIV), 139.17 (CIV), 139.07 
(CIV), 136.97 (CIV), 135.93 (CIV), 135.79 (CIV), 127.67 (CHar), 126.46 (CHar), 126.36 (CHar), 125.08 (CHar), 124.68 
(CHar), 124.57 (CHar), 124.54 (CHar), 123.86 (CHar), 123.66 (CHar), 122.20 (CHar), 121.40 (CHar), 99.64 (C≡C), 98.65 
(C≡C), 83.65 (CIV), 82.80 (CIV), 28.17 (CH3), 27.81 (CH3), -0.24 (TMS). 
IR (neat, ATR) ν [cm-1]: 3060 (CH sp2), 2975 (CH sp3), 2253 (C≡C) , 2144 (C≡C), 1718 (C=O), 1310, 1139, 843 (C-
S). 
MS (ESI, m/z): 665.5 [M+Na]+. 
 
2,5-Bis-benzo[b]thiophen-2-yl-3,6-bis-trimethylsilanylethynyl-pyrazine-1,4-dicarboxylic acid di-tert-butyl 
ester (68) 
 
Yellow oil 
Rf : 0.65 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
To a solution of starting iodide 66 (200 mg, 0.29 mmol, 1.00 equiv.) in an freshly distilled triethylamine (4 mL) 
was added trimethylsilylacetylene (0.12 mL, 0.83 mmol, 4.40 equiv.). The solution was degassed and backfilled 
with argon for three times. Then, catalysts PdCl2(PPh3) (26 mg, 0.038 mmol, 0.20 equiv.) and CuI (18 mg, 0.094 
mmol, 0.50 equiv.) were introduced. The reaction was carried out for 4 h at 50°C. The content of flask was 
 230
filtered through a fritted glass, washed with diethyl ether and concentrated. Residues were taken up into 
diethyl ether, washed with a 5% solution of HCl, distilled water, saturated solution of NaHCO3 and brine. After 
drying over MgSO4, filtration and concentration, the crude was purified on column chromatography (silica gel, 
PE/EtOAc: 90/10) to give 110 mg (79% yield) of product 68 as a yellow-orange oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.85-7.75 (m, 2H), 7.43-7.30 (m, 3H), 1.41 (s, 9H), 0.29 (s, 9H). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 150.61 (C=O), 140.37 (C
IV), 139.56 (CIV), 139.37 (CIV), 137.22 (CIV), 136.75 
(CIV), 125.45 (CHar), 125.09 (CHar), 124.51 (CHar), 124.07 (CHar), 122.30 (CHar), 102.31 (C≡C), 99.15 (C≡C), 83.35 
(CIV), 28.12 (CH3), -0.16 (TMS). 
IR (neat, ATR) ν [cm-1]: 3057 (CH sp2), 2978 (CH sp3), 2158 (C≡C) , 1976 (C≡C), 1726 (C=O), 1299, 1141. 
MS (ESI, m/z): 627.5 [M-2tBu]+, 683.5 [M-tBu]+, 739.5 [M]+,761.5 [M+Na]+. 
 
Di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)-3-ethynylpyrazine-1,4-dicarboxylate (69) 
 
Orange oil 
Rf : 0.29 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
To a solution of starting alkyne 67 (28 mg, 0.05 mmol, 1.00 equiv.) in an freshly distilled THF (3 mL) was added 
TBAF (0.09 mL, 0.09 mmol, 2.00 equiv.). The reaction was carried out for 3 days at room temperature. The 
reaction was stopped by dilution with EtOAc and hydrolysis with distilled water. Residues were extracted with 
EtOAc, washed with distilled water and brine. After drying over MgSO4, filtration and concentration, the crude 
was purified on column chromatography (silica gel, PE/EtOAc: 9/1) to give 6.5 mg (25% yield) of product 69 as 
an orange oil. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.79-7.69 (m, 4H), 7.63 (s, 1H), 7.38-7.29 (m, 5H), 7.14 (s, 1H), 3.10 (s, 1H), 
1.38 (s, 9H), 1.22 (s, 9H). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 151.7 (C=O), 149.7 (C=O), 139.9 (C
IV), 139.0 (CIV), 138. 6 (CIV), 138.5 (CIV), 
137.2 (CIV), 136.6 (CIV), 135.6 (CIV), 126.7 (CHar), 126.1 (C
IV), 125.3 (CHar), 124.8 (CHar), 124.7 (CHar), 124.3 (CHar), 
123.7 (CHar), 122.4 (2xCHar), 121.6 (C≡C), 121.3 (CHar), 83.9 (C
IV), 83.2 (CIV), 80.3 (C≡CH), 28.2 (3xCH3), 27.8 
(3xCH3). 
IR (neat, ATR) ν [cm-1]: 3060 (CH sp2), 2978 (CH sp3), 2123 (C≡C), 1716 (C=O), 1298, 1140, 748. 
MS (ESI, m/z): 459.0 [M-2tBu]+, 515.5 [M-tBu]+, 571.5 [M+H]+,593.5 [M+Na]+. 
 
[2-(2-Azido-ethoxy)-ethoxymethyl]-benzene (70) 
 
Colorless oil 
Rf = 0.19 (PE/ EtOAc: 8/2) revelator KMnO4 
 
Procedure: 
 
The methylsulfonyl chloride (0.095 mL, 1.22 mmol, 1.20 equiv.), was slowly added to the solution of 2-(2-
benzyloxy-ethoxy)-ethanol (200 mg, 1.02 mmol, 1.00 equiv.) with triethylamine (0.2 mL, 1.53 mmol, 1.50 
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equiv.) in anhydrous CH2Cl2 (10 mL) at 0 °C. The reaction was left for delicate warming up overnight, 
hydrolyzed, extracted twice with CH2Cl2 and washed with distilled water and brine. All organic phases were 
resembled, dried over MgSO4, filtered and concentrated. The crude was used directly for the next step. 
To the stirred solution of methanesulfonic acid 2-(2-benzyloxy-ethoxy)-ethyl ester (240 mg) in distilled DMF (10 
mL), NaN3 (99.5 mg, 1.53 mmol, 1.75 equiv.) was added. The reaction was carried out for 48 h at 80 °C. After 
cooling down to room temperature, the reaction mixture was diluted with CH2Cl2 and washed five times with 
distilled water and brine. The organic phase was dried over MgSO4, filtered and concentrated. The crude was 
purified by column chromatography (silica gel, PE/EtOAc: 9/1) to provide 118 mg of product 70 as a colorless oil 
(52% after 2 steps).  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.44-7.10 (m, 5H), 4.57 (s, 2H), 3.71-3.58 (m, 6H), 3.38 (t, J = 5.1, 2H). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 138.31 (C
IV), 128.49 (2xCHar), 127.83 (2xCHar), 127.73 (CHar), 73.43 (CH2), 
70.86 (CH2), 70.18 (CH2), 69.62 (CH2), 50.83 (CH2). 
IR (neat, ATR) ν [cm-1]: 3031 (CH sp2), 2860 (CH sp3), 2097 (N=N), 1679, 1283, 1105, 2737, 698. 
MS (ESI, m/z) 222.0 [M+H]+, 244.0 [M+Na]+. 
 
N-(3-azidopropyl)methanesulfonamide (71) 
 
 
 
Colorless oil 
Rf = 0.39 (PE/EtOAc: 8/2) revelator KMnO4 
 
Procedure: 
 
The methylsulfonyl chloride (0.62 mL, 7.99 mmol, 1.20 equiv.) was slowly added to the solution of 3-
aminopropanol (500 mg, 6.66 mmol, 1.00 equiv.) with triethylamine (1.39 mL, 9.99 mmol, 1.50 equiv.) in 
anhydrous CH2Cl2 (25 mL) at 0 °C. The reaction was left for delicate warming up overnight and hydrolyzed, 
extracted twice with CH2Cl2 and washed with distilled water and brine. All organic phases were resembled, 
dried over MgSO4, filtered and concentrated. The crude was used directly for the next step. 
To the stirred solution of methanesulfonic acid (500 mg) in distilled DMF (10 mL), NaN3 (425 mg, 6.54 mmol, 
2.00 equiv.) was added and the reaction was carried out for 18h at 80°C. After cooling down to room 
temperature, the reaction mixture was diluted with CH2Cl2 and washed five times with distilled water and 
brine. The organic phase was dried over MgSO4, filtered and concentrated. The crude was purified by column 
chromatography (silica gel, PE/EtOAc: 9/1) to give 240 mg of product 71 as a colorless oil (20% after 2 steps).  
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 4.42 (s, 1H), 3.47 (t, J = 6.3 Hz, 2H), 3.26 (q, J = 6.5 Hz, 2H), 2.98 (s, 3H), 1.85 
(quint, J = 6.5 Hz, 2H). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 48.5 (CH2), 40.5 (CH2), 39.8 (CH2), 29.2(CH2). 
IR (neat, ATR) ν [cm-1]: 3291 (NHSO2), 2935 (CH sp
2), 2873 (CH sp3), 2095 (N=N), 1412, 1310.1, 1082, 974, 764. 
MS (ESI, m/z) 179.0 [M+H]+, 201.0 [M+Na]+. 
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2,5-Bis-benzo[b]thiophen-2-yl-3-{1-[2-(2-benzyloxy-ethoxy)-ethyl]-1H-[1,2,3]triazol-4-yl}-pyrazine-1,4-
dicarboxylic acid di-tert-butyl ester (72) 
 
 
Yellow solid 
Rf = 0.06 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
The solution of TMS alcyne 67 (37 mg, 0.057 mmol, 1.00 equiv.) and azide (13 mg, 0.057 mmol, 1.00 equiv.) 
was prepared in CH2Cl2 at room temperature and TBAF (1.0 M in THF, 0.23 mL, 0.23 mmol, 4.00 equiv.) was 
added dropwise. Parallel, the solution of CuSO4∙5H2O (14 mg, 0.057 mmol, 1.00 equiv.) was prepared in 
distilled water (1 mL) and L-(+) sodium ascorbate was introduced (23 mg, 0.115 mmol, 2.00 equiv.). This 
solution was immediately added to the alcyne-azide solution and was vigorously stirred for 2h at room 
temperature. The reaction was stopped by dilution with CH2Cl2 and extracted with CH2Cl2. The organic phase 
was washed with distilled water and brine, dried over MgSO4, filtered and evaporated. Purification by column 
chromatography (silica gel, PE/EtOAc: 95/5) gave 22 mg (53% yield) of product 72 as a yellow solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.77-7.69 (m, 5H), 7.68 (s, 1H), 7.54 (s, 1H), 7.36-7.21 (m, 10H), 4.43 (s, 4H), 
3.77 (s, 2H), 3.38 (d, J = 4.8 Hz, 4H), 1.26 (s, 9H), 1.20 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 152.2 (C=O), 140.4 (C
IV) , 140.1 (CIV), 139.2 (CIV), 139.1 (CIV), 138.2 (CIV), 
135.8 (CIV), 128.6 (CHar), 128.4 (CHar), 127.9 (CHar), 127.9 (CHar), 126.1 (C
IV), 125.2 (CHar), 124.7 (CHar), 124.6 
(CHar), 124.3 (CHar), 124.1 (CHar), 123.8 (CHar), 122.4 (CHar), 122.3 (CHar), 121.5 (CH), 83.5 (C
IV), 82.4 (CIV), 73.4 
(CH2), 70.8 (CH2), 69.6 (CH2), 69.4 (CH2), 50.5 (CH2), 28.1 (CH3), 27.9 (CH3).  
IR (neat, ATR) ν [cm-1]: 3061 (CH sp2), 2971 (CH sp3), 2926, 2852, 1705 (C=O), 1311, 1132, 749. 
MS (ESI, m/z): 792.5 [M+H]+, 814.5 [M+Na]+ . 
HRMS (ESI, m/z): [M]+ calculated for C43H46N5O6S2: 792.2884, found: 792.2886; [M+Na]
+ calculated for 
C43H46N5NaO6S2: 814.2704, found: 814.2701. 
Mp = 177°C. 
 
2,5-Bis-benzo[b]thiophen-2-yl-3-[1-(3-methanesulfonylamino-propyl)-1H-[1,2,3]triazol-4-yl]-pyrazine-1,4-
dicarboxylic acid di-tert-butyl ester (73) 
 
Yellow oil 
Rf : 0.30 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
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The solution of TMS alcyne 67 (50 mg, 0.078 mmol, 1.00 equiv.) and azide (24 mg, 0.135 mmol, 1.70 equiv.) 
was prepared in CH2Cl2 at room temperature and TBAF (1.0 M in THF, 0.27 mL, 0.269 mmol, 3.50 equiv.) was 
added dropwise. Parallel, the solution of CuSO4∙5H2O (34 mg, 0.1347 mmol, 1.70 equiv.) was prepared in 
distilled water (2 mL) and L-(+) sodium ascorbate (53 mg, 0.269 mmol, 3.50 equiv.) was introduced. This 
solution was immediately added to the alcyne-azide solution and was stirred vigorously for 18h at room 
temperature. The reaction was stopped by dilution with CH2Cl2, then extracted with CH2Cl2. The organic phase 
was washed with distilled water and brine, dried over MgSO4, filtered and evaporated. Purification by column 
chromatography (silica gel, PE/EtOAc: 9/5) gave 26 mg (45% yield) of product 73 as a yellow solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.77 (dd, J = 19.7 and 10.2 Hz, 4H), 7.66 (d, J = 11.9 Hz, 2H), 7.51 (s, 1H), 
7.31 (ddd, J = 17.4 and 14.5 Hz, 7.2, 5H), 4.79 (t, J = 6.3 Hz, 1H), 4.36 (t, J = 6.1 Hz, 2H), 2.99-2.90 (m, 2H), 2.80 
(s, 3H), 2.04 (t, J = 5.8 Hz, 2H), 1.26 (s, 9H), 1.19 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 152.3 (C=O), 150.3 (C=O) , 142.7 (C
IV), 140.4 (CIV), 140.0 (CIV), 139.2 (CIV), 
139.0 (CIV), 137.5 (CIV), 135.7 (CIV), 128.4 (CHar), 125.9 (C
IV), 125.3 (CHar), 124.8 (CHar), 124.7 (CHar), 124.3 (CHar), 
129.0 (CHar), 123.8 (CHar), 122.6 (CHar), 122.4 (CHar), 122.2 (CHar), 121.4 (CHar), 83.6 (C
IV), 82.6 (CIV), 46.9 (CH2) , 
40.1 (CH3), 39.8 (CH2), 30.7 (CH2), 28.1 (CH3), 27.8 (CH3). 
IR (neat, ATR) ν [cm-1]: 3273 (NHSO2), 3049 (CH sp
2), 2977 (CH sp3), 2929, 1714 (C=O), 1359, 1144, 748. 
MS (ESI, m/z): 749.0 [M+H]+, 771.5 [M+Na]+. 
HRMS (ESI, m/z): [M+H]+ calculated for C36H41N6O6S3: 749.2244, found: 749.2251; [M+Na]
+ calculated for 
C36H40N6NaO6S3: 771.2064, found: 771.2068. 
 
2,5-Bis-benzo[b]thiophen-2-yl-3,6-bis-{1-[2-(2-benzyloxy-ethoxy)-ethyl]-1H-[1,2,3]triazol-4-yl}-pyrazine-1,4-
dicarboxylic acid di-tert-butyl ester (74) 
 
Yellow oil 
Rf = 0.55 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
The solution of TMS alcyne 68 (61 mg, 0.083 mmol, 1.00 equiv.) and azide (37 mg, 0.165 mmol, 2.00 equiv.) 
was prepared in CH2Cl2 (1mL) at rt and TBAF (1.0 M in THF, 0.33 mL, 0.33 mmol, 4.00 equiv.) was added 
dropwise. Parallel, the solution of CuSO4∙5H2O (21 mg, 0.083 mmol, 1.00 equiv.) was prepared in distilled water 
(2 mL) and L-(+) sodium ascorbate (33 mg, 0.165 mmol, 2.00 equiv.) was introduced, this solution was 
immediately added to the alcyne-azide solution and was stirred vigorously for 36h at room temprature. The 
reaction was stopped by dilution with CH2Cl2, then it was extracted with CH2Cl2. The organic phase was washed 
with distilled water and brine, dried over MgSO4, filtered and evaporated. Purification by column 
chromatography (silica gel, PE/EtOAc: 6/4 then 5/5 then 4/6) gave 30 mg (35% yield) of product 74 a yellow oil. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.07 (d, J = 8.1 Hz, 2H), 7.81-7.65 (m, 2H), 7.35-7.17 (m, 7H), 4.57 (td, J = 4.5 
and 1.8 Hz, 2H), 4.45 (s, 2H), 3.87 (t, J = 5.1 Hz, 2H), 3.62-3.41 (m, 4H), 1.18 (s, 9H). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 151.5 (C=O), 142.0 (C
IV), 140.2 (CIV), 139.7 (CIV), 138.2 (CIV), 137.0 (CIV), 130.9 
(CIV), 128.6 (2xCHar), 127.9 (2xCHar), 127.4 (CHar), 126.2 (CHar), 125.2 (CHar), 124.9 (CHar), 124.5 (CHar), 122.1 
(CHar), 82.7 (C
IV), 73.4 (CH2), 70.9 (CH2), 69.8 (CH2), 69.4 (CH2), 50.7 (CH2), 28.0 (CH3). 
IR (neat, ATR) ν [cm-1]: 3055 (CH sp2), 2971 (CH sp3), 2926, 2864, 1718 (C=O), 1305, 1144, 745. 
MS (ESI, m/z): 1037.5 [M+H]+, 1060.5 [M+Na]+ . 
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HRMS (ESI, m/z): [M+H]+ calculated for C56H61N8O8S2: 1037.4048, found: 1037.4053; [M+Na]
+ calculated for 
C56H60N8NaO8S2: 1059.3868, found: 1059.3869. 
 
2,5-Bis-benzo[b]thiophen-2-yl-3,6-bis-[1-(3-methanesulfonylamino-propyl)-1H-[1,2,3]triazol-4-yl]-pyrazine-
1,4-dicarboxylic acid di-tert-butyl ester (75) 
 
Yellow solid 
Rf = 0.18 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
The solution of TMS alcyne 68 (50 mg, 0.068 mmol, 1.00 equiv.) and azide (24 mg, 0.135 mmol, 2.00 equiv.) 
was prepared in CH2Cl2 at room temperature and TBAF (1.0 M in THF, 0.27 mL, 0.27 mmol, 4.00 equiv.) was 
added dropwise. Parallel, the solution of CuSO4∙5H2O (17 mg, 0.068 mmol, 1.00 equiv.) was prepared in 
distilled water (2 mL) and L-(+) sodium ascorbate (27 mg, 0.135 mmol, 2.00 equiv.) was introduced. This 
solution was immediately added to the alcyne-azide solution and was stirred vigorously for 2h at rt. The 
reaction was stopped by dilution with CH2Cl2, then extracted with CH2Cl2. The organic phase was washed with 
distilled water and brine, dried over MgSO4, filtered and evaporated. Purification by column chromatography 
(silica gel, PE/EtOAc: 5/5 then 4/6 then 0/10) provided 20 mg (30% yield) of product 75 as a yellow oil. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.99 (d, J = 2.8 Hz, 2H), 7.76 (dd, J = 19.0 and 7.5 Hz, 2H), 7.28 (dd, J = 12.7 
and 5.2 Hz, 2H), 5.04 (s, 1H), 4.46 (s, 2H), 3.02 (s, 2H), 2.80 (d, J = 3.0 Hz, 3H), 2.11 (s, 2H), 1.17 (d, J = 2.8 Hz, 
9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 151.4 (C=O), 141.7 (C
IV), 139.9 (CIV), 139.3 (CIV), 136.5 (CIV), 131.3 (CIV), 
127.1 (CHar), 125.3 (C
IV), 125.0 (2xCHar), 124.5 (CHar), 124.2 (CHar), 122.0 (CHar), 82.8 (C
IV), 47.0 (CH2), 39.8 (CH3), 
39.7 (CH2), 30.6 (CH2), 27.7 (CH3). 
IR (neat, ATR) ν [cm-1]: 3267 (NHSO2), 2974 (CH sp
3), 2929 (CH sp3), 1724 (C=O), 1305, 1144, 749. 
HRMS (ESI, m/z): [M+H]+ calculated for C42H51N10O8S4: 951.2769, found: 951.2781. 
Mp = 170°C. 
 
Di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)-3-formylpyrazine-1,4-dicarboxylate (76) 
 
N
N
SBoc
Boc
S
O
H
 
Red-orange glossy solid 
Rf = 0.47 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
A solution of 1,4-dihydropyrazine derivative9 (1.00 g, 1.83 mmol, 1.00 equiv.) was prepared in distilled THF (40 
mL) under argon and cooled down to -78 °C. Then, the solution of LDA (2 M in THF, 3.66 mL, 7.32 mmol, 4.00 
equiv.) was introduced dropwise and mixture was stirred for 40 minutes at -78 °C. Subsequently, HMPA (0.64 
mL, 3.66 mL, 2.00 equiv.) was introduced and the mixture was stirred for 10 min. In a second round bottomed 
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flask, under argon and with molecular sieves (4A), a solution of DMF (0.71 mL, 9.15 mmol, 5.00 equiv.) was 
prepared in distilled THF (4 mL) and introduced by cannula to the first flask over 5 min. The resulting mixture 
was stirred for 2h at -78 °C. Then reaction was hydrolyzed with a saturated solution of NH4Cl, warmed up and 
extracted with EtOAc (2x50 mL). All organic phases were collected and washed with distilled water and brine, 
dried over MgSO4, filtered and concentrated. The crude was purified by flash column chromatography 
(PE/EtOAc: 9/1 to 8/2) to isolate 900 mg (86% yield) of a red-orange oil 76 crystallized after stocking. 
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 9.52 (s, 1H), 8.07-8.00 (m, 1H), 7.99-7.96 (m, 3H), 7.88-7.85 (m, 1H), 
7.54 (s, 1H), 7.51-7.47 (m, 2H), 7.38-7.36 (m, 3H), 1.31 (s, 9H), 1.14 (s, 9H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 184.7 (CHO), 148.6 (C=O), 145.0 (C=O), 182.5 (CIV), 141.5 (CIV), 139.0 
(CIV), 138.2 (CIV), 137.8 (CIV), 133.7 (CIV), 131.5 (CH), 129.8 (CHar), 125.4 (C
IV), 124.9 (CHar), 124.8 (CHar), 123.8 
(CHar), 123.7 (CHar), 122.6 (CHar), 122.4 (CHar), 121.5 (CHar), 84.5 (C
IV), 82.0 (CIV), 27.5 (3xCH3), 27.0 (3xCH3). 
MS (ESI) [m/z]: 597.5 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C31H30N2O5NaS2: 597.1494, found: 597.1487. 
IR (neat, ATR) ν [cm-1]: 2977 (CH, sp3), 2925 (CH, sp2), 1722 (C=O), 1679, 1306, 1137, 747. 
Mp = 113 °C. 
 
(E)-Di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)-3-(2-cyanovinyl)pyrazine-1,4-dicarboxylate (77) 
 
Orange foam 
Rf = 0.43 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
A solution of sodium hydride (30 mg, 0.743 mmol, 1.10 equiv.) was prepared in distilled THF (5 mL) at 0 °C 
under argon and diethylcyanomethyl phosphonate (0.12 mL, 0.743 mmol, 1.10 equiv.) was introduced drop by 
drop. This mixture was stirred for 1h30 at 0 °C. Then, the solution of the aldehyde 76 (388 mg, 0.675 mmol, 
1.00 equiv.) prepared in distilled THF (4 mL) was added dropwise via cannula and the reaction was left for slow 
warming up to room temperature for 6 h. The reaction was diluted with EtOAc, hydrolyzed with a saturated 
solution of NH4Cl and extracted with EtOAc (2x30 mL). All organic phases were collected and washed with 
distilled water and brine, dried over MgSO4, filtered and concentrated. The crude was purified by flash column 
chromatography (PE/EtOAc: 9/1 to 8/2) to isolate 370 mg (92% yield) of product 77 as an orange foam. 
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 8.07-7.98 (m, 4H), 7.81 (m, 1H), 7.78 (d, J = 4.8 Hz, 1H), 7.54 (s, 1H), 
7.50-7.46 (m, 2H), 7.39 (m, 2H), 7.33 (s, 1H), 6.11 (d, J = 16.0 Hz, 1H), 1.34 (s, 9H), 1.10 (s, 9H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 152.0 (C=O), 148.8 (C=O), 142.3 (CH), 140.1 (CIV), 139.6 (CIV), 138.9 (CIV), 
138.0 (CIV), 136.6 (CIV), 136.2 (CIV), 133.3 (CIV), 128.4 (CIV), 128.3 (CHar), 125.8 (C
IV), 125.6 (CHar), 125.0 (CHar), 
124.7 (CHar), 124.6 (CHar), 124.1 (CHar), 123.6 (CHar), 122.4 (CHar), 122.3 (CHar), 121.8 (CHar), 121.7 (CHar), 99.5 
(CIV), 97.7 (CH), 84.0 (CIV), 80.4 (CIV), 28.2 (3xCH3), 27.5 (3xCH3). 
MS (ESI) [m/z]: 598.0 [M+H]+, 621.0 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C33H31N3O4NaS2 [M+Na]
+: 620.1654, found: 620.1672. 
IR (neat, ATR) ν [cm-1]: 2976 (CH, sp3), 2929 (CH, sp2), 2213 (CN), 1722 (C=O), 1296, 1138, 843, 746. 
Mp = 115 °C. 
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(E)-di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)-3-(3-ethoxy-3-oxoprop-1-enyl)pyrazine-1,4-dicarboxylate (78) 
 
Orange foam 
Rf= 0.5 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
A solution of sodium hydride (38 mg, 0.957 mmol, 1.10 equiv.) was prepared in distilled THF (10 mL) at 0 °C 
under argon and triethyl phosphonate (0.19 mL, 0.957 mmol, 1.10 equiv.) was introduced drop by drop. This 
mixture was stirred for 1h30 at 0 °C. Then, the solution of aldehyde 76 (500 mg, 0.870 mmol, 1.00 equiv.) 
prepared in distilled THF (6 mL) was added dropwise via cannula and the reaction was left for slow warming up 
to room temperature for 16 h. The reaction was diluted with EtOAc, hydrolyzed with a saturated solution of 
NH4Cl and extracted with EtOAc (2x30 mL). All organic phases were collected and washed with distilled water 
and brine, dried over MgSO4, filtered and concentrated. The crude was purified by flash column 
chromatography (PE/EtOAc: 9/1 to 8/2) to isolate 450 mg (80% yield) of product 78 as an orange foam. 
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 8.08 (m, 1H), 8.01 (m, 2H), 7.88 (m, 1H), 7.54 (s, 1H), 7.72 (s, 1H), 7.68 
(s, 1H), 7.59 (s, 1H), 7.47 (m, 3H), 7.36 (m, 2H), 6.23 (d, J = 9.5 Hz, 1H), 4.14 (q, J = 4.5 Hz, 2H), 1.32 (s, 9H), 1.19 
(t, J = 4.3 Hz), 1.16 (s, 9H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 165.8 (C=O), 152.0 (C=O), 148.8 (C=O), 140.0 (CIV), 139.6 (CIV), 138.8 
(CIV), 136.9 (CH), 133.8 (CIV), 127.8 (CHar), 125.8 (CHar), 125.1 (CHar), 124.9 (CHar), 124.8 (C
IV), 124.7 (CHar), 124.6 
(CIV), 124.5 (CH), 123.7 (CH), 122.5 (CHar), 122.3 (CHar), 122.0 (C
IV), 120.9 (CHar),119.3 (CHar), 83.9 (C
IV), 82.2 (CIV), 
60.2 (CH2), 27.4 (3xCH3), 26.9 (3xCH3), 14.1 (CH3). 
MS (ESI) [m/z]: 668.0 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C35H36N2O6NaS2 [M+Na]
+: 667.1913, found: 667.1923.  
IR (neat, ATR) ν [cm-1]: 2977 (CH, sp3), 1716 (C=O), 1619, 1297, 1139, 844, 747. 
 
Ethyl 3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propanoate (79) 
 
Orange solid 
Rf = 0.6 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The solution of ester derivative 78 (280 mg, 0.434 mmol) was dissolved in dry CH2Cl2 (8 mL), then TMSI (0.296 
mL, 2.083 mmol, 4.80 equiv.) was introduced dropwise. The solution was stirred at room temperature for 60 
minutes. The mixture was then hydrolyzed with a saturated solution of NH4Cl (20 mL) and stirred for 10 min. 
The solution was extracted twice with CH2Cl2. All organic phases were collected and washed with distilled water 
and brine, then dried over MgSO4, filtered and concentrated under vacuum. The concentrated solution was 
precipitated with diethyl ether. The brown-beige solid was filtered through Milipore and washed twice with 
diethyl ether then n-pentane to isolate the product 79 (147 mg, 76% yield) as a orange solid. 
 
Analyses: 
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1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.84 (s, 1H), 7.95 (s, 1H), 7.87 (m, 4 H), 7.40 (m, 5H), 4.24 (q, J = 7.3 Hz, 2H), 
3.60 (t, J = 6.8 Hz, 2H), 3.08 (t, J = 6.8 Hz, 2H), 1.31 (t, J = 7.0 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 173.2 (C=O), 157.6 (C
IV), 147.6 (CIV), 143.9 (CIV), 143.3 (CIV), 143.1 (CIV), 
142.3 (CHpyr), 139.6 (2xC
IV), 138.6 (CIV), 138.4 (CIV), 125.0 (CHar), 124.4 (CHar), 124.3 (CH2), 124.0 (CHar), 123.2 
(2xCHar), 122.9 (2xCHar), 119.6 (CHar), 119.3 (CHar), 61.3 (CH2), 34.2 (CH2), 33.0 (CH2), 14.1 (CH3). 
IR (ATR, neat) ν [cm-1]: 3346, 3244, 2983 (CH sp2), 1725, 1646, 1413, 1081, 744. 
MS (ESI, m/z) 445.1 [M+H]+, 467.1 [M+Na]+. 
Mp = 200 °C 
 
3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propanenitrile (80) 
 
Beige solid 
Rf= 0.8(PE: EtOAc 6: 4) revelator CAN 
 
Procedure: 
 
The solution of nitrile derivative 77 (200 mg, 0.335 mmol) was dissolved in dry CH2Cl2 (8 mL), then TMSI (0.23 
mL, 1.606 mmol, 4.80 equiv.) was introduced dropwise. The solution was stirred at room temperature for 90 
minutes. The mixture was then hydrolyzed with a saturated solution of NH4Cl (20 mL) and left to stir for 10 min. 
The solution was extracted twice with CH2Cl2. All organic phases were collected and washed with distilled water 
and brine, dried over MgSO4, filtered and concentrated under vacuum. The concentrated solution was 
precipitated with diethyl ether. The brown-beige solid was filtered through Milipore and washed twice with 
diethyl ether then n-pentane to isolate the product 80 (130 mg, 99% yield) as a beige solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 9.00 (s, 1H), 7.98 (s, 1H), 7.91-7.88 (m, 4H), 7.45-7.40 (m, 5H), 3.64 (t, J = 7.5 
Hz, 2H), 3.18 (t, J = 7.5 Hz, 2H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 157.5 (CIV), 147.5 (CIV), 144.0 (CIV), 143.6 (CIV), 143.4 (CIV), 142.1 (CHpyr), 
140.9 (CIV), 140.3 (CIV), 139.6 (2xCIV), 124.6 (2xCHar), 124.3 (2xCHar), 122.8 (CHar), 122.3 (CHar), 119.5 (2xCHar), 
117.7 (CN), 28.7 (CH2), 17.9 (CH2). 
MS (ESI) [m/z]: 398.0 [M+H]+, 420.0 [M+Na]+. 
HRMS (ESI) [m/z]: calculated for C35H36N2O6NaS2 [M+Na]
+: 667.1913, found: 667.1923.  
IR (neat, ATR) ν [cm-1]: = 3052(CH, sp3), 2976, 2251, 1563, 1413, 1158, 953, 748. 
Mp = 250 °C (decomposition) 
 
3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propan-1-ol (82) 
 
Yellow solid 
Rf = 0.13 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
The solution of ester derivative 79 (100 mg, 0.225 mmol) was dissolved in dry THF (15 mL), then cooled down 
to 0 °C and LiAlH4 (17 mg, 0.450 mmol, 2.00 equiv.) was introduced in one portion. The solution was stirred at 0 
°C for 15 minutes and the mixture was diluted with EtOAc, hydrolyzed with a saturated solution of NH4Cl (30 
mL) and left to warm up. The solution was extracted with EtOAc three times. All organic phases were collected 
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and washed with distilled water and brine, dried over MgSO4, filtered and concentrated under vacuum. The 
product 82 (90 mg, 100% yield) was obtained as a yellow solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.96 (s, 1H), 7.95 (s, 1H), 7.87 (m, 4 H), 7.41 (m, 5H), 3.90 (t, J = 6.3 Hz, 2H), 
3.43 (t, J = 7.0 Hz, 2H), 2.34 (qt, J = 7.0 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 156.4 (C
IV), 148.6 (CIV), 143.9 (CIV), 143.7 (CHpyr), 143.5 (C
IV), 143.3 (CIV), 
140.9 (CIV), 140.7 (CIV), 139.6 (CIV), 139.3 (CIV), 124.4 (2xCHar), 124.2 (2x CHar), 132.3 (CHar), 132.1 (CHar), 122.8 
(2xCHar), 119.5 (CHar), 119.1 (CHar), 62.4 (CH2), 34.5 (CH2), 31.1 (CH2). 
IR (ATR, neat) ν [cm-1]: 3308 (large), 3055, 2926 (CH sp2), 2852, 1563, 1411, 1333, 1156, 1048, 744, 724. 
HRMS (ESI, m/z) [M+H]+ calculate for C23H19N2OS3: 403.0939, found: 403.0921. 
Mp = 185 °C. 
 
2,5-di(benzo[b]thiophen-2-yl)-3-(3-bromopropyl)pyrazine (83)  
 
Red solid 
Rf = 0.8 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The solution of alcohol derivative 82 (39 mg, 0.097 mmol) was dissolved in dry DMF (5 mL) under argon, then 
PPh3 (89 mg, 0.340 mmol, 3.50 equiv.) and NBS (43 mg, 0.243 mmol, 2.50 equiv.) were introduced. The solution 
was stirred at 60 °C for 15 minutes. The mixture was cooled down and a red precipitate appeared The content 
of the flask was filtered through Milipore, washed four times with Et2O and dried under vacuum to isolate the 
product 83 (30 mg, 66% yield) as a red solid. 
 
Analyses: 
 
1
H NMR (400 MHz, DMSO-d6) δ [ppm]: 9.61 (s, 1H), 8.47 (s, 1H), 8.40 (s, 1H), 8.08 (m, 4H), 7.61 (m, 4H), 5.16 (t, 
J = 8.0 Hz, 2H), 4.00 (t, J = 8.0 Hz, 2H), 2.56 (qt, J = 8.0 Hz, 2H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 150.3 (CHpyr), 150.0 (C
IV), 148.2 (CIV), 141.6 (CIV), 140.8 (CIV), 140.7 (CIV), 
139.5 (CIV), 139.3 (CIV), 132.6 (CHar), 132.0 (CHar), 129.2 (C
IV), 129.2 (CHar), 129.1 (CHar), 128.2 (CHar), 127.9 
(CHar), 126.4 (CHar), 126.3 (CHar), 126.0 (CHar), 123.3 (CHar), 122.8 (C
IV), 67.8 (CH2), 12.8 (CH2), -14.6 (CH2). 
HRMS (ESI) [m/z]: [M-Br+H]+ calculated for C23H17N2S2: 385.0833, found: 385.0833. 
IR (ATR, neat) ν [cm-1]: 3056 (CH sp3), 2950, 1516, 1371, 1156, 831, 751, 725. 
Mp > 260 °C. 
 
 
2,5-di(benzo[b]thiophen-2-yl)-3-(3-iodopropyl)pyrazine (84) 
 
Dark red solid 
Rf = 0.9 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
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The solution of alcohol derivative 82 (100 mg, 0.248 mmol) was dissolved in distilled toluene (9 mL) under 
argon, then PPh3 (85 mg, 0.322 mmol, 1.30 equiv.) and imidazole (51 mg, 0.744 mmol, 3.00 equiv.) were 
introduced. The solution was stirred at room temperature for 5 minutes and then, I2 (82 mg, 0.322 mmol, 1.30 
equiv.) was added. The mixture was stirred for 30 minutes at 60 °C. After cooling down, a dark red solid 
appeared. The content of flask was evaporated to reduce the volume of solvent to 2 mL and Et2O was added to 
precipitate product with PPh3O. The crude was purified by column chromatography (PE/EtOAc: 6/4) to isolate 
the product 84 (85 mg, 67% yield) as a dark red solid. 
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 9.62 (s, 1H), 8.49 (s, 1H), 8.42 (s, 1H), 8.14 (m, 4H), 7.61 (m, 4H), 5.16 (t, 
J = 7.5 Hz, 2H), 4.02 (t, J = 7.6 Hz, 2H), 2.62 (qt, J = 7.5 Hz, 2H). 
13
C NMR (101 MHz, DMSO-d6) δ [ppm]: 149.5 (CIV), 147.4 (CIV), 146.8 (CHpyr), 140.5 (C
IV), 140.3 (CIV), 140.2 (CIV), 
138.9 (CIV), 138.8 (CIV), 137.3 (CIV) 132.1 (CHar), 128.8 (CHar), 129.2 (C
IV), 127.2 (CHar), 127.0 (CHar), 125.9 
(2xCHar), 125.8 (CHar), 125.5 (CHar), 122.8 (CHar), 122.7 (2xCHar), 60.5 (CH2), 33.4 (CH2), 20.6 (CH2). 
MS (ESI) [m/z] [M-I]+: 385.0, [M-I+NH4]
+: 401.0. 
IR (ATR, neat) ν [cm-1]: 3056 (CH sp3), 2866 (CH sp2), 1515, 1440, 1124, 828, 751. 
Mp > 260 °C. 
 
3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propyl 2-bromoacetate (85) 
 
Orange solid 
Rf = 0.44 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The solution of alcohol 82 (90 mg, 0.224 mmol) was dissolved in distilled CH2Cl2 (7 mL) under argon and cooled 
down to 0 °C, then Et3N (30 µL, 0.224 mmol, 1.00 equiv.) was introduced. In the second flask, the solution of 
bromoacetic bromide (20 µL, 0.224 mmol, 1.00 equiv.) was prepared in 5 mL of CH2Cl2 and added to the first 
solution dropwise via cannula. The solution was stirred at 0 °C for 30 minutes and left to warm up slowly. The 
mixture was hydrolyzed with 20 mL of a saturated solution of NH4Cl. The solution was extracted twice with 
CH2Cl2. All organic phases were collected, washed with distilled water and brine, then dried over MgSO4, 
filtered and concentrated under vacuum. The crude was purified by flash column chromatography (PE/EtOAc: 
9/1 to 8/2) to isolate the product 85 (92 mg, 79% yield) as an orange solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.95 (s, 1H), 7.95 (s, 1H), 7.86 (m, 4H), 7.78 (s, 1H), 7.40 (m, 4H), 4.45 (t, J = 
4.0 Hz, 2H), 3.84 (s, 2H), 3.35 (t, J = 8.0 Hz, 2H), 2.43 (qt, J = 8.0 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 167.5 (C=O), 151.8 (C
IV), 145.4 (CIV), 145.3 (CIV), 142.5 (CIV),142.0 (CIV), 141.7 
(CIV), 141.6 (CIV), 140.9 (CIV), 140.6 (CIV), 137.5 (CHpyr), 125.9 (CHar), 125.8 (CHar), 125.0 (CHar), 124.9 (CHar), 124.8 
(CHar), 124.7 (CHar), 124.7 (CHar), 122.8 (CHar), 122.5 (CHar), 122.4 (CHar), 66.1 (CH2), 32.0 (CH2), 26.1 (CH2), 26.0 
(CH2). 
MS (ESI) [m/z]: [M+H]+ 523.0. 
HRMS (ESI) [m/z]: [M+Na]+ calculated for C25H19
79BrN2NaO2S2: 544.9969, found: 544.9970; [M+K]
+ calculated 
for C25H19
79BrKN2O2S2: 560.9708, found: 560.9725. 
IR (ATR, neat) ν [cm-1]: 3056 (CH sp3), 2921, 2848, 1729 (C=O), 1413, 1278, 1164, 951, 748, 726. 
Mp = 177 °C. 
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tert-butyl 2,2',2''-(10-(2-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propoxy)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (86) 
 
Yellow-brown solid 
Rf = 0.38 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
The solution of bromide derivative 85 (65 mg, 0.130 mmol) was dissolved in distilled THF (5 mL) under argon. 
Parallel, the solution of cyclen DO3A (80 mg, 0.156 mmol, 1.20 equiv.) with Na2CO3 (32 mg, 0.390 mmol, 3.00 
equiv.) in 5 mL of distilled THF was stirred at romm temperature for 30 minutes in a flask equipped with a CaCl2 
trap. The solution of bromide derivative was added dropwise to the second flask and the reaction was refluxed 
for 20h. After cooling down, the content of flask was filtered through glass frit to remove solids and the solvent 
from filtrate was evaporated to obtain the crude product. After purification by column chromatography 
(CH2Cl2/MeOH: 9/1), the product 86 (90 mg, 73% yield) was obtained as a yellow-brown solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.97 (s, 1H), 7.96 (s, 1H), 7.85 (m, 4H), 7.77(s, 1H), 7.41 (m, 4H), 4.31 (m br, 
2H), 3.71 (qt, J = 5.0 Hz, 2H),3.33 (m br, 14 H), 2.36 (m br, 12H), 1.45 (s, 27 H). 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 173.6 (C=O), 173.0 (C=O), 172.9 (C=O), 151.7 (C
IV), 145.4 (CIV), 145.2 (CIV), 
142.5 (CIV), 142.0 (CIV), 141.7 (CIV), 141.6 (CIV), 140.3 (CIV), 137.3 (CHpyr), 125.7 (CHar), 124.9 (CHar), 124.8 (CHar), 
124.6 (CHar), 124.5 (CHar), 124.4 (2xCHar), 122.3 (CHar), 122.3 (CHar), 122.2 (CHar), 81.8 (C
IV), 64.6 (CH2), 55.7 
(CH2), 54.8 (CH2), 52.4 (CH2), 48.5 (CH2), 31.3 (CH2), 27.9 (CH3), 26.1 (CH2). 
MS (ESI) [m/z] [M+Na]+ 979.5.  
IR (ATR, neat) ν [cm-1]: 2978 (CH sp3), 2827 (CH sp2), 1722 (C=O), 1450, 1367, 1227, 1157, 1105, 753. 
Mp = 96 °C. 
 
 
 
3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propan-1-amine (87) 
 
Red glossy solid 
Rf = 0.38 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The solution of nitrile derivatives 80 and 81 (130 mg, 0.329 mmol) was dissolved in dryTHF (10 mL) under 
argon, then LiAlH4 (25 mg, 0.658 mmol, 2.00 equiv.) was introduced in one portion. The solution was stirred at 
room temperature for 16 hours. The mixture was quenched by addition of 250 µL of a 5% solution of NaOH and 
let stirring for an hour. Solid residues were separated by filtration on the glass frit, washed three times with 
THF. After evaporation and drying, the product 87 (100 mg, 76% yield) as a red glossy solid was obtained. 
 
Analyses: 
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1
H NMR (400 MHz, DMSO-d6 δ[ppm]: 9.32 (s, 1H), 8.39 (s, 1H), 8.17 (s, 1H), 8.07-7.91 (m, 5H), 7.52-7.39 (m, 
5H), 7.25 (s, 1H), 3.38 (s, 3H), 3.10 (t, J = 7.2, 2H), 2.37-2.11 (m, 2H). 
13
C NMR (101 MHz, DMSO-d6) δ[ppm]: 154.5 (CIV), 148.6, (CIV), 143.9 (CIV),143.8 (CHpyr), 143.7 (C
IV), 143.0 (CIV), 
139.8 (CIV), 136.8 (CIV), 132.0 (CIV), 129.7 (CIV), 127.0 (2xCHar), 125.9 (CHar), 124.9 (2xCHar),122.8 (CHar), 122.3 
(CHar),122.0 (CHar), 119.8 (CHar), 118.0 (CHar), 39.9 (CH2), 39.7 (CH2), 38.6 (CH2). 
HRMS (ESI) [m/z]: calculated for C23H20N3S2 [M+H]
+: 402.1099, found: 402.1097.  
IR (ATR, neat) ν [cm-1]: 3440, 3242, 3195, 2922 (CH sp2), 1714, 1634, 1077, 800, 748. 
Mp = 145 °C. 
 
2-bromo-N-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propyl)acetamide (88) 
 
Orange solid 
Rf = 0.29 (CH2Cl2/MeOH: 95/5) revelator CAN 
 
Procedure: 
 
The solution of amine derivative 87 (40 mg, 0.099 mmol) was dissolved in dry CH2Cl2 (5 mL) under argon and 
cooled down to 0 °C, then Et3N (10 µL, 0.099 mmol, 1.0 equiv.) was introduced. In the second flask, the solution 
of bromoacetic bromide (9 µL, 0.099 mmol, 1.00 equiv.) in 2 mL of CH2Cl2 was prepared and added to the first 
solution dropwise via cannula. The solution was stirred at 0 °C for 60 min. and then left to warm up slowly. The 
mixture was hydrolyzed with 5 mL of distilled water. The solution was extracted with CH2Cl2 three times. All 
organic phases were collected, washed with distilled water and brine, then dried over MgSO4, filtered and 
concentrated under vacuum. The crude was purified by flash column chromatography (CH2Cl2 to CH2Cl2/MeOH: 
95/5) to isolate the product 88 (39 mg, 75% yield) as an orange solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.96 (s, 1H), 7.95 (s, 1H), 7.84 (m, 4H), 7.71 (s, 1H), 7.38 (m, 4H), 6.83 (s br, 
NH), 3.88 (s, 2H), 3.50 (q, J = 6.0 Hz, 2H), 3.33 (t, J = 11.3 Hz, 2H), 2.31 (qt, J = 11.1 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 182.7 (C=O), 155.2 (CHpyr), 148.6 (C
IV), 143.9 (CIV),143.4 (2xCIV), 140.7 
(2xCIV), 139.8 (CIV), 139.6 (CIV), 138.5 (CIV), 127.7 (CHar), 125.9 (CHar), 125.8 (CHar), 125.1 (CHar), 124.9 (CHar), 
124.8 (CHar), 124.7 (CHar), 122.8 (CHar), 122.6 (CHar), 122.4 (CHar), 45.2 (CH2), 39.9 (CH2), 29.9 (CH2), 29.5 (CH2). 
MS (ESI) [m/z]: [M+H]+ 524.0 
HRMS (ESI) [m/z]: calculated for C25H21BrN3OS2: 522.0304, found: 522.0302. 
IR (ATR, neat) ν [cm-1]: 3285 (NHCO), 3056 (CH sp3), 2917, 2848, 1728 (C=O), 1646, 1528, 1156, 744, 724. 
Mp = 185 °C. 
 
tert-butyl 2,2',2''-(10-(2-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (89) 
 
 
Yellow-brown solid 
Rf = 0.38 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
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The solution of bromide derivative 88 (51 mg, 0.098mmol) was dissolved in distilled THF (8 mL) under argon. 
Parallel, the solution of cyclen DO3A (55 mg, 0.107 mmol, 1.10 equiv.) with Na2CO3 (31 mg, 0.293 mmol, 3.00 
equiv.) in 8 mL of distilled THF was stirred at room temperature for 30 minutes in a flask equipped with a CaCl2 
trap. The solution of bromide derivative was added dropwise to the second flask and the reaction was refluxed 
for 20h. After cooling down, the content of flask was filtered through glass frit to remove solids and the solvent 
from filtrate was evaporated to obtain the crude product. After purification by column chromatography 
(CH2Cl2/MeOH: 9/1), the product 89 (90 mg, 73% yield) was obtained as a yellow-brown solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.87 (s, 1H), 8.27 (s, 1H), 7.85 (s, 1H), 7.81 (m, 4H), 7.35 (m, 4H), 3.51 (m br, 
2H), 3.41 (m br, 2H), 2.27 (m br, 20H), 1.80 (m br, 4H), 1.44 (s, 27 H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 209.9 (C=O), 182.4 (C=O), 172.3 (C=O), 171.7 (C
IV),170.5 (CIV),169.6 
(CIV),153.1 (CIV),144.6 (CIV),144.4 (CIV),141.2 (CIV), 140.9 (CIV),140.4 (CIV),140.3 (CIV), 136.6 (CHpyr), 128.0 (CHar), 
125.3 (2xCHar), 124.6 (CHar), 124.4 (CHar), 124.3 (CHar), 122.4 (CHar), 121.8 (CHar), 121.6 (CHar), 81.7 (C
IV), 58.1 
(CH2), 56.3 (CH2), 55.7 (CH2), 52.4 (CH2), 49.2 (CH2), 45.0 (CH2), 39.0 (CH2), 33.7 (CH2), 29.5 (CH2), 28.2 (CH3), 
27.5 (CH2). 
HRMS (ESI) [m/z] [M+H]+ calculated for C51H70N7O7S2: 956.4773, found: 956.4783. 
IR (ATR, neat) ν [cm-1]: 3056 (CH sp3), 2866 (CH sp2), 1731, 1516, 1340, 1124, 828, 750. 
 
2,2',2''-(10-(2-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetic acid (90) 
 
Yellow-brown solid 
Rf = 0.30 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A 2% vol. solution of triisopropyl silane (TIS) was prepared in TFA (10 µL in 0.5 mL of TFA). The solution of ester 
89 (34 mg, 0.035 mmol) was prepared in 0.5 mL of CH2Cl2 at room temperature. The solution of TFA/TIS was 
introduced dropwise to the solution of ester 89 and stirred overnight under argon. All solvents were 
evaporated and recovered solid was precipitated in Et2O, filtered through Milipore and washed 3 times with 
Et2O. 29 mg of product 90 as a yellow-brown solid (94% yield) were recuperated.  
 
Analyses: 
 
1
H NMR (250 MHz, DMSO-d6) δ [ppm]: 9.28 (s, 1H), 8.39 (s, 1H), 8.02 (m, 4H), 7.44 (m, 5H), 3.42 (s, 2H), 3.03 
(m, 6H), 2.74 (m br, 16H), 2.08 (s br, 6H). 
HRMS (ESI) [m/z] [M+H]+ calculated for C39H45N7O7S2: 779.2662, found: 779.2659. 
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2,2',2''-(10-(2-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate neodymium complex (91) 
 
Yellow-brown solid 
 
Procedure: 
 
A solution of tricetic acid 90 (10 mg, 12.69 µmol, 1.00 equiv.) was prepared in MeOH (2 mL) and Nd(OTf)3 (7.5 
mg, 12.69 µmol, 1.00 equiv.) was added. The mixture was heated at 50 °C for 18h. The volume solvent was 
reduced under vacuum to 0.5 mL and the solid was precipitated by addition of Et2O (2 mL), filtered through 
Milipore and washed three times with Et2O. 9.9 mg (85% yield) of yellow-brown solid was obtained. 
 
Analyses: 
 
HRMS (ESI) [m/z] [M+H]+ calculated for C39H45N7Nd O7S2: 926.1664, found: 926.1675. 
 
2,2',2''-(10-(2-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate ytterbium complex (92) 
 
 
Yellow-brown solid 
 
Procedure: 
 
A solution of tricetic acid 90 (10 mg, 12.69 µmol, 1.00 equiv.) was prepared in MeOH (2 mL) and Yb(OTf)3 (7.9 
mg, 12.69 µmol, 1.00 equiv.) was added. The mixture was heated at 50 °C for 18h. The volume solvent was 
reduced under vacuum to 0.5 mL and the solid was precipitated by addition of Et2O (2 mL), filtered through 
Milipore and washed three times with Et2O. 10 mg (82% yield) of product 92 as a yellow-brown solid was 
obtained. 
 
Analyses: 
 
HRMS (ESI) [m/z] [M+H]+ calculated for C39H45N7O7S2Yb: 961.2210, found: 961.2205. 
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2,2',2''-(10-(2-(3-(3,6-di(benzo[b]thiophen-2-yl)pyrazin-2-yl)propylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate gadolinium complex (93) 
 
 
Yellow-brown solid 
 
Procedure: 
 
A solution of tricetic acid 90 (6 mg, 7.61 µmol, 1.00 equiv.) was prepared in MeOH (2 mL) and Gd(OTf)3 (4.6 mg, 
7.61 µmol, 1.00 equiv.) was added. The mixture was heated at 50 °C for 16h. The volume solvent was reduced 
under vacuum to 0.5 mL and the solid was precipitated by addition of Et2O (2 mL), filtered through Milipore 
and washed three times with Et2O. 6 mg (83% yield) of yellow-brown solid 93 was obtained. 
 
Analyses: 
 
HRMS (ESI) [m/z] [M+H]+ calculated for C39H45Gd N7O7S2: 945.2055, found: 945.2063. 
 
 
Di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)-3-(hydroxymethyl)pyrazine-1,4-dicarboxylate (94) 
N
N
SBoc
Boc
S OH
 
 
Yellow solid 
Rf = 0.53 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
A solution of aldehyde 76 (100 mg, 0.17 mmol, 1.00 equiv.) was prepared in distilled THF (4 mL) under argon 
and cooled down to 0 °C. Then, LiAlH4 (6 mg, 0.17 mmol, 1.00 equiv.) was introduced and reaction was stirred 
for 30 min. at 0 °C. The reaction was hydrolyzed slowly with saturated solution of NH4Cl, warmed up and 
extracted with EtOAc (2x10 mL). All organic phases were collected and washed with distilled water and brine, 
dried over MgSO4, filtered and concentrated. This reaction does not require further purification because there 
is no byproduct. After evaporation of solvents, 100 mg (quantitative) of product 94 as a yellow solid was 
obtained. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.80 (m, 5H), 7.71 (d, J = 4.0Hz, 1H), 7.34 (m, 4H), 7.10 (s, 1H), 4.88 (s br, 
1H), 4.28 (s br, 2H), 1.26 (s, 9H), 1.19 (s br, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 153.8 (C=O), 140.2 (C
IV), 139.8 (CIV), 139.7 (CIV), 139.0 (CIV), 138.1 (CIV), 
131.4 (CIV), 126.5 (CHar), 125.0 (C
IV), 124.9 (CHar), 124.8 (CHar), 124.6 (CHar), 123.6 (2xCHar), 122.5 (CHar), 122.4 
(CHar), 121.9 (2xCHar), 121.8 (CH), 120.7 (CHar), 83.8 (C
IV), 83.7 (CIV), 62.1 (CH2), 28.1 (3xCH3), 27.9 (3xCH3). 
MS (ESI) [m/z]: 599.0 [M+Na]+, 615.0 [M+K]+. 
IR (neat, ATR) ν [cm-1]: 3497 (OH), 2978 (CH, sp3), 1684 (C=O), 1325, 1141, 848, 748. 
Mp = 135 °C. 
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2,5-Di(benzo[b]thiophen-2-yl)-3-methylpyrazine (95) 
 
Beige solid 
Rf = 0.66 (PE/EtOAc: 8/2) CAN relevator 
 
Procedure: 
 
A solution of the alcohol 94 (50 mg, 0.087 mmol, 1.00 equiv.) was prepared in distilled CH2Cl2 (2 mL) under 
argon and cooled down to 0 °C. Then, TMSI (0.06 mL, 0.416 mmol, 4.80 equiv.) was introduced and reaction 
was stirred for 15 minutes at 0 °C. The reaction was slowly hydrolyzed with a saturated solution of NaHCO3, 
warmed up and extracted with CH2Cl2 (3x10 mL). All organic phases were collected, washed with distilled 
water, saturated solution of Na2S2O3 and brine, dried over MgSO4, filtered and concentrated. Residues were 
precipitated with diethyl ether to obtain 28 mg (90% yield) of product 95 as a beige solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.93 (s, 1H), 7.94 (s, 1H), 7.83 (m, 4H), 7.81 (s, 1H) 7.38 (m, 4H), 2.98 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 150.0 (C
IV), 146.2 (CIV), 146.1 (CIV), 142.2 (CIV), 141.6 (CIV), 140.8 (CIV), 140.6 
(CIV), 137.6 (CHar), 125.7 (CHar), 125.0 (CHar), 124.8 (CHar), 124.7 (CHar), 124.7 (CHar), 124.6 (CHar), 122.8 (CHar), 
122.4 (CHar), 25.1 (CH3). 
MS (ESI) [m/z]: 359.0 [M+H]+. 
IR (neat, ATR) ν [cm-1]: 3053 (CH, sp2), 2920 (CH, sp3), 2867, 1702 (C=O), 1458, 1307, 1151, 945, 820, 748. 
Mp = 205 °C. 
 
8,11-di-tert-butyl 9-(1-benzothiophen-2-yl)-10-(hydroxymethyl)-4-methyl-3,5-dioxo-14-thia-4,8,11-
triazapentacyclo[11.7.0.0
2,6
.0
7,12
.0
15,20
]icosa-1(13),9,15,17,19-pentaene-8,11-dicarboxylate (96) 
 
Orange oil 
Rf = 0.20 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
A solution of the alcohol 94 (50 mg, 0.087 mmol, 1.00 equiv.) and N-methylmaleimide (48 mg, 0.434 mmol, 
5.00 equiv.) in distilled toluene (2 mL, c = 0.04 M) was heated for 72 h at 90 °C in the sealed tube. After cooling 
down solvent was removed under vacuum and the crude was purified by flash column chromatography 
(PE/EtOAc: 9/1) to isolate 20 mg (34% yield) of 96 as an orange oil. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.05 (m, 2H), 7.82 (m, 2H), 7. 36 (m, 2H), 7.22 (m, 3H), 5.33 (d, J = 9.0 Hz, 
1H), 4.60 (s br, 1H), 4.43 (m, 2H), 4.26 (s, 1H), 3.26 (t, J = 7.5 Hz, 1H), 3.19 (s, 3H), 2.87 (t, J = 8.0 Hz, 1H), 1.59 (s, 
9H), 1.12 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 177.6 (C=O), 174.7 (C=O), 140.6 (C
IV), 139.6 (2xCIV), 138.0 (CIV), 128.6 (CHar), 
127.4 (CIV), 126.8 (CHar), 125.9 (CHar), 125.8 (CHar), 124.8 (CHar), 124.4 (CHar), 124.2 (CHar), 122.1 (CHar), 121.3 
(CHar), 84.2 (C
IV), 82.6 (CIV), 62.5 (CH2), 56.1 (CH), 46.9 (CH), 45.5 (CH), 44.6 (CH), 28.2 (CH3), 27.6 (CH3), 25.2 
(CH3N). 
MS (ESI) [m/z]: 710.0 [M+Na]+, 726.0 [M+K]+. 
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HRMS (ESI) [m/z]: calculated for C33H37N3NaO7S2 [M+Na]
+: 710.1965, found: 710.1964. 
IR (neat, ATR) ν [cm-1]: 3472 (OH), 3060, 2978 (CH, sp3), 2927, 1699 (C=O), 1342, 1278, 1159, 750. 
 
9-(1-benzothiophen-2-yl)-4,10-dimethyl-14-thia-4,8,11-triazapentacyclo[11.7.0.0
2,6
.0
7,12
.0
15,20
]icosa-
7(12),8,10,15,17,19-hexaene-3,5-dione (97) 
 
 
Yellow solid 
Rf = 0.21 (PE/EtOAc: 7/3) CAN relevator 
 
Procedure: 
 
A solution of the alcohol 96 (40 mg, 0.058 mmol, 1.00 equiv.) was prepared in distilled CH2Cl2 (5 mL) under 
argon and cooled down to 0 °C. Then, TMSI (0.04 mL, 0.279 mmol, 4.80 equiv.) was introduced and reaction 
was stirred for 30 minutes at 0 °C. The reaction was slowly hydrolyzed with a saturated solution of NaHCO3, 
warmed up and extracted with CH2Cl2 (3x10 mL). All organic phases were collected, washed with distilled water 
and brine, dried over anhydrous MgSO4, filtered and concentrated. Residues were purified by column 
chromatography to yield 24 mg (88% yield) of product 97 as a yellow solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.22 (d, J = 8.0 Hz, 1H), 7.69 (m, 3H), 7.50 (s, 1H), 7.36 (m, 4H),5.17 (d, J = 
5.5 Hz, 1H), 4.65 (dd, J = 5.5 Hz, 2.0 Hz, 1H), 4.53 (dd , J = 8.2, 1.5, 1H), 4.23 (dd, J = 8.2 and 2.9, 1H), 3.02 (s, 
3H), 2.56 (s, 3H). 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 176.5 (C=O), 175.1 (C=O), 159.1 (C
IV), 156.4 (CIV), 140.8 (CIV), 140.3 (CIV), 
139.5 (CIV), 139.1 (CIV), 137.2 (CIV), 134.7 (CIV), 126.5 (CHar), 126.2 (CHar), 124.8 (2xCHar), 124.7 (CHar), 124.6 
(CHar), 124.5 (CHar), 123.4 (CHar), 122.2 (CHar), 53.3 (CH), 50.2 (CH), 45.1 (CH), 40.1 (CH), 25.3 (CH3), 25.2 (CH3). 
MS (ESI) [m/z]: 470.5 [M+H]+, 486.5 [M+NH4]
+, 502.0 [M+Na]+. 
IR (neat, ATR) ν [cm-1]: 3033 (CH, sp2), 2922 (CH, sp3), 2867, 1700 (C=O), 1465, 1307, 945, 822, 749, 726. 
 
Di-tert-butyl 2,5-di(benzo[b]thiophen-2-yl)-3-((3-hydroxypropylamino)methyl)pyrazine-1,4-dicarboxylate 
(98) 
 
Yellow oil 
Rf = 0.45 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
The solution of aldehyde 76 (50 mg, 0.09 mmol) was prepared in MeOH (2 mL). 3-aminopropanol (20 µL, 0.26 
mmol, 3.00 equiv.), Et3N (12 µL, 0.09 mmol, 1.00 equiv.) and Ti(iPrO)4 (10 mg, 0.03 mmol, 0.4 equiv.) were 
introduced with few molecular sieves (4Å). The mixture was stirred for 60 hours at room temperature (the 
progress of reaction followed by TLC PE:EtOAc 4: 6). MeOH was evaporated and the mixture was diluted in 
CH2Cl2, washed with a saturated solution of NaHCO3 and distilled water. The organic phase was dried over 
MgSO4, filtered and concentrated to give a red-orange oil (characterized by NMR as an imine), which was 
directly used to the reduction step. The crude (46 mg, 0.07 mmol) was dissolved in MeOH (5 mL) and NaBH4 (4 
mg, 0.10 mmol, 1.00 equiv.) with H3BO3 (6 mg, 0.10 mmol, 1.00 equiv.) were introduced. A reaction mixture 
was stirred vigirously overnight, then quenched with distilled water and extracted with CH2Cl2, dried over 
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MgSO4, filtered and evaporated. The crude was purified by column chromatography (PE/EtOAc: 5/5) to yield 
16.7 mg (30% yield) of product 98 as a yellow oil. 
 
Analyses:  
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.80-7.70 (m, 4H), 7.41-7.29 (m, 6H), 7.24 (s, 1H), 4.06 (s br, 1H), 3.75 (s, 
1H), 3.68 (m, 2H), 2.88 (m, 3H), 2.41 (s, 1H), 1.51 (s, 2H), 1.32 (s, 9H), 1.17 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 152.3 (C=O), 140.1 (C
IV), 139.9 (CIV), 139.3 (CIV), 138.7 (CIV), 136.0 (CIV), 
132.2 (CIV), 129.3 (CIV), 126.4 (CHar), 125.3 (CHar), 124.9 (CHar), 124.8 (CHar), 124.8 (CHar), 124.2 (CHar), 123.6 
(CHar), 122.4 (CHar), 122.4 (C
IV), 120.4 (CHar), 83.4 (C
IV), 83.1 (CIV), 64.4 (CH2), 48.4 (CH2), 47.6 (CH2), 30.7 (CH2), 
28.1 (3xCH3), 27.9 (3xCH3). 
MS (ESI) [m/z]: [M+H]+: 634.5, [M-tBu]+: 578.5. 
 
Di-tert-butyl 3-((2-aminobenzylamino)methyl)-2,5-di(benzo[b]thiophen-2-yl)pyrazine-1,4-dicarboxylate (99) 
 
Orange oil 
Rf = 0.36 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
The solution of aldehyde 76 (25 mg, 0.05 mmol) was prepared in MeOH (2 mL). 2-(aminomethyl)aniline (5 mg, 
0.05 mmol, 1.00 equiv.) was introduced with one drop of acetic acid. The mixture was stirred for 2 hours at 
room temperature (the progress of reaction followed by TLC PE/EtOAc: 8/2). After whole consumption of 
starting materials, NaBH(OAc)3 (13 mg, 0.62 mmol, 1.4 equiv.) was added and mixture was stirred for 18 h at 
room temperature. A reaction was quenched with distilled water and residues were extracted with EtOAc, 
washed three times with distilled water, dried over MgSO4, filtered and evaporated. The crude was purified by 
column chromatography (PE/EtOAc: 8/2) to yield 27 mg (93% yield) of product 99 as an orange oil. 
 
Analyses:  
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.98-7.80 (m, 4H), 7.63 (s, 2H), 7.51-7.35 (m, 6H), 6.98 (s, 1H), 6.69-6.65 (m, 
2H), 5.27 (s, 2H), 3.76 (s, 2H), 3.22 (m, 2H), 2.41 (s, 1H), 1.38 (s, 9H), 1.15 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 148.2 (2xC=O), 146.9 (2xC
IV), 140.3 (CIV), 140.2 (CIV), 138.9 (CIV), 138.7 (CIV), 
137.4 (CIV), 134.0 (CIV), 129.5 (2xCHar), 127.6 (2xCHar), 124.6 (2xCHar), 124.3 (2xCHar), 122.3 (CHar), 121.9 (CHar), 
118.8 (CHar), 116.2 (CHar), 116.1 (C
IV), 110.4 (2xCHar), 83.4 (C
IV), 83.2 (CIV), 51.9 (CH2), 46.4 (CH2), 28.1 (3xCH3), 
27.9 (3xCH3). 
MS (ESI) [m/z]: [M+H]+: 682.5, [M+Na]+: 704.5. 
 
(E)-4-((4-bromophenyl)diazenyl)aniline (101) 
 
Yellow orange powder 
Rf = 0.3 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
A solution of NaNO2 (400 mg, 5.81 mmol, 1.00 equiv.) was prepared in an ice-water mixture and 4-
bromoaniline (1.00 g, 5.81 mmol, 1.00 equiv.) was then suspended in this solution. The content of flask was 
poured into concentrated HCl (2.3 mL) cooled in the ice-water bath. The solution was vigorously stirred for 30 
min at 0°C. The solution of diazonium salt was dripped in a suspension of aniline (0.56 mL, 6.10 mmol, 1.05 
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equiv.) in 100 mL of acetic buffer (1.2 M, pH = 6) at 0°C. A red-orange precipitate appeared. The reaction was 
carried out for 1h. The red-orange precipitate was filtered through Milipore, rinsed with distilled water and 
dried under vacuum. The residue was purified by flash column chromatography (PE/EtOAc: 9/1 + 0.5% TEA) to 
provide 1.49 g (93% yield) of 101 as a yellow-orange powder. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.80 (d, J = 8.7 Hz, 2H), 7.72 (d, J = 8.7 Hz, 2H), 7.60 (d, J = 8.7 Hz, 2H), 6.73 
(d, J = 8.8 Hz, 2H), 4.13 (s, 2H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 151.7 (C
IV), 149.9 (CIV), 145.4 (CIV), 132.1 (CHar), 132.0 (C
IV), 125.3 (CHar), 
123.8 (CHar), 114.6 (CHar). 
MS (ESI) [m/z]: 278.0 [MH]+, 280. 0 (isotope 81Br). 
IR (neat, ATR) ν [cm-1]: 3449 (NH2), 3367 (NH2), 3211, 2951 (CH, sp
3), 2917, 2854, 1614, 1595, 1502. 
Mp = 160°C. 
 
(E)-4-((4-bromophenyl)diazenyl)-2,5-dimethoxyaniline (102) 
 
 
Red solid 
Rf = 0.43 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
A solution of NaNO2 (400 mg, 5.81 mmol, 1.00 equiv.) was prepared in an ice-water mixture and 4-
bromoaniline (1.00 g, 5.81 mmol, 1.00 equiv.) was then suspended in this solution. The content of flask was 
poured into concentrated HCl (2.3 mL) cooled in the ice-water bath. The solution was vigorously stirred for 30 
min at 0°C. The solution of diazonium salt was dripped in the suspension of 2,5-dimethoxyaniline (934.4 mg, 
6.10 mmol, 1.05 equiv.) in 100 mL of acetic buffer (1.2 M, pH = 6) at 0°C. A red-brown precipitate appeared. 
The reaction was carried out for 2h. The red-orange precipitate was filtered through Milipore, rinsed with 
distilled water and dried under vacuum. The residue was purified by flash column chromatography (PE/EtOAc 
+0.5% TEA: 7/36/45/5) to provide 1.10 g (57% yield) of 102 as a red solid. 
 
Analyses: 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.70 (d, J = 8.8 Hz, 2H), 7.56 (d, J =8.8 Hz, 2H), 7. 36 (s, 1H, ar), 6.35 (s, 1H, 
ar), 4.37 (s, 1H), 3.94 (s, 3H, CH3O), 3.89 (s, 3H, CH3O). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 154.8 (C
IV), 152.3 (CIV), 142.5 (CIV), 141.8 (CIV), 133.9 (CHar), 127.5 (CHar), 
124.7 (CHar), 123.0 (CHar), 98.2 (CHar), 98.1 (CHar), 56.9 (CH3), 55.8 (CH3). 
MS (ESI) [m/z]: 336.0 [MH]+, 338. 0 (isotope 81Br). 
IR (neat, ATR) ν [cm-1]: 3479 (NH2), 3369 (NH2), 2924 (CH, sp
3), 1604, 1505, 1290. 
Mp = 125°C. 
 
(E)-4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyaniline (103) 
 
 
Red needles 
Rf = 0.23 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
A solution of NaNO2 (135 mg, 1.96 mmol, 1 equiv.) was prepared in an ice-water mixture and 4-chloroaniline 
(250 mg, 1.96 mmol, 1 equiv.) was suspended in this solution. The content of flask was poured into 
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concentrated HCl (1 mL) cooled in the ice-water bath. The solution was vigorously stirred for 30 min at 0°C. The 
solution of diazonium salt was dripped in the suspension of 2,5-dimethoxyaniline (300  mg, 1.96 mmol, 1.05 
equiv.) in 30 mL of acetic buffer (1.2 M, pH = 6) at 0°C. A red precipitate appeared. The reaction was carried out 
for 1h. The red-orange precipitate was filtered through Milipore, rinsed with distilled water and dried under 
vacuum. The residue was purified by flash column chromatography (PE/EtOAc: 8/26/4) to provide 150 mg 
(26% yield) of 103 as a red solid. 
 
Analyses:  
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.77 (d, J = 8.8 Hz, 2H), 7.40 (d, J = 8.84 Hz, 2H), 7.36 (s, 1H, ar), 6.34 (s, 1H, 
ar), 4.38 (s, 1H), 3.93 (s, 3H, CH3O), 3.86 (s, 3H, CH3O). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 154.9 (C
IV), 152.1 (CIV), 142.7 (CIV), 141.0 (CIV), 134.9 (CIV), 133.7 (CIV), 129.3 
(2xCHar), 123.7 (2xCHar), 98.4 (CHar), 98.2 (CHar), 57.1 (CH3), 56.0 (CH3). 
MS (ESI) [m/z]: 292.0 [MH]+, 294.0 (isotope 37Cl). 
IR (neat, ATR) ν [cm-1]: 3477 (NH2), 3354 (NH2), 2966 (CH, sp
3), 16171, 1509, 1301. 
Mp = 124°C. 
 
(E)-2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)aniline (104) 
 
 
Red-orange needles 
Rf = 0.81 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
A solution of p-anisidine (163 mg, 1.24 mmol, 1 equiv.) in 1 mL of concentrated HCl was prepared at 0°C and 
then the solution of NaNO2 (86 mg, 1.24 mmol, 1 equiv.) in iced water was introduced. The solution was 
vigorously stirred for 30 min at 0°C. The solution of diazonium salt was dripped in the suspension of 2,5-
dimethoxyaniline (200 mg, 1.31 mmol, 1.05 equiv.) in 20 mL of acetic buffer (1.2 M, pH = 6) at 0°C. A violet 
precipitate appeared. The reaction was carried out for 2h, then pH was adjusted to 8.5-9.0 by addition of 5% 
sodium hydroxide. The precipitate was filtered through Buchner funnel, rinsed with distilled water and dried 
under vacuum. The residue was purified by flash column chromatography (PE/EtOAc: 7/3) to provide 300 mg 
(84% yield) of 104 as a red-orange solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 7.83 (d, J = 8.0 Hz, 2H), 7.36 (s, 1H, ar), 6.96 (d, 2H, J = 8.0 Hz), 6.36 (s, 1H, 
ar), 4.26 (s, 1H), 3.93 (s, 3H, CH3O), 3.86 (s, 3H, CH3O), 3.84 (s, 3H, CH3O). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 160.9 (C
IV), 154.0 (CIV), 148.0 (CIV), 142.1 (CIV), 141.4 (CIV), 133.9 (CIV), 124.2 
(2xCHar), 114.2 (2xCHar), 98.0 (CHar), 98.5 (CHar), 57.3 (CH3), 56.0 (CH3), 56.7 (CH3). 
MS (ESI) [m/z]: 288.0 [MH]+. 
IR (neat, ATR) ν [cm-1]: 3431 (NH2), 3344 (NH2), 3222, 3004, 2924 (CH, sp
3), 2836, 1633, 1578, 1301, 1035. 
Mp = 164°C. 
 
(E)-4-((2-(aminomethyl)phenyl)diazenyl)-2,5-dimethoxyaniline (105) 
 
 
Dark red powder 
Rf = 0.11 (PE/EtOAc: 8/2) revelator CAN 
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Procedure: 
 
A solution of NaNO2 (565 mg, 8.19 mmol, 1 equiv.) was prepared in an ice-water mixture and 2-
aminobenzylamine (1.00 g, 8.19 mmol, 1 equiv.) was suspended in this solution. The content of flask was 
poured into concentrated HCl (2.3 mL) cooled in an iced water bath. The solution was vigorously stirred for 30 
min at 0°C. The solution of diazonium salt was dripped in the suspension of 2,5-dimethoxyaniline (1.30 g, 8.45 
mmol, 1.05 equiv.) in 100 mL of acetic buffer (1.2 M, pH = 6) at 0°C. A red precipitate appeared. The reaction 
was carried out for 1h and the reaction mixture was neutralized with a 5N solution of potassium hydroxide. The 
precipitate was filtered through Milipore, rinsed with distilled water and dried under vacuum. The residue was 
purified by flash column chromatography (PE/EtOAC + 0.5% TEA: 6/4 ) to provide 1.90 g (81% yield) of 105 as a 
dark red solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.85 (dd, J = 1.4 and 7.9 Hz, 1H), 7.39 (m, 2H, ar), 7.33 (s, 1H, ar), 7.30 (m, 
1H, ar), 6.35 (s, 1H, ar), 4.64 (s, 2H), 4.48 (s, 2H, NH2), 3.92 (s, 3H), 3.88 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 155.0 (C
IV), 153.1 (CIV), 143.2 (CHar), 142.1 (C
IV), 134.2 (CIV), 133.4 (CIV), 
131.1 (CHar), 129.1 (CHar), 128.8 (CHar), 125.3 (CHar), 98.5 (CHar), 97.9 (CHar), 64.3 (CH2), 56.7 (CH3), 56.2 (CH3). 
MS (ESI) [m/z]: 288.0 [MH]+. 
IR (neat, ATR) ν [cm-1]: 3470 (NH2), 3330 (NH2), 3207 (NH2), 2939 (CH, sp
3), 2842, 1634, 1512, 1303. 
Mp = 148°C. 
 
 
(E)-4-((2-(aminomethyl)phenyl)diazenyl)-2,5-dimethoxyaniline (106)
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White solid 
Rf = 0.61 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
A solution of p-nitrophenol (1.40 g, 10.00 mmol, 1 equiv.) was prepared in DMF (20 mL, c = 0.5 M) and K2CO3 
(4.20 g, 30.00 mmol, 3 equiv.) was added and the mixture was heated at 60 °C for 30 min. The reaction was 
cooled to room temperature and propargyl bromide (1.34 mL, 12.00 mmol, 1.2 equiv.) was slowly introduced. 
The content of flask was stirred at room temperature for 60 hours. Solid residues were filtered and the filtrate 
was reduced under vacuo to recover white solid, which was directly used for a next step. Residues were 
dissolved in dioxane (30 mL) at 10 °C and the solution of SnCl2 (11.00 g, 50.00 mmol; 5 equiv.) in concentrated 
HCl (5 mL) was dripped to the solution for 30 minuntes. The reaction was carried out for 30 hours. Distilled 
water was added and the solution was extracted with CH2Cl2 four times, organic phases were collected and 
dried over MgSO4. The residue was purified by flash column chromatography (PE/EtOAC: 4/6 ) to provide 0.97 g 
(66% yield) of 106 as a white solid. 
 
Analyses: 
 
1
H NMR (250 MHz, Acetone) δ [ppm]: 7.46 (d, J = 8.0 Hz, 1H), 7.23 (m, 1H, ar), 7.15 (m, 2H, ar), 4.86 (t, J = 2.5 
Hz, 2H), 3.15 (qt, J = 2.5 Hz, 1H). 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 158.6 (C
IV), 157.9 (CIV), 127.4 (CHar), 127.0 (CHa), 116.7 (CHa), 116.3 (CHa), 
79.5 (CIVr), 77.6 (CH), 56.8 (CH2). 
MS (ESI) [m/z]: 148.0 [M+H]+. 
IR (neat, ATR) ν [cm-1]: 3251 (NH2), 2864 (CH, sp
3), 2133 (C≡C), 1509, 1246, 1025. 
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(E)-4-((4-nitrophenyl)diazenyl)phenol (107) 
 
 
Red-orange solid 
Rf = 0.64 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
A solution of p-nitroaniline (690 mg, 5.00 mmol, 1.00 equiv.) in 2 mL of concentrated HCl was prepared at 0°C 
and then the solution of NaNO2 (345 mg, 5.00 mmol, 1.00 equiv.) in iced water was introduced. The solution 
was vigorously stirred for 30 min at 0°C. The solution of phenol (492 mg, 5.25 mmol, 1.05 equiv.) was prepared 
in 3.75 mL of solution of NaOH (1.4 M) and added to the 170 mL of buffer NH4
+/NH3. The solution of diazonium 
salt was dripped in this solution at 0°C and reaction was carried out for 2h. An orange precipitate appeared. 
The precipitate was filtered through Büchner funnel, rinsed with distilled water and dried under vacuum. The 
residue was purified by flash column chromatography (PE/EtOAc: 7/3) to provide 692 mg (57% yield) of 107 as 
a red-orange solid. 
 
Analyses: 
 
1
H NMR (400 MHz, MeOD) δ [ppm]: 8.34 (d, J = 8.7 Hz, 2H), 7.95 (d, J = 8.7 Hz, 2H), 7.86 (d, J = 8.7 Hz, 2H), 6.93 
(d, J = 8.7 Hz, 2H. 
13
C NMR (101 MHz, MeOD) δ [ppm]: 162.2 (CIV), 156.1 (CIV), 148.1 (CIV), 146.1 (CIV), 125.5 (2xCHar), 124.3 
(2xCHar), 122.6 (2xCHar), 115.6 (2xCHar). 
MS (ESI) [m/z]: 244.0 [MH]+. 
Mp = 204°C. 
 
(E)-1-(4-nitrophenyl)-2-(4-(prop-2-ynyloxy)phenyl)diazene (108) 
 
 
 
Red-orange solid 
Rf = 0.64 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
The solution of 107 (200 mg, 0.82 mg, 1.0 equiv.) in 2 mL of ethanol was prepared, then NaOH (33 mg, 0.82 
mmol, 1.0 equiv.) was added and reaction was stirred for 1 h at rt. Propargyl bromide (0.13 mL, 1.23 mmol, 1.5 
equiv.) was added dropwise and a solution was left for 18 h at reflux. After cooling down to room temperature, 
a product was extracted with diethyl ether and washed three times with distilled water and once with brine. 
The organic phase was dried over anhydrous MgSO4, filtered and concentrated under vacuo. The crude product 
was crystallized from EtOH to yield 185 mg of 108 (81 % yield) as red-orange solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.39 (d, J = 8.9 Hz, 2H), 8.00 (d, J = 8.8 Hz, 4H), 7.15 (d, J = 9.0 Hz, 2H), 4.80 
(s, 2H), 2.58 (s, 1H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 210.2 (C
IV), 148.5 (CIV), 127.7 (CIV), 125.7 (2xCHar), 124.9 (2xCHar), 123.4 
(2xCHar), 115.6 (2xCHar), 115.5 (C
IV), 80.7 (CC), 76.4 (CH), 56.3 (CH2). 
MS (ESI) [m/z]: 282.0 [M+H]+, 304.0 [M+Na]+, 320.0 [M+K]+. 
IR (neat, ATR) ν [cm-1]: 3265 (C≡CH), 2927 (CH, sp3), 2129 (C≡C), 1580, 1512, 1335, 1016. 
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(E)-4-((4-(prop-2-ynyloxy)phenyl)diazenyl)aniline (109) 
 
 
Orange needles 
Rf = 0.33 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The starting amine 106 (57 mg, 0.39 mmol, 1 equiv.) was dissolved in HCl concentrated (1mL) and the solution 
was placed in an ice-water bath, then a cooled solution of NaNO2 (27 mg, 0.39 mmol, 1 equiv.) was added by 
syringe. The solution was vigorous stirred for 30 min at 0°C. In the same time, a suspension of 2,5-
dimethoxyaniline (63 mg, 0.41 mmol, 1.05 equiv.) was prepared in 20 mL of acetic buffer (pH=6) and 
transferred to an ice-water bath (0-5°C). The solution of diazonium salt was added dropwise to this suspension 
and the colour of the mixture changed to deep dark red. The reaction was carried out for 1h, then residues 
were precipitated in basic conditions (addition dropwise of a 5% solution of sodium hydroxide). A red-orange 
precipitate was filtered through paper filter and then taken up into solution in acetone. The residue was 
purified by the flash column chromatography (PE/EtOAc: 6/4) to provide 56 mg (46% yield) of 109 as a red 
solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.82 (d, J = 9.0 Hz, 2H), 7.38 (s, 1H), 7.03(d, J = 9.0 Hz, 2H), 6.39 (s, 1H), 4.74 
(d, J = 2.25 Hz, 2H), 4.29 (s, 2H, NH2), 3.96 (s, 3H), 3.89 (s, 3H), 2.53 (t, J = 2.5 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 158.76 (C
IV), 154.17 (CIV), 148.57 (CHar), 142.05 (C
IV), 141.60 (CIV), 133.92 
(CHar), 124.11 (CHar), 115.24 (CHar), 98.90 (CHar), 98.48 (CHar), 78.51 (C
IV), 75.95 (CH), 57.27 (CH3), 56.22 (CH2), 
56.06(CH3). 
MS (ESI) [m/z]: 312.0 (MH+.). 
IR (neat, ATR) ν [cm-1]: 3453, 3338, 3285 (NH2), 2920 (CH2 sp
3), 2128 (C≡C), 1623 (C=O), 1508, 1299, 1018. 
Mp = 163°C. 
 
(E)-di-tert-butyl-3-((2-((4-amino-2,5-dimethoxyphenyl)diazenyl)benzylamino)methyl)-2,5-
di(benzo[b]thiophen-2-yl)pyrazine-1,4-dicarboxylate (110) 
 
Yellow oil 
Rf = 0.20 (PE/EtOAc: 8/2) revelator CAN 
 
Procedure: 
 
The solution of aldehyde 76 (50 mg, 0.09 mmol) was prepared in MeOH (5 mL) and amine 105 (30 mg, 0.10 
mmol, 1.20 equiv.) was introduced, followed by AcOH (4 µL, 0.09 mmol, 1.00 equiv.). The mixture was stirred 
for 1 hour at room temperature and NaBH3CN (7 mg, 0.10 mmol, 1.20 equiv.) was added. The reaction was 
continued for 48 h. The mixture was diluted with CH2Cl2, washed with distilled water twice and with brine. An 
organic phase was dried over MgSO4, filtered and concentrated. The crude was purified by column 
chromatography (PE/EtOAc: 7/3 to 6/4) to yield 41 mg (54% yield) of product 110 as a yellow oil. 
 
Analyses:  
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1
H NMR (250 MHz, CDCl3) δ [ppm]: 7.84-7.82 (m, 2H), 7.74-7.59 (m, 2H), 7.40-7.25 (m, 8H), 7.16-7.15 (m, 2H), 
7.02 (s, 1H), 6.51 (s, 1H), 5.82 (s, 1H), 5.66 (m br, 1H), 4.73 (m br, 1H), 4.48-4.38 (m, 3 H), 3.92 (s, 3H), 3.64 (s, 
1H), 1.25 (s, 18H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 155.6 (C=O), 152.08 (C
IV), 141.7 (CIV), 139.4 (CIV), 139.1 (CIV), 138.5 (CIV), 
132.0 (CIV), 131.2 (CIV), 130.5 (CIV), 128.3 (CHar), 125.4 (CHar), 124.9 (CHar), 124.6 (CHar), 124.3 (CHar), 123.1 
(CHar), 122.3 (CHar), 121.9 (CHar), 97.0 (CHar), 83.2 (C
IV), 82.8 (CIV), 63.9 (CH2), 56.5 (CH2), 55.8 (CH2), 29.7 (CH2), 
27.8 (3xCH3), 27.7 (3xCH3). 
MS (ESI) [m/z]: [M+H]+ 846.5, [M+H-tBu]+: 790.0, [M+H-2tBu]+: 734.0. 
 
(E)-2-bromo-N-(4-((4-bromophenyl)diazenyl)-2,5-dimethoxyphenyl)acetamide (111) 
 
 
Dark orange solid 
Rf = 0.59 (PE/EtOAc: 6/4) 
 
Procedure: 
 
The starting amine 102 (200 mg, 0.60 mmol, 1.00 equiv.) was dissolved in dry THF (20 mL) and the solution was 
placed in an ice-water bath, then the pyridine (60 µL, 0.74 mmol, 1.25 equiv.) was introduced. The solution of 
bromoacetic bromide (52 µL, 0.60 mmol, 1.00 equiv.) in dry THF (3 mL) was prepared and introduced to the 
first solution by syringe. The reaction was vigorous stirred for 30 min at 0°C. After TLC control, reaction was 
hydrolyzed with distilled water. The residue was extracted with ethyl acetate, washed twice with distilled water 
and dried over magnesium sulfate. After filtration, the residue was concentrated and purified by flash column 
chromatography (PE/EtOAc: 6/4) to provide 258 mg (95% yield) of 111 as a dark orange solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.98 (s, 1H, NH), 8.33 (s, 1H, ar), 7.79 (d, J = 8.5 Hz, 2H), 7.63 (d, J = 8.5 Hz, 
2H), 7.38 (s, 1H, ar), 4.06 (s, 2H), 4.03 (s, 3H, CH3O), 3.95 (s, 3H, CH3O). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 163.8 (C=O), 153.3 (C
IV), 152.0 (CIV), 142.9 (CIV), 137.3 (CIV), 132.4 (CHar), 
131.7 (CIV), 124.9 (CIV), 124.5 (CHar), 104.4 (CHar), 98.1 (CHar), 57.2 (CH3), 56.5 (CH3), 29.8 (CH2). 
MS (ESI) [m/z]: 458.0 [MH]+, 480.0 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3391 (NH2), 3354 (NH2), 2970, 1690, 1523, 1477, 830. 
Mp = 176°C. 
 
(E)-2-bromo-N-(4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyphenyl)acetamide (112) 
 
 
Dark orange solid 
Rf = 0.78 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The starting amine 103 (100 mg, 0.34 mmol, 1.00 equiv.) was dissolved in dry THF (10 mL) and the solution was 
placed in an ice-water bath, then the pyridine (35 µL, 0.43 mmol, 1.25 equiv.) was introduced. The solution of 
bromoacetic bromide (30 µL, 0.34 mmol, 1.00 equiv.) in dry THF (2 mL) was prepared and introduced to the 
first solution by syringe. The reaction was vigorous stirred for 30 min at 0°C. After TLC control, reaction was 
hydrolyzed with distilled water. The residue was extracted with ethyl acetate, washed twice with distilled water 
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and dried over magnesium sulfate. After filtration, the residue was concentrated and purified by flash column 
chromatography (PE/EtOAc: 6/4) to provide 133 mg (94% yield) of 112 as a dark orange solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.96 (s, 1H, NH), 8.33 (s, 1H, ar), 7.84 (d, J = 8.7 Hz, 2H), 7.46 (d, J = 9.43 Hz, 
2H), 7.37 (s, 1H, ar), 4.04 (s, 2H), 4.01 (s, 3H, CH3O), 3.93 (s, 3H, CH3O). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 163.8 (C=O), 153.3 (C
IV), 151.7 (CIV), 142.9 (CIV), 137.3 (CIV), 136.5 (CIV), 131.7 
(CIV), 129.5 (CHar), 124.3 (CHar), 104.6 (CHar), 98.1 (CHar), 57.2 (CH3), 56.5 (CH3), 29.8 (CH2). 
MS (ESI) [m/z]: 414.0 [MH]+, 436.0 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3371 (NHCO), 2942 (CH sp2), 1691 (amide), 1595, 1468, 1035. 
Mp = 170°C. 
 
(E)-2-bromo-N-(2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)phenyl)acetamide (113) 
 
 
 
Red solid 
Rf. = 0.82 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The starting amine 104 (150 mg, 0.52 mmol, 1.00 equiv.) was dissolved in dry THF (20 mL) and the solution was 
placed in an ice-water bath, then the pyridine (50 µL, 0.65 mmol, 1.25 equiv.) was introduced. The solution of 
bromoacetic bromide (45 µL, 0.52 mmol, 1.00 equiv.) in dry THF (3 mL) was prepared and introduced to the 
first solution by canulla. The reaction was vigorous stirred for 60 minutes at 0°C. After TLC control, reaction was 
hydrolyzed with distilled water. The residue was extracted with ethyl acetate, washed twice with distilled water 
and dried over magnesium sulfate. After filtration, the residue was concentrated and purified by flash column 
chromatography (PE/EtOAc: 7/3) to provide 207 mg (97% yield) of 113 as a red solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.97 (s, 1H, NH), 8.32 (s, 1H, ar), 7.93 (d, J = 7.0 Hz, 2H), 7.39 (s, 1H, ar), 7.02 
(d, J = 7.0 Hz, 2H), 4.07 (s, 2H), 4.04 (s, 3H, CH3O), 3.96 (s, 3H, CH3O), 3.89 (s, 3H, CH3O). 
13
C NMR (63 MHz, CDCl3) δ [ppm]: 163.8 (C=O), 161.9 (C
IV), 152.3 (CIV), 147.6 (CIV), 142.9 (CIV), 137.7 (CIV), 130.5 
(CIV), 124.9 (2xCHar), 114.3 (2xCHar), 104.6 (CHar), 98.3 (CHar), 57.2 (CH3), 56.5 (CH3), 55.7 (CH3), 29.8 (CH2). 
MS (ESI) [m/z]: 408.0 [MH]+, 430.0 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3371 (NHCO), 2942 (CH sp2), 1691 (amide I), 1595, 1468, 1035. 
Mp = 152°C. 
 
(E)-2-bromo-N-(2,5-dimethoxy-4-((4-(prop-2-ynyloxy)phenyl)diazenyl)phenyl)acetamide (114) 
 
 
Dark orange powder 
Rf. = 0.83 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
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The starting amine 109 (30 mg, 0.10 mmol, 1.00 equiv.) was dissolved in dry THF (3 mL) and the solution was 
placed in an ice-water bath, then the pyridine (11 µL, 0.14 mmol, 1.45 equiv.) was introduced. The solution of 
bromoacetic bromide (10 µL, 0.11 mmol, 1.45 equiv.) in dry THF (1 mL) was prepared and introduced to the 
first solution by syringe. The reaction was vigorous stirred for 30 min at 0°C. After TLC control, reaction was 
hydrolyzed with distilled water. The residue was extracted with ethyl acetate, washed twice with distilled water 
and dried over magnesium sulfate. After filtration, the residue was concentrated and purified by flash column 
chromatography (PE/EtOAc: 4/6) to provide 33 mg (81% yield) of 114 as a dark orange solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.94 (s, 1H, NH), 8.31 (s, 1H), 7.89 (d, J = 9.1 Hz, 2H), 7.37 (s, 1H), 7.05 (d, J = 
9.1 Hz, 2H), 4.75 (d, J = 2.4 Hz, 2H), 4.05 (s, 2H, CH2), 4.02 (s, 3H), 3.94 (s, 3H), 2.56 (t, J = 2.4 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 163.70 (C
IV, C=O), 159.68 (CIV), 152.53 (CIV), 148.16 (CHar), 142.86 (C
IV), 
137.58 (CIV), 130.69 (CIV), 124.77 (CHar), 115.29 (CHar), 104.54 (CHar), 98.26 (CHar), 78.27 (C
IV), 76.13 (CH), 57.19 
(CH3), 56.49 (CH3), 56.19 (CH2), 29.80 (CH2). 
MS (ESI) [m/z]: 431.0[M]+. 
IR (neat, ATR) ν [cm-1]: 3369 (NHCO), 3237, 2924 (CH2 sp
3), 2125 (C≡C), 1689 (C=O), 1596, 1480, 1204, 1030, 
833. 
Mp = 140°C. 
 
 
(E)-tert-butyl 2,2',2''-(10-(2-(4-((4-bromophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (115) 
 
 
Red orange powder 
Rf. = 0.0 (PE/EtOAc: 6/4) revelator CAN 
 
Procedure: 
 
The solution of DO3A 53 (56 mg, 0.11 mmol, 1.00 equiv.) in anhydrous THF (5 mL) with Na2CO3 (34 mg, 0.33 
mmol, 3.00 equiv.) was stirred for 30 min. at room temperature. Then, the solution of bromo derivative XX (50 
mg, 0.11 mmol, 1.00 equiv.) in anhydrous THF (2 mL) was added dropwise and the reaction was refluxed for 8h 
and cooled down to room temperature. The residue was filtered through fritting glass, washed with 
dichloromethane and methanol. The filtrate was concentrated and purified by column chromatography 
(CH2Cl2/MeOH: 95/5) to provide 95 mg (98% yield) of 115 as a red solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.63 (s, 1H, NH), 8.10 (s, 1H, ar), 7.75 (d, J = 11 Hz, 2H), 7.60 (d, J = 11 Hz, 
2H), 7.35 (s, 1H, ar), 3.92 (s, 3H), 3.89 (s, 3H, CH3O), 3.69 (m, 2H), 3.10 (m, 8H), 2.27 (m br, 16 H), 1.47 (s, 12H), 
1.40 (s, 16H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 172.9 (C=O), 171.6 (C
IV), 153.1 (CIV), 152.0 (CIV), 144.0 (CIV), 137.6 (CIV), 
136.5 (CIV), 132.3 (CIV), 132.3 (CHar), 124.7 (C
IV), 124.4 (CHar), 107.0 (CHar), 97.9 (CHar), 82.0 (C
IV), 57.6 (CH3), 56.3 
(CH3), 56.2 (CH2), 55.6 (CH2), 28.0 (CH3). 
MS (ESI) [m/z]: 892.5 [MH]+, 912.5 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3350 (NHCO), 2973 (CH sp2), 2821, 1724 (amide), 1525, 1261, 1223. 
Mp = 146°C. 
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(E)-tert-butyl 2,2',2''-(10-(2-(4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (116) 
 
 
Red orange powder 
Rf. = 0.42 (CH2Cl2/MeOH: 95/5) revelator CAN 
 
Procedure: 
 
The solution of DO3A 53 (63 mg, 0.12 mmol, 1.00 equiv.) in anhydrous THF (5 mL) with Na2CO3 (38 mg, 0.36 
mmol, 3.00 equiv.) was stirred for 30 min. at room temperature. Then, the solution of bromo derivative XX (50 
mg, 0.12 mmol, 1.00 equiv.) in anhydrous THF (2 mL) was added dropwise. The reaction was refluxed for 18h 
and then cooled down to room temperature. Residues were filtered through fritting glass, washed with 
dichloromethane and methanol. Filtrate was concentrated and purified by column chromatography 
(CH2Cl2/MeOH: 95/5) to provide 95 mg (98% yield) of 116 as a red solid. 
 
Analyses: 
 
1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.60 (s, 1H, NH), 8.10 (s, 1H, ar), 7.82 (d, J = 6.8 Hz, 2H), 7.46 (d, J = 6.8 Hz, 
2H), 7.35 (s, 1H, ar), 3.93 (s, 3H), 3.87 (s, 3H, CH3O), 3.65 (m, 2H), 3.03 (m, 4H), 2.36 (m br, 16 H), 2.06 (s br, 2H) 
1.47 (s, 9H), 1.40 (s, 18H). 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 172.9 (C=O), 171.6 (C
IV), 153.1 (CIV), 151.6 (CIV), 144.0 (CIV), 137.5 (CIV), 136.2 
(CIV), 133.0 (CIV), 129.4 (CHar), 124.2 (CHar), 106.9 (CHar), 97.9 (CHar), 82.0 (C
IV), 57.6 (CH3), 56.3 (CH3), 56.2 (CH2), 
55.6 (CH2), 28.0 (CH3). 
MS (ESI) [m/z]: 790.5 [M-tBu]+, 812.5[M-Cl]+, 846.5 [M]+, 870.5 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3384 (NHCO), 2974, 2828 (CH2 sp
3), 1724 (C=O), 1527, 1223, 1105, 1008. 
Mp = 134°C. 
 
(E)-tert-butyl 2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)phenylamino)-2-oxoethyl)-
1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate (117) 
 
Red orange solid 
Rf. = 0.05 (PE/EtOAc: 4/6) revelator CAN 
 
Procedure: 
 
The solution of DO3A 53 (236 mg, 0.46 mmol, 1.00 equiv.) in anhydrous THF (15 mL) with Na2CO3 (144 mg, 1.37 
mmol, 3.00 equiv.) was stirred for 30 minutes at room temperature. Then the solution of bromo derivative XX 
(187 mg, 0.46 mmol, 1.00 equiv.) in anhydrous THF (6 mL) was added dropwise. The reaction was refluxed for 
16h and cooled down to room temperature. Residues were filtered through fritting glass, washed with 
dichloromethane and methanol. The filtrate was concentrated and purified by flash column chromatography 
(PE/EtOAc: 4/6->0/10->EtOH) to provide 219 mg (57% yield) of 117 as a red-orange solid. 
 
Analyses: 
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1
H NMR (250 MHz, CDCl3) δ [ppm]: 8.35 (s, 1H, NH), 8.09 (s, 1H, ar), 7.90 (d, J = 6.9 Hz, 2H), 7.35 (s, 1H, ar), 7.01 
(d, J = 7.1 Hz, 2H), 3.92 (s, 3H), 3.89 (s, 3H, CH3O), 3.87 (s, 3H, CH3O), 3.41 (m, 2H), 3.08 (m, 8H), 2.56 (br, 6H), 
2.36 (br, 4H), 1.99 (s br, 4 H), 1.47 (s, 9H), 1.40 (s, 18H). 
13
C NMR (61 MHz, CDCl3) δ [ppm]: 172.8 (C=O), 171.1 (C
IV), 161.7 (CIV), 152.2 (CIV), 147.5 (CIV), 143.6 (CIV), 137.8 
(CIV), 130.8 (CIV), 124.7 (CHar), 114.2 (CHar), 107.1 (CHar), 98.0 (CHar), 81.9 (C
IV), 57.8 (CH3), 57.6 (CH2), 56.2 (CH3), 
56.2 (CH2), 56.1 (CH2), 55.6 (CH3), 55.6 (CH2), 27.9 (CH3). 
MS (ESI) [m/z]: 842.5 [MH]+, 864.5 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3406 (NHCO), 2980, 2831 (CH2 sp
3), 1725, 1594, 1225, 1157, 1104. 
Mp = 168°C. 
 
(E)-tert-butyl 2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-(prop-2-ynyloxy)phenyl)diazenyl) 
phenylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate (118) 
 
 
Red solid 
Rf. = 0.45 (CH2Cl2/MeOH: 9/1) revelator CAN 
 
Procedure: 
 
The solution of DO3A 53 (39 mg, 0.08 mmol, 1.00 equiv.) in anhydrous THF (3 mL) with Na2CO3 (24 mg, 0.23 
mmol, 3.00 equiv.) was stirred for 30 min. at room temperature. Then, the solution of bromo derivative XX (33 
mg, 0.08 mmol, 1.00 equiv.) in anhydrous THF (1 mL) was added dropwise. The reaction was refluxed for 18h 
and cooled down to room temperature. Residues were filtered by fritting glass, washed with dichloromethane 
and methanol, then filtrate was concentrated and purified by flash column chromatography (CH2Cl2/MeOH: 
9/1) to provide 63 mg (95% yield) of 118 as a red solid. 
 
Analyses: 
 
1
H NMR (400 MHz, CDCl3) δ [ppm]: 8.40 (s, 1H, NH), 8.00 (s, 1H, ar), 7.83 (d, J = 8.9 Hz, 2H), 7.27 (s, 1H, ar), 7.02 
(d, J = 12.4 Hz, 2H), 4.69 (s, 2H), 3.85 (s, 3H), 3.79 (s, 3H, CH3O), 3.25 (m, 16H), 2.50 (t, J = 2.3 Hz, 1H), 2.23 (m 
br, 8H), 1.40 (s, 9H), 1.33 (s, 18H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 172.8 (C=O), 171.2 (C
IV), 159.5 (CIV), 152.4 (CIV), 148.0 (CIV), 143.9 (CIV), 
137.8 (CIV), 131.2 (CIV), 124.6 (CHar), 115.2 (CHar), 107.2 (CHar), 98.0 (CHar), 82.0 (C
IV), 78.2 (C≡CH), 76.1 (C≡C), 
57.8 (CH3), 57.5 (CH2), 56.2 (CH2), 56.1 (CH3), 55.6 (CH3), 27.9 (CH3). 
MS (ESI) [m/z]: 866.5 [MH]+, 888.5 [MNa]+. 
IR (neat, ATR) ν [cm-1]: 3360 (NHCO), 3291, 2974, 2834 (CH2 sp
3), 2107 (C≡C), 1723 (C=O), 1673, 1593, 1250, 
1023, 840. 
Mp = 143°C. 
 
(E)-2,2',2''-(10-(2-(4-((4-bromophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetic acid (119) 
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Red semi-solid 
Rf = 0.0 (CH2Cl2/MeOH: 9/1) revelator CAN 
 
Procedure: 
 
A solution of triisopropylsilane (30µL, 0.25 mmol, 4.72 equiv.) was prepared in trifluoroacetic acid (1.5mL, 8.83 
mmol) and was stirred for 5 minutes. This solution was added to the starting ester 115 (47 mg, 0.053 mmol, 
1.00 equiv). The reaction of deprotection was carried out for 60 min. at room temperature. Volatile compounds 
were evaporated and the product was precipitated with diethyl ether (5mL). After filtration through Milipore 
and washings with diethyl ether, the residue was dried under vacuum to provide 38 mg (quantitive) of 119 as a 
red semi-solid.  
 
Analyses: 
 
1
H NMR (250 MHz, MeOD) δ [ppm]: 8.28 (d, J = 30.0 Hz, 1H), 7.95–7.82 (m, 2H), 7.55 (dd, J = 8.6 and 3.2 Hz, 
2H), 7.40 (d, J = 6.7 Hz, 1H), 4.02 (s, 3H), 3.99 (s, 3H), 3.92 (s, 2H), 3.88 (s, 2H), 3.52 (br m, 6H), 2.76 (br, 14H). 
13
C NMR (101 MHz, MeOD) δ [ppm]: 211.5 (C=O), 184.0 (CIV), 156.5 (CIV), 154.3 (CIV), 133.6 (2xCHar), 129.0 
(CHar), 125.5 (2xCHar), 74.1 (CHar), 56.8 (CH3), 49.7 (CH3), 46.6 (CH2), 28.5 (CH2), 19.1 (CH2). 
MS (ESI) [m/z] mode negative: 722.5 [M]-, 744.0 [M+Na]-, 758.0 [M+K]-. 
IR (neat, ATR) ν [cm-1]: 3375 (OH), 2974, 2852, 1679 (C=O), 1593, 1534, 1454, 1394, 1125, 832, 720. 
 
(E)-2,2',2''-(10-(2-(4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetic acid (120) 
 
 
Red-orange semi-solid 
Rf = 0.02 (CH2Cl2/MeOH: 9/1) revelator CAN 
 
Procedure: 
 
A solution of triisopropylsilane (20µL, 0.16 mmol, 3.40 equiv.) was prepared in trifluoroacetic acid (1.0mL, 5.89 
mmol) and was stirred for 5 minutes. This solution was added to the starting ester 116 (40 mg, 0.047 mmol, 
1.00 equiv). The reaction of deprotection was carried out for 60 min. at rt.  Volatile compounds were 
evaporated and the product was precipitated with diethyl ether (4 mL). After filtration through Milipore and 
washings with diethyl ether, the residue was dried under vacuum to provide 30 mg (quantitive) of 120 as a red-
orange semi-solid. 
 
Analyses: 
 
1
H NMR (250 MHz, MeOD) δ [ppm]: 8.34 (s, 1H), 8.22 (s, 1H), 7.88 (m, 2H), 7.56 (m, 2H), 4.02 (s, 3H), 3.99 (s, 
3H), 3.92 (d, J=8.9 Hz, 2H), 3.49 (m, 6H), 3.04 (m br, 6H), 2.47 (m br, 8H). 
13
C NMR (101 MHz, MeOD) δ [ppm]: 211.5 (C=O), 184.0, 156.5, 130.6, 130.5, 129.0, 125.4, 125.3, 74.1, 56.8, 
49.6, 49.4, 49.2, 19.1. 
MS (ESI) [m/z] mode negative: 678.0 [M]-, 713.5 [M-3H+K]-. 
IR (neat, ATR) ν [cm-1]: 3395 (OH), 2971, 2854, 1675 (C=O), 1593, 1183, 721. 
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(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetic acid (121) 
 
 
Violet gum 
Rf = 0.14 (CH2Cl2/MeOH: 95/5) revelator CAN 
 
Procedure: 
 
A solution of triisopropylsilane (40µL, 0.32 mmol, 5.3 equiv.) was prepared in trifluoroacetic acid (2.0mL, 11.78 
mmol) and was stirred for 5 minutes. This solution was added to the starting ester 117 (50 mg, 0.06 mmol, 1.00 
equiv). The reaction was carried out for 60 min. at room temperature. Volatile compounds were evaporated 
and the product was precipitated with diethyl ether (8 mL). After filtration through Milipore and washings with 
diethyl ether, the residue was dried under vacuum to provide 35 mg (88% yield) of 121 as a dark violet gum. 
 
Analyses: 
 
1
H NMR (250 MHz, MeOD) δ [ppm]: 8.32 (s, 1H), 8.11 (s, 1H), 7.91 (d, J = 8.7 Hz, 2H), 7.39 (s, 1H), 7.10 (d, J = 8.8 
Hz, 1H), 4.01 (s, 3H), 3.91 (s, 6H), 3.62 (m, 14H), 2.50 (s br, 10H). 
13
C NMR (101 MHz, MeOD) δ [ppm]: 211.45 (C=O), 183.97, 163.32, 162.97, 156.49, 129.00, 125.94, 125.75, 
119.73, 116.83, 115.52, 74.03, 58.03, 56.88, 56.33, 50.00, 49.65, 49.43, 49.22, 46.54, 19.06.  
MS (ESI) [m/z] mode negative: 672.0 [M-H]+, 694.0 [M-H+Na]+, 710.0 [M-H+K]+. 
IR (neat, ATR) ν [cm-1]: 3548, 3468, 3408 (OH), 3094, 2956, 2837, 1682 (C=O), 1594, 1251, 1204, 1012, 842 
 
(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-(prop-2-ynyloxy)phenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetic acid (122) 
 
 
Red-violet semi-solid 
Rf = 0.02 (CH2Cl2/MeOH: 9/1) revelator CAN 
 
Procedure: 
 
A solution of triisopropylsilane (40µL, 0.32 mmol, 4.8 equiv.) was prepared in trifluoroacetic acid (2.0mL, 11.78 
mmol) and was stirred for 5 minutes. This solution was added to the starting ester 118 (57 mg, 0.066 mmol, 
1.00 equiv). The reaction was carried out for 60 min. at room temperature. Volatile compounds were 
evaporated and the product was precipitated with diethyl ether (8 mL). After filtration through Milipore and 
washings with diethyl ether, the residue was dried under vacuum to provide 40 mg (87% yield) of 122 as a red-
violet solid was obtained. 
 
Analyses: 
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1
H NMR (250 MHz, MeOD) δ [ppm]: 8.09 (s, 1H), 7.88 (d, J = 9.2 Hz, 2H), 7.37 (s, 1H), 7.15 (d, J = 6.8 Hz, 2H), 
3.95 (s, 3H), 3.88 (s, 3H), 3.58 (m br, 8H), 3.01 (s, 10H), 2.69 (s, 1H), 2.45 (s br, 6H). 
13
C NMR (101 MHz, CDCl3) δ [ppm]: 175.1 (C=O), 163.4, 162.8, 161.6, 153.1, 149.2, 125.8 (2xCHar), 120.5 (CHar), 
116.5 (2xCHar), 115.8 (CHar), 109.4, 99.5, 79.5 (C≡CH), 77.4 (C≡CH), 58.8 (CH3), 58.0 (CH3), 57.1 (CH2), 28.6 (CH2), 
9.3 (CH2). 
MS (ESI) [m/z] mode positive: 736.5 [M+K]+. 
IR (neat, ATR) ν [cm-1]: 3387, 3285 (OH), 2923, 2848, 1674 (C=O), 1591, 1236, 1017, 720. 
 
(E)-2,2',2''-(10-(2-(4-((4-bromophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate neodymium(III) complex (123) 
 
 
Red-violet solid 
Rf = 0.11 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 119 (10 mg, 13.84 µmol, 1.00 equiv.) was prepared in methanol (2 mL) and then 
Nd(OTf)3 (8.2 mg, 13.84 µmol, 1.00 equiv.) was added in one portion. The reaction was carried out for 24 h at 
50 °C. Residues were taken up into methanol. Then the volume of solvent was reduced under vacuum and a 
violet-red solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with 
diethyl ether, the residue was dried under vacuum to provide 11 mg (92% yield) of 123 as a red-violet solid. 
 
Analyses: 
 
MS (ESI) [m/z] mode negative: 863.0 [M]-. 
HRMS (ESI) [m/z] positive mode: calculated for C30H38BrN7NdO9: 861.0986, found: 861.0978; double charged 
ion calculated for C30H39BrN7NdO9: 431.0529, found: 431.0529. 
 
(E)-2,2',2''-(10-(2-(4-((4-bromophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate ytterbium(III) complex (124) 
 
 
Red-violet solid 
Rf = 0.20 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 119 (10 mg, 13.84 µmol, 1.00 equiv.) was prepared in methanol (2 mL). Then 
Yb(OTf)3 (8.6 mg, 13.84 µmol, 1.00 equiv.) was added in one portion. The reaction of complexation was carried 
out for 24 hours at 50 °C. Residues were taken up into methanol. The volume of solvent was reduced under 
vacuum and a violet-red solid was precipitated with diethyl ether (5mL). After filtration through Milipore and 
washings with diethyl ether, the residue was dried under vacuum to provide 9 mg (73% yield) of 124 as a red-
violet solid. 
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Analyses: 
 
MS (ESI) [m/z] mode negative : 889.0 [M-H]-. 
HRMS (ESI) [m/z] positive mode: calculated for C30H38BrN7O9Yb: 893.1285, found: 893.1275; double charged 
ion calculated for C30H39BrN7O9Yb: 447.0679, found: 447.0679. 
 
(E)-2,2',2''-(10-(2-(4-((4-bromophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate europium(III) complex (125) 
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Orange-red solid 
Rf = 0.20 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 119 (20 mg, 27.68 µmol, 1.00 equiv.) was prepared in methanol (4 mL) and then 
EuCl3∙6H2O (10.1 mg, 27.68 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 20 
hours at 50 °C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a 
orange-red solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with 
diethyl ether, the residue was dried under vacuum to provide 17 mg (71% yield) of 125 as an orange-red solid. 
 
Analysis: 
 
HRMS (ESI) [m/z] positive mode: calculated for C30H38BrEuN7O9: 872.1107, found: 872.1107; double charged 
ion calculated for C30H39BrEuN7O9: 436.5590, found: 436.5594. 
 
(E)-2,2',2''-(10-(2-(4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate neodymium(III) complex (126) 
 
 
Red-violet solid 
Rf. = 0.11 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 120 (8 mg, 11.80 µmol, 1.00 equiv.) was prepared in methanol (2 mL). Then Nd(OTf)3 
(7 mg, 11.80 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 24 hours at 50 °C. 
Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 8 mg (82% yield) of 126 as a red-violet solid. 
 
Analyses: 
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HRMS (ESI) [m/z] positive mode: calculated for C30H38ClN7NdO9: 817.1491, found: 817.1484; double charged 
ion calculated for C30H39ClN7NdO9: 409.0782, found: 409.0787. 
 
(E)-2,2',2''-(10-(2-(4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate ytterbium(III) complex (127) 
 
 
Red-violet solid 
Rf. = 0.11 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 120 (8 mg, 11.80 µmol, 1.00 equiv.) was prepared in methanol (2 mL). Then Yb(OTf)3 
(7.3 mg, 11.80 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 24 hours at 50 °C. 
Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 7.5 mg (75% yield) of 127 as a red-violet solid was 
obtained. 
 
Analyses: 
 
HRMS (ESI) [m/z] positive mode: calculated for C30H38ClN7O9Yb: 849.1798, found: 849.1783; double charged ion 
calculated for C30H39ClN7O9Yb: 425.0935, found: 425.0931. 
 
(E)-2,2',2''-(10-(2-(4-((4-chlorophenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate europium(III) complex (128) 
 
 
Red-violet solid 
Rf. = 0.11 (CH2Cl2/MeOH: 8/2) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 120 (10 mg, 14.81 µmol, 1.00 equiv.) was prepared in methanol (2 mL) and 
EuCl3∙6H2O (5.4 mg, 14.81 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 24 h at 
50 °C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-
red solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 10 mg (81% yield) of 128 as a red violet solid. 
 
Analysis: 
 
HRMS (ESI) [m/z] positive mode: calculated for C30H38ClEuN7O9: 828.1619, found: 828.1612; double charged ion 
calculated for C30H39ClEuN7O9: 414.5846, found: 414.5841. 
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(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate neodymium(III) complex (129) 
 
 
Dark violet solid 
Rf. = 0.11 (CH2Cl2/MeOH: 2/8) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 121 (10 mg, 14.84 µmol, 1.00 equiv.) was prepared in methanol (2 mL) and then 
Nd(OTf)3 (8.8 mg, 14.84 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 24 h at 50 
°C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 10.5 mg (90% yield) of 129 as a dark violet solid. 
 
Analyses: 
 
MS (ESI) [m/z] negative mode: 812.5 [M-H]-, positive mode: 814.0 [M+H]+, 835.0 [M+Na]+. 
HRMS (ESI) [m/z] positive mode: calculated for C31H41N7NdO10: 813.1987, found: 813.1978; double charged ion 
calculated for C31H42N7NdO10: 407.1030, found: 407.1031. 
 
(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate ytterbium(III) complex (130) 
 
 
Dark violet solid 
Rf. = 0.11 (CH2Cl2/MeOH: 2/8) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 121 (29 mg, 43.02 µmol, 1.00 equiv.) was prepared in methanol (6 mL). Then 
Yb(OTf)3 (26.7 mg, 43.02 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 24 h at 
50 °C. Residues were taken up into mehanol. The volume of solvent was reduced under vacuum and a violet-
red solid was precipitated with diethyl ether (10 mL). After filtration through Milipore and washings with 
diethyl ether, the residue was dried under vacuum to provide 27.4 mg (75% yield) of 130 as a dark violet solid. 
 
Analyses: 
 
MS (ESI) [m/z] negative mode: 842.5 [M-H]-, positive mode: 844.5 [M+H]+, 867.0 [M+Na]+. 
HRMS (ESI) [m/z] positive mode: calculated for C31H41N7O10Yb: 845.2303, found: 845.2308; double charged ion 
calculated for C31H42N7O10Yb: 423.1188, found: 423.1196. 
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(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-methoxyphenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate gadolinium(III) complex (131) 
 
 
Dark brown solid 
Rf. = 0.11 (CH2Cl2/MeOH: 2/8) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 121 (10 mg, 14.84 µmol, 1.00 equiv.) was prepared in methanol (2 mL). Then 
Gd(OTf)3 (8.9 mg, 14.84 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 24 h at 50 
°C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the redidue was dried under vacuum to provide 9.8 mg (82% yield) of 131 as a dark brown solid. 
 
Analyses: 
 
MS (ESI) [m/z] negative mode: 827.5 [M-H]-, positive mode: 829.0 [M+H]+, 849.0 [M+Na]+. 
HRMS (ESI) [m/z] positive mode: calculated for C31H41GdN7O10: 829.2157, found: 829.2167; double charged ion 
calculated for C31H42GdN7O10: 415.1115, found: 415.1122. 
 
(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-(prop-2-ynyloxy)phenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate neodymium(III) complex (132) 
 
 
Dark violet solid 
Rf. = 0.11 (CH2Cl2/MeOH: 6/4) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 122 (10 mg, 14.32 µmol, 1.00 equiv.) was prepared in methanol (2 mL). Then 
Nd(OTf)3 (8.5 mg, 14.32 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 7 h at 50 
°C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 10 mg (81% yield) of 132 as dark brown-violet crystals. 
 
Analyses: 
 
MS (ESI) [m/z] positive mode: 839.5 [M+H]+, 861.0 [M+Na]+. 
HRMS (ESI) [m/z] positive mode: calculated for C33H41N7NdO10: 837.1987, found: 837.1979; double charged ion 
calculated for C33H42N7NdO10: 419.1030, found: 419.1035. 
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(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-(prop-2-ynyloxy)phenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate ytterbium(III) complex (133) 
 
 
Dark violet solid 
Rf. = 0.08 (CH2Cl2/MeOH: 6/4) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 122 (10 mg, 14.32 µmol, 1.00 equiv.) was prepared in methanol (2 mL). Then 
Nd(OTf)3 (8.9 mg, 14.32 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 7 h at 50 
°C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 12 mg (quantitive) of 133 as dark brown-violet crystals. 
 
Analyses: 
 
MS (ESI) [m/z] positive mode: 869.0 [M+H]+, 890.0 [M+Na]+. 
HRMS (ESI) [m/z] positive mode: calculated for C33H41N7O10Yb: 869.2303, found: 869.2304; double charged ion 
calculated for C33H42N7O10Yb: 435.1188, found: 435.1193. 
 
(E)-2,2',2''-(10-(2-(2,5-dimethoxy-4-((4-(prop-2-ynyloxy)phenyl)diazenyl)phenylamino)-2-oxoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate gadolinium(III) complex (134) 
 
 
Dark brown-violet semi-solid 
Rf. = 0.08 (CH2Cl2/MeOH: 6/4) revelator CAN 
 
Procedure: 
 
A solution of triacetic acid 122 (13 mg, 18.62 µmol, 1.00 equiv.) was prepared in methanol (2.5 mL). Then 
Gd(OTf)3 (11.2 mg, 18.62 µmol, 1.00 equiv) was added in one portion. The reaction was carried out for 7 h at 50 
°C. Residues were taken up into methanol. The volume of solvent was reduced under vacuum and a violet-red 
solid was precipitated with diethyl ether (5mL). After filtration through Milipore and washings with diethyl 
ether, the residue was dried under vacuum to provide 16 mg (quantitive) of 134 as dark brown-violet semi-
solid. 
 
Analyses: 
 
HRMS (ESI) [m/z] positive mode: calculated for C33H41GdN7O10: 853.5151, found: 853.2158; double charged ion 
calculated for C33H42GdN7O10: 427.1114, found: 427.1115. 
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2,2',2''-(10-(2-(4-((E)-(4-((1-(4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-
3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)butyl)-1H-1,2,3-triazol-4-
yl)methoxy)phenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-
triyl)triacetate neodymium(III) complex (135) 
 
Yellow-orange powder  
HPLC (Nucleosil
(R) 
300-5  RP- C18) gradient CH3CN:H2O (0.1% TFA) 22->37%, 3 mL/min. tR=17.2 min. 
 
Procedure: 
 
Solution A: an Nd complex 132 (15.0 mg, 17.29 µmol, 1.00 equiv.) in MiliQ water (500µL) was mixed with a 
solution of cyclopeptide RGD (16.3 mg, 25.94 µmol, 1.50 equiv.) in HEPES buffer (500µL, 100 mM, pH=7.5). 
Separately in a small eppendorf, a solution B of ligand THPTA (37.3 mg, 85.85 µmol, 5.00 equiv.) and 
aminoguanidine (28.7 mg, 259.4 µmol, 15.00 equiv.) was prepared in 500 µL of HEPES buffer, then solution of 
CuSO4∙5H2O (17.3 mg, 69.16 µmol, 4.00 equiv.) in 200 µL of MiliQ was added (an apparition of intensive blue 
color), followed by the solution of sodium ascorbate (27.4 mg, 138.32 µmol, 8.00 equiv.) in 250 µL of HEPES 
(the solution became slightly yellow). The mixture B was immediately added to the solution A.  
The reaction vigorously stirred for 30 minutes at room temperature, checked by HPLC and stopped with 
addition of 1mL of MiliQ water with 5% of TFA. The content of flask was centrifuged to remove the precipitate 
The supernatant was concentrated to 10 mL and purified by semipreparative HPLC (Nucleosil, RP-C18, gradient 
CH3CN/H2O (+0.1% TFA) 22%/78%-->37%/63% , 3mL/min., 30 min.). The whole conversion of starting material 
was observed, the yield after purification was 40%. 
 
Analyses: 
 
HRMS (ESI) [m/z] positive mode: double charged ion calculated for C60H81N18NdO17: 733.7547, found: 733.7550, 
double charged sodium adduct, calculated for C60H80N18 NaNdO17: 744.7456, found: 744.74520, double charged 
potassium adduct, calculated for C60H80KN18NdO17: 752.7326, found: 752.7320. 
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2,2',2''-(10-(2-(4-((E)-(4-((1-(4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-
3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)butyl)-1H-1,2,3-triazol-4-
yl)methoxy)phenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-
triyl)triacetate ytterbium(III) complex (135) 
 
Yellow solid. 
HPLC (Nucleosil
(R) 
300-5  RP- C18) gradient CH3CN/H2O (0.1% TFA) 22%->37%, 3 mL/min. 
tR = 17.2 min. 
 
Procedure: 
 
Solution A: an Yb complex 133 (15.0 mg, 17.90 µmol, 1.00 equiv.) in MiliQ water (500µL) was mixed with a 
solution of cyclopeptide RGD (16.9 mg, 26.85 µmol, 1.50 equiv.) in HEPES buffer (500µL, 400 mM, pH=7.5), this 
solution A was diluted with 500 µL of water MiliQ, followed by one drop of DMF to solubilise peptide. 
Separately in a small eppendorf, a solution B of ligand THPTA (41.27 mg, 94.98 µmol, 5.30 equiv.) and 
aminoguanidine (29.7 mg, 268.5 µmol, 15.0 equiv.) was prepared in 500 µL of water MiliQ, then solution of 
CuSO4∙5H2O (17.88 mg, 71.6 µmol, 4 equiv.) in 200 µL of MiliQ was added (an apparition of intensive blue 
color), followed by the solution of sodium ascorbate (27.94 mg, 143.2 µmol, 8 equiv.) in 250 µL of HEPES (the 
solution became slightly yellow). The mixture B was immediately added to the solution A.  
The reaction was vigorously strirred for 30 minutes at room temperature, checked by HPLC and quenched by 
addition of 1mL of a 5% TFA MiliQ water. The content of flask was centrifuged to remove the precipitate. The 
supernatant was concentrated to 10 mL and purified by semipreparative HPLC (Nucleosil, RP-C18, gradient 
CH3CN/H2O (+0.1% TFA) 22%/78%-->37%/63% , 3mL/min., 30 min.). The whole conversion of starting material 
was observed, the yield after purification on HPLC column was 40%.  
 
Analyses: 
 
HRMS (ESI) [m/z] positive mode: double charged ion calculated for C60H81N18O17Yb: 749.7707, found: 749.7704. 
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2,2',2''-(10-(2-(4-((E)-(4-((1-(4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-
3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)butyl)-1H-1,2,3-triazol-4-
yl)methoxy)phenyl)diazenyl)-2,5-dimethoxyphenylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-
triyl)triacetate gadolinium(III) complex (136) 
 
Yellow solid. 
HPLC (Nucleosil
(R) 
300-5  RP- C18) gradient CH3CN/H2O (0.1% TFA) 22%->37%, 3 mL/min. 
tR = 15.8 min. 
 
Procedure: 
 
Solution A: an Gd complex 134 (18.0 mg, 21.55 µmol, 1.00 equiv.) in MiliQ water (500µL) was mixed with a 
solution of cyclopeptide RGD (20.3 mg, 32.32 µmol, 1.50 equiv.) in HEPES buffer (500µL, 100 mM, pH=7.5). 
Separately in a small eppendorf, a solution B of ligand THPTA (46.8 mg, 107.75 µmol, 5.00 equiv.) and 
aminoguanidine (35.7 mg, 323.25 µmol, 15.00 equiv.) was prepared in 500 µL of HEPES buffer, then solution of 
CuSO4∙5H2O (21.5 mg, 86.2 µmol, 4.00 equiv.) in 200 µL of MiliQ was added (an apparition of intensive blue 
color), followed by the solution of sodium ascorbate (34.2 mg, 172.4 µmol, 8.00 equiv.) in 250 µL of HEPES (the 
solution became slightly yellow). The mixture B was immediately added to the solution A.  
The reaction was vigorously stirred for 30 minutes at room temperature, checked by HPLC and stopped 
with addition of 1mL of MiliQ water with 5% of TFA. The content of flask was centrifuged to remove the 
precipitate. The supernatant was concentrated to 10 mL and purified by semipreparative HPLC (Nucleosil, RP-
C18, gradient CH3CN/H2O (+0.1% TFA) 22%/78%-->37%/63% , 3mL/min., 30 min.). The whole conversion of 
starting material was observed, the yield after purification on HPLC column was 36%.  
 
Analyses: 
 
HRMS (ESI) [m/z] positive mode: mono charged ion calculated for C60H80GdN18O17: 1482.5201, found: 
1482.5175; double charged ion calculated for C60H81GdN18O17: 741.7636, found: 741.7639; triple charged ion 
calculated for C60H82GdN18O17: 494.8448, found: 494.8450. 
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I. Determination of the enantiomeric excess of chiral compounds 
Supercritical fluid chromatography (SFC) is a relatively recent chromatographic technique, 
commercially available since only about 1982. What differentiates SFC from other chromatographic 
techniques (gas chromatography (GC) and high performance liquid chromatography (HPLC)) is the 
use of a supercritical fluid as the mobile phase.  
Supercritical fluid chromatography has several main advantages over other conventional 
chromatographic techniques (GC and HPLC). Compared with HPLC, SFC provides rapid separations 
without or with small quantity of organic solvents, such as methanol or ethanol. Because SFC 
generally uses carbon dioxide collected as a byproduct of other chemical reactions or is collected 
directly from the atmosphere, it contributes no new chemicals to the environment. In addition, SFC 
separations can be done faster than HPLC separations because the diffusion of solutes in supercritical 
fluids is about ten times greater than that in liquids (and about three times less than in gases). This 
results in a decrease in resistance to mass transfer in the column and allows for fast high resolution 
separations. Compared with GC, capillary SFC can provide high resolution chromatography at much 
lower temperatures. This allows fast analysis of thermo labile compounds.  
I.1. Analysis of organophosphorus chiral compounds by SFC 
Enantiomeric excesses and purity were determined by chiral SFC measurement on a Waters 
Investigator SFC (Waters, Guyancourt, France) equipped with a Waters 2998 Photodiode Array 
detector with high-pressure resistant cell. The column was a Lux Cellulose-1 (250 x 4.6 mm, 5 µm) 
from Phenomenex (Torrance, CA). Operating conditions were always isocratic, with methanol or 
ethanol modifier. Flow rate was 3 mL/min, outlet pressure 15 MPa, column oven temperature 25°C. 
Retention times (tR) are given in minutes. Enantiomers were identified by comparison of retention 
times, whenever the second enantiomer could be synthesized, and by comparison of UV spectra as 
provided by the photodiode-array detector. 
Below we present the chromatograms of synthesized enantiomeric couples for compounds 22-25, 
which served as a model for the calculation of enantiomeric excess and permits to optimize the 
separation conditions. 
  
 
Compound 22 
Fig. 183 Lux Cellulose-1 (250 x 4.6 mm, 5 µm), CO
tR (R,R): 4.61; tR (S,S): 5.14. 
 
Compound 23 
 
Fig. 184 Lux Cellulose-1 (250 x 4.6 mm, 5 µm), CO
tR (R,R): 7.62; tR (S,S): 9.14. 
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2-methanol 90:10 (v/v), 3 mL/min, 25°C, 15 MPa.
 
2-methanol 90:10 (v/v), 3 mL/min, 25°C, 15 MPa.
 
 
 
Compound 24 
Fig. 185 Lux Cellulose-1 (250 x 4.6 mm, 5 µm), CO
tR (R,R): 5.72; tR (S,S): 5.35. 
 
Compound 25 
Fig. 186 Lux Cellulose-1 (250 x 4.6 mm, 5 µm), CO
tR (R,R): 9.64; tR (S,S): 14.3. 
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2-methanol 90:10 (v/v), 3 mL/min, 25°C, 15 MPa.
 
2-methanol 90:10 (v/v), 3 mL/min, 25°C, 15 MPa.
 
 
 
I.2. SFC separation of racemic mixtures of 
acids 
All synthesized products were subjected to chiral separation by Supercritical Fluid Chromatography. 
As stated before, conducted reactions were no stereoselective, even in the case of (
application, thus the purification of enantiomers was required. The purification on the semi
preparative SFC system on the column Lux Cellulose
dimethylphenylcarbamate)) and Lux Cellulose
were performed.275 Separation conditions were optimized to achieve the highest resolution in face of 
short purification time. On the Fig. 
with high resolution, every separation complete
 
Fig. 187 The best separation conditions: 5% of EtOH, 30 °C, 150 bar backpressure, 3 mL/min, column Lux 1 for compounds 
43,47, 48 and Lux 2 for 42 and 46. 
  
                                                          
275 C. West, A. Bouet, I. Gillaizeau, G. Coudert, M. Lafosse, E. Lesellier, 
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 Streszczenie  
Związki heterocykliczne zawierające atom azotu stanowią ważną grupę produktów 
syntetycznych, są one obecne w większości biologicznie czynnych cząsteczek, takich jak kwasy 
nukleinowe, witaminy, przekaźniki energii chemicznej w metabolizmie komórek (ATP), kofaktory 
białek i wiele innych. Występują one również w przemyśle chemicznym (barwniki, konserwanty, 
perfumy), farmaceutycznym i rolnictwie jako środki ochrony roślin. Ze względu na ich 
wszechobecność i biologiczne zapotrzebowanie, syntezowanie nowych pochodnych jest centralnym 
zagadnieniem w chemii heterocyklicznej. Enkarbaminiany i enamidy to grupa nieaktywowanych 
enamin, należąca do wszechstronnych produktów pośrednich w syntezie związków heterocyklicznych 
zawierających atom azotu.  
Reakcje sprzęgania krzyżowego pochodnych eterów enolowych katalizowane związkami 
palladu stanowią korzystne podjeście do syntezy enkarbaminianów i enamidów pośród dostępnych 
metod. Wiele grup badawczych zaprezentowało użyteczność pochodnych laktamów i imidów do 
otrzymywania fosforanów enolowych jako produktów przejściowych w syntezie enamidów. Zdolność 
do przekształcenia powyższych fosforanów enoli w reakcji sprzęgania krzyżowego typu Suzuki-
Miyaura, Stille, Sonogashira, itp. w obecności różnych heteroatomów czyni je użytecznymi 
substratami w konstrukcji różnorodnych systemów heterocyklicznych. W oparciu o tą metodę, 
opracowaną i udoskonalaną od kilku lat w laboratorium prof. I. Gillaizeau, cały szereg struktur 
heterocyklicznych (tj. pochodne 1,4-dihydropirydyny, 1,4-oksazyny, 1,4-dihydropirazyny) 
posiadających ugrupowanie enkarbaminianu zostało zsyntezowane (Schemat 1). 
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Schemat 1 
Biorąc pod uwagę ekspertyzę i badania przedsięwzięte w grupie prof. Gillaizeau dotyczące 
otrzymywania i reaktywności enkarbaminianów, niniejsza rozprawa doktorska będzie podejmowała 
tematykę syntezy nowych związków heterocyklicznych i ich wszechstronne zastosowanie. Pierwsza 
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część rozprawy doktroskiej zostanie poświęcona reaktywności enkarbaminianów i enamidów w 
reakcji sprzęgania krzyżowego katalizowanej kompleksami palladowymi, tworząc bezpośrednio 
wiązanie C-P oraz w reakcji addycji nukleofilowej anionu fosfinowego w celu utworzenia nowych 
bloków syntetycznych zawierających atom fosforu. Druga część pracy doktorskiej będzie dotyczyć 
otrzymywania i charakteryzacji oryginalnych chromoforów opartych na rdzeniu pirazynowym, 
wywodzących się z ugrupowania dihydropirazynowego. Powyższe związki chromoforowe zostały 
zaprojektowane w celu utworzenia systemów sensybilizujących kationy lantanowców i tym samym, 
mogą zostać one wykorzystane jako oryginalne sensybilizatory organiczne do obrazowania 
molekularnego w bliskiej podczerwieni. 
 
Pierwszy rozdział: Heterocykliczne związki organofosforowe - tworzenie wiązania C-P 
 
Podstawowym celem pierwszej części pracy doktorskiej było zsyntytezowanie nowych, na stan 
obecny nieopublikowanych, produktów organofosforowych na drodze oryginalnych ścieżek syntezy 
opracowanych w grupie prof. Gillaizeau. 
Otrzymywanie nowych związków zawierających atom fosforu jest tematem stale budzącym 
zainteresowanie w chemii organicznej ostatnich lat. Produkty organofosforowe mają szerokie 
zastosowanie w wielu dziedzinach życia codziennego oraz przemysłu chemicznego. Z biologicznego 
punktu widzenia, pełnią one istotną rolę w procesach przemiany materii (ATP), w przekazie materiału 
genetycznego (DNA, RNA) oraz stanowią materiał budulcowy błon komórkowych (fosfolipidy). Ze 
względu na izosteryczność grupy fosforowej z grupą karboksylową, fosforowe analogi aminokwasów i 
peptydów są ważną grupą związków farmaceutycznych stosowanych jako inhibitory enzymów, 
związki antybakteryjne i anty-HIV. Dodatkowo, organofosforany posiadają właściwości inhibujące 
acetylocholinesterazę przez co są szeroko stosowane jako pestycydy, insektycydy i herbicydy oraz 
jako gazy bojowe. 
W przemyśle chemicznym są one wykorzystywane jako chiralne ligandy dla kompleksów metali 
przejściowych w reakcjach katalizy. Umożliwiają one otrzymywanie enancjomerycznie czystych 
produktów w asymetrycznych przemianach, takich jak uwodornienie, utlenianie, nukleofilowa 
addycja organometalicznych reagentów do aldehydów, ketonów i imidów, reakcje aldolowe, reakcje 
cyklizacji i wiele innych. Dużą zaletą ligandów zawierających atom fosforu jest różnorodność 
możliwych kombinacji podstawników oraz ewentualność wprowadzenia centrum asymetrycznego 
zarówno na atomie fosforu, jak i na atomie węgla sąsiadującym z fosforem oraz poprzez chiralność 
osiową. Ponadto, związki organofosforowe znalazły zastosowanie jako organokatalizatory, ze 
względu na ich właściwości jednocześnie nukleofilu i kwasu Brønsteda (pod postacią aksjalnie 
chiralnych kwasów fosforowych). 
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Część literaturowa pierwszego rozdziału rozprawy doktorskiej zostanie poświęcona reakcjom 
tworzenia wiązania C-P. Najstarszą, lecz ciągle używaną metodą, jest reakcja Arbuzowa opierająca się 
na nukleofilowym ataku fosforynu na halogenek alkilowy tworząc fosfiniany dialkilowe. Kolejna 
cytowana metoda to reakcja fosfa-Michaela, addycja nukleofilowego reagenta fosforowego do 
olefinowego akceptora. Reakcja ta stała się wszechstonną ścieżką syntezy licznych asymetrycznych 
pochodnych fosforowych w łagodnych warunkach reakcji. Następną metodą otrzymywania 
tytułowych związków jest hydrofosfonylacja - przyłączanie fosfonianu do aktywowanego wiązania 
podwójnego. Reakcja sprzęgania krzyżowego katalizowana kompleksami metali przejściowych to 
ostatnia i najszerzej opisana metoda syntezy związków organofosforowych. Niniejszy podrozdział 
został poświęcony licznym przykładom tych reakcji z różnymi substratami fosforowymi (tlenkami 
fosfin, trialkil- lub triarylfosfinami, boranowymi kompleksami fosfin i chlorkami fosfin) jako 
partnerami w sprzęganiu. Dodatkowo sprzęganie tworzące wiązanie C(sp)-P oraz C(sp
3
)-P i przykłady 
reakcji asymetrycznych zostały zaprezentowane. 
Część eksperymentalną pierwszego rozdziału zadedykowano syntezie oryginalnych 
pochodnych α-amidofosfin na drodze nowatorskiej metody sprzęgania krzyżowego pomiędzy 
fosforanami enolu oraz boronowymi kompleksami fosfin. Zastosowana metoda prowadząca 
bezpośrednio do tworzenia wiązania C-P nigdy dotychczas nie została opisana. Produkty pośrednie 
syntezy - fosforany enolu - to łatwo dostępne, stabilne i mniej kosztowne odpowiedniki 
trifluorometanosulfonianów i tosylanów, stosowane szeroko w laboratorium. Do optymalizacji 
warunków reakcji zastosowano niechiralny kompleks boranowy difenylfosfiny. Stosując różne zasady 
nieorganiczne, rozpuszczalniki, czas i temperaturę reakcji wytypowano najlepszy układ katalizujący, a 
następnie rozszerzono powyższą syntezę o związki chiralne - z centrum asymetrycznym 
umieszczonym na atomie fosforu i na atomie węgla w pozycji α do atomu fosforu (Schemat 2). 
 
Schemat 2 
Na podstawie badań czystości enancjomerycznej otrzymanych produktów, poprzez superkrytyczną 
chromatografię cieczową z chiralną fazą stacjonarną, stwierdzono, że reakcja substratów  
z asymetrycznym atomem fosforu spowodowała racemizację centrum chiralnego. Natomiast  
w przypadku związków niosących centrum asymetryczne na atomach węgla α w stosunku do fosforu, 
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chiralność reakcji została zachowana. Cykliczne kompleksy fosfin i cylkiczne tlenki fosfolanów zostały 
otrzymane z umiarkowanymi do dobrych wydajnościami i wysokimi nadmiarami enancjomerycznymi. 
W drugiej części pierwszego rozdziału niniejszej rozprawy opisano reakcję nukleofilowej 
addycji aninów fosfinowych do niecyklicznych enkarbaminianów, prowadzącą do fosfinowych 
pochodnych nienaturalnych aminokwasów. Zaprojektowana ścieżka syntezy opiera się na 
specyficznej spontanicznej migracji grupy alkoksykarbonylowej od atomu azotu do 
czwartorzędowego atomu węgla poprzez formację cyklu azirydynowego jako stanu pośredniego 
(Schemat 3). 
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Schemat 3 
Powyższa ścieżka syntezy zaproponowana została na podstawie badań z innymi czynnikami 
nukleofilowymi takimi jak litowe zasady organiczne (MeLi, PhLi, n-BuLi oraz LDA) opisanymi  
w literaturze, a mechanizm wewnątrzcząsteczkowej migracji grupy alkoksykarbonylowej popraty 
został obliczeniami teoretycznymi. Dodatkowo, wyizolowano z mieszaniny reakcyjnej związki 
zawierające utleniony atomu fosforu, co świadczy o reaktywności tych fosfin. Przeprowadzono więc 
doświadczenie badające wpływ ilości nukleofilowego substratu fosforowego w stosunku do 
wyjściowego enkarbaminianu na proporcje otrzymanych produktów: z transferem grupy 
alkoksykarbonylowej lub bez transferu, z utlenionym atomem fosforu lub zachowanym P(III) 
(Schemat 4). 
 
Schemat 4 
Na podstawie tego doświadczenia stwierdzono, iż zmniejszenie ilości nukleofila w układzie prowadzi 
do zwiększenia wydajności produktu nietransferowanego C, co świadczy iż kinetyczny wpływ 
reprotonacji jest znacznie szybszy niż wewnątrzcząsteczkowa migracja grupy tert-
butoksykarbonylowej.  
Otrzymane fosforowe pochodne nienaturalnych aminokwasów posiadają czwartorzędowy 
atom węgla, jednakże niemożliwa była stereokontrola tej reakcji addycji. Przeprowadzono więc próby 
z (-)-sparteiną jako chiranym ligandem kompleksującym utworzony anion, jednakże bezskutecznie. 
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Dodatkowo zastosowano chiralne fosfiny jako substraty w reakcji, niemniej jednak utworzenie 
anionu fosfinowego w tym przypadku było niemożliwe.  
Struktury pięciu spośród dwudziestu dwóch nowo otrzymanych produktów zostały zbadane 
metodami dyfrakcyjnymi monokryształów. Potwierdzono charakterystyczną architekturę wokół 
atomów fosforu, stan utlenienia oraz chiralność centrów asymetrycznych. 
Wobec zaprezentowanych w niniejszej rozprawie doktorskiej badań i obserwacji można 
stwierdzić, iż cel badań został osiągnięty i zaproponowane ścieżki syntetyczne dają dostęp do 
oryginalnych związków organofosforowych. Przedstawione metody syntezy są nowatorskie i 
umożliwiają rozszerzenie syntezy na dowolne produkty wyjściowe, pochodne fosforanów enolu. W 
przypadku pochodnych nienaturalnych aminokwasów odpowiedni dobór substratów do reakcji 
sprzęgania krzyżowego oraz reagentów fosforowych otwiera możliwość syntezy bibliotek 
interesujących produktów. Ponadto, możliwe jest zastosowanie innych czynników nukleofilowych 
(dla przykładu, związków krzemu). 
 
Drugi rozdział: Oryginalne sensybilizatory kompleksów lantanowców wywodzące się z 
pochodnych pirazynowych 
 
Luminescencyjne właściwości kompleksów lantanowców są szeroko badane pod kątem 
technologii konwertujących światło, takich jak lasery, diody emitujące światło, wyświetlacze 
plazmowe i katodowe. Związki lantanowców posiadają dobrze zdefiniowane, nienakładające się na 
siebie wąskie pasma emisyjne w zakresie widzialnym widma elektromagnetycznego i w bliskiej 
podczerwieni. Od ostatniej dekady, ich szczególne własności spektroskopowe znalazły zastosowanie 
w dziedzinie obrazowania medycznego. Zwłaszcza związki kompleksowe neodymu i iterbu, 
wykazujące intensywne pasma emisyjne wokół 1000 nm, budzą zainteresowanie w optycznej 
diagnostyce medycznej, ponieważ ich widma wpisują się w zakres "okna biologicznego" do badań 
spektroskopowych, niezaburzonych poprzez fluorescencję pochodzącą od płynów biologicznych i od 
hemoglobiny. Co więcej, fotony z zakresu bliskiej podczerwieni nie ulegają fotowybielaniu, mogą być 
selektywnie wzbudzane poprzez zastosowanie charaktyrystycznych długości fal, rozpraszają się w 
tkankach biologicznych w znacznie mniejszym stopniu niż fotony z zakresu widzialnego oraz mogą 
przechodzić przez tkanki na odległość kilku centymetrów bez ich uszkodzenia. Wszystkie wymienione 
cechy czynią kompleksy neodymu i iterbu obiecującymi sondami biologicznymi. Mają one jednakże 
jedną ujemną stronę, a mianowicie, ich bezpośrednie wzbudzenie jest prawie niemożliwe 
(współczynniki absorpcji są zakresu 1-10 M-1∙cm-1). Wymagają one zastosowania systemu 
wzbudzającego, który absorbuję energię pod postacią fotonów, a następnie poprzez szereg przejść 
wewnątrz- i międzysystemowych przenosi ją do stanu wzbudzonego lantanowca, prowokując jego 
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emisję. Ten układ sensybilizujący, zwany również anteną, może być cząsteczką organiczną, 
nanokryształem, strukturą metalo-organiczną lub dendrymerem.  
Celem niniejszego rozdziału jest przedstawienie systemów sensibilizujących zbudowanych ze 
związków organicznych oraz opisanie syntezy oryginalnych sensybilizatorów opartych na rdzeniu 
pirazynowym i z cząsteczką cyklenu jako ligandem chelatującym kation lantanowca. Rozdział ten 
został podzielony na część literaturową wprowadzającą do tematyki pracy, ze szczególnym naciskiem 
położonym na systemach anten organicznych, na część eksperymentalną opisującą otrzymywanie 
poszczególnych związków, na część dyskusyjną i opisanie rezultatów, wyniki spektroskopowe oraz 
podsumowanie. Krótki podrozdział, zawierający opis otrzymywania oraz badania spektroskopowe 
chromoforów z grupy związków azowych, został zawarty na końcu pracy. 
Część bibliograficzna tegoż rozdziału obejmuje opis zagadnień dotyczących aktywności 
luminescencyjnej cząsteczek na przykładzie diagramu Jabłońskiego oraz zjawiska sensybilizacji. 
Zawiera ona przegląd współczesnej literatury naukowej związanej z organicznymi systemami 
sensybilizującymi i opisuje przykłady zastosowania lantanowców jako sond molekularnych w bliskiej 
podczerwieni. Kolejne fragmenty części literaturowej poświęcone są chromoforom pirazynowym i ich 
właściwościom. 
Część eksperymentalna zawiera szczegółowy opis zastosowanych ścieżek syntezy 
prowadzących do oryginalnych systemów sensybilizujących dla lantanowców. Badania te zostały 
zainspirowane na wcześniejszych, zachęcających wynikach dla układów dihydropirazynowych. 
Według zaproponowanego konceptu, zamierzony sensybilizator będzie posiadał rdzeń pirazynowy, 
połączony ramieniem łącznikowym z cząsteczką cyklenu, który tworzy termodynamicznie i 
kinetycznie stabilne kompleksy z kationami lantanowców (Schemat 5). 
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Schemat 5 
Na podstawie wstępnych badań przeprowadzonych na ugrupowaniu dihydropirazynowym ustalono, 
iż system ten nadaje się do wprowadzenia licznych modyfikacji i grup funkcyjnych umożliwiajacych 
przyłączenie cyklenu. Zaproponowano dwie oddzielne drogi syntezy: 
 poprzez reakcję cykloaddycji Diels-Aldera z gamą różnych dienofili 
 przez funkcjonalizację związku wyjściowego w warunkach anionowych, przyłączając rozmaite 
elektrofile poddające się standardowym transformacjom. 
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Finalnym krokiem konstrukcji systemów antenowych jest reakcja odłączenia grupy blokującej i 
aromatyzacja prowadząca do oczekiwanego rdzenia pirazynowego. 
Na kolejnych stronach ninejszej rozprawy opisano zastosowane metody syntetyczne. Najpierw 
wykonano szereg badań pozwalających na wytypowanie najlepszego dienofila w reakcji Diels-Aldera, 
następnie skupiono się na systemie czterocyklicznym dającym najlepsze wyniki. Związek ten został 
poddany reakcji aromatyzacji i trans-imidyfikacji, dając dostęp do dwóch pochodnych, potencjalnych 
systemów antenowych ze skondensowanym, sprzężonym systemem chromoforowym. Jednakże 
ostatni etap przewidzianej syntezy - przyłączenie cyklenu, na dany moment, nie został zrealizowany 
ze względu na brak reaktywności otrzymanych pochodnych hydroksylowych i aminowych w 
zastosowanych przemianach (Schemat 6). W perspektywach do tej części pracy przewidziana jest 
zmiana zastosowanych grup funkcyjnych. 
 
Schemat 6 
Następnie przeprowadzono próby funkcjonalizacji układu dihydropirazynowego poprzez 
przyłączenie atomu jodu oraz grupy aldehydowej. Zaproponowane podejście daje dostęp do licznych 
pochodnych - substratów w reakcji sperzęgania typu Sonogashira, produktów wyjściowych w reakcji 
olefinacji typu Wittig-Horner-Emmons, w reakcji redukcji i reduktywnej aminacji. Spośród 
przeprowadzonych licznych reakcji chemicznych, wytypowano najefektywniejszą ścieżkę syntezy 
poprzez aldehyd do pochodnej bromoamidowej pirazyny, która została przyłączona do cząsteczki 
cyklenu z odpowiednio zmodyfikowanymi grupami aminowymi, tak aby po odblokowaniu grup 
funkcyjnych otrzymać chelat zdolny do kompleksowania kationu lantanowca (Schemat 7). 
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Schemat 7 
Otrzymano kompleksy neodymum iterbu i gadolinu z oryginalnymi sensybilizatorami i zbadano ich 
właściwości spektroskopowe. Widma absorpcyjne, eksytacyjne i emisyjne w zakresie widzialnym  
i w bliskiej podczerwieni zostały zarejestrowane dla tych związków kompleksowych. Zmierzono 
również wydajność kwantową emisji lantanowców oraz czas życia fluorescencji w celu oszacowania 
zdolności sensybilizujących oryginalnych systemów antenowych. Powyższe badania zostały 
przeprowadzone w Centrum Biofizyki Molekularnej w Orleanie pod opieką dr S. Petoud i dr S. 
Villette. Otrzymane wyniki wskazują, iż badany system sensybilizujący jest wydajny, niezawodny, daje 
możliwość testowania równolegle kilku kationów lantanowców.  
Ostatni podrozdział pracy doktorskiej został poświęcony otrzymywaniu nowych chromoforów 
opartych na systemach azowych. Związki azowe charakteryzują się absorpcją w zakresie widzialnym 
widma elektromagnetycznego, posiadają intensywne i nieblaknące kolory, dzięki czemu znalazły 
zastosowanie w chemii barwników i indykatorów chemicznych. Biorąc pod uwagę ich właściwości 
spektroskopowe, przewidziano użyteczność tych związków jako sensybilizatorów oraz grup 
łącznikowych do systemamów pirazynowych zwiększających ich zdolność do sensybilizacji. 
 
Schemat 8 
Otrzymano szereg związków azowych na drodze reakcji diazotacji i sprzęgania diazowego z 
pochodnymi aniliny, a następnie sfunkcjonalizowano powyższe produkty w reakcji z bromkiem 
bromoacetylu, aby przyłączyć je do pochodnych cyklenu i skompleksować z kationami lantanowców. 
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Dodatkowo przeprowadzono badania mające na celu przyłączenie powyższych związków do 
ugrupowania dihydropirazynowego i do biocząsteczek o wysokim powinowactwie do komórek 
nowotworowych, tj. cyklopeptyd RGD (Schemat 9).  
 
Schemat 9 
Przedstawione badania ukazują dużą przydatność powyższych systemów jako sond 
molekularnych w zakresie bliskiej podczerwieni. Wykazują one wzbudzenie w szerokim zakresie 
długości fali (aż do 500 nm) dając intensywne pasma emisyjne badanych komplesków lantanowców. 
Czas życia fluorescencji badanych związków mieści się w zakresie kilkuset nanosekund do kilku 
mikrosekund, co plasuje je w obrębie dobrych układów sensybilizujących. 
Wobec zaprezentowanych w niniejszej rozprawie doktorskiej badań, spostrzeżeń i konkluzji 
można stwierdzić, iż postawiony cel został osiągnięty, a zaproponowane strategie syntez dają dostęp 
do nowej, dotychczas nieopisanej grupy systemów sensybilizujących dla kompleksów lantanowców. 
Przedstawione wstępne badania spektroskopowe ukazują zdolność pochodnych pirazynowych do 
efektywnego przekazu energii do systemu chelatującego metalu. Dodatkowo możliwość 
wprowadzenia modyfikacji na każdym etapie syntezy oraz elastyczność funkcjonalizacji jest dużym 
atutem przedstawionych badań. W perspektywach do tego projektu, przewidziane jest przyłączenie 
poszczególnych systemów sensybilizujących do biomolekuł specyficznie wykrywających komórki i 
tkanki rakowe w celu stworzenia markerów cząsteczkowych do badań w zakresie bliskiej 
podczerwieni. Ponadto, przewidziane jest przyłączenie do sensybilizatora więcej niż jednej cząsteczki 
cyklenu, co pozwoli na różnicowanie odpowiedzi spektralnej lub wzmocnienie rejestrowanego 
sygnału. 
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 Résumé  
Les composés hétérocycliques azotés représentent une classe importante de produits 
synthétiques. Ils sont présents dans de nombreuses molécules biologiquement actives telles que les 
acides nucléiques, les vitamines, les relais de l'énergie chimique dans le métabolisme cellulaire (ATP), 
les cofacteurs de protéines et beaucoup d'autres encore. Les hétérocycles azotés sont également 
utilisés dans l'industrie chimique (colorants, conservateurs, parfums), les produits pharmaceutiques, 
ainsi qu’en agriculture comme produits phytosanitaires. En raison de leur omniprésence et leur 
intérêt biologique, une attention particulière est accordée au développement de méthodologie pour 
leur synthèse et leur fonctionnalisation. Dans ce but, la conception de nouvelles voies de synthèse 
pour la fonctionnalisation d’énamides constitue une thématique importante pour la communauté 
des chimistes et des biologistes car ces motifs s’avèrent être des intermédiaires synthétiques 
polyvalents permettant d’introduire une fonctionnalité azotée dans de nombreux composés plus 
complexes. Les réactions de couplage pallado-catalysées constitue une méthode de choix rapide et 
éco-efficiente pour la synthèse d'énamides et/ou de ènecarbamates. Cette méthodologie décrite 
depuis plusieurs années dans l’équipe du Pr. I. Gillaizeau permet d’accéder à des énamides variés via 
des couplages métallo-catalysés (ex. Suzuki-Miyaura, Stille, Sonogashira) de phosphates d'énols issus 
de lactames, d’imides ou d’amides, intermédiaires facilement accessibles. Ainsi, un grand nombre de 
structures hétérocycliques (dérivés 1,4-dihydropyridine; 1,4-oxazines; 1,4-dihydropyrazines …) 
originales ou difficilement accessibles ont été synthétisées (Schéma 1).  
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Tenant compte de l'expertise et des recherches entreprises dans le groupe du Prof. I. Gillaizeau 
sur l'obtention, la polyvalence et la réactivité des ènecarbamates, cette thèse a pour but la synthèse 
et l’identification structurale de nouveaux composés hétérocycliques porteurs d’un groupe 
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organophosphorés d’une part, ainsi que de nouvelles sondes pyraziniques pour la détection en 
proche infra-rouge.  
 
Première chapitre : Synthèse de dérivés de phosphines originaux 
 
Le premèr chapitre de la thèse porte sur l’étude de la réactivité d’énamides pour la 
préparation de dérivés alpha-enamido-phosphines ou d’acides aminés non naturels porteurs d’un 
groupe organophosphorés en béta, blocs synthétiques pouvant être utilisés pour accéder à des 
molécules plus complexes.  
Une partie bibliographique introduit l’ensemble de ce chapitre mettant en évidence l’intérêt 
des produits organophosphorés, largement utilisés dans de nombreux domaines de la vie 
quotidienne et l'industrie chimique. D'un point de vue biologique, ils jouent un rôle important dans le 
métabolisme (ATP), le transfert de matériel génétique (ADN, ARN) et sont les éléments constitutifs 
des membranes cellulaires (phospholipides). En raison des groupes phosphate isostériques avec le 
groupe carboxyle, les analogues phosphatés d'acides aminés et des peptides sont des groupes 
importants de composés pharmaceutiques utilisés comme inhibiteurs de réactions enzymatiques, 
composés antibactériens et anti-HIV. En outre, les composés organophosphorés ont des propriétés 
d'inhibition d'acetylcholinesterase et sont donc largement utilisés comme pesticides, insecticides et 
herbicides ainsi que comme gaz toxiques. Dans l'industrie chimique, ils sont utilisés comme ligands 
chiraux pour des complexes de métaux de transition dans les réactions catalytiques. Ils permettent 
d'obtenir des produits énantiomériquement purs dans de nombreuses transformations 
asymétriques. L'avantage de ligands contenant un atome de phosphore est la versatilité de ses 
substituants et la possibilité d'introduire d'un centre asymétrique soit sur l'atome de phosphore, soit 
sur l'atome de carbone adjacent au phosphore, ou encore par chiralité axiale. Une étude 
bibliographique concernant les réactions de formation des liaisons C-P est également décrite.  
Le couplage organopalladié C-P de phosphines boranes secondaires chirales ou achirales avec 
des phosphates d’alpha-amido-énol a été étudié donnant des ènamido-phosphines boranes 
correspondantes avec 28 à 95 % de rendement (Schéma 2). Ce couplage C-P original qui est réalisé 
dans des conditions douces avec des dérivés cétoniques de nature différente, offre de nombreuses 
possibilités pour la constitution d’une librairie de phosphines fonctionnalisées originales. Il est à 
noter que dans le cas d’une phosphine secondaire borane P-chirogénique, l'analyse du mélange 
réactionnel par chromatographie supercritique sur phase chirale, indique que le couplage est 
racémisant dans les conditions de réaction. Ce phénomène peut s’expliquer par une inversion de 
l’anion phosphure-borane en milieu basique, avant l’échange de ligand dans la sphère de 
coordination du palladium. Les études qui ont été menées en changeant la température de réaction 
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(TA à 60°C, avec ou sans activation microonde), le solvant (CH3CN, DMSO) ou encore les conditions 
de réaction par l’ajout de BH3 supplémentaire, conduisent toujours au produit racémique.  
 
Schéma 2 
En revanche, lorsque la réaction est réalisée avec une phosphine secondaire borane cyclique, 
porteuse de la chiralité non plus sur l'atome de phosphore mais sur le cycle phospholane, le produit 
de couplage est obtenu stéréosélectivement avec une excellente pureté énantiomèrique (Schéma 3) 
(ee> 99.4%). 
 
Schéma 3 
La structure par diffraction de RX de ces composés a été réalisée en collaboration avec Pr. K. 
Lewinski de l’Université de Jagellonne à Cracovie en Pologne. 
 
Parallèlement à ce travail, l’addition nucléophile de phosphures sur divers ène-carbamates 
acycliques préparées par couplage à partir de phosphates d’énol acyclique, a été étudiée. Il a ainsi 
été montré qu’il était possible d’accéder par carbolithiation intermoléculaire à divers ène-
carbamates acycliques, qui réagissent ensuite avec un phosphure pour donner des acides alpha-
aminés béta-phosphorés originaux, porteurs d’un carbone quaternaire en alpha de l’azote. La 
réaction de carbolithiation se déroule avec une migration concomitante du groupement Boc de 
l’atome azote sur le carbone placé en alpha via la formation d'une aziridine intermédiaire. Des 
études concernant l’addition d'organophosphorés chiraux (phosphines ou oxydes de phosphine) ont 
également été menées, malheureusement sans succès. 
 
Schéma 4 
Il est à noter que des composés constitués d’un atome de phosphore oxydé ont également été 
isolés. Toutefois, en augmentant la quantité d'anion phosphure au sein du milieu réactionnel, la 
réaction d’oxydation de la phosphine est limitée. Par ailleurs, une diminution de la quantité d'anion 
phosphure induit une diminution de la migration de l’alkoxyle N-> C, nous permettant ainsi de 
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conclure que la cinétique de reprotonation est beaucoup plus rapide que la migration 
intramoléculaire d'un groupe de tert-butoxycarbonyle. 
 
Schéma 5 
Les dérivés phosphorés des acides aminés non naturels possèdent un atome de carbone 
quaternaire en alpha de l’azote dont la stéréochimie n'est pas contrôlable au cours de la réaction 
d'addition nucléophile. Différents test avec notamment l’utilisation d’inducteur chiral telle que la (-)-
spartéine ont été effectués, mais en vain. L'utilisation d'une phosphine chirale pour induire un 
stéréo-contrôle lors de l'étape de transfert du groupement tert-butoxycarbonyle n'a pas aboutit, 
l’anion lithé n’ayant pu être obtenu. 
Les structures de cinq des vingt-deux produits nouvellement obtenus ont été analysées par la 
méthode de diffraction des monocristaux. Cela a permis de confirmer l'architecture caractéristique 
autour des atomes de phosphore, son état d'oxydation et la configuration des centres asymétriques. 
Les buts et objectifs fixés en début de thèse ont été atteints et les voies de synthèse proposées 
ont permis l'obtention de composés organo-phosphorés originaux. Les méthodes de synthèse 
développées sont innovantes et peuvent s'étendre à la synthèse de nombreux autres composés à 
partir d’enol ethers variés. Dans le cas des dérivés non-naturels d'acides aminés, une sélection 
appropriée des substrats et des réactifs phosphorés engagés dans la réaction de couplage croisé 
palladocatalysée ouvre une perspective intéressante pour la conception d'une bibliothèque de 
produits originaux. Deux publications correspondent à ce sujet. 
 
Deuxième chapitre : Sensibilisateurs originaux de complexes de lanthanides basés sur les 
dérivés pyraziniques 
 
Le deuxième chapitre de la thèse porte sur la préparation et la caractérisation de 
chromophores organiques originaux sur la base d’un noyau pyrazinique et qui sont susceptibles de 
présenter des propriétés de fluorescence. Ces composés sont conçus pour former des nouveaux 
systèmes sensibilisateurs de cations de lanthanides, et donc être utilisés comme sensibilisateurs 
organiques pour l'imagerie moléculaire dans le proche infrarouge.  
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Les propriétés luminescentes des complexes de lanthanides sont testés pour les technologies 
de conversion de lumière telles que les lasers, les diodes émettrices de lumière ou encore les écrans 
à plasma. Ces composés ont des bandes d’émission bien définies et étroites, qui se ne superposent 
pas dans le domaine visible du spectre électromagnétique et dans le proche infrarouge. Durant la 
dernière décennie, la spécificité de leurs propriétés spectroscopiques ont été utilisées dans le 
domaine de l'imagerie médicale. En particulier, des complexes de néodyme et de l'ytterbium, 
montrant une bande d'émission forte à environ 1000 nm, possèdent un intérêt pour le diagnostic 
médical optique. En raison de leur spectre en proche infrarouge, ils émettent dans la "fenêtre 
biologique" pour des études spectroscopiques, non perturbées par la fluorescence provenant de 
fluides biologiques et de l'hémoglobine. En outre, les photons dans le proche infrarouge ne montrent 
pas de photo-blanchiment. Ils peuvent être excités sélectivement en appliquant des longueurs 
d'onde caractéristiques et leur dispersion dans les tissus biologiques est bien moindre que les 
photons de la lumière visible. Ils peuvent traverser les tissus sur plusieurs centimètres sans les 
endommager. Toutes ces caractéristiques rendent prometteuse l'utilisation des complexes de 
néodyme et d'ytterbium comme sondes biologiques et notamment la possibilité de développer des 
sondes non-invasives pour la détection tumorale par imagerie proche infrarouge. Les cations 
lanthanides ont toutefois un inconvénient, leur excitation directe est presque impossible (les 
coefficients d'absorption sont dans la plage 1-10 M-1 cm-1) et ils exigent l'application d'un système 
d'excitation (système sensibilisateur) permettant l'absorption d'énergie sous forme de photons via 
une série de transitions intra- et inter-système jusqu'à l'état excité des lanthanides. S'en suit une 
émission de photons dans le proche infrarouge. Ce système sensibilisateur, également appelé 
"antenne", peut être une molécule organique, un nanocrystal, la structure métallo-organique ou de 
dendrimère. 
Le but de ce chapitre est de fournir des systèmes sensibilisateurs fabriqués à partir de 
composés organiques, et de décrire la synthèse de sensibilisateurs originaux basés sur un noyau 
pyrazinique et un dérivé de cyclène comme ligand chélateur de cations lanthanides. Ce chapitre est 
divisé en deux parties; la partie bibliographique décrit le thème du travail, avec un accent particulier 
sur les systèmes d'antennes organiques; la partie expérimentale décrit la préparation de chaque 
composé, une discussion sur les résultats obtenus, les études spectroscopiques et un résumé. Une 
courte section décrivant la préparation et les études spectroscopiques du groupe chromophore 
azoïque, a été incluse à la fin des travaux. 
La partie bibliographique comprend une introduction dédiée à l'activité de molécules 
luminescentes à l'aide du diagramme de Jablonski et du phénomène de sensibilisation. Il contient un 
aperçu de la littérature scientifique contemporaine liée aux systèmes sensibilisateurs organiques et 
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décrit des exemples d'utilisation des lanthanides comme sonde moléculaire dans le proche 
infrarouge.  
La partie principale de ce chapitre contient une description détaillée des voies de synthèse 
conduisant à des sensibilisateurs originaux pour les systèmes de lanthanides. Ces études ont été 
inspirées par des résultats encourageants de propriétés de fluorescence obtenus en série 
pyraziniques et conduits au sein dans notre laboratoire. Le concept proposé est constitué d’un 
sensibilisateur de nature pyrazinique relié par un bras espaceur à une molécule du cyclène, qui forme 
un complexe thermodynamiquement et cinétiquement stable avec des cations lanthanides (Schéma 
6). 
 
Schéma 6 
Basé sur des études préliminaires effectuées sur le motif dihydropyrazinique, il a été constaté 
que le système est adapté pour l'introduction de nombreuses modifications et groupes fonctionnels, 
permettant l’ancrage du cyclène. Nous avons proposé deux voies distinctes de synthèse de ces 
composés cibles: 
 Par cycloaddition de Diels-Alder en faisant réagir une large gamme de différents diénophiles, 
 Par fonctionnalisation du composé de départ en conditions anioniques avec une variété 
d'électrophiles et en appliquant des transformations classiques. 
Dans les deux cas, l'étape finale dans la construction de ces systèmes d'antennes est la 
réaction de coupure du groupe protecteur suivi d'une aromatisation, conduisant à la base pyrazine 
prévue. 
Concernant l’approche via la cycloaddition de Diels Alder, plusieurs études ont été réalisées 
afin de choisir le meilleur diénophile, la N-méthylmaléimide. Après déprotection des atomes d’azote 
suivie d’une étape d’aromatisation, nous avons envisagé introduire le bras espaceur suivant une 
réaction de trans imidification, malheureusement sans succès. Des travaux sur ce sujet sont 
actuellement en cours dans le laboratoire.  
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Schéma 7 
Parallèlement, la fonctionnalisation du noyau dihydropyrazinique a été réalisée soit via une 
réaction de couplage de type Sonogashira, selon une réaction d’olefination de Wittig-Horner-
Emmons, et selon une réaction d’amination réductrice par fixation d’un atome d'iode ou d'un groupe 
aldéhyde. Les méthodes proposées offrent l’accès à plusieurs dérivés, la voie la plus efficace étant 
décrite dans le Schéma 8. 
Schéma 8 
Les sensibilisateurs originaux résultant de la complexation de cations de l'ytterbium, du 
neodymum et du gadolinium ont été obtenus et leurs propriétés spectroscopiques ont été étudiées. 
Les spectres d'absorption et d'émission dans le domaine visible et du proche infrarouge ont été 
enregistrés pour ces composés. Nous avons mesuré le rendement quantique de l'émission des 
lanthanides et le temps de vie de fluorescence pour estimer la capacité de ces systèmes d'antenne 
originaux. Ces études ont été menées au Centre de Biophysique Moléculaire à Orléans sous la 
responsabilité du Dr. S. Petoud et Dr. S. Villette. Les résultats montrent que le système sensibilisateur 
est efficace, fiable, et qu'il permet parallèlement plusieurs tests de cations lanthanides. 
Le dernier sous-paragraphe de ce chapitre est consacré à la préparation de nouveaux 
chromophores basés sur des systèmes azoïques. Les composés azoïques sont caractérisés par une 
absorption dans le domaine visible du spectre électromagnétique. Ils ont une couleur intense, si bien 
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que ces produits chimiques sont utilisés dans les colorants et les indicateurs chimiques. Compte tenu 
de leurs propriétés spectroscopiques, ces composés peuvent être utilisés comme sensibilisateurs, 
soit seuls soit ancrés sur un système pyrazinique permettant l'amélioration de leur capacité de 
sensibilisation. 
 
Schéma 9 
Une série de composés azoïques a été obtenue par réaction de diazotation et de couplage 
diazoïque sur des dérivés de l'aniline. Ces produits ont été fonctionnalisés par réaction avec le 
bromure de bromoacétyle pour fixer le cyclène. La deprotection des groupements protecteurs du 
cyclène suivie par la complexation avec des cations de lanthanides, ont permis d'obtention de 
différents composés. Une étape supplémentaire a été réalisée en collaboration avec l’équipe d’Agnès 
Delmas et de Vincent Aucagne au CBM d’Orléans en accrochant une biomolécule à haute affinité 
pour les cellules cancéreuses, la cyclopeptide RGD (Schéma 10). 
Schéma 10 
Des études préliminaires montrent une grande utilité de ces systèmes en tant que sondes 
moléculaires dans le proche infrarouge. Ils présentent un large éventail de longueurs d'onde 
d'excitation (jusqu'à 500 nm), ce qui donne une bande d'émission intense de complexes de 
lanthanides. Les temps de vie de fluorescence des composés testés sont dans la gamme de quelques 
nanosecondes à quelques microsecondes, ce qui les place au sein des sensibilisateurs efficaces. 
 
A la vue des résultats présentés dans cette thèse, nous pouvons affirmer que les objectifs 
ambitieux de départ ont été atteints. Nous avons proposé des stratégies des synthèses pour l'accès à 
de nouveaux groupes de systèmes sensibilisateurs pour les complexes de lanthanides. Les études 
préliminaires spectroscopiques montrent l'aptitude des dérivés pyraziniques à transférer d'énergie 
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au système de chélation de métal. En outre, la possibilité d'apporter des modifications à n'importe 
quel stade de la synthèse et la flexibilité de fonctionnalisation est un atout majeur pour cette 
recherche. Les perspectives de ce projet sont de relier les différents systèmes de sensibilisateurs et 
avec des biomolécules afin de détecter spécifiquement les cellules et les tissus cancéreux et de 
développer des marqueurs moléculaires dans le proche infrarouge. En outre, il est prévu pour 
connecter plusieurs dérivés cyclène sur un sensibilisateur, ce qui permettrait de distinguer la réponse 
spectrale ou d'améliorer le signal enregistré. 
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Monika 
Synthèse, étude structurale et évaluation de sensibilisateurs pyraziniques de 
lanthanides émettant dans le proche infrarouge et de nouvelles phosphines
Résumé :  
En raison de l’omniprésence des hétérocycles azotés et de leurs propriétés biologiques, une 
attention particulière est accordée au développement de méthodologie pour leur synthèse et leur 
fonctionnalisation. L’étude de la fonctionnalisation d’énamides cons
car ces motifs s’avèrent être des outils synthétiques polyvalents permettant d’accéder à des dérivés 
hétérocycliques complexes. Les réactions de couplage Pd
choix rapide et efficace pour la synthèse d'énamides
de lactames, d’imides ou d’amides. 
Le premier chapitre de ce travail porte sur le couplage organopalladié C
boranes secondaires chirales ou achirales avec des phosphat
réalisé dans des conditions douces, conduit aux 
offre de nombreuses possibilités pour la constitution d’une librairie de phosphines originales. 
Parallèlement à ce travail, l’addition nucléophile d’anion
acycliques conduit à des acides alpha
quaternaire en alpha de l’azote.  
Le deuxième chapitre de la thèse porte sur la préparation e
organiques originaux basés sur un
propriétés de fluorescence. Ces composés sont conçus pour former des nouveaux systèmes 
sensibilisateurs de cations de lanthan
l'imagerie moléculaire dans le proche infrarouge.
 
Mots clés : Enamides, phosphate d’énol, couplage C
boranes, acides alpha-aminés béta
proche infrarouge. 
Synthesis, structural investigations and evaluation of pyrazine sensitizers for 
lanthanides emitting in near
Summary:  
On account of the ubiquity of 
attention is paid to developing methodologies of their synthesis and functionalization. For this purpose, 
the study of functionalization of enamides constitutes an important topic due to the 
motifs in the construction of complex heterocyclic derivatives. Palladium
coupling are rapid and efficient methods of choice for synthesis of enamides particularly starting from 
enol phosphates derived from lac
The first chapter of the thesis evokes the original C
secondary phosphine boranes with different enol phosphates in mild reaction conditions, leading to 
corresponding enamido-phosphine boran
novels phosphines. Also, the reaction of nucleophilic addition of phosphide anions onto various 
enecarbamates acyclic was elaborated, giving an access to original beta
acids, bearing the quaternary carbon on alpha position to nitrogen.
The second chapter is devoted to the preparation and characterization of organic chromophores 
based on the pyrazinic core, which are likely to exhibit the fluorescence properties. These compou
were designed to form new sensitizing systems for lanthanide cations and could be used as organic 
sensitizers for molecular imaging in near infrared.
 
Keywords: Enamides, vinyl phosphate, C
boranes, beta-phosphino alpha
infrared 
 
 
301
CIEŚLIKIEWICZ-BOUET 
 
titue une thématique importante 
-catalysées constitue
, notamment à partir de phosphates d'énol
 
es d’énols. Ce couplage C
énamido-phosphines boranes correspondantes et 
s phosphures sur divers ène
-aminés béta-phosphorés originaux, porteurs d’un carbone 
t la caractérisation de chromophores 
 noyau pyrazinique et qui sont susceptibles de présenter des 
ides, et être utilisés comme sensibilisateurs organiques pour 
 
-P pallado-catalysé, ènamido
-phosphorés, complexes de lanthanides, antenne hétérocyclique, 
-infrared and novel phosphine derivatives
nitrogen heterocycles and their biological properties, the great 
-catalyzed reactions of cross
tams, imides or amides. 
-P coupling reaction of chiral and achiral 
es. This methodology permits the construction of libraries of 
-phosphino alpha
 
 
-P palladium catalyzed cross-coupling, 
-amino acids, lanthanide complexes, heterocyclic 
Institut de Chimie Organique et Analytique, 
UMR 7311, Rue de Chartres, 
45067 Orléans cedex 2 
 
nt une méthode de 
s issus 
-P de phosphines 
-P original, 
-carbamates 
-phosphines 
 
utility of these 
-
-amino 
nds 
enamido-phosphine 
antenna, near 
 
